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Abstract 
The colicin and lectin-like bacteriocins are a broad class of antimicrobial proteins 
produced by Gram-negative bacteria. They are generally narrow spectrum, killing or 
inhibiting the growth of closely related bacteria. Numerous Gram-negative bacteria that 
are important pathogens of both animals and plants produce and are susceptible to these 
bacteriocins. As such, these proteins represent an attractive alternative to traditional 
small molecule antibiotics for controlling bacterial infection. 
 
Very little is known about bacteriocins produced by Gram-negative plant pathogens and 
so the aim of this work was to discover novel bacteriocins active against globally 
important plant pathogens from the genera Pectobacterium and Pseudomonas. The 
bacteriocins discovered in this study were then structurally and functionally characterised 
and assessed for their ability to impart disease resistance when expressed in a model 
transgenic system.  
 
This study presents the discovery and characterisation of the bacteriocins syringacin M, 
syringacin L1 and pyocin L1 from the genus Pseudomonas, As well as the discovery and 
characterisation of the unusual ferredoxin containing pectocins from the genus 
Pectobacterium. Also presented is the discovery of a novel virulence related 
ferredoxin/iron-uptake system in Pectobacterium, which is parasitised by the pectocins 
for cell entry. Additionally, the transgenic expression of the bacteriocin putidacin L1 in 
both Arabidopsis thaliana and Nicotiana benthamiana was shown to provide these plants 
with resistance to infection by strains of the plant pathogen P. syringae.  
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1 Introduction 
  
2 
 
1.1 Aim of this study 
The broad objective that formed the basis of this study was to investigate the potential of 
colicin- and lectin-like bacteriocins, highly potent, narrow spectrum protein antibiotics, as 
a tool for combating bacterial disease in plants. 
 
Bacteriocins are widely produced by Gram-negative bacteria for intra-species competition 
and have potential for the treatment of bacterial disease of both plants and animals. 
Despite this potential, very little research has been performed on the structure and 
mechanisms of bacteriocins produced by (and thus active against) plant pathogens or 
their potential application to disease prevention in crops.     
 
As such, the aims of this study were to: 
1. Identify novel bacteriocins produced by the plant pathogenic bacteria, 
Pseudomonas syringae and Pectobacterium spp.  
2. To characterise these bacteriocins, providing information about their structure, 
mechanism of action and host range 
3. To express suitable proteins identified in aims 1 and 2, in the model plants 
Nicotiana benthamiana and Arabidopsis thaliana to provide a preliminary 
indication of the ability of bacteriocin expressing transgenic plants to resist 
bacterial infection 
 
1.2 Plant disease and bacterial phytopathogens 
Feeding a rapidly growing world population is one of this century’s key scientific 
challenges. Currently humanity relies on just fourteen crop plants to provide more than 
90% of its basic nutritional requirements. This number is further reduced when it is 
considered that the big four; rice, wheat, maize and potato constitute the vast majority of 
this 90% (19). Modern crop plants are grown over wide areas, distant from their 
geographic origins and have been bred to near genetic homogeneity through the 
selection of individuals producing the greatest yield (20). The results of this genetic 
homogeneity and the large scale monocultures of modern agriculture make plant crops 
prone to disease, often with devastating consequences (21). Additionally, the 
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vulnerability of crop plants to disease in some regions is likely to be exacerbated by 
climate change, creating a further challenge to food security (22).  Bacteria are 
responsible for a significant proportion of the > £100 billion per annum lost worldwide to 
disease and spoilage of crops caused by plant pathogens (19). Gram-negative bacterial 
pathogens account for much of these losses and cause disease in all of the major plant-
crops (23). Significant Gram-negative plant pathogens include:  
 Enterobacterial soft-rot pathogens of the genus Pectobacterium and Dickeya 
which cause significant damage to potato and other field vegetables across 
Europe and worldwide, with losses as high as 25 % reported for some potato 
cultivars (24). 
 Xanthomonas oryzae pv. oryzae the causal agent of bacterial blight and bacterial 
leaf spot in rice constrains the growth of this crop over much of Africa and Asia, 
with losses as high as 75% reported (25). Xanthomonas species also cause diseases 
with analogous symptoms in maize, sugar cane and plantain (26,27). 
 P. syringae which causes serious disease in a number of major plant crops, with 
major recent outbreaks in New Zealand threatening the kiwifruit industry and in 
the UK threatening the horse chestnut. (28,29)  
1.3 Phytopathogenic bacteria targeted in this work 
The phytopathogenic bacterial species Pseudomonas syringe, Pectobacterium 
atrosepticum and Pectobacterium carotovorum were selected as the target organisms for 
this study as they represent globally distributed, economically significant pathogens of 
multiple agricultural crops that are known to produce bacteriocins (30,31). Because of 
their importance they have been the focus of relatively intensive study, with a 
considerable number of annotated genome sequences available in public databases. 
These genome sequences allow rapid identification of putative bacteriocin genes and 
operons, based on homology to previously characterized bacteriocins from other Gram-
negative bacteria. In order to determine how bacteriocins can best be applied to combat 
infection by these pathogens, it is important to understand the bacteria’s physiology and 
pathogenic mechanisms, and as such these are discussed briefly below.  
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1.3.1 Pseudomonas syringae 
The phytopathogen P. syringae is a Gram-negative, rod-shaped, obligate aerobe, 
belonging to the γ subclass of the Proteobacteria. The first P. syringae strain was isolated 
from diseased lilac (lilac genus name = Syringa) in 1899, hence the species name (32). 
Historically, P. syringae had been divided into pathovars based on the host plant from 
which it was isolated, as well as the disease symptoms it causes. This classification 
scheme has led to the designation of approximately 57 pathovars (33). 
Although it is still in use, the use of pathovars to classify P. syringae has been shown to be 
inconsistent with contemporary genetic and biochemical studies, which have found a 
pattern of relatedness different to pathovar classification  (34,35). Phylogenetic analysis 
based on multilocus sequence typing shows that P. syringae can be broadly divided into 4 
groups, with strains assigned to the same pathovar frequently distributed among 
different phylogenetic groups  (36). Consequently, predictions of relatedness based on 
pathovar designation are unreliable, and there is significant contention in the literature 
about the best method for classification of members of this diverse species (34). 
As indicated by the wide range of pathovars classified, P. syringae causes disease in a 
wide range of economically important plant species, including ‘bacterial speck’ on 
tomato, ‘leaf spot’ of soy bean, and trunk cankers and ‘blast’ diseases on woody tree 
fruits and olive (37). Individual pathogenic strains are generally specialized and are 
pathogenic only to a single or small number of plant species (32).  P. syringae has a hemi-
biotrophic mode of infection, causing disease in the leaves of the host plant by invading 
the apoplast of the leaf through the stomata. Once it has invaded the leaf it multiples 
intercellularly without invading the host plant cells. In this intercellular phase it subverts 
host defences by injecting numerous effectors into the host cells, via the type III secretion 
system (38). This most aggressive phase of intercellular growth occurs in the absence of 
cell death. However, in the later stages of disease, as the plant succumbs to infection, 
infection is associated with extensive necrosis of infected tissues (38,39). P. syringae also 
infects the ligneous tissues of woody plants, leading to the formation of characteristic 
lesions or cankers (40). 
In addition to its pathogenic lifestyle, P. syringae is widely present in the environment 
and is a common isolate from the epidermis of plant leaves, where it can exist and grow 
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in a non-pathogenic state (32). It has also been suggested that P. syringae has an 
important role in global weather by stimulating cloud formation through the production 
of ice nucleation proteins (32).  
An illustration of the importance of P. syringae as a disease causing agent in global 
agriculture is the epidemic infection of kiwifruit by strains of P. syringae pv. actinidae. 
Serious outbreaks of infection of kiwifruit by this strain were first reported in Japan in the 
1980’s, and subsequently serious losses to kiwifruit production have been reported in 
continental Asia, Europe and New Zealand (41). A recent review of this disease suggested 
that losses of up to $410 million NZD (209 million GBP) are predicted over the next 5 
years (42). Antibiotics such as streptomycin, kanamycin or tetracycline and copper salts 
have been used extensively to treat P. syringae pv. actinidae, however they rarely 
succeed in eradicating infection and high levels of resistance to these compounds are 
now endemic in pathogen populations (29). The development of new control strategies 
are urgently required, both to decrease losses due to P. syringae, but also to provide an 
alternative to the use of valuable antibiotics required to treat human infection. 
 
 
 
Figure 1-1 Trunk lesions on Kiwifruit (Actinidia spp.) as a result of infection by 
Pseudomonas syringae pv.  actinidiae.  
(Source: http://www.infojardin.com/foro/showthread.php?p=6960593&posted=1) 
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1.3.2 Pectobacterium  
The genus Pectobacterium contains Gram-negative plant pathogens of the family 
Enterobacteriaceae that exhibit both broad and restricted host ranges. Members of this 
genus cause soft rot, stem rot, bacterial wilt, and black leg disease in angiosperm species 
representing over 35% of plant orders (including the economically important crop plants, 
potato, sugar beet, maize, pineapple and cabbage). The genus has been divided into four 
species (Pectobacterium atrosepticum, betavasculorum, carotovorum and wasabiae) 
based on multiple genetic and phenotypic factors.  However, these classifications are 
inconsistently applied and somewhat contentious (43,44). Generally, strains from 
carotovorum, wasabiae and carotovorum subsp. brasiliensis (discussed below) are all 
broad host range, with atrosepticum being restricted to potato and betavasculorum to 
sugar beet (45). A study by Ma et al (2007) using multilocus sequence analysis of a 
number of housekeeping genes of 36 members of these species found that species 
designations correlated cladistically for these genes, with the exception of recently 
identified P. carotovorum subsp. brasiliensis which formed a separate Clade (I) (45). Based 
on this evidence the authors suggested that the classification of brasiliensis warrants a 
separate species designation and is sometimes reported as such (46,47).  
Members of the genus Pectobacterium were previously assigned to the genus Erwinia and 
like Erwinia species more generally they are distinguished by the production of large 
quantities of pectin and cellulose degrading enzymes that enable them to macerate 
parenchymatous tissues of plants. This leads to a characteristic soft rot disease 
phenotype (Figure 1-2) (45). Geographically only P. carotovorum and P. atrosepticum 
have been reported in the same environments. P. carotovorum strains are found 
worldwide, while P. atrosepticum is generally found in cool climates (43). Ecologically and 
genetically much more information is available about P. carotovorum and atrosepticum 
than other species. P. atrosepticum is of specific interest to this study as it causes black 
leg and soft rot disease in the stems and tubers of potato during growth and storage and 
together with the closely related soft rot pathogen Dickeya dadantii, is the most 
damaging bacterial pathogen of potato in Europe (30). Recent estimates place losses as 
high as 22 % of total potato production due to these pathogens and associated diseases 
(48). 
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The main virulence mechanism of P. atrosepticum and D. dadantii in potato is the quorum 
sensing coordinated production of a prolific variety of plant cell wall degraded enzymes, 
which are secreted into the extracellular environment by the Type I and Type II secretion 
systems (49). In addition, the delivery of the cognate effector DspA/E and helper/hairpin 
proteins (HrpN/HrpW) by the Type III secretion system have been shown to be required 
for full virulence (50). In potato, P. atrosepticum and D. dadantii cause black leg in plants 
in the field and soft rot of tubers post-harvest. They are also known to live 
asymptomatically as epiphytes or saprophytes in the soil or groundwater, making their 
control difficult (51). During the early stages of infection, plants begin to yellow and wilt 
in the absence of environmental stress (i.e. water shortage). Blackleg lesions then can 
develop de novo in the stem well above ground level; however in the vast majority of 
cases lesions start at the base of the stem at the point of contact with an already infected 
and decaying mother tuber. Soft rot Pectobacterium spp. are primarily vascular 
pathogens when inoculated directly into stems and progressive decay of stem tissue 
follows movement of the bacteria through the vascular system. In tubers, rotting initially 
starts in small pockets, generally under wet anaerobic conditions and rapidly consumes 
the tuber (52).   
Current strategies for the control of these and other pathogens are limited to the 
application of copper compounds and high levels of sanitation during handling of food 
tuber and seed stock. Copper compounds can be effective in preventing infection but are 
ineffective once infection is established (53). Prevention and control of Pectobacterium 
and Dickeya infection remains challenging due to their wide environmental distribution 
and latent infection of tubers, weeds and rotation crops (53). The development of 
alternative strategies, are required for the control of this significant agricultural pathogen 
(54,55).  
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Figure 1-2 Cut potato tuber inoculated with P. carotovorum LMG2410 and incubated at 30˚C degrees for 
72 hours,  
Over 70% of the tuber was macerated at this point. 
 
1.4 Bacteriocins: structure function and mechanism of action 
1.4.1 Overview 
Life is a competitive business. Not least for bacteria who being single celled and tiny have 
limited capacity as individuals to modify their environment. Energy and nutrients required 
for growth and the environments in which they are found are limited, and as such 
competition between microbes occupying the same environmental niche is fierce. This 
competition results in a dynamic struggle for survival. This struggle provides the impetus 
for the evolution of systems that prevent the growth of competitor organisms directly by 
interfering with their cellular machinery or structure in a way which inhibits metabolism 
and growth, and/or leads to lysis and cell death. This struggle is as old as life itself, and 
the results of more than 3.8 billion years of evolution (56) are seen in the considerable 
9 
 
variety of anti-microbial compounds that have been discovered and the certain existence 
of a wealth of systems and compounds still to be discovered and characterized (57). 
These compounds range from small molecule antibiotics, such as those currently used in 
clinical practice, to antimicrobial peptides and proteins, through to large multi protein 
complexes which appear to result from the genetic debris of phage infection (58). 
Bacteriocins are loosely defined as: biologically active proteins or peptides with a 
bactericidal or bacteriostatic mode of action (59). This definition is applied across the 
literature to describe a variety of compounds from small peptide anti-microbials to the 
large phage tail complexes such as the R and F-type pyocins (58,60). Bacteriocins are 
generally produced during times of nutrient and environmental stress as weapons to kill 
close competitors, increasing the proportion of available resources and thus the chances 
of survival for the bacterial population producing them (57). 
Colicin- and lectin-like bacteriocins which form the focus of this study represent a 
subclass of bacteriocins, consisting of proteins between 25-80 kDa with a modular 
domain structure and a variety of cytotoxic mechanisms, including nucleic acid  
degradation, inner-membrane pore formation or interference with peptidoglycan 
synthesis (59). This class of bacteriocin is typified by the intensively studied colicins of 
Escherichia coli and the S-type pyocins of Pseudomonas aeruginosa. The colicins of E. coli 
are the most extensively studied group of these proteins, with a domain structure 
generally consisting of an N-terminal translocation domain, which facilitates transport of 
the protein into the target cells, followed by a receptor binding domain which interacts 
with receptors on the surface the target cell, forming the initial contact between the 
bacteriocin and its target. The C-terminal domain of these proteins contains a functional 
domain with killing activity and for nuclease colicins, the region to which an associated 
immunity protein binds (4). The killing activity of this domain varies between colicins 
displaying; membrane pore forming activity, endonuclease activity (DNase, tRNase, and 
rRNase) or a phosphatase directed against lipid II which abolishes peptidoglycan synthesis 
(61).  
The pyocins of P. aeruginosa are evolutionarily related to colicins, share a modular 
domain structure and have C-terminal cytotoxic domains homologous in structure and 
function. However, while pyocins share a similar modular structure and are composed of 
structurally analogous domains the order of the domains is different to that of the 
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colicins.  In addition, colicins are often encoded on ‘colicinogenic’ plasmids, whereas the 
pyocins discovered to date are chromosomally encoded (62). 
Putative bacteriocins with a similar structure to the colicins and pyocins have been 
identified in  numerous other members of the γ-proteobacterial family including; 
Pseudomonas fluorescens, Pseudomonas putida, P. syringae, Klebsiella pneumonia, 
Yersinia pestis, Photorhabdus luminescens, P. atrosepticum and P. carotovorum (11,58).  
Information available about the various structural and functional features of this class of 
bacteriocin are reviewed below, primarily using data available for colicins as they 
constitute the best characterised examples. A schematic showing the size and domain 
structure of representative colicins and pyocins is provided in Figure 1-3 and Figure 1-4. 
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Figure 1-3 Colicins with different cytotoxic mechanisms share a common modular domain structure, and 
conserved structural features  
Analysis of the domain structure of notable colicin shows conserved domains and features shared 
between bacteriocins. Nuclease colicins (see colicin E2) have a tightly associated immunity protein that 
binds to and inactivates the nuclease domain, while pore forming colicins (colicin B and N) and colicin M 
have immunity proteins which protect the cell without strong interactions with the bacteriocin. As 
illustrated by E2, B and N, various colicins combine different cytotoxic or cell entry associated modules to 
create active toxins. IUTD = Inherently unstructured translocation domain (6) 
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Figure 1-4 Pyocin domain structure mirrors that found in the colicins 
Nuclease pyocins (see colicin AP41) possess structurally analogous nuclease domains to colicins. They 
also possess structurally analogous receptor binding and translocation domains; however the order of 
these domains appears to be reversed. Structural analysis of M-class bacteriocins from Pseudomonas 
spp. (see pyocin M) shows that they share structurally homology throughout the entire length of the 
protein, despite no detectable sequence identity in the receptor binding and translocation domains 
(1,2). Homologues of the recently identified lectin-like bacteriocins (see putidacin L1) are 
unrepresented in the colicins, they have unique tandem MMBL β-prism domains (11) 
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Figure 1-5 Colicins are constituted by distinct combinations of structurally related cell entry and 
cytotoxicity domains 
A stereo view of the structural alignment of the colicins N, B and E3 illustrates the modular structure of 
colicins. Colicins N and B both share a structurally homologous pore forming cytotoxic domain, but 
unrelated receptor binding and translocation domain.  Colicin B and E3 share a large globular domain 
implicated in colicin translocation, despite unrelated pore forming and RNA degrading cytotoxic domains 
(18,63,64). 
 
1.4.2 Colicin-like bacteriocin domain structure and evolution 
The highly modular domain structure of colicin-like bacteriocins, with distinct functional 
domains for: binding to the cell surface, translocation across the outer-envelope and cell 
killing, allow for the generation of new bacteriocin specificities through genetic 
recombination (65). As discussed in detail below, different receptor binding domains bind 
to specific receptors on the surface of the bacterial cell, with translocation domains 
targeting either the Ton or Tol machinery, inner-membrane complexes with related but 
distinct function, for cell entry (4,66). Susceptible bacterial cells can escape killing by a 
specific bacteriocin through mutation in the cell surface receptor or translocation 
machinery, or by acquiring the gene encoding the corresponding immunity protein for a 
bacteriocin. Genetic recombination creating new combinations of receptor binding, 
translocation and cytotoxic domains provides a means circumventing this immunity (57). 
As a result, the vast majority of colicin-like bacteriocins identified consist of mosaics of 
structurally and evolutionarily related domains (Figure 1-5). Analysis of the genetic 
context of colicin-like bacteriocins shows them to be hot spots of genetic recombination, 
confirming it as a major force in the evolution of these proteins (65).  
 
1.4.3 Genetic structure and regulation 
In E. coli, the majority of colicins that have been characterised are produced by strains 
containing a ‘colicinogenic’ plasmid. They are found on two types of plasmids, type I 
plasmids are small (6-10 kb) in size, having around 20 copies per cell and are mobilisable. 
Type II plasmids are large (40 kb) monocopy plasmids which are conjugative (4). 
For nuclease type colicins the first gene is the colicin gene, followed by the immunity 
protein gene directly downstream. Transcription of the immunity protein gene is under 
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the control to two promoters: an SOS induced promoter and a constitutive promoter. The 
constitutive promoter provides a constant low level expression to ensure immunity to 
incoming colicin molecules (67). Often colicinogenic plasmids also contain additional 
genes encoding immunity proteins with different colicin specificities. These genes are 
constitutively expressed and provide additional protection to the plasmid harbouring 
strain. The last gene encodes a lysis protein, the production of which causes cell lysis and 
allows release of the colicin from the cell (68). Colicin production is induced by DNA 
damage, and as such it is generally induced in the laboratory by physical DNA damaging 
agents like UV or mitomycin C. Transcription of colicin operons is strongly repressed by 
LexA, with the LexA binding site (SOS box) located immediately upstream of the Pribnow 
box. In the SOS response RecA becomes activated and cleaves LexA, activating 
transcription of the colicin operon and other genes of the SOS regulon (4). 
In contrast to the plasmid encoded colicins, all pyocins identified thus far are 
chromosomally encoded, consisting of a pyocin gene followed by one or more immunity 
protein genes (11). No pyocin associated lysis protein encoding genes have been 
identified and the mechanism through which pyocins are secreted from the producing cell 
remains to be discovered. Pyocins are also inducible in response to DNA damage. Despite 
this regulation pyocins have no upstream SOS box, but instead an upstream consensus 
sequence named a ‘P box’ has been identified which is bound by the activator protein 
PrtN. Under normal conditions the PrtN protein is transcriptionally repressed by a partner 
protein PrtR. When DNA damage activates RecA, it cleaves PrtR, enabling transcription of 
prtN with its product PrtN then activating pyocin transcription (69).  
 As with the pyocins, all bacteriocins identified in P. syringae, P. atrosepticum and P. 
carotovorum are chromosomally encoded, often in conjunction with a downstream 
immunity protein. Production of a number of bacteriocins in Pectobacterium sp. has been 
shown to be induced by UV and mitomycin C (70). However detailed information on the 
mechanisms of the regulation of bacteriocin production has not been elucidated for these 
species. 
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1.4.4 Cytotoxic mechanisms of colicin-like bacteriocins 
Colicin-like bacteriocins target cells using a variety of cytotoxic mechanisms. The most 
prevalent of which are pore formation and the degradation of nucleic acids. However, 
other modes of action including degradation of peptidoglycan or inhibition of 
peptidoglycan synthesis have been reported (4). The mechanism through which the 
recently described lectin-like bacteriocins kill cells remains to be discovered (15). 
 
1.4.4.1 Nuclease type bacteriocins 
The cytotoxic domain of the nuclease type bacteriocins degrades target cell nucleic acids 
leading to cell death. A number of colicins and pyocins with nuclease domains have been 
experimentally characterised degrading either DNA, tRNA or rRNA (71).  Almost all DNA 
degrading pyocins and colicins described at the time of writing (colicins E2, E7, E8 and E9 
and pyocins S1, S2 and AP41) belongs to the H-N-H nuclease super family (4). The 
exception to this is pyocin S3, which has a DNA degrading catalytic domain with no 
obvious homology to studied proteins.  Structurally these enzymes consist of a central 
three-stranded antiparallel-sheet surrounded by helices. The DNA degrading H-N-H motif 
of the enzyme is approximately 34 AA in length, and contains 4 conserved histidine 
residues. Three of these residues are involved in coordinating a catalytic metal ion (Figure 
1-6-A), with the fourth most N-terminal histidine acting as a general base in the DNA 
cleavage reaction (71).  The H-N-H motif is a versatile DNA binding domain, which has 
been identified in over 500 enzymes of divergent function, including mobile intron 
homing, DNA repair, mammalian apoptosis and DNA restriction. The H-N-H site 
architecture is related to a superfamily of nucleases distributed across all kingdoms of life 
(72). H-N-H DNase colicins non-specifically nick DNA, with multiple nicking events 
cumulating in double stranded breaking of the DNA (4). Coordination of a metal ion in the 
active site is essential for enzymatic activity with, Mg2+ being the likely physiological 
metal ion cofactor for DNA cleavage, although certain members of this family have been 
shown to be active with a variety of metal ion cofactors including Zn2+ and Ni2+  (Figure 
1-6-B) (71,73).  The nuclease domains of the colicins (E2, E7, E8 and E9) share 65% 
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approximately AA identity, with pyocin (S1, S2 and AP41) and colicin domains sharing 
approximately 50% identity (11).  
In order to prevent cell suicide upon bacteriocin production, H-N-H bacteriocins (and 
nuclease bacteriocins more generally) are co-transcribed with an immunity protein. This 
protein, which also serves to protect the cell against incoming nuclease domains, binds 
with extremely high affinity to the nuclease domain and inactivates it. The immunity 
protein for H-N-H bacteriocins binds adjacent to the active site of the nuclease domain, 
inactivating it through steric hindrance of the substrate, rather than directly blocking the 
active site (Figure 1-6-A) (74).  This exosite binding has the consequence of allowing 
divergent selection to occur at the immunity protein nuclease domain interface while 
retaining catalytically important residues, facilitating the generation of new 
bacteriocin/immunity protein pairs. This has led to rapid diversification of DNase 
bacteriocin immunity protein specificities, and provides a possible explanation for the 
identification of a larger number of DNase type colicin-immunity protein complexes (57).  
As a result of this most of the amino acid variation in the DNase domains occurs at the 
immunity protein binding interface (3). The C-terminal domains of non-DNAase, nuclease 
colicin-like bacteriocins elicit cell death through the inhibition of protein synthesis by 
cleaving specific phosphodiester bonds of RNA. These enzymes do not require metal ion 
cofactors and can be separated into two groups based on activity, those that cleave the 
16S rRNA subunit (colicins E3, E4 and E6 and pyocin S6) and those that cleave the 
anticodon loop of specific tRNAs (colicins E5 and D and pyocin S4) (4,71).  
Colicins E3, E4 and E6 all share significant homology over the length of their C-terminal 
domains, which suggests a common evolutionary origin.  They specifically attack 
the 30S ribosomal subunit of the target cells, cleaving 16S rRNA towards the 3’ end 
between nucleotides A1493 and G1494 (75). 
Although the tRNAse colicins E5 and D (pyocin S4 is homologous to colicin E5) both have 
very similar cytoplasmic targets (E5 targets tRNAs carrying Tyr, His, Asn and Asp, D targets 
4 different tRNAs for Arg), sequence and structural comparisons suggest that the C-
terminal domains of these proteins have acquired similar functions through convergent 
evolution (76). Crystal structures of the catalytic domains of these proteins show 
recognizable RNA binding domains which lack structural similarity, suggesting a distinct 
evolutionary ancestry (4). 
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In order to prevent cell suicide the immunity proteins for RNase type bacteriocins are also 
co-transcribed with the bacteriocin.  As is the case for the H-N-H bacteriocins, rRNase 
immunity proteins inactivate the toxin domain by binding adjacent to the active site (77). 
Alternatively, the immunity proteins for the structurally unrelated tRNase colicins E5 and 
D bind directly to the active site, through substrate mimicry. This more classic mode of 
enzyme inhibition is similar to the inhibition mechanisms of other RNase inhibitors, such 
as the barstar the inhibition of barnase (78).  
Nuclease colicins are released from cells as a heterodimer, complexed with an immunity 
protein. As affinity between the immunity protein and cognate bacteriocin is very high 
(the Kd for colicin E9+Im E9 is 10
-16 M) and removal of the immunity protein is required to 
activate the toxin, a significant energy input and/or partial unfolding of the complex is 
required for separation and activation of the nuclease (79). Current evidence suggests the 
this energy for dissociation is provided during translocation of the bacteriocin into the 
target cell (74).     
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Figure 1-6 The structure of the colicin H-N-H nuclease domain.  
A) The crystal structure of colicin E2 in complex with its immunity protein. The immunity protein binds to 
nuclease domain adjacent to the active site, inactivating the domain by steric hindrance and electrostatic 
effects (3). B) A stereo representation of the crystal structure of the colicin E7 H-N-H DNase domain in 
complex with 12 bp of double stranded DNA, showing the extended DNA binding interface, with the DNA in 
close proximity to the divalent metal ion (in this case zinc) in the active site (17). 
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1.4.4.2 Lipid II-hydrolysing, M-class bacteriocins 
Colicin M the initial member of the M-class bacteriocins was first described and 
characterised in the 1970s (80). Subsequently, a number of homologues from other 
Gram-negative bacterial species, for example pyocin M (PaeM) from P. aeruginosa and 
fluoricin M from P. fluorescens have subsequently been identified (81,82).  The cytotoxic 
domain of M-class bacteriocins is a metal dependent phosphatase that elicits its lethal 
effect through hydrolysis of lipid II between its pyrophosphate and undecaprenyl moieties 
(83,84).  Lipid II resides in the inner membrane and functions in the transport of 
peptidoglycan subunits of the bacterial cell wall from their site of synthesis in the 
cytoplasm, to the periplasm where the cell wall is assembled (Figure 1-7) (85,86). 
Cleavage of lipid II by the M-class bacteriocins occurs at the periplasmic face of the inner 
membrane and prevents recycling of the carrier lipid. Ordinarily during cell wall synthesis 
the peptidoglycan subunit of lipid II is removed by the penicillin binding proteins (PBPs) 
and is incorporated into the cell wall, leaving undecaprenyl-pyrophosphate embedded in 
the inner membrane. Undecaprenyl-pyrophosphate is then modified to a 
monophosphate in the periplasm, before being transported to the cytoplasm where it is 
regenerated to lipid II (86). The lipid II cleavage reaction catalysed by M-class bacteriocin 
leads to the dephosphorylation of undecaprenyl moiety, decoupling the lipid II synthetic 
process, and ultimately to an arrest of cell wall synthesis and lysis of the cell (83,87).  In 
order to protect the producing cell from the lethal effects of the toxin, the colicin M 
operon encodes an immunity protein (Cmi), directly downstream of the gene for colicin M 
(88). Unlike the immunity proteins from nuclease bacteriocins a strong interaction 
between colicin M and its immunity protein has not been demonstrated. Cmi possesses a 
signal anchor transmembrane helix, which directs it to the periplasmic face of the inner 
membrane where it mitigates the effect of colicin M on the cell. While the crystal 
structure of Cmi has been determined, how it confers immunity to colicin M remains 
unknown (89,90). Recent work by Helbig et. al., showed that in addition to Cmi conferred 
immunity, the level of expression on the cytoplasmically localised flavin containing 
protein CbrA also modulates the sensitivity of E. coli to colicin M (91). Interestingly, 
pyocin M and other predicted M-class bacteriocins from Pseudomonas and Burkholderia 
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sp. are not associated with an immunity protein gene homologous to Cmi, suggesting 
diverse mechanisms of immunity for M-class bacteriocins. (1,82,92) 
 
 
Figure 1-7 2D-schematic of peptidoglycan precursor molecule lipid II from Gram-negative bacteria (93) 
 
1.4.4.3 The lysozyme-like pesticin cytotoxic domain 
Pesticin, a colicin-like bacteriocin produced by Yersinia pestis, the causal agent of the 
bubonic plague, possesses a cytotoxic domain which is structurally related to 
bacteriophage T4 lysozyme (94,95). Pesticin, like its phage lysozyme homologue, has been 
shown to degrade the peptidoglycan cell wall, leading to cell lysis due to the cells internal 
osmotic pressure. Interestingly, an engineered pesticin protein, in which the cytotoxic 
domain was replaced with either T4 or chicken egg white lysozyme was cytotoxic to cells 
which possessed the pesticin receptor FyuA (96). 
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1.4.4.4 Pore forming bacteriocins 
The cytotoxic domains of the pore forming bacteriocins are structurally homologous in all 
colicin-like bacteriocins studied to date and consists of a compact 9-helix bundle. Pore 
forming bacteriocins target cells by creating a pore in the cytoplasmic membrane, 
dissipating the proton gradient across this membrane and thus disabling the cell (97). 
Studies have shown that these toxins act with single molecule kinetics, indicating that 
multimerisation of the protein is not required to achieve this (97,98). The central helices 
of the pore forming domain are hydrophobic and this has led to the postulation of an 
umbrella model of pore formation, in which the initial insertion of the central helices into 
the inner membrane, is followed by rearrangement or ‘opening’ of the bundle to form the 
pore (99). Interestingly the crystal structures of colicins B, N and Ia show that pore 
forming domains exist conjugated to structurally diverse receptor binding and 
translocation domains to form active bacteriocins, with these bacteriocins ranging in size 
from colicin N at 387 AA to colicin IA at 624 AA (Figure 1-8). 
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1.4.5 Lectin-like bacteriocins  
The lectin-like bacteriocins are a recent and interesting addition to the bacteriocin family. 
Unlike the generally asymmetric domain structure of the colicin-like bacteriocins, they 
consist of two carbohydrate-binding domains of the monocot mannose-binding lectin 
(MMBL) family, and a C-terminal β-hairpin extension (100-104). Lectin-like bacteriocins 
from Pseudomonas spp. BW11M1 (putidacin L1 or LlpABW) P. syringae (LlpAPss642) and P. 
fluorescens (LlpA1Pf-5) have been characterised and have the unprecedented ability to kill 
strains from a broad range of bacterial species within the genus Pseudomonas, but are 
not active outside this genus (101,103,104). Similarly the lectin-like bacteriocins LlpAXcm761 
and LlpAAU1054 from Xanthomonas citri pv. malvacearum LMG 761  and Burkholderia 
cenocepacia AU1054, respectively, have the ability to kill various species within their 
respective genus (101,105). The molecular basis of this unusual genus specific activity has 
yet to be determined. Lectins are a structurally and evolutionarily diverse class of proteins 
produced widely by prokaryotes and eukaryotes and are defined by their ability to 
recognise and bind carbohydrates. This binding is specific and mediates a range of diverse 
functions, including cell-cell interaction, immune recognition and cytotoxicity (106,107). 
MMBLs represent a structurally conserved lectin subclass, of which the mannose-binding 
lectin Galanthus nivalis agglutinin (GNA) was the first to be characterised (108). The 
MMBL-fold consists of a three sided β-prism; each face of which contains a sugar binding 
motif with the conserved sequence QxDxNxVxY (5). While originally identified in 
monocots such as G. nivalis and Allium sativum, it is now recognised that proteins of this 
class are distributed widely throughout prokaryotes and eukaryotes, where they have 
Figure 1-8 Pore forming colicins utilise receptor binding and translocation domains of diverse structure 
to deliver a common cytotoxic domain to the periplasm.  
The crystal structures of pore forming colicins illustrate the structural diversity of colicin cell entry 
domains. Pore forming colicins S4 and N both belong to group A colicins that gain entry to the cell through 
interactions with TolA or TolB, however they possess receptor binding domains with different specificities. 
The colicin S4 receptor binding domain interacts with OmpW, whereas the colicin N receptor binding 
domain binds to cell surface LPS. Similarly, the B group pore formers Colicin B and colicin IA enter the cell 
through interactions with TonB, but bind to different TonB-dependent nutrient receptors on the cell 
surface. Colicin B binds FepA, while colicin IA binds Cir (7) (9,10) (12,13).       
 
24 
 
evolved to mediate diverse functions (108-111). Structural and biochemical analysis of 
MMBLs have shown that they are generally translated as a single polypeptide chain 
containing tandem β-prism domains that are then proteolytically processed into 
monomers. These domains often form homo- or hetero-dimers by strand exchange and 
-stacking (Figure 1-9-A)(112). Unusually, the lectin-like bacteriocins are not 
proteolytically processed and thus consist of a single peptide chain, containing tandem β-
prism domains (Figure 1-9-A/B). Sequence alignments of members of this class from 
Pseudomonas spp. show complete conservation of two QxDxNxVxY sugar binding motifs 
on the C-terminal domain and partial conservation of two sites on the N-terminal domain 
(100). Recent work by Ghequire et al (100) on the characterisation of putidacin L1 shows 
these motifs to be important for cytotoxicity. Mutagenesis of the first C-terminal motif 
has the most dramatic effect on activity, while mutagenesis of the second C-terminal and 
first N-terminal sugar binding motifs leads to a synergistic reduction in activity. This study 
also showed low-affinity binding between putidacin L1 and methyl-α-D-mannose or a 
range of mannose containing oligosaccharides. However, Kds for these protein-
carbohydrate complexes were reported in the range from 46 mM for methyl-α-D-
mannoside to 2 mM for a mannose containing pentasaccharide (100). An extensive 
search for high affinity carbohydrate binding through the use of glycan arrays failed to 
detect high affinity carbohydrate binding for this lectin-like bacteriocin (100). 
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Figure 1-9 The lectin-like bacteriocins share a common structure and evolutionary origin with 
plant MMBL lectins 
A) The crystal structure mannose binding lectin from A. sativum (Garlic), a protein of unknown 
physiological function present at high concentrations in garlic tubers (5), B) The crystal structure of 
putidacin L1 produced by Pseudomonas spp. BW11M1, with killing activity against other 
Pseudomonas spp.. Structurally the tandem β-prism domains with the π-stacking tryptophan motif 
are conserved, however putidacin L1 consists of a single peptide chain whereas plant like lectins are 
homo or heterodimers. Lectin-like bacteriocins also possess a C-terminal extension shown to be 
essential for activity of the protein (14-16).   
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1.4.6 Cell surface binding and entry by colicin and lectin-like bacteriocins 
In order to deliver the cytotoxic domain to its site of action in the target cell, colicin-like 
bacteriocins must first penetrate the Gram-negative cell envelope. To achieve this, these 
proteins possess additional domains, termed receptor binding and translocation domains, 
which deliver the cytotoxic domain to its site of action (6).  
As the name suggests, the receptor binding domain of colicin-like bacteriocins mediates a 
high affinity interaction between the bacteriocin and its outer membrane receptor. For 
most bacteriocins studied thus far this is a TonB-dependent nutrient receptor, however 
two bacteriocins (colicin N and pyocin L1; pyocin L1 discussed in chapter 6) have recently 
been shown to utilise lipopolysaccharide (LPS) as a cell surface receptor (12,15).  TonB-
dependent receptors have a physiological role in the uptake of valuable nutrient 
substrates (for example iron siderophores or cobalamin) too large to enter the cell by 
diffusion through outer membrane  pores (113). The specific receptor utilised varies 
between different groups of bacteriocins, with for example, the E colicins utilising BtuB, 
colicin IA utilising Cir, colicin M utilising FhuA and the S-type pyocins, S2, S3 and S4, which 
use receptors involved in uptake of the siderophore pyoverdine (Figure 1-10) (4,114). 
Despite the variety of receptors used, what is invariably true is that the interaction 
between the colicin-like bacteriocin and its receptor is highly specific, with disassociation 
constants of low µM to nM reported (6). Binding to its cell surface receptor serves to 
remove the bacteriocin from the three dimensional milieu, fixing it to the surface of the 
outer membrane (115). The bacteriocins then needs to enter the target cell, the 
mechanism by which colicins-like bacteriocins achieve this crossing or ‘translocation’  can 
be used to divide these proteins into different groups, based on the domains utilised and 
the interacting partners required to gain entry to the cell (66). Early genetic screens were 
able to broadly classify colicins into two groups, A and B based on their requirement for 
components of either Tol or Ton complexes (116). The Ton and Tol systems are 
evolutionarily related protein complexes, with divergent functions, that both play a 
physiological role in transducing stored energy from the proton gradient across the inner 
membrane to performed functions at the  outer membrane (117,118). While the exact 
function of the Tol system in unknown, it has been is shown to be recruited to the 
septation apparatus during cell division, where it plays a role in stabilizing the outer 
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membrane (113,119). More generally, mutants in genes encoding its components or its 
interacting partner Pal have been found to display defects in outer membrane 
permeability and stability (120).  The Ton complex provides the energy required for the 
import of iron containing siderophores and related substrates through TonB-dependent 
receptors. This occurs through interaction with a specific binding epitope (the TonB box) 
at the N-terminus of the receptor plug domain subsequent to binding of the substrate on 
the outer surface of the receptor (113). Subsequent to binding, it has been postulated 
though not conclusively proven that energy provided by the Ton complex through TonB 
causes removal or rearrangement of the receptor plug domain allowing ingress of the 
substrate into the cell (121).  
It was subsequently discovered that colicins (and potentially colicin-like bacteriocins more 
generally) possess an intrinsically unstructured translocation domain at their N-terminus 
(IUTD). Removal of this domain, leads to a bacteriocin unable to kill cells, but still active in 
receptor binding and cytotoxic domain activity in vitro (66). The IUTD of both A and B 
group bacteriocins has been shown to deliver a binding epitope to the periplasm, which 
directly mediates binding to the Tol or Ton complexes. While the specific details of the 
process are still poorly understood, this interaction presumably allows the bacteriocin to 
access the energy transduced by these complexes to cross the outer membrane (122). In 
group B colicins this binding epitope has been shown to be analogous to the epitope 
which mediates interaction between TonB and the TonB-dependent receptors, suggesting 
molecular mimicry is involved in colicin-TonB interactions (123). 
Colicin-like bacteriocins studied structurally adopt both highly elongated and more 
compact structures. The elongated colicins (E colicins and colicin Ia) bind to their TonB-
dependent receptor via an elongated helical receptor binding domain, while the IUTD 
searches for a secondary receptor/translocator, the abundant outer membrane porin 
OmpF for the nuclease colicins (E2, E7, E8 and E9), and in the case of colicin E1 and Ia, 
TolC and Cir, respectively (4). The IUTD of the nuclease E-group colicins has been shown 
experimentally to thread through the pore of OmpF to deliver its binding epitope to the 
periplasm (122). Compact colicins like colicins M, B, D and pesticin have only been shown 
to bind to a single TonB-dependent receptor, which likely serves both receptor binding 
and translocator function (6,96). Interestingly, while different colicins recruit different 
receptor and translocation proteins, Tol/Ton dependence for importation can for some 
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colicins be switched by changing the epitope on the IUTD from a Ton to a Tol specific 
sequence (124). This suggests colicins bind to cell surface receptors regardless of their 
endogenous function in order to capture transmembrane systems that transduce the 
PMF to the outer membrane. Upon entering the periplasm pore forming colicins, colicin 
M and pesticin, can exert their toxic effects, however the nuclease colicins still need to 
cross the inner membrane and enter cytoplasm of the cell. Limited experimental evidence 
on this process is available, however work by Walker et al in 2007, showed that both the 
net positive charge on the colicin E9 nuclease domain and the presence of anionic 
phospholipids in the outer membrane were important for colicin killing. Additionally, the 
authors demonstrated that FtsH, an inner membrane ABC transporter responsible for the 
retro-translocation of misfolded membrane proteins was necessary for colicin toxicity. 
The model proposed by the authors to explain this data suggests that interactions 
between the colicin DNAse domain and the inner membrane lead to destabilisation and 
partial unfolding of the protein, which facilitates its translocation into the cytoplasm via 
FtsH (125). A schematic of the colicin translocation process is presented in (Figure 1-11). 
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Figure 1-11 Cell entry and cytotoxicity of A- and B-group colicins  
A-group colicins bind to their cell surface receptor, before recruiting the porin OmpF as a translocator. The 
IUTD of the colicins threads through the lumen of OmpF interacting with the Tol complex in the periplasm. 
This interaction with Tol facilitates entry of the bacteriocin, with energy provided by the proton motive 
force (4). 
B-group also interact with a cell surface receptor, however with the exception of colicin IA which utilises a 
second copy of its receptor Cir as it’s translocator, a secondary translocator has not been identified. B-
group colicins interact with TonB via a TonB-binding epitope to gain entry to the target cell (18). 
Figure 1-10 Binding of colicin E3 to its cell surface receptor BtuB 
The crystal structure of BtuB in complex with the colicin E3 receptor binding domain show in atomic 
detail were the colicin interacts with BtuB. An overlay of the crystal structure of  full length colicin 
E3, with the receptor binding domain from this complex shows the position and conformation of 
colicin E3 (and other E colicins which share its domain architecture) on the bacterial cell surface (8). 
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1.5 Colicin and lectin-like bacteriocins produced by 
phytopathogenic bacteria 
Limited experimental work has been performed characterising colicin-like bacteriocins 
from phytopathogens. However, genes encoding putative bacteriocins can be readily 
identified in the available genome sequences of the economically important plant 
pathogens such as P. syringae, P. atrosepticum, P. carotovorum, D. solani, Xanthomonas 
spp. and Agrobacterium spp. indicating that bacteriocin production is widespread among 
phytopathogenic bacteria. (58,126). Despite this potential wealth of bacteriocins, to date 
only a handful of bacteriocins produced by phytopathogens have been described. Three 
bacteriocins from Pectobacterium spp. with catalytic domains homologous to colicin-like 
bacteriocins have recently been characterised. These proteins were designated ‘carocins’ 
based on the identity of the producing species, P. carotovorum. All three proteins have 
catalytic domains with nuclease activity, with the first protein identified, carocin S1, 
possessing a DNase domain homologous to the cytotoxic domain of pyocin S3 (127). 
Similarly, carocin S2 possesses a tRNase domain homologous to the cytotoxic domain of 
colicin D, while carocin D possesses DNase activity (70,128). Previous experimental and 
bioinformatic analysis show that strains of P. syringae also produce bacteriocins 
homologous to the colicin-like bacteriocins. However, characterization of these proteins 
has been limited (126,129). Syringacin M produced by P. syringae pv. tomato DC3000, 
which is a focus of this study was first reported by Barreteau et. al.. This protein, which 
has a catalytic domain homologous to that of colicin M, was purified and shown to have 
catalytic activity against the lipid II. However, no cytotoxic activity was observed against 
the Pseudomonas strains tested (82). Other studies on bacteriocin production in P. 
syringae and closely related plant-associated pseudomonads have identified high 
molecular weight phage tail-type bacteriocins and bacteriocins analogous to 
recombination hot spot (rhs) proteins (105,130). Lectin-like bacteriocins active against 
phytopathogens, have also been identified (105). The initial member of this class, 
putidacin L1 (LlpA1) was isolated from a rhizosphere dwelling Pseudomonas isolate from 
the P. putida cluster and was found to have cytotoxic activity against a number of 
phytopathogenic Pseudomonad species (103). Further studies identified and cloned 
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lectin-like bacteriocins from the plant pathogenic/commensal bacteria P. fluorescens, P. 
syringae, Xanthomonas citri. Limited characterization of these bacteriocins has been 
performed. However, they have been shown to possess cytotoxicity at comparable 
concentrations to putidacin L1 and possess a genus level killing spectrum 
(104,105,131,132).  
 
1.6 Utilisation of bacteriocins to combat bacterial disease in 
plants 
1.6.1 Current implementation of bacteriocins in the bio-control of 
phytopathogenic bacteria 
To date, bacteriocins have not been used extensively to prevent or limit the effects of 
bacterial disease in plants. However, this is predominantly due to lack of research into the 
diversity and mechanisms of action of these proteins in phytopathogenic bacteria, rather 
than their potential (60). A number of studies have shown bacteriocins to be effective 
agents in the treatment of bacterial disease. Lavermicocca et. al., reported the use of an 
uncharacterized bacteriocin from P. syringae pv. ciccaronei in the prevention of olive knot 
disease. This study showed a 60-80% reduction in knot formation when stem wounds 
were pretreated with a crude bacteriocin preparation prior to infection with the casual-
agent of the disease P. syringae pv. savastanoi. Additionally, a 350-400 fold decrease in 
the epiphytic numbers of the pathogen was observed when unwounded olive plants were 
treated with a crude preparation of the bacteriocin (40). A study by Kerr and Htay, 
showed that co-inoculation of a non-pathogenic bacteriocin producing strain 
Agrobacterium radiobacter strain 84, with pathogenic Agrobacterium strains led to 
attenuation of gall formation relative to only inoculation with the pathogenic strain (133). 
This attenuation was shown to be due to bacteriocin production, with only one 
bacteriocin sensitive pathogenic strain not subject to biological control. It transpired that 
this strain produced a bacteriocin active against A. radiobacter 84 (133). Based on this 
work, A. radiobacter strain 84 and the bacteriocin it produces, identified as the leucyl-
32 
 
tRNA synthetase inhibiting agrocin 84, have been used extensively for the bio-control of 
pathogenic Agrobacterium spp. (134-136).   
It is well established that bacteriocin resistant mutants arise upon treatment of a 
susceptible population. This is often stated as a counter case to the use of bacteriocins as 
disease control agents. However, it should be noted that the majority of mutants isolated 
are defective in either the outer membrane receptor responsible for bacteriocin binding 
or the periplasmic machinery involved in its uptake (137). The normal physiological 
function of bacteriocin outer membrane receptors and the periplasmic uptake machinery 
is frequently the uptake of nutrients such as iron, required during infection for growth, 
and as such these mutations may represent a fitness cost to the bacteria (6). As nutrient 
limitation represents a key defense strategy in many host pathogen interactions, it might 
be expected and has in fact been observed that bacteriocin resistant mutants are also 
attenuated in virulence (133,138).   
 
1.6.2 Utilising bacteriocins to create transgenic plants 
The ultimate aim of this work is the utilisation of bacteriocins in disease control through 
the creation of transgenic plants expressing multiple bacteriocins. Colicin and lectin-type 
bacteriocins are attractive targets for this approach for a number of reasons. Firstly, 
bacteriocins of this class are unmodified monomeric proteins encoded by a single open 
reading frame, making the creation of transgenic plants expressing one or a number of 
bacteriocins a relatively simple procedure. Secondly, the narrow spectrum of these toxins 
allows for the targeting of specific pathogens without disturbing the wider microbial 
community. This narrow spectrum also means the consumption of transgenic food crops 
expressing bacteriocins, is unlikely to negatively impact the health of humans or their gut 
flora. Finally these proteins are highly potent, often only requiring a single molecule to kill 
a bacterial cell (4). 
The genetic modification of crop plants is an attractive option for introducing desirable 
genes, which are outside of the species range of the plant and thus inaccessible to regular 
breeding techniques. GM technology provides the ability to create crop plants with 
additional agriculturally or nutritionally desirable traits (139). While the technology 
required for creating transgenic plants has been under-development since the mid-1980s, 
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significant regulatory and social pressures have limited the diversity of its application. In 
2012, the estimated cost of developing and obtaining approvals for a transgenic plant is 
$134 million USD, with the estimated cost of obtaining regulatory approvals alone 
estimated at $34 million USD (140). The requirement of such a significant investment has 
largely limited the application of the technology in commodity crops, such as maize and 
soybean and to traits which provide a significant commercial benefit (140). As such, the 
two most successful applications of the technology are the addition of genes providing 
resistance to the herbicide glyphosate (so called Roundup Ready® plants) and for the 
production of toxins from Bacillus thuringiensis (Bt crops) to provide resistance to insect 
pests (141). Genes imparting these traits have been engineered into a number of 
important crop plants and are grown over large areas. In 2012, genetically modified crops 
were grown in 28 countries and on more than 170 million hectares of land, consisting 
mainly of corn, soybean, canola, and cotton (140), with 77 % of soybean and 50 % of 
cotton grown globally being genetically modified (141). Despite the dominance of Bt and 
Roundup ready crops in terms of area, numerous other beneficial traits have been 
engineered  into crop plants. These include resistance to genes for viral or oomycete 
pathogens, in papaya and potato respectively and the addition of the β-carotene 
biosynthetic pathway to create so called Golden Rice (142,143). The diversity of crop 
species to which GM technology has been applied and the variety of traits that have been 
engineered provides proof of concept for the creation of bacteriocin expressing 
transgenic plants. 
Focusing future work on the identification and characterisation bacteriocins that target 
economically important plant pathogens will contribute towards the creation of a library 
of bacteriocins suitable for the creation of disease resistant transgenic plants. Delineating 
the functional domains and dissecting the catalytic mechanisms of these proteins will 
provide data required for protein engineering to create novel bacteriocins with an 
expanded host range. Multiple bacteriocin genes can then be ‘stacked’ into host plants to 
provide robust resistance to a broad spectrum of pathogenic strains under field 
conditions. In addition, expression of bacteriocins in tubers will provide an ideal agent for 
preventing tuber rot during storage This kind of application using small peptide 
bacteriocins from ‘lactic acid’ bacteria has gained attention in the food industry (58).   
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2 Materials and Methods 
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2.1 Chemicals and growth media 
All chemicals used in this study were analytical grade and were purchased from Melfold, 
Sigma Aldrich or Fischer Scientific unless stated otherwise. 
 
2.2 Bacterial strains, plasmids and growth conditions  
Strains and plasmids utilised in this study are presented in Table 2-1 and Table 2-2 
respectively.  Strains of P. aeruginosa and E. coli were grown in LB (10 g tryptone, 5 g 
yeast extract, 10 g NaCl) at 37 °C. P. syringae were grown in Kings B Media (KB) (20 g 
peptone, 10 g glycerol, 1.5 g MgSO4, 1.5 g K2HPO4 per liter adjusted to pH 7.5) at 28 °C. 
Pectobacterium strains were grown in LB at 28 °C. A. tumefaciens was grown in LB at 28  
°C. Bacteria were maintained short term at 4 °C on agar plates and long term in 30-50% 
glycerol at -80 °C 
Table 2-1 Strains utilised, isolated or derived during this study 
Strain or Plasmid Relevant Characteristic(s) Source 
   
E. coli   
DH5α F
-
, φ80dlacZΔM15, Δ(lacZYA-
argF)U169, deoR, recA1, endA1, hsdR17(rk
-
, 
mk
+
), phoA, supE44, λ
-
, thi-1, gyrA96, relA1 
Invitrogen 
BL21DE3 F– ompT hsdSB(rB–, mB–) gal dcm (DE3) Invitrogen 
BL21(DE3)pLysS F
-
 ompT hsdSB (rB
-
mB
-
) gal dcm (DE3) pLysS 
(Cam
R
) 
Invitrogen 
SM10 (λpir) KmR, thi-1, thr, leu, tonA, lacY, supE, recA::RP4-
2-Tc::Mu, pir. 
BCCM 
   
A. tumefaciens   
GV3101 Rif
r
, Gent
r
, contains helper plasmid for binary 
vector mobilisation 
(144) 
   
P. syringae   
pv. tomato DC3000 isolated from Solanum lycopersicum BCCM 
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pv. tomato NCPPB 1107 isolated from Solanum lycopersicum NCPPB 
pv. tomato NCPPB 2563 isolated from Solanum lycopersicum NCPPB 
pv. tomato NCPPB 3160 isolated from Solanum lycopersicum NCPPB 
pv. coronafaciens LMG 5060 isolated from Avena sativa BCCM 
pv. lachrymans LMG 5456 isolated from Cucumis sativus BCCM 
pv. maculicola LMG 2208 isolated from Brassica oleracea BCCM 
pv. morsprunorum LMG2222 isolated from Prunus avium BCCM 
pv. syringae LMG1247 isolated from Syringa vulgaris, type strain BCCM 
pv. syringae LMG 5082 isolated from Zea mays BCCM 
pv. syringae LMG 5084 isolated from Pyrus communis BCCM 
Carilse 1 isolated from Tilia tomentosa This study 
Carlise 2 isolated from Tilia tomentosa This study 
LMG2222 Imut derived from pv. LMG2222 morsprunorum, 
putidacin L1 tolerant mutant 
This study 
LMG2222 In50 derived from pv. LMG2222 morsprunorum, 
putidacin L1 tolerant mutant 
This study 
LMG2222 20(1) derived from pv. LMG2222 morsprunorum, 
putidacin L1 tolerant mutant 
This study 
LMG5456 MDC2 derived from pv. LMG5456 morsprunorum, 
syringacin M resistant mutant 
This study 
LMG5456 MDC3 derived from pv. LMG5456 morsprunorum, 
syringacin M resistant mutant 
This study 
   
P. aeruginosa   
PAO1 Clinical isolate (145) 
E2 Environmental isolate (15) 
P8 Clinical isolate This study 
   
P. carotovorum subsp. carotovorum   
LMG 2378 Isolated from Solanum tuberosum BCCM 
LMG 2383 Isolated from Solanum tuberosum BCCM 
LMG 2384 Isolated from Solanum tuberosum BCCM 
LMG 2385 Isolated from Solanum tuberosum BCCM 
LMG 2394 Isolated from Solanum tuberosum BCCM 
LMG 2410 Isolated from Cucumis sativus BCCM 
LMG 2412 Isolated from Hyacinthus orientalis BCCM 
LMG 2442 Isolated from Brassica oleracea BCCM 
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LMG 2444 Isolated from Solanum tuberosum (tuber soft 
rot) 
BCCM 
LMG 2913 Isolated from soil BCCM 
   
P. atrosepticum   
LMG 2374 Isolated from Apium graveolens var. dulce BCCM 
LMG 2375 Isolated from Solanum tuberosum (tuber soft 
rot) 
BCCM 
LMG 2386 Isolated from Solanum tuberosum (stem rot) BCCM 
LMG 2390 Isolated from soil BCCM 
LMG 2391 Isolated from soil BCCM 
LMG 2413 Isolated from soil BCCM 
LMG 2443 Isolated from Brassica oleracea BCCM 
LMG 2454 Isolated from Chrysanthemum morifolium BCCM 
SCRI 1043 Isolated from Solanum tuberosum (tuber soft 
rot) 
SCRI 
LMG2386 ∆FupA derived from LMG2386 with 1000bp deletion 
of FupA gene 
This study 
LMG2386 MPCI1 to 7 derived from LMG2386, 7 isolates tolerant or 
resistant to pectocin M1 
This study 
 
Table 2-2 Plasmids utilised or created in this study 
Plasmid Relevant Characteristic(s) Source 
   
Cloning/Knockout 
Vectors 
  
pJexpress411 Kan
r, 
cloning/expression vector, T7 promoter DNA 2.0 
pJexpress404 Amp
r, 
cloning/expression vector, T5 promoter DNA 2.0 
pET21-a(+) Amp
r, 
cloning/expression vector, T7 promoter Novagen 
pET28-a(+) Kan
r, 
cloning/expression vector, T7 promoter Novagen 
pENTR Kan
r 
Gateway cloning entry vector, No promoter Invitrogen 
pMRS101 Amp
r
, Str
r
, Suc
S
, Suicide Vector based on pKNG101 (146) 
   
pENTRPL1 pENTR with putidacin L1 inserted using gateway system This study 
pENTRSL1 pENTR with syringacin L1 inserted using gateway system This study 
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pENTRMDC pENTR with syringacin M inserted using gateway system This study 
   
   
Agrobacterium 
Binary Vectors 
  
pGWB5 Kan
r, 
Hyg
r
, Gateway binary vector, 35s promoter, C 
terminal-sGFP fusion 
(147) 
pGWB6 Kan
r, 
Hyg
r
, Gateway binary vector, 35s promoter, N 
terminal-sGFP fusion 
(147) 
pGWB17 Kan
r, 
Hyg
r
, Gateway binary vector, 35s promoter, C 
terminal-sGFP fusion 
(147) 
pGWB18 Kan
r, 
Hyg
r
, Gateway binary vector, 35s promoter,  N 
terminal-sGFP fusion 
(147) 
pJO530 Kan
r, 
Hyg
r
, Binary vector, 35s promoter, No-tag (148) 
   
pG5PL1 pGWB5 with Putidacin L1 inserted by gateway 
recombination 
This study 
pG6PL1 pGWB6 with Putidacin L1 inserted by gateway 
recombination 
This study 
pG17PL1 pGWB17 with Putidacin L1 inserted by gateway 
recombination 
This study 
pG18PL1 pGWB18 with Putidacin L1 inserted by gateway 
recombination 
This study 
pG5SL1 pGWB5 with Syringacin L1 inserted by gateway 
recombination 
This study 
pG6SL1 pGWB6 with Syringacin L1 inserted by gateway 
recombination 
This study 
pG17SL1 pGWB17 with Syringacin L1 inserted by gateway 
recombination 
This study 
pG18SL1 pGWB18 with Syringacin L1 inserted by gateway 
recombination 
This study 
pG5MDC pGWB5 with Syringacin M inserted by gateway 
recombination 
This study 
pG6MDC pGWB6 with Syringacin M inserted by gateway 
recombination 
This study 
pG17MDC pGWB17 with Syringacin M inserted by gateway 
recombination 
This study 
pG18MDC pGWB18 with Syringacin M inserted by gateway This study 
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recombination 
pJOPL1-Cmyc pJO530 with Putidacin L1 plus C-terminal 4xMyc tag 
inserted into KpnI site 
This study 
pJOPL1-Nmyc pJO530 with Putidacin L1 plus N-terminal 4xMyc tag 
inserted into KpnI site 
This study 
pJOSL1 pJO530 with Syringacin L1 untagged inserted into KpnI site This study 
pJOP19 pJO530 with bushy stunt virus silencing repressor P19 
ligated into KpnI site 
(149) 
   
Protein Expression 
Vectors 
  
pETMDC pET21-a(+) with syringacin M inserted into NdeI/XhoI sites, 
C-term 6X his tag 
This study 
pETMDC-10 As pETMDC, with -10 N-terminal amino acids of syringacin 
M 
This study 
pETMDC-20 As pETMDC, with -20 N-terminal amino acids of syringacin 
M 
This study 
pETMDC_D232A As pETMDC, with Aspartate 232 mutated to Alanine of 
syringacin M 
This study 
   
pJMPCI pJexpress411 with Pectocin M1 inserted into NdeI/XhoI 
sites, No tag 
DNA 2.0 
 
pETMPCI pET21-a(+) with Pectocin M1 inserted into NdeI/XhoI sites, 
C-term 6X his tag 
This study 
pETMPCI_D226A As pETMPCI, with Aspartate 226 mutated to Alanine of 
pectocin M1 
This study 
pJMBPR pJexpress411 with Pectocin M2 inserted into NdeI/XhoI 
sites, No tag 
DNA 2.0 
 
pETMBPR pET21-a(+) with Pectocin M2 inserted into NdeI/XhoI sites, 
C-term 6X his tag 
This study 
pJPP1 pJexpress404 with Pectocin P inserted into NdeI/XhoI sites, 
C-term 6X his tag 
DNA 2.0 
 
   
pETMPCIfer pET21-a(+) with Pectocin M1 amino acids 1-92, inserted 
into NdeI/XhoI sites, C-term 6X his tag 
This study 
pETARAfer pET21-a(+) with Arabidopsis ferredoxin 1, inserted into 
NdeI/XhoI sites, C-term 6X his tag 
This study 
pETMAZfer pET21-a(+) with Maize ferredoxin 1, inserted into NdeI/XhoI This study 
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sites, C-term 6X his tag 
pETPOTfer pET21-a(+) with Potato ferredoxin 1, inserted into 
NdeI/XhoI sites, C-term 6X his tag 
This study 
pETSPNfer pET21-a(+) with Spinach ferredoxin 1, inserted into 
NdeI/XhoI sites, C-term 6X his tag 
This study 
   
pJPL1 pJexpress411 with Putidacin L1 inserted into NdeI/XhoI 
sites, No tag 
DNA 2.0 
pETPL1 pET21-a(+) with Putidacin L1 inserted into NdeI/XhoI sites, 
C-term 6X his tag 
This study 
pJSL1 pJexpress411 with Putidacin L1 inserted into NdeI/XhoI 
sites, No tag 
DNA 2.0 
pETSL1 pET21-a(+) with Syringacin L1 inserted into NdeI/XhoI sites, 
C-term 6X his tag 
This study 
pET28SL1 pET28-a(+) with Syringacin L1 inserted into NdeI/XhoI sites, 
N-term 6X his tag 
This study 
pETPyoL1 pET21-a(+) with Pyocin L1 inserted into NdeI/XhoI sites, C-term 6 
his tag + RRRAVV linker 
(15) 
pETPyoL1_N1 As pETPyoL1 with  Aspartate  31 mutated to Alanine (15) 
pETPyoL1_N2 As pETPyoL1 with  Aspartate  97 mutated to Alanine (15) 
pETPyoL1_C1 As pETPyoL1 with  Aspartate  150 mutated to Alanine (15) 
pETPyoL1_C2 As pETPyoL1 with  Aspartate  180 mutated to Alanine (15) 
   
pETFR1043 pET21-a(+) with FupA1043 inserted into NdeI/XhoI sites, No-tag This study 
pT5FR1043 pJexpress404 with FupA1043 inserted into NdeI/XhoI sites, No-
tag 
This study 
pETFR2913 pET21-a(+) with FupA2913 inserted into NdeI/XhoI sites, No-tag This study 
pT5FR2913 pJexpress404 with FupA2913 inserted into NdeI/XhoI sites, No-
tag 
This study 
pETFRIB1043 pET28-a(+) with FupA1043 -20 N-terminal amino acids, inserted 
into NdeI/XhoI sites, N-terminal 6x his tag 
This study 
pETFRIB2913 pET28-a(+) with FupA2913 -20 N-terminal amino acids, inserted 
into NdeI/XhoI sites,  N-terminal 6x his tag 
This study 
pETFRIB2386 pET28-a(+) with FupA2386 -20 N-terminal amino acids, inserted 
into EcoRI/HindIII sites,  N-terminal 6x his tag 
This study 
   
pETFRKO1_2386 pET21-a(+) with FupA2386 first 1000bp inserted into SalI, XbaI This study 
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sites, Ending with stop codon 
pETFRKO2_2386 pET21-a(+) with FupA2386 last 1000bp inserted into XbaI, SalI 
sites, Ending with stop codon 
This study 
pMRFRKO2386 pMRS101 with FRKO1 and FRKO2 fragments ligated at Xba site, 
ligated into vector SalI site 
This study 
pKNFRKO2386 pMRFRKO2386 with Col1 origin of replication containing NdeI 
fragment removed 
This study 
 
2.3 DNA manipulations 
2.3.1 Polymerase chain reaction 
Primers utilised for cloning in this study are outlined in Table 2-3. These primer sets were 
utilised to create all the vectors in the plasmid table and for sequencing and diagnostic 
purposes where necessary. 
 
Table 2-3 Primers utilised and created during this study 
Name  RE Site Sequence 5’ to 3’ Purpose 
FupA2386 F 
KO   
SalI GCATCGTCGACATGAATAA
GAACGTCTATTTAATGATG 
FupA2386 knockout construction 
forward gene start 
FupA2386 R 
KO  
SalI GCATCGTCGACTTACCAGG
TGTAAGCGACGC 
FupA2386 knockout construction 
reverse gene end 
FupA2386 R 
KO  
HindIII GCATCAAGCTTTTACCACCG
CCGTTATTGGTATAAG 
FupA2386 knockout construction 
forward middle 
FupA2386 F 
KO  
HindIII GCATCAAGCTTGCGTGCGT
GTCACATATGATGA 
FupA2386 knockout construction 
reverse middle 
    
FupA2386 F 
IB        
EcoRI GCATCGAATTCATGACACCT
CTGCCGATGAAA 
FupA2386 ∆20 cloning forward  
FupA2386 R 
IB  
HindIII GCATCAAGCTTTTACCAGGT FupA2386 ∆20 cloning reverse 
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GTAAGCGACGC 
FupA1043 F  NdeI GCATCCATATGAATAAGAAC
GTCTATTTAATGATGATT 
FupA1043 and FupA2913 cloning 
forward 
FupA1043 F 
IB  
NdeI GCATCCATATGCAGCAAAA
CGACACCTCTGC 
FupA1043 and FupA2913 ∆20 cloning 
forward 
FupA1043 R 
IB  
XhoI GCATCCTCGAGTTACCAGG
TGTAAGCGACGC 
FupA1043 and FupA2913 cloning 
reverse 
    
Maz Fer F  NdeI  GCATCCATATGGCTACCTAC
AATGTGAAAC 
Maize ferredoxin cloning forward 
Maz Fer R  XhoI GCATCCTCGAGCAGCAGGT
CGTCTTCTTTGTG 
Maize ferredoxin cloning reverse 
Pot Fer F  NdeI  GCATCCATATGGCGAGCTA
CAAGGTG 
Potato ferredoxin cloning forward 
Pot Fer R  XhoI GCATCCTCGAGAGCGGTCA
GTTCTTCTTCTTTATG 
Potato ferredoxin cloning reverse 
Spin Fer F   NdeI GCATCCATATGGCGGCTTA
CAAGGTC 
Spinach ferredoxin cloning forward 
Spin Fer R  XhoI GCATCCTCGAGTGCCGTCA
GTTCTCTTCTTTATG 
Spinach ferredoxin cloning reverse 
Ara Fer F  NdeI  GCATCCATATGGCTACCTAC
AAGGTCAAGTTC 
Arabidopsis ferredoxin cloning 
reverse 
Ara Fer R  XhoI GCATCCTCGAGCATAATGG
CTTCTTCTTTGTGGG 
Arabidopsis ferredoxin cloning 
reverse 
MPCI Fer R  XhoI ATCCCTCGAGCATCTCTTCC
ACGCCCGTTTT 
Pectocin M1 ferredoxin domain 
cloning reverse 
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PL1 F KpnI GCTTAGGTACCATGGCAGG
TCGTACCCGC 
Putidacin L1 cloning forward (for 
pJO530) 
PL1  R KpnI GCATCGGTACCTTAGAAGT
GCCAGGTCCAGATG 
Putidacin L1 cloning reverse (for 
pJO530) 
PL1 CACC F - CACCATGGCAGGTCGTACC
CGC 
Putidacin L1 cloning forward 
(Gateway) 
PL1 F NdeI GGTTCCATATGGCAGGTCG
TACCCGC 
Putidacin L1 cloning forward 
PL1 R XhoI GCATCCTCGAGTTAGAAGT
GCCAGGTCCAGATG 
Putidacin L1 cloning reverse 
Myc  F KpnI GCATCGGTACCATGAGCGG
GTTAATTAACGGTG 
N-term Myc tag cloning forward (for 
pJO530) 
Myc R KpnI GCATCGGTACCTAAGCGCT
ACCGTTCAAGTC 
C-term Myc tag cloning reverse (for 
pJO530) 
SL1 F KpnI GCTTAGGTACCATGGCTGT
AAATTACAAACCGCTC 
Syringacin L1 cloning forward (for 
pJO530) 
SL1  R KpnI GCATCGGTACCTTAAAACTC
GTAGCCGATATGACC 
Syringacin L1 cloning reverse (for 
pJO530) 
SL1 CACC F - CACCATGGCTGTAAATTACA
AACCGCTC 
Syringacin L1 cloning forward 
(Gateway) 
SL1 F NdeI CATATGGCTGTAAATTACAA
ACCGCTC 
Syringacin L1 cloning forward 
SL1 R  stop XhoI CTCGAGAAACTCGTAGCCG
ATATGACCG 
Syringacin L1 cloning reverse (No 
stop codon) 
SL1 R No 
stop 
XhoI CTCGAGTTAAAACTCGTAGC
CGATATGACC 
Syringacin L1 cloning reverse (No 
stop codon) 
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MPCI F  NdeI GCATCCATATGGCTACGTA
CAAAATCAAGGATC 
Pectocin M1 cloning forward 
MPCI R  XhoI GCATCCTCGAGTAAACGTT
GACCGCGACCGC 
Pectocin M1 cloning reverse 
MBPR F NdeI GCATCCATATGGCGACGTA
CAAAGTTAAGTTAA 
Pectocin M2 cloning forward 
MBPR R XhoI GCATCCTCGAGTTTCTTACC
ATTTTCTTTAATCTTCAATTC 
Pectocin M2 cloning reverse 
    
MDC -10 NdeI GCATCCATATGACCCCTTAT
CCTGAAATTAGCG 
Syringacin M -10 truncation cloning 
forward 
MDC -20 NdeI TGCAGCATATGAATGGTAC
CTATCGTGGTCAAG 
Syringacin M -20 truncation cloning 
forward 
MDC CACC 
F 
 CACCATGGCAGGTCGTACC
CGC 
Syringacin M cloning forward 
(Gateway) 
MDC F NdeI GCTACCATATGCCTATTGAG
CTTCCTCC 
Syringacin M cloning forward 
MDC R XhoI GCTACCTCGAGGTTGCCAC
TAACCGTAACCG 
Syringacin M cloning reverse 
    
MPCI 
D226A F 
- GCATCCGCGCATATAACGC
TCTGTATGATGCTAATCCG 
Pectocin M1 D222A mutagenesis 
forward 
MPCI 
D226A R 
- CGGATTAGCATCATACAGA
GCGTTATATGCGCGGATGC 
Pectocin M1 D222A mutagenesis 
reverse 
MDC 
D232A F 
- GCGCCTTCAATGCTGTCTA
CGATGCCAATCCGTC 
Syringacin M D232A mutagenesis 
forward 
MDC - GACGGATTGGCATCGTAGA Syringacin MD232A mutagenesis 
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D232A R CAGCATTGAAGGCGC reverse 
 
 
Amplification PCR reactions were performed with the following range of conditions: 
Table 2-4  Standard PCR Reaction Components 
Temperature (°C) 
Step Duration (s) 
95 Initial Denaturing 300 
95 Denaturing* 45 
52-60 Annealing* 45 
72 Extension* 60(/kb) 
72 Final Extension* 600 
10 Hold! Indefinite 
* steps repeated for 30 cycles 
With the following reaction composition: 
 
Table 2-5 Standard PCR Reaction Components 
Component 
Concentration Volume 
Pfu Turbo  Stock 1 µl 
Reaction Buffer 10X 5 µl 
Reverse Primer 1 nM 5 µl 
Reverse Primer 1 nM 5 µl 
Template Variable 1-5 µl 
dNTPs 5mM 1 µl 
H2O 100% 28-32 µl 
  50 µl 
 
For colony PCR a small amount of a bacterial colony on agar from plate was transferred to 
50 µl of 10 mM Tris [pH 7.5] and heated for 5 minutes at 96°C. The resulting solution was 
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clarified by centrifugation and diluted 1:10 into distilled H2O. 5 µl was used as template 
for PCR reaction. For PCR from plasmid template or PCR product, the stock was diluted 
1:10 and 1 µl was used as reaction template.  
If initial PCR conditions did not yield the desired product the reaction was optimized by 
the inclusion of 5-10 % DMSO and variation of the annealing temperature. 
 
Mutagenic PCR reactions were performed with the following conditions: 
 
Table 2-6 Mutagenesis PCR Conditions 
Temperature (°C) 
Step Duration (s) 
95 Initial Denaturing 30 
95 Denaturing* 30 
55 Annealing* 60 
68 Extension* 60/kb 
72 Final Extension* 600 
* steps repeated for 18 cycles 
 
Table 2-7 Mutagenesis PCR Reaction Components 
Component 
Concentration Volume 
Pfu Turbo  Stock 1 µl 
Reaction Buffer 10X 5 µl 
Reverse Primer 1 nM 5 µl 
Reverse Primer 1 nM 5 µl 
Template Plasmid 2.5 µl 1 µl 
dNTPs 5mM 1 µl 
H2O 100% 32 µl 
  50 µl 
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A negative control reaction lacking polymerase was run to assess transformation 
background.  10 µl of reaction was run on an agarose gel (see below) to assess the 
success of amplification. 1 µl of DpnI was added to the reaction mixture and this was 
incubated at 37 °C for 1-2 hours to remove methylated template plasmid. 2-5 µl was used 
to transform competent DH5α with appropriate selection (see below). 
 
2.3.2 DNA Ligation 
PCR and vector fragments were ligated by first digesting plasmid and insert DNA with the 
appropriate restriction enzymes. Generally 10 µl of PCR product and 10 µl of 100 µg/ml 
vector were digested. Digested DNA was run on an agarose gel; the bands were excised 
and cleaned up by gel extraction. Resulting DNA fragments were used for the ligation 
reaction with the following composition: 8 µl insert, 3 µl vector, 2 µl 10x ligation buffer, 1 
µl T4 Ligase, H2O to 20 µl. When a ligation was performed with two insert fragments 6 µl 
of each insert and 3 µl of vector was used, in a final volume of 25 µl. Ligation reaction was 
performed for 3 hours on the bench and then 2-5 µl was used to transform DH5α with 
appropriate selection (see below). 
 
2.3.3 Electrophoresis  
DNA was separated on a 0.8-2 % agarose gel in 2x TBE buffer and visualized with GelRED 
(Cambridge Biosciences, UK), SYBR Safe (Life Technologies) gel stains. 
 
2.3.4 Extraction of genomic DNA 
Genomic DNA for genome sequencing was extracted from 1 ml of overnight bacterial 
culture using the QIAamp DNA Mini Kit (Qiagen) following the manufacturer’s supplied 
protocol. 
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2.3.5 Plasmid DNA extraction  
Plasmid DNA was prepared from 5 ml of overnight culture of the plasmid bearing strain 
using a plasmid mini-prep kit (Qiagen) and the standard protocol. It is important to note 
that for non-endA minus strains (i.e. E. coli SM10 or Pectobacterium sp.) the PB wash 
must be performed to remove the contaminating nuclease. For standard cloning strains 
i.e. DH5α, this step can be omitted. 
 
2.3.6 Bacterial transformation 
Commercially prepared chemically competent E. coli DH5α and BL21 derivatives were 
used for transformations using the manufacturer supplied protocol. The electroporation 
method was utilized for non-standard strains of E. coli, Pectobacterium and A. 
tumefaciens. 50 ml of cells were cultured in LB to an approximate OD600 of 0.6, chilled on 
ice for 10 minutes and harvested by centrifugation at 4500 g for 10 minutes. Cells were 
then rinsed twice in 40 ml of ice cold sterile H2O, and then resuspended in 1 ml of ice cold 
sterile 10 % (v/v) glycerol. 100 µl of cells and 2-5 µl of DNA were added to an 
electroporation cuvette and 2.5 kV applied at a capacitance of 25 µF using an 
electroporator (Invitrogen, UK). Cells were recovered immediately in 700 µl of LB at 37 or 
28 °C, before plating on LB agar with the appropriate selection. 
 
2.3.7 Creation of deletion mutants in Pectobacterium 
 The suicide pMRS101 plasmid was utilized in the creation of deletion mutants in 
Pectobacterium spp.(146). This vector is derived from pKNG101 with the addition of the 
high copy number Col0 origin of replication on an NdeI fragment to increase plasmid yield 
and to allow initial manipulations in DH5α. pKNG101 has a conditional origin of 
replication requiring the replication factor λpir for propagation and thus is unable to 
replicate in most Gram-negative bacteria.(150) The initial and final 1000bp of the target 
gene were fused with a stop codon inserted at the fusion site. This cassette was inserted 
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into pMRS101 at the unique SalI site and the Col0 origin of replication excised by NdeI 
digestion. After this step the vector (designated pKNFRKO2386) needed to be propagated 
in E. coli SM10 λpir with 50 µg.ml-1 streptomycin as the selection agent.  
The vector was then transformed into the Pectobacterium knockout target (LMG2386) by 
electroporation and cells were selected on 50 µg.ml-1 streptomycin. It was found to be 
important to use 50 µg.ml-1 streptomycin rather than the published 25 µg.ml-1 to prevent 
the isolation of spontaneously resistant colonies. Isolated streptomycin resistant colonies 
had the entire pKNFRKO2386 plasmid recombined into the Pectobacterium genome via 
recombination in one 1000 bp gene fragment.  
pMRS101 possesses the sacB gene which imparts sucrose sensitivity on Gram-negative 
bacteria (150). Recombination in the second 1000 bp fragment, which leads to excision of 
the plasmid and either regeneration of the whole gene or creation of the knockout was 
selected for by growth in NaCl free LB broth +10 % sucrose (LB sucrose), followed by serial 
dilutions onto LB sucrose agar (and LB streptomycin agar to test for completeness of 
plasmid excision). Sucrose resistant colonies were screened by PCR using primers for the 
target gene, with PCR products truncated to 2000 bp indicative of a successful knockout.                         
 
2.4 Determination of protein concentration 
Concentration of purified protein was determined by the spectroscopic method, using the 
absorbance of the protein solution at 280 nm. The webtool ‘Protparam’  (current weblink 
= http://web.expasy.org/protparam/) was used to estimate the molar extinction 
coefficient for the protein and this was utilised to calculate the protein concentration 
using the following equation. The ratio of absorbance between 280 and 260 nm was 
monitored to assess for contamination of the sample with nucleic acids. 
 
      
 
Where: 
C = Protein concentration 
A = Absorbance of sample (over a path length of 1 cm) 
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) 
 
To determine the protein concentration of non-homogenous samples the Bradford assay 
was employed (ref). The Biorad Quick Start Bradford Protein assay kit was employed, 
using the standard manufacturer supplied protocol. 
 
2.5 Bacteriocin toxicity assays 
2.5.1 Overlay spot plate method 
Soft agar overlay spot plates were performed using the method of Fyfe et. al.(151). 150 µl 
of test strain culture at OD600 nm = 0.6 was added to 6 ml of 0.8% soft agar and poured 
over an LB or KB agar plate, as appropriate. 5 µl of neat or serially diluted bacteriocin 
solution was spotted onto the plates and incubated for 20 hours at 37 or 28 °C, as 
appropriate. After incubation plates were inspected for zones of inhibition, growth 
enhancement (in the case of pectocins or ferredoxins) or interference between proteins.  
To assess bacterial strains directly for the production of bacteriocins the colony 
antagonism agar overlay assay was utilised. Individual colonies were grown on an agar 
plate under appropriate inducing conditions (i.e. 200 μM mitomycin C) and lysed using 
chloroform vapours, by exposure of the plate face down to filter paper disk (2 cm by 2 
cm) soaked in chloroform. The chloroform was allowed to dissipate for 15-30 minutes and 
then soft agar containing the strain to be tested for sensitivity was overlaid, as above. 
 
2.5.2 Liquid growth assays 
For inhibition of growth in liquid culture, cells were grown in LB or KB broth with or 
without 200 µM 2,2′-bipyridine. Purified bacteriocin was added at an appropriate time 
point and the OD600, along with phenotypic changes and cell lysis was monitored 
throughout the experiment. 
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2.6 Identification of bacteriocins by ammonium sulphate 
precipitation   
Bacteriocins responsible for the cytotoxicity of strains of P. syringae showing inhibition in 
colony antagonism agar overlay assay were identified by ammonium sulphate 
precipitation of clarified stationary phase culture of the producing strain.  Strains were 
grown for 24-48 h in 2 × 625 ml of Kings B media with mitomycin C (50-200 μM). The 
culture was clarified by centrifugation and the supernatant concentrated by ammonium 
sulfate precipitation; 3 M ammonium sulfate was added to the supernatant and 
precipitation was allowed to proceed at 4 °C with stirring for 1 h. Precipitate was 
collected via centrifugation (3000 g for 20 minutes) and resuspended in sample buffer (50 
mM Tris, 20 mM NaCl, 1 mM DTT, 1 mM ETDA, pH 7.5) with protease inhibitor tablets 
(Complete EDTA free, Roche) and was dialyzed against sample buffer and tested for killing 
activity by spotting onto a KB agar plate overlaid with soft agar containing 200 μl of 0.6 
OD600 culture of a test strain. Proteins were separated by native PAGE at 4 °C. Samples 
were run in duplicate, gels were halved and killing activity was tested via soft agar overlay 
of half the gel. The other half was stained with Coomassie Brilliant Blue 250, the band 
corresponding to zones of inhibition in the soft agar overlay assay were excised and 
identified via tandem mass spectrometry (MS/MS), with trypsination as the 
fragmentation step.   
 
2.7 Isolation of bacteriocin tolerant mutants  
1.5 ml of a culture of appropriate bacterial strain (OD600 nm = 0.6 to 1) was centrifuged and 
resuspended in 100-500 µl of 50mM Tris, 50mM NaCl [pH7.5], containing purified 
bacteriocin at a concentration of 50-300 µM. The bacteria and bacteriocin mixture was 
then incubated with shaking at 28 °C for 30 minutes to 1 hour. The mixture then spread 
on appropriate nutrient agar plate and incubated for between 20 and 48 hours at 28 °C. 
Isolated colonies were initially screened to exclude contamination by PCR amplification of 
16S DNA followed by sequencing. Mutants were then subjected to phenotypic 
characterization and genome sequencing. 
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2.8 Lipid II cleavage assay  
Lipid II hydrolysis assays were performed using a modified version of the assay described 
by Barreteau et al. (82), with non-radiolabeled lipid II substrate obtained from the UK 
Bacterial Cell Wall Biosynthesis Network (152,153).  Assays were carried out in 100 mM 
Tris, 150 mM NaCl, 0.2% n-dodecyl-D-maltoside with 5 µg of lipid II and 10 µg of wildtype 
or mutant M-class bacteriocins. To test the metal dependence of the M-class 
bacteriocins, assays were performed in the presence of MgCl2, CaCl2, MnCl2, CoCl2, ZnCl2 
or NiSO4 at 20 mM or with 1 mM EGTA.  Reactions were performed at 30 °C for 0-120 
minutes and terminated by heating at 100 °C. Reaction products were separated by thin-
layer chromatography on LK6D silica gel plates with 2-propanol: ammonium hydroxide: 
water (6:3:1) as the mobile phase and visualised by staining with 20% phosphomolybdic 
acid solution in ethanol and heating. A band corresponding to lipid II was observed with 
an Rf of 0.7 as reported previously.(82)     
 
2.9 SDS-PAGE, silver staining and immunoblotting 
Purified proteins and LPS in this study resolved by electrophoresis on 10 to 18 % SDS-
polyacrylamide gels. Proteins resolved by the gels were visualised by coomassie blue 
staining (0.1 % Coomassie Blue R250 in 10 % acetic acid, 50 % methanol, in H2O) for 30 
minutes, followed by destaining (10 % acetic acid, 10 % methanol, in H2O). Low 
concentration protein or LPS was visualised by silver staining using the Invitrogen 
ultrafast silver staining method. For immunoblotting protein was transferred onto 
nitrocellulose membranes blocked in TN tween (0.1% Tween 20, 100 mM Tris, 150 mM 
NaCl pH7.5) with 20% milk powder and then visualised using appropriate primary 
(incubation in 1:2000 dilution in TN tween for 30 minutes) and secondary antibody 
(incubation in 1:5-10000 dilution in TN tween for 30 minutes) combinations, with 1 x 30 
followed by 5 x 5 minute washes with TN tween between blocking and antibody 
incubation steps. The blots were developed using Clarity Western ECL Substrate (Life 
Science Research). 
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2.10 LPS purification and isolation of LPS-derived polysaccharide  
LPS was purified from P. aeruginosa and P. syringae strains as described previously, with 
modifications (154). Cells were grown for 20 hours at 37 °C and 28 °C for P. aeruginosa 
and P. syringae respectively, pelleted by centrifugation at 6000 g for 20 minutes, and 
resuspended in 50 mM Tris, pH 7.5 containing lysozyme (2 mg ml-1) and DNase I (0.5 mg 
ml-1). Cells were lysed by sonication and the cell lysate was incubated at 20 °C for 30 
minutes before EDTA was added to a final concentration of 2 mM. An equal volume of 
aqueous phenol was added and the solution was heated at 70 °C for 20 minutes, with 
vigorous mixing. The solution was then cooled on ice for 30 minutes, centrifuged at 7000 
g for 20 minutes and the aqueous phase extracted. Proteinase K was added to a final 
concentration of 0.05 mg ml-1 and dialysed for 12 hours against 2 x 5 L dH2O. LPS was 
pelleted by ultracentrifugation at 100,000 g for 1 hour, resuspended in dH2O and heated 
to 60°C for 30 minutes to remove residual proteinase K activity. LPS-derived 
carbohydrates were isolated by heating LPS in 2% acetic acid for 1.5 hours at 96 °C. Lipid 
A was removed by centrifugation at 13,500 g for 3 minutes followed by extraction with an 
equal volume of chloroform. The aqueous phase was then lyophilised. 
 
2.11 Whole genome sequencing 
The genomes of wildtype bacterial strain and bacteriocin tolerant mutants were 
sequenced at the Glasgow Polyomics Facility, generating paired-end reads on an Illumina 
MiSeq Personal Sequencer. Reads from wildtype strain were trimmed using quality scores 
and assembled de novo using the CLC genomics workbench. Assembled contigs were then 
annotated by the Xbase webserver (155), using the most closely related available genome 
sequence as a reference. To identify genetic changes in mutant strains, reads were 
trimmed and mapped to annotated wildtype genome, probabilistic variant detection was 
utilized to identify potential SNPs and INDELs using CLC genomics workbench. Variations 
from wildtype were inspected manually to verify authenticity.   
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2.12 Isothermal titration calorimetry 
ITC experiments were performed on a VP-ITC microcalorimeter (MicroCal LLC). For 
monosaccharide binding, titrations were carried out at 298 K with regular 15 µl injections 
of ligands into 60-100 μM pyocin L1 or putidacin L1 at 300 second intervals. 50 mM D-
mannose and D-rhamnose were used as titrants and reactions were performed in 0.2 M 
sodium phosphate buffer, pH 7.5. Proteins were dialysed into reaction buffer overnight 
and sugar solutions were made using this dialysis buffer. For O-antigen-pyocin L1 binding 
reactions, pyocin L1 was used as titrant at 150 μM with cleaved O-antigen sugars 
dissolved at 1 mg ml-1 in the chamber. For curve fitting we estimated the molar 
concentration of LPS-derived CPA containing carbohydrate chains at 20 µM based on an 
estimated average molecular weight of 10 kDa for CPA containing polysaccharides and 
estimating the percentage of total LPS represented by CPA containing carbohydrates as 
20% of the total by weight (156). This value may not be accurate and as such the 
stoichiometry implied by the fit is likely to be unreliable. However, the use of this 
estimated value has no impact on the reported parameters of ΔH, ΔS and Kd. For O-
antigen-putidacin L1 binding reactions, O-antigen was used as the titrant at 3 mg ml-1 
with 60 µM putidacin L1 in the chamber. Reactions were performed in 20 mM HEPES 
buffer pH 7.5. All samples were degassed extensively prior to the experiments. 
Calorimetric data were calculated by integrating the area under each peak and fitted with 
a single-site binding model with Microcal LLC Origin software. The heats of dilution for 
each titration were obtained and subtracted from the raw data.  
 
2.13 Identification of FupA by pull down 
A 2 L suspension culture of Pba LMG 2386 was grown in LB with 200 µM bipryidine until 
stationary phase was reached. Cells were harvested by centrifugation, resuspended in 20 
ml of 50 mM Tris, 10 mM EDTA, pH 7.2. Protease inhibitors and 2 mg ml-1 lysozyme were 
added and cells were lysed by sonication. Cellular debris were removed by centrifugation 
at 8000 g for 10 minutes and membranes were then pelleted by ultracentrifugation at 
100,000 g at 4°C, for 1 h. Pelleted membranes were resuspended with a tight fitting 
homogeniser in 20 ml of 50 mM Tris, 0.5% sarkosyl pH 7.2, left to solubilise for 20 
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minutes at room temperature and the outer membrane fraction pelleted by 
centrifugation at 100,000 g at 4 °C, for 1 h. The pellet was resuspended as before in 20 ml 
of 20 mM Tris, 1% n-octyl-β-D-glucoside (β-OG) pH 7.2 and solubilised for 12 hours at 4°C. 
Purified pectocin M1 in 50 mM Tris, 50 mM NaCl, pH 7.5 was immobilised on a 1 ml His-
trap column. Bound pectocin M1 was washed with 20 column volumes of Tris buffer (50 
mM Tris, 500 mM NaCl, 10 mM imidazole, pH 8.0). The solubilised OM fraction from Pba 
LMG 2386 was passed through the column, which was subsequently washed with 20 
column volumes of Tris buffer as above. Proteins were eluted from the column with Tris 
buffer containing an increasing concentration of imidazole (20, 50, 100 and 150 mM with 
pectocin M1 eluting at 100 mM imidazole). Control experiments were performed in which 
the Pba LMG 2386 solubilised OMs were passed down a column with no pectocin bound 
and imidazole elutions were undertaken for a column to which no OM fraction had been 
added (Figure 2-1). Proteins were visualised by Coomassie and sliver staining of SDS-PAGE 
gels and bands unique to the pectocin M1 plus OM fraction experiment were excised and 
identified by peptide mass fingerprinting. 
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Figure 2-1: Outline of pull down experiment for the identification of FupA 
 
2.14 Recombinant protein expression and purification 
2.14.1 Syringacin M 
 Syringacin M was overexpressed from E. coli BL21 (DE3) carrying the plasmid pETMDC.  5 
L of LB broth was inoculated (1:100) and overnight culture and cells were grown at 37 °C 
in a shaking incubator to an OD600 = 0.6.  Protein production was induced by the addition 
of 0.3 mM IPTG, the cells were grown for a further 12 hours at 24 °C and harvested by 
centrifugation. The cell pellet was resuspended in 20 mM Tris-HCl and 100 mM NaCl 
containing 5 mM imidazole (pH 7.5). Selenomethionine derivative protein was produced 
by expressing syringacin M in the methionine auxotrophic E. coli strain B834 (DE3), grown 
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in M9 minimal media supplemented with 2 mg l-1 thiamine, 40 mg l-1 of each of 9 
essential amino acids (excluding methionine) and 50 mg ml-1 selenomethionine. Cells 
were grown to 0.4 OD600, induced with 1 mM IPTG and grown for a further 8 hours at 28 
°C.  Cells were lysed using a MSE Soniprep 150 (Wolf Laboratories, UK) and the cell debris 
separated by centrifugation. The cell-free lysate was applied to a 5 ml His Trap™ HP 
column (GE Healthcare, USA) and the protein eluted over a 0-350 mM imidazole gradient. 
Syringacin M containing fractions were dialysed overnight into 20 mM Tris-HCl, 20 mM 
NaCl (pH 8.0) and the protein was further purified by gel filtration chromatography on a 
Superdex S75 26/60 column (GE Healthcare) equilibrated in the same buffer.  The protein 
was concentrated to 10-15 mg.ml-1 stored at -80 °C in this buffer until required.  
 
 
2.14.2 Pectocin M1, M2 and P 
Expression and purification of His-tagged proteins was as for syringacin M, using plasmids 
pETMBPR, pETMPCI and pJPP1 in E. coli BL21 (DE3) pLysS. 5% glycerol was added to all 
buffers when purifying pectocin M1 and pectocin P as it was found to enhance protein 
stability. Expression of untagged pectocin M1 and M2 was performed in the pectocin 
resistant strain P. carotovorum subsp. carotovorum LMG2410, containing pJMPCI or 
pJBMPR. 5 L of LB broth was inoculated (1:100), cells were grown at 28 °C to OD600 = 0.6 
and then induced with 0.3 mM IPTG and growth for an additional 12 hours at 28 °C. Cells 
were lysed and clarified as for syringacin M and supernatant applied to a DE-52 anion 
exchanged column (Whatman) equilibrated in 50 mM Tris-HCl, pH 7.5, 20 mM NaCl. 
Bound protein was eluted with a linear gradient of 20-600 mM NaCl in lysis buffer. 
Protein was then purified by gel filtration and concentrated and frozen as for syringacin 
M. 
 
2.14.3 Putidacin and syringacin L1 
Expression and purification of His-tagged proteins was performed as described for 
syringacin M, using plasmids pETPL1, pETSL1 and pET28SL1 in E. coli BL21 (DE3) for 
putidacin L1 and E. coli BL21 (DE3) pLysS for syringacin L1. 
58 
 
2.14.4 FupA 
The FupA open reading frames (ORF) from Pba SCRI1043 (FupA1043), Pbc LMG2913 
(FupA2913) and Pba LMG2386 (FupA2386) were amplified by PCR in their entirety or lacking 
the region coding for the 20 amino acid N-terminal signal sequence (∆20) (For Pba 
LMG2836 for only the ∆20 construct was made). The full-length ORF was ligated into 
pET21a at the NdeI and XhoI restriction sites. The ∆20 ORF was ligated into pET28a at the 
NdeI and XhoI (or EcoRI and HindIII for Pba LMG2386) restriction sites to encode a protein 
with an N-terminal His6-tag. Plasmids were transformed into E. coli BL21 (DE3) for 
expression. Cells expressing full-length FupA were induced at OD600 = 0.6 with 0.1 mM 
IPTG and grown at 28 °C for 12 h. The outer membrane fraction from these cells was 
isolated and co-elution experiments performed as described in section 2.12.  
Cells expressing  FupA ∆20 constructs as inclusion bodies were grown at 37 °C for 36 h in 
auto-inducing super broth (157). Inclusion bodies were refolded using the method of 
Saleem et. al. with modifications (158). Cells were harvested and lysed as for syringacin 
M, the insoluble fraction (containing the inclusion bodies) was isolated by centrifugation 
at 18,000 g for 25 minutes and homogenised using a tight fitting homogeniser in with 50 
mM Tris, 1.5% LDAO, pH 7.5 and incubated at room temperature with shaking for 30 
minutes. Inclusion bodies were pelleted by centrifugation at 18,000 g for 25 minutes and 
homogenised once more in 50 mM Tris, 1.5% LDAO (v/v), pH 7.5, pelleted and washed 
once in 50 mM Tris pH 7.5 before pelleting a final time. Inclusion bodies were then 
denatured in denaturing buffer (10 mM Tris, 1 mM EDTA, 8 M Urea, 1 mM DTT pH 7.5) at 
a ratio of 0.5 g of inclusion body to 40 ml of buffer using a tight fitting homogeniser, 
followed by incubation with shaking at 56 °C for 30 minutes. Insoluble material was then 
removed by centrifugation at 8000g for 10 minutes.  
FupA in denaturing buffer was then added drop wise to an equal volume of rapidly 
stirring refolding buffer (20 mM Tris, 1M NaCl, 5% (v/v) LDAO pH 7.9), followed by stirring 
for 1.5 h. Refolded FupA was then dialysed (10-15,000 Mw cut off membrane) into 2 x 5L 
of dialysis buffer (20 mM Tris, 0.5 M NaCl, 0.1% (v/v) LDAO pH 7.9) over 16 hours at 4 °C. 
Refolded FupA was then purified by Ni-affinity chromatography, with dialysis buffer used 
for binding FupA to the nickel column and dialysis buffer with 0.5 M imidazole used to 
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elute the protein. The protein was further purified using a superdex S200 26/60 column 
equilibrated in 50 mM Tris, 200 mM NaCl, 0.1 % (v/v) LDAO pH 7.9.  
For crystallisation experiments in β-OG, FupA was exchanged into buffer containing 0.8-1 
% β-OG, by immobilisation on a nickel column followed by washing with 10 column 
volumes of  50 mM Tris, 200 mM NaCl, 0.8-1 % (v/v) β-OG pH 7.9 and eluted with the 
same buffer with 0.5 M imidazole. The protein was then concentrated to 10-15 mg.ml-1 
before dialysis (10-15,000 Mw cut off membrane) for 20 h against 50 mM Tris, 200 mM 
NaCl, 0.8-1 % (v/v) β-OG, pH 7.9, to remove imidazole and normalise β-OG concentration. 
Successful refolding of FupA was confirmed by analytical gel filtration and circular 
dichroism. Refolded FupA1043 was concentrated and dialysed against a final buffer of 50 
mM Tris, 50 mM NaCl, 0.1% LDAO pH 7.5, for storage or 50 mM sodium phosphate, 0.1% 
LDAO for NMR experiments.  
 
2.15 Crystallisation, data collection and structure solution 
2.15.1 Syringacin M  
Initial crystallisation trials were performed using a Cartesian Honeybee 8+1 dispensing 
robot into 96 well plates via the sitting drop method (reservoir volume of 80 µl, drop size: 
0.5 µl protein, 0.5 µl reservoir solution) by vapour diffusion with syringacin M at a final 
concentration of 6 mg ml-1.  Hexagonal shaped crystals that diffracted to 6-7 Å at a home 
X-ray source were obtained in 10 % w/v PEG 8000, 20 % v/v ethylene glycol, 0.03 M CaCl2, 
0.03 M MgCl2, 0.1 M Bicine/Trizma base pH 8.5 at 20 °C from the MORPHEUS 
crystallisation screen (159). This crystal form had a symmetry of the space group P6322 
and an unusually high solvent content of approximately 80%. Optimisation was 
performed in sitting drop plates around this condition for both wildtype and D232A 
mutant protein. The best hexagonal crystals (Figure 9-1-A) were obtained in 7% w/v PEG 
8000, 30% v/v ethylene glycol 0.03 M CaCl2, 0.03 M MgCl2, 5% dimethyl sulfoxide, 0.1 M 
Bicine/Tris base pH 8.5 at 16 °C, and used for data collection at Diamond Light Source, 
Oxfordshire (DLS) with diffraction to 2.83 Å and 3.12 Å for wildtype and mutant proteins, 
respectively (Figure 9-2-A). All data sets collected at the DLS were processed with the 
programs XDS (160) and Scala (161). Phasing was attempted by molecular replacement 
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(MR) using PHASER (162), with the catalytic domain from colicin M as the search model. 
This proved unsuccessful and selenomethionine labelled protein (SeMet) was prepared 
and crystallised in the above conditions. A SeMet labelled crystal, producing diffraction to 
3.1 Å, was used to collect multiple-wavelength anomalous dispersion (MAD) data near 
the selenium absorption edge at the DLS. Phases were determined by MAD/SAD 
techniques using programs SHARP/autoSHARP (163,164), SHELXC/D/E (165),  and a partial 
model was built using ARP/wARP (166) and BUCCANEER (167). Further modelling and 
refinement against the wildtype or mutant data was performed with programs COOT 
(168), REFMAC (169) and various other programs from the CCP4 suite (170). Quality 
control of the geometry of the model was performed using RAMPAGE (171).  
The limited resolution of data from the hexagonal crystal form resulted in difficulty in 
modelling of the β-strands and connecting loops and so in situ trypsin digestion/ 
crystallisation was performed to change the crystal packing (172). Trypsin was added to 
syringacin M (15 mg ml-1) at a ratio of 1:200 on ice, immediately prior to addition to drop. 
Stacks of thin plates, diffracting to 2.1 Å at a home X-ray source, were grown in 8% w/v 
PEG 8000, 30% v/v ethylene glycol, 0.13 M CaCl2, 0.03 M MgCl2, 0.1 M Bicine/Tris base pH 
8.5 at 4 °C. To obtain single crystals, crystals grown under these conditions were crushed 
in the above reservoir buffer and 3-fold serial dilutions of this solution were used to seed 
sitting drops of the same composition at 16 °C. Single rhombic crystals formed after two 
days (Figure 9-1-B). These crystals had symmetry of the P21 space group and a solvent 
content of 52 %. Diffraction data were collected for the crystal of this form at DLS, 
reaching a resolution of 1.46 Å (Figure 9-2-B). This data was phased by MR using PHASER 
(162) and the model previously built against the data for the hexagonal crystal form, 
excluding the N-terminal 38 amino acids. High resolution data allowed for improved 
structure modelling in COOT (168) and final refinement with the use of individual atom 
anisotropic thermal parameters performed by REFMAC (169). Model based on monoclinic 
data was subsequently used to improve the full-length wildtype and mutant models from 
the hexagonal form. The N-terminal residues 2-38 were also modelled using the 
hexagonal form data for both wildtype and the D232A mutant. Features of the N-terminal 
electron density suggested some degree of conformational disorder, which limited the 
quality of the modelling of this region. Despite this, numerous interactions between N-
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terminus and the rest of the protein were observed. Data collection and refinement 
statistics for both crystal forms of syringacin M are presented in Table 2-8. 
Table 2-8 Data collection and refinement statistics for syringacin M 
  Monoclinic  Hexagonal  Hexagonal D232A  
Data Collectiona    
Space group  P21 P6322 P6322 
Cell dimensions    
    a, b, c (Å) 55.81, 96.60, 64.27 159.69, 159.68, 
100.17 
160.35, 160.35,  
100.74 
    α, β, γ (°) 90, 114.17, 90 90, 90, 120 90, 90, 120 
Resolution (Å) 50.92 - 1.46 (1.50 - 
1.46) 
46.34 - 2.83 (2.91 - 
2.83) 
40.09 - 3.12 (3.20 - 
3.12) 
Solvent content ~50% ~80% ~80% 
No. of unique 
observations  
106648 (7853) 17330 (1337) 13347 (1018) 
Multiplicity 6.2 (6.0) 8.2 (8.6) 15.5 (16.2) 
Completeness (%) 99.7 (99.7) 99.12 (100) 99.53 (100) 
Rmerge (%) 5.2 (96.6) 5.9 (69) 4.8 (78.7) 
Rpim (%)
b 2.5 (51.5) 2.2 (25.7.8) 1.8 (28.4) 
Mean I/σ(I) 13.6 (2.9) 19.5 (3.1) 26.9 (4.3) 
    
Refinement Statistics    
Rwork/Rfree (%) 15.2/20.1 20/23.9 18.2/22.4 
Non-hydrogen atoms 4412 2139 2123 
RMSD of bond length 
(Å) 
0.020 0.020 0.012 
RMSD of angle (°) 2.097 2.028 1.513 
Waters 551 35 27 
Mean/Wilson plot B-
value (Å2) 
28.94/23.1 84.27/102.3 98.7/107.9 
Ramachandran plot 
(%)c 
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Favoured/Allowed/O
utliers 
97.9/2.1/0 88.3/9.9/1.8 89.1/8.4/2.6 
PDB identifier  4FZL 4FZN 4FZM 
a Values in parentheses refer to the highest resolution shell. 
b Rpim = Σhkl[1/(N - 1)
1/2Σi|Ii(hkl) - <I(hkl)>|/ΣhklΣiIi(hkl) 
c Percentages of residues in favoured/allowed regions calculated by the program RAMPAGE 
(27) 
 
2.15.2 Pectocin M2  
Initial crystallisation trials were performed at the high throughput crystallization facility of 
the University of Zurich using the vapour diffusion method (reservoir volume of 50 µl, 
drop size: 100 nl protein, 100 nl reservoir solution) with pectocin M2 at a final 
concentration of 15 mg ml-1. Pectocin M2 formed crystals or spherulites in a number of 
conditions containing ammonium sulphate and PEG 3350. Crystals were extracted from 
one of these conditions (15 % PEG 3350, 0.2 M ammonium sulphate, 3 % 2-methyl-2,4-
pentanediol (MPD), 0.1 M bis-tris pH 6.5), cryoprotected by increasing PEG 3350 to 30 % 
and data were collected at 100 °K to 2.3 Å in the space group P21, at the SLS (Zurich). Re-
crystallisation screening of pectocin M2 was performed, using a custom screen with 
variations in the concentration/ratio of precipitants from the original condition 
(ammonium sulphate and PEG 3350), pH and additives. Clusters of large rod-shaped 
crystals formed at high ammonium sulphate concentrations (Figure 9-1-C). This was 
optimised giving a final condition of 1.8 M ammonium sulphate, 3 % MPD, 0.1 M MES, pH 
6.5. These crystals were manually separated and cryoprotected with 15-20 % glycerol. 
Data were collected at 100 K on beamlines I02 and I03 at the Diamond Light Source 
(Oxfordshire, UK) to a resolution of 1.86 Å (Figure 9-2-C). Automatic data-processing was 
performed with Xia2 within the EDNA package (173). Datasets for experimental phasing 
using the iron-sulphur cluster of pectocin M2 were collected at the iron K-edge (1.7433 Å) 
and high-resolution data were collected at 0.9796 Å.  
Phases for the P21 and P3121 datasets, were obtained from the anomalously scattering 
substructure from the pectocin-ferredoxin domain iron-sulphur cluster, determined for 
the iron-edge dataset using the Hybrid Substructure Search from the Phenix package 
(174). Four positions were located per ASU corresponding to two iron-sulphur clusters 
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(correlation coefficient = 0.5) from two pectocin M2 molecules. These positions were 
then utilised by Phaser-EP to determine initial phases for the map (162,170,174). Phases 
were improved by density modification using RESOLVE density modification from the 
Phenix package, and the initial model was built and refined using Phenix Autobuild (174). 
In the P3121 form the autobuilt model was then utilised by Phaser to obtain phases for 
the high-resolution dataset and the model was further built and refined manually using 
Coot 0.7 and Refmac5 (162,168,169). Validation of refined structures was performed 
using the Molprobity web server and Procheck from CCP4i (175,176). Data collection and 
refinement statistics for both crystal forms of pectocin M2 are presented in Table 2-9. 
Table 2-9 Data collection and refinement statistics for pectocins M2 
  High Resolution Data Iron Edge Data 
Data Collectiona    
Space Group  P21 P3121 P3121 
Cell Dimensions    
    a, b, c (Å) 44.65, 116.75, 60.78 117.45, 117.45, 128.45 117.26, 117.26, 128.53 
    α, β, γ (°) 90, 94.96, 90 90, 90, 120 90, 90, 120 
Resolution (Å) 50.00-2.30 (2.44-2.30) 64.22-1.86 (1.91 - 1.86) 43.31-2.01 (2.06-2.01) 
Rmerge (%) 5.0 (59.9) 3.4 (68.3) 3.8 (69.3) 
Rpim (%)b - 0.9 (15.7) 2.0 (31.0) 
Mean I/sigma(I) 12.41 (1.85) 47.1 (5.5) 28.9 (3.1) 
Completeness 
(%) 
96.6 (95.7) 100.0 (99.9) 99.4 (98.7) 
Redundancy  3.2 (2.8) 20 (20.8) 8 (6.6) 
    
Refinement     
Resolution (Å) 50.00-2.30 (2.44-2.30) 64.22-1.86 (1.91 - 1.86)  
No. Reflections 52652 (8438) 86092 (6304)  
Rwork / Rfree 
(%) 
21.0/27.2 16.8/19.1  
No. Atoms    
Protein 4093 4175  
Ligand/ion 34 388  
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Water 49 438  
B factors    
Protein 69.1 45.5  
2Fe-2S 74.6 35.4  
SO42- / Cl- 95 68.2  
Glycerol / MPD - 70.7  
Water 42.4 56.0  
r.m.s deviations    
Bond lengths (Å) 0.016 0.024  
Bond angles (°) 1.757 2.55  
PDB identifier 4N59 4N58  
a Values in parentheses refer to the highest resolution shell 
b Rpim = Σhkl[1/(N - 1)]
1/2Σi|Ii(hkl) - <I(hkl)>|/ΣhklΣiIi(hkl) 
c Percentages of residues in favoured/allowed regions calculated by the program RAMPAGE 
(68) 
 
2.15.3 Pyocin L1 
Purified pyocin L1 at a concentration of 15 mg ml-1 was screened for crystallisation 
conditions using the Morpheus and PGA crystallisation screens (Molecular Dimensions) 
(177). Clusters of needle shaped crystals grew in a number of conditions in each screen 
over 3 to 7 days. Two of these conditions, condition 1 (20% v/v ethylene glycol, 10% w/v 
PEG 8000, 0.03 M CaCl2, 0.03 M MgCl2, 0.1 M Tris/Bicine, pH 8.5) and condition 2 (20% 
PEG 550 MME, 20% PEG 20K, 0.03 M CaCl2, 0.03 M MgCl2 0.1 M MOPS/HEPES, pH 7.5) 
from the Morpheus screen were selected for optimisation in 24 well plates. Clusters of 
needles from these trays were mechanically separated. The un-soaked crystals were from 
condition 1, while soaked crystals were from condition 2. Un-soaked crystals were looped 
and directly cryo-cooled to 110 K; D-mannose and D-rhamnose soaked crystals were 
soaked for 2-12 minutes in artificial mother liquor containing 4 M D-mannose or 2 M D-
rhamnose, before cryo-cooling to 110 K. X-ray diffraction data were collected at the 
Diamond Light Source, Oxfordshire, UK at beam lines I04, I04-1 and I24. Automatic data 
processing was performed with Xia2 within the EDNA package (173).  
A dataset from an un-soaked pyocin L1 crystal was submitted to the Balbes pipeline along 
with the amino acid sequence for pyocin L1 (178). Balbes produced a partial molecular 
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replacement solution based on the structure of Galanthus Nivalis agglutinin (PDB ID: 
1MSA). Initial phases from Balbes were improved via density modification and an initial 
model was built using Phase and Build from the Phenix package.(179) The model was 
then built and refined using REFMAC5 and Coot 0.7 (180,181). Validation of all models 
was performed using the Molprobity web server and Procheck from CCP4-I (175,176). 
Two structures of sugar soaked pyocin L1 were solved by molecular replacement using 
Phaser (182), with the sugar-free pyocin L1 as the search model. Additional electron 
density corresponding to bound sugars, was observed in both 2Fo-2Fc and Fo-Fc maps 
(183). Sugars were fitted and structures refined using Coot 0.7 and REFMAC5. β-D-
mannose (PDB ID: BMA) corresponded best to the density of bound D-mannose. The 
density in the D-rhamnose complex best corresponded to α-D-rhamnose, for which no 
PDB ligand exists; a model for α-D-rhamnose was prepared by removing the oxygen from 
carbon 6 of α-D-mannose and submitting these PDB coordinates to the Prodrg server, 
which generated the model and modelling restraints (183). The resultant α-D-rhamnose 
was designated with the PDB ID: XXR.  Data collection and refinement statistics for pyocin 
L1 apo and sugar bound crystals are presented in Table 2-10 . 
 
Table 2-10 Data collection and refinement statistics for pyocin L1 
  Sugar Free Form D-Rhamnose 
Soak 
D-Mannose Soak 
Data collectiona    
Space group  C2221 C2221 C2221 
Cell dimensions, a, b, c (Å) 53.41,  158.40,  147.67 52.99, 160.65, 
150.57 
53.42, 162.1, 152.5 
Resolution (Å)  36.42 - 2.09 (2.14 - 
2.09) 
54.99 - 2.37 
(2.43 - 2.37) 
55.53  -2.55 (2.67 - 
2.55) 
Solvent content (%) 56 55 56 
No. of unique observations  37131 (2751) 26242 (1922) 22096 (2901) 
Multiplicity 4.8 (4.9) 4.4 (4.5) 5.5 (5.7) 
Completeness (%) 99.0 (99.8) 99.1 (99.5) 99.9 (100.0) 
Rmerge (%) 7.2 (59.2) 5.9 (83.0) 7.1 (85.6) 
Rpim (%)
b 4.1 (33.0) 3.4 (44.9) 3.3 (39.2) 
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Mean I/sigma (I) 14.3 (2.1) 19.0 (2.1) 13.3 (2.3) 
    
Refinement statistics    
Rwork/Rfree (%) 17.8/22.2 20.9/25.7 19.4/24.8 
No. of non-hydrogen atoms 4505 4178 4138 
RMSD of bond lengths (Å) 0.02 0.015 0.013 
RMSD of bond angles (°) 1.96 1.63 1.70 
No. of waters 344 95 27 
Mean/Wilson plot B-value 
(Å2) 
40.2/33.8 54.2/43.6 65.9/59.1 
Ramachandran plot (%)c    
Favoured/Allowed/Outliers 97.2/2.2/0.6 97.4/2.2/0.4 96.6/3.0/0.4 
PDB identifier  4LE7 4LED 4LEA 
a Values in parentheses refer to the highest resolution shell 
b Rpim = Σhkl[1/(N - 1)]
1/2Σi|Ii(hkl) - <I(hkl)>|/ΣhklΣiIi(hkl) 
c Percentages of residues in favoured/allowed regions calculated by the program RAMPAGE 
(68) 
 
2.15.4 FupA crystallisation 
Crystallisation trials for FupA were conducted on refolded FupA1043 in a buffer containing 
50 mM Tris, 200 mM NaCl and 1 % β-OG, approximately 800 conditions from commercial 
screens (Memplus, Memgold I/II, Morpheus, JCSG +, Midas, PACT, PGA, Memstart) were 
tested (159). Very small needle like crystals (5-20 µM) grew in a number of conditions, 
with the best forming in Midas condition H12 (15 % PVP-K15, 25 % PEG MME 5500, 0.1 M 
Tris, pH 8.0. Crystals from the initial screen failed to diffract and so were subjected to 
extensive optimisation. The results of this optimisation yielded conditions (11-14 % PVP, 
14 % PEG 2000 MME, 0.1 Tris, 0.05 M MgCl2 pH 7.5, with a FupA concentration of 15 
mg.ml-1 in 50 mM Tris, 200 mM NaCl, 0.8-1 % (v/v) β-OG, 0.4 % LDAO pH 7.9) producing 
crystals with somewhat improved morphology, still possessing a long needle-like 
structure, but being thicker and much larger (100-700  µm) (Figure 9-1-E). Crystals were 
cryoprotected with 20% ethylene glycol and data collected at DLS at 100 K.  The crystals 
were in the space group P21 and diffracted with extreme variability, with the best data 
recorded reflections to 2.8 Å and the best autoprocessed dataset to 3.76 Å (Table 2-11) 
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(Figure 9-2-E). Selenomethionine labelled FupA was expressed and refolded, but despite 
extensive screening and optimisation failed to crystallise reproducibly, with the best 
examples diffracting to 7 Å.  
 
Table 2-11 Data collection statistics for FupA 
Data collectiona  
Space group  P21 
Cell dimensions, a, b, c (Å) 137.4, 78.36,  137.93 
Resolution (Å) 68.95-3.76 (3.86-3.76) 
Solvent content (%) 45-65 
No. of unique observations  30209 (2221) 
Multiplicity 3.4 (3.5) 
Completeness (%) 99.8 (99.8) 
Rmerge (%) 11.3 (52.7) 
Rpim (%)
b 8.6 (39.8) 
Mean I/sigma (I) 9.2 (2.0) 
  
 
2.15.5 Crystallisation of syringacin L1 and pectocins P  
During the course of this study crystallisation of a number of other targets was 
attempted. Hits were obtained for both syringacin L1 and pectocin P. 
Syringacin L1 was purified from BL21 pLysS (DE3) containing pET28SL1, by nickel affinity 
chromatography followed by size exclusion on an S75 column, as for syringacin M. The N-
terminal 6xhis tag was subsequently cleaved by overnight incubation in SEC buffer, with 
thrombin conjugated to agarose beads (Sigma).  The cleavage tag was removed by 
passage through a nickel column and the protein was concentrated to approximately 20 
mg/ml. Sitting drop crystal trails were set up with 100 nl + 100 nl protein to precipitant, in 
Morpheus,  JCSG and PACT crystallisation screens. Hexagonal shaped crystals formed in 
condition A10 of JCSG (0.2 M potassium formate, 20 % w/v PEG 3350) that appeared 
proteaceous in nature. However these crystals were destroyed during looping and so 
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their diffraction potential remains unknown. Due to the difficultly experienced in 
consistently obtaining syringacin L1 these crystallisation trials were not repeated in this 
study. 
Pectocin P was purified from BL21 pLysS (DE3) containing pJPP1, and purified by nickel 
affinity chromatography and size exclusion on an S75 column, as for syringacin M. the 
protein was concentrated to approximately 15 mg.ml-1 and approximately 1000 
conditions were screened. A number of characteristically red crystals grew after 8 months 
in wells B12, D12 and E12 of the Morpheus screen (159). Crystals from B12 were shot at 
Diamond Lightsource beamline I24 producing diffraction to approximately 3 Å, the crystal 
was of the space group P1, with unit cell parameters of 58.0, 71.3, 74.5 Å and 71.3, 66.9, 
89.5 ˚, however due to radiation damage and robot malfunction a complete dataset  
could not be collected. Optimisation trays for these conditions were set however no 
crystals were obtained during this study. 
 
   
2.16 NMR 
2.16.1 For pyocin L1 
NMR chemical shift perturbation analysis of sugar binding by pyocin L1 and putidacin L1 
was carried out at 305 K and 300 K respectively. Fast-HSQC spectra (184) were recorded 
using 15N labelled proteins (0.1-0.2 mM) and unlabelled ligands, D-rhamnose and D-
mannose (100 mM), on a Bruker AVANCE 600 MHz spectrometer. Protein samples were 
prepared with and without the sugars present and volumes were exchanged at fixed 
ratios, making sure the protein concentration remained unchanged. The spectra were 
processed with Topspin and analysed with CCPNmr analysis (185). 
 
2.16.2 For FupA 
Fast-HSQC spectra (186) were recorded for 15N-labelled Arabidopsis ferredoxin and 
pectocin M1 ferredoxin (100 µM) on a Bruker AVANCE 600 MHz spectrometer.  The 
interaction of these proteins with FupA was explored by acquiring spectra for 1:1 ratio 
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mixtures. LDAO (0.1%)-containing buffer was used as a negative control to ensure that 
chemical shifts were not caused by the presence of the zwitterionic detergent. In the case 
of the Arabidopsis ferredoxin-FupA complex, TROSY spectra were acquired to try to 
detect 15N-labelled ferredoxin in slow exchange with FupA. All spectra were processed 
with AZARA (W. Boucher, www.bio.cam.ac.uk/azara) and analysed with CCPNmr analysis 
(187).   
2.17 Analytical ultracentrifugation  
Sedimentation velocity (SV) was carried out in a Beckman Coulter Optima XL-I analytical 
ultracentrifuge using an An-50 Ti 4-hole rotor.  Sample (90 l) was loaded into a 3 mm 
path-length centrepiece and spun at 49,000 rpm for 12 h at 15C. Scans were collected 
every 7 minutes using absorbance optics (at 280 nm; a radial range of 5.8 - 7.2 cm, and 
radial step-size of 0.005 cm). 50 mM Tris, 200 mM NaCl, 2 mM α-sulfo myristic acid 
(C14SF), pH 7.5 was used as the buffer and this buffer lacking C14SF as a reference.  Data 
were analysed with SEDFIT(188) using the continuous c(s) distribution model. SEDNTERP 
was used to calculate the partial specific volume, the buffer density and viscosity at 15 C 
and 20 C. 
2.18 SAXS data collection and analysis  
SAXS data were collected on the X33 beamline at the Deutsches Elektronen Synchrotron 
(DESY, Hamburg, Germany). A range of pectocin M2 and pyocin M concentrations 
between 0.4-4.0 mg ml-1 was used. The scattering from buffer was acquired before and 
after each sample and an average of the buffer scattering was subtracted from the 
sample scattering. The first 200 points (low angle data) of the scattering curve obtained 
for 1 mg ml-1 protein were merged with the rest of the high angle data from the 4 mg ml-1 
sample to avoid the influence on the data of any inter-particle interference. All data 
processing was performed using PRIMUS (189).  Porod-Debye (I(q)q4 vs q4) and 
normalised Kratky (I(q)q2 vs q) plots were used to assess particle flexibility as described in 
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the Results section(190),(191). The distance distribution function, p(r), was obtained by 
indirect Fourier transform of the scattering intensity using GNOM (192). A Guinier plot (ln 
I(s) vs s2) was used to determine the radius of gyration, Rg, of pectocin M2 and pyocin M. 
US-SOMO (193) was used to determine hydrodynamic parameters based on the crystal 
structures of pectocin M2. CRYSOL (194) was used to compute theoretical scattering 
curves from high-resolution X-ray structures. 
2.19 Lipid II docking simulations   
To simulate the active form of the enzyme the structure of pectocin M2 was modified to 
include a Mg2+ ion coordinated by the D226 side chain and backbone carbonyls from L202 
and N204, no modifications were performed on the syringacin M structure. The docked 
model for lipid II was derived from the Nisin-Lipid II complex structure (158) (PDB 
=1WCO), the pentapeptide and N-acetylglucosamine groups were removed to create the 
model used in docking simulations. Autodock vina (195) embedded in UCSF Chimera (196) 
molecular viewer was utilised to perform docking simulations. A search volume of 67 by 
36 by 32 Å was defined containing the catalytic domain of either pectocin M2 or 
syringacin M. The docking simulation was run with charges normalised and non-polar 
hydrogen atoms removed, water molecules were ignored. The number of binding modes 
was set to 9 with the best scored docking, in which the full lipid II molecule (i.e. with the 
pentapeptide and N-acetylglucosamine groups) would not cause major clashes (solution 
1/9 for pectocin M2, solution 2/9 for syringacin M) was selected.  Search exhaustiveness 
was set to 8, with a maximum energy difference of 3 kcal/mol.  
 
2.20 Plant transformation and infection 
2.20.1 Transient expression of bacteriocins in Nicotiana benthamiana 
The leaves of N. benthamiana plants between 4 to 8 weeks of age were syringe infiltrated 
with 0.2 OD600 A. tumefaciens GV3101 containing the desired binary vector in 10 mM 
sterile MgCl2. To activate the A. tumefaciens DNA transfer machinery the plant wounding 
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hormone acetosyringone was added to the solution at 200 M 2 hours prior to 
infiltration. Infiltration was achieved by filling a 1 ml syringe with bacterial solution, 
applying the tip to the leaf underside while holding the top of the leaf and ejecting the 
syringe. To limit silencing of the transiently expressed bacteriocins A. tumefaciens 
GV3101 with a binary vector containing the bushy stunt virus P19 silencing repressor was 
co-inoculated in the same MgCl2 solution for all constructs at an OD600 of 0.2 (149).  
Expression of bacteriocins was monitored from 2 and 7 days by grinding transformed leaf 
material, snap frozen in liquid nitrogen, in extraction buffer (50 mM Tris, 200 mM NaCl, 
pH 7.5, with protease inhibitor cocktail (Roche)). Buffer was then clarified and tested for 
expression using the soft agar overlay assay or western blotting.  
Expression of GFP-tagged proteins was visualised by confocal microscopy. A 1cm2 leaf 
section of transformed N. benthamiana was excised and infiltrated with H2O by repeated 
application of suction in a water filled syringe. The leaf section was then immobilised on a 
microscope slide under a cover slip secured with contact adhesive. GFP fluorescence was 
observed using a GFP filter set with the excitation laser at to 485 nm, and emission 
detected at 520-560 nm.           
 
2.20.2 P. syringae infection of N. benthamiana 
A solution of 104-107 cfu/ml of P. syringae in sterile 10 mM MgCl2 was syringe infiltrated 
into the leaves of N. benthamiana, the extent of the infiltration area was marked on leaf. 
Bacterial growth and lesion formation was monitored visually and by cfu/cm counts from 
the infected area. Triplicate 0.7 mm leaf disks from infected plants were homogenised 
separately in 1.5 ml Epindorf tubes using a tissue homogeniser in 100 l of sterile H2O. 
Lysate was clarified by centrifugation and 10 fold serial dilutions in sterile H2O were 
performed, 3x10 l spots of each dilution were plated on KB agar. Plates were incubated 
at 28C for 16 hours and colonies at the highest dilution with >4 colonies per spot were 
used to determine leaf bacterial concentration.        
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2.20.3 Stable transformation of Arabidopsis thaliana with bacteriocins 
For stable transformation of A. thaliana with gene for putidacin L1 or syringacin L1 the 
vector pJO530 (pJOPL1-Nmyc or pJOSLI) was utilised. The floral dip method was used as 
per Zhang et. al. 2006 with modifications (197). Arabidopsis plants (approximately 4 per 
pot) were grown in pots covered with fabric mesh, and grown under long day conditions 
to induce flowering. When approximately 10-20 % of flower heads had formed green 
seed pods, the entire flower head was submerged for 30 seconds in 500 ml of a stationary 
phase culture of A. tumefaciens containing pJO530 derived binary vector dissolved in 500 
ml 5 % sucrose and 0.02% Silwet L-77 (Momentive). Plants were kept in high humidity (i.e. 
plastic bag) for 12 hours and dipping repeated after 24 hours. Plants were then grown 
until flower heads formed mature seed pods. 
Seeds from transformed plants were harvested and sterilised by suspension in: 70 % 
ethanol for 1 minute, followed by suspension for 10 minutes in a seed sterilisation 
solution consisting of: 5 ml of a solution of a chlorine tablet sterilisation tablet dissolved 
in 20 ml of H2O plus 5 drops of triton X-100, added to 45 ml of 100 % ethanol. Seeds were 
then washed for 2 minutes in 70 % ethanol, followed by washing for 3 x 1 minutes in 
sterile H2O. Sterilised seeds were then plated onto MS agar (4.3 g Murashige & Skoog 
salts, 10 g sucrose, 0.5 g MES, 8 g agar per liter; pH 5.7) with 25 µg.ml-1 hygromycin B (the 
selection for pJO530). Plates were incubated at 4 C for 72 hours and maintained in the 
dark for 5 days. For collection of seed from T0 to T2 generations plants were then grown 
under long day conditions. Plates were inspected for successful transformants after 
approximately 2-3 weeks. All seeds are capable of germination and chlorophyll 
production under hygromycin selection, however sensitive plants are able to not exhibit 
normal growth and are unable to undergo significant root development or production of 
a second set of leaves. Resistant plants were transferred to soil and grown until the 
formed mature seeds for collection. Leaves from resistant plants were harvested and 
tested for bacteriocin expression as for N. benthamiana experiments.   
Seeds from initial transformations (T0 generation) were selected for hygromycin 
resistance on MS agar with 25 ug.ml-1 hygromycin B as above and the ratio of resistant to 
sensitive plants assessed to identify lines with a single insertion event. Resistant plants 
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from lines displaying a 3:1 resistant to sensitive ratio were grown to maturity and seeds 
collected (T1 generation).  
Seeds from multiple plants from each line of T1 generation were selected for hygromycin 
resistance and those producing progeny with a 100 % resistant phenotype, thus 
possessing a homozygous transgenic phenotype, were utilised for future study. 
 
2.20.4 P. syringae infection of transgenic Arabidopsis      
The leaves of wildtype and transgenic Arabidopsis growth under short day conditions in 
individual pots were utilised for infection assays. Plants between 4 and 6 weeks of age 
were infiltrated with 105 to 107 cfu/ml of P. syringae in sterile 10 mM MgCl2, using the 
syringe infiltration method described above. Plants were maintained at high humidity (i.e. 
by covering growth trays with a clear plastic lid) for 16 hours post infiltration as it was 
found to assist in successful infection. Disease phenotype and bacterial growth in the leaf 
tissue was monitored as for N. benthamiana infections.     
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3 Discovery and characterisation of syringacin M from 
Pseudomonas syringae pv. tomato DC3000 
Results from this section are included in: 
Grinter, R.*, Roszak, A. W.*, Cogdell, R. J., Milner, J. J., and Walker, D. (2012) The Crystal 
Structure of the Lipid II-degrading Bacteriocin Syringacin M Suggests Unexpected 
Evolutionary Relationships between Colicin M-like Bacteriocins. J. Biol. Chem. 287, 
38876-38888 
* Denotes joint first authorship  
 
 
Disclaimer on work performed:  
Data collection from syringacin M crystals, structural solution and model building in this 
chapter were performed in conjunction with and under the guidance of Dr. Aleksander 
Roszak.   
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3.1 Introduction 
At the outset of this study a number of P. syringae strains of UK origin, isolated from a 
diverse array of plant species, were obtained from the Belgian Coordinated Collection of 
Microorganisms (BCCM) and National Collection of Plant Pathogenic Bacteria (NCPPB) in 
the UK. Along with these strains, for which genome sequences were unpublished, the 
well-studied P. syringae isolate, pv. tomato DC3000 was obtained. As discussed in this 
chapter, these strains were tested for the production of bacteriocins, which resulted in 
the identification of the novel M-class bacteriocin syringacin M. Syringacin M, which is 
produced by the P. syringae isolates DC3000 and LMG1247, was previously cloned by 
Barreteau et. al. in 2009, however it was not shown to exhibit any cytotoxic activity 
against strains tested (82). The data presented in this chapter shows that this protein is 
indeed an active bacteriocin and provides insight into the catalytic mechanism and 
evolution of M-class bacteriocins. Prior to this work the crystal structure of colicin M, the 
first M-class bacteriocin to be identified, had been solved and the cytotoxicity of M-class 
bacteriocins has been shown to be due to the degradation of Lipid II in the periplasm 
(83,198). However, limited information was available about M-class bacteriocins from 
other species. The structural and biochemical analysis of syringacin M presented in this 
chapter significantly expands our knowledge of this class of antimicrobial protein.   
 
3.2 Screening of P. syringae isolates for bacteriocin production 
and the identification of syringacin M 
In order to identify potential bacteriocins to use to combat P. syringae infection, a soft 
agar overlay assay of chloroform lysed colonies of P. syringae was used to screen a 
number of diverse pathovars of P. syringae for the production of bacteriocins in the 
presence of the DNA damaging agent mitomycin C (Table 2-1, Table 9-1).  Of these 
potential bacteriocin producing strains, P. syringae pv. syringae LMG1247 (the type strain 
for this pathovar) produced a large diffuse zone of inhibition, reminiscent of the S-type 
pyocins from P. aeruginosa, against two indicator strains (P. syringae LMG5456 and 
LMG5084) in soft agar overlay experiments. In order to identify this bacteriocin a 1 L 
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culture of Pss. LMG1247 was grown in the presence of mitomycin C and subjected to 
ammonium sulphate precipitation to isolate secreted proteins.  Secreted proteins were 
then separated by native-PAGE and the native gel was used in a soft agar overlay assay 
against a sensitive indicator strain. A band which correlated with cytotoxicity was excised, 
trypsinised and subjected to LC-MS/MS (Figure 3-1-A).  Analysis and database searching 
of MS/MS data using the MASCOT search engine matched the secreted bacteriocin 
through 5 peptides to  a predicted colicin M-like bacteriocin, ZP_07266212 from Pss. 642  
for which the genome sequence is available (Figure 3-1-B). Primers were designed based 
on this sequence to amplify and identify the corresponding gene from Pss. LMG1247.  
Successful amplification and sequencing of this gene showed that Pss. LMG1247 harbours 
a bacteriocin encoding gene that shares 99 and 94 % sequence identity at the amino acid 
level to ZP_07266212 from Pss. 642 and a close homologue Q88A25 from Pto DC3000, 
respectively.  This homologue from Pto. DC3000 has been purified previously and shown 
to have lipid II degrading activity in vitro; the study however did not find any cytotoxic 
activity associated with the bacteriocin when tested against 24 strains of P. syringae or 
isolates of P. aeruginosa and P. fluorescens (82).  To support the idea that Q88A25 from 
Pto DC3000 and the trivially different homologous bacteriocin from Pss. LMG1247 are in 
fact active bacteriocins, we cloned the Q88A25 gene from Pto DC3000 into the E. coli 
expression vector pET21a and produced and purified recombinant C-terminally His6-
tagged protein (Figure 3-2-A). The spectrum of activity of this recombinant protein was 
identical to the secreted bacteriocin from Pss. LMG1247, supporting the MS/MS 
identification data (Figure 3-2-B). To standardize the nomenclature for bacteriocins from 
P. syringae, this bacteriocin was named syringacin M.  In addition to the 10 P. syringae 
test strains, the activity of syringacin M was tested against various strains of P. 
aeruginosa, Pectobacterium spp, P. fluorescens and P. putida (Table 2-1).  Killing of these 
bacterial species was not detected.  Thus, syringacin M is an active bacteriocin, whose 
targets, like other colicin-like bacteriocins are bacterial strains that are closely related to 
the producing strain.  
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Figure 3-1 Identification of the bacteriocin produced by Pss. LMG1247 
 Native-PAGE gel (8%) of DEAE anion exchange purification fraction from concentrated culture 
medium of Pss. LMG1247, coomassie strained and overlayed with soft agar seeded with test strain 
Psl. LMG 5456. Band corresponding to zone of growth clearing excised and identified using tandem 
mass spectrometry. 
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3.3 Domain structure of syringacin M  
For colicin M and other colicins the N-terminal domain of the protein, which is often fully 
or partially disordered, corresponds to the translocation domain, and the central domain 
is involved in receptor binding (4). However, for the closely related S-type pyocins of P. 
aeruginosa the literature reports that the order of these domains is reversed and the 
receptor binding functionality resides within the N-terminal domain (69). To 
Figure 3-2 Purification and characterization of wildtype syringacin M and deletion mutants  
A) 15% SDS-PAGE gel showing purified syringacin M (SyrM) and mutant proteins generated in this 
study, B) Light field image of five-fold serial dilutions (37.5 μM to 1 nM, MIC = 60 nM) of syringacin M 
spotted onto a soft agar overlay of susceptible strain P. syringae pv. lachrymans LMG 5456,  C) Dark 
field image of interference of killing activity of syringacin M on soft agar overlay by adjacent spotting 
of inactive mutants (proteins spotted at 100 μM). 
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unambiguously assign functionality to the N-terminal and central domains of syringacin M 
we created truncated syringacin M variants lacking the first 10 or 20 amino acids. Both 
deletion mutants lacked discernible bactericidal activity, indicating an essential functional 
role for the N-terminal domain of syringacin M. In order to determine whether these 
mutants possessed an intact receptor binding domain competition experiments were 
performed by spotting syringacin M Δ10 and Δ20 protein within the diffusion zone of 
wildtype protein in a soft agar overlay experiment, both proteins inhibited killing by the 
wildtype syringacin M (Figure 3-2-C). This inhibition is attributable to competition for 
binding to the cell surface receptor required for entry of syringacin M into the target cell 
and indicates that the mutants possess a functional receptor binding domain.  The N-
terminal domain is therefore a translocation domain, while the globular central domain is 
the receptor binding domain. These data suggest that syringacin M displays a colicin-like 
arrangement of domains with an N-terminal translocation domain, a central receptor 
binding domain and a C-terminal cytotoxic domain.  
 
3.4 The crystal structure of syringacin M 
Crystals were obtained and intensity data collected for two crystal forms of purified 
syringacin M, one of full length protein in the hexagonal form diffracting to 2.83 Å and 
another resulting from in situ trypsin digested protein, in the monoclinic form diffracting 
to 1.46 Å. Hexagonal crystal data produced electron density corresponding to residues 2-
276, although quality of density corresponding to residues 2-38 suggested partial disorder 
in this region, with some sections having a high degree of conformational flexibility 
(Figure 3-3-A). Threading of this region was attempted but the Ramachandran geometry 
was imperfect (171).   The monoclinic crystal contained two molecules per asymmetric 
unit related by a non-crystallographic 2-fold symmetry with only minor differences due to 
crystal packing. Electron density from this data allowed unambiguous modelling of 
residues 38-276, which correlates well with the presence of a predicted trypsin cleavage 
site between R37 and G38. Figure 3-3-B presents a cartoon representation of molecule A. 
Alignment of residues 38-276 from hexagonal wildtype and monoclinic trypsin-digested 
models gave a backbone RMSD of 0.47 Å and showed that the conformation of the 
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protein is the same in both crystal forms. As such, the high resolution model will be used 
in the further discussion except for where the N-terminus is discussed.  
 
 
Figure 3-3 Crystal structure of syringacin M 
A) Full length structure of syringacin M showing AA 38-276 as a surface model and the unstructured N-
terminus (AA 2-37) is a ribbon model. The Fo-Fc omit map of electron density at 2.7 σ for AA 2-37 is shown 
as a chicken wire model  B) cartoon representation of high resolution structure of syringacin M (AA 38-276) 
showing receptor binding domain (green), cytotoxic domain (red) and Ca
2+
 ion (orange).  
 
3.5 Structural description of syringacin M  
 The structure of syringacin M reveals a protein with a compact mixed sheet/helix 
structure and a partially disordered N-terminus consisting of 39 amino acids. Disordered 
or partially disordered translocation domains are also observed in a number of other 
colicin structures and like the N-terminal 39 amino acids of syringacin M they are rich in 
Pro, Ala, Ser and Gly residues.  In colicin E3, where the first 83 amino acids of the protein 
are disordered, an unstructured N-terminal domain is required to enable threading of this 
region of the protein through the lumen of the OmpF porin to deliver the TolB interacting 
region of the protein into the periplasm (64,66).  Similarly, in colicin M, the N-terminal 35 
residues, although visible in the crystal structure display markedly higher temperature 
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factors than other regions of the protein and lack regular secondary structure (198). Thus 
syringacin M possesses an N-terminal translocation domain that is typical of colicin-like 
bacteriocins.  As with colicin M the receptor binding domains and catalytic domains of 
syringacin M do not form obviously distinct structural entities.  However, on the basis of 
truncation experiments Barreteau et. al. reported that the minimum catalytically active 
region of colicin M corresponds to amino acids 122-271 and that helix 1 (37-46) is 
required for receptor binding. This delineates the receptor binding domain as a compact 
bundle of 5 helices spanning residues 37-122 (40-127 in syringacin M) (199).  As expected 
from the extensive sequence similarity (Figure 3-4) the structures of the colicin M and 
syringacin M catalytic domains are structurally homologous (RMSD 2.6 Å). However, for 
syringacin M well defined electron density for a single metal ion is present in the active 
site.  This density correlates well with the presence of Ca2+ which is present at high 
concentration in the crystallization buffer. In the syringacin M model, Ca2+ is coordinated 
by backbone carbonyl groups of residues L202, N204 and the side chain of a highly 
conserved aspartic acid, D232. The corresponding aspartic acid in colicin M (D226) is 
critical for catalytic activity in colicin M with mutation to a number of chemically similar 
residues (including glutamic acid) abolishing activity (200) .  
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Figure 3-4 Sequence alignment of colicin and syringacin M.  
Sequence alignment of syringacin M and colicin M, showing conserved (dark blue) and similar (light blue) 
residues, secondary structure (sheets and helices) for syringacin M (top) and colicin M (bottom), location of 
truncation for -10 and -20 deletion mutants of syringacin M generated in this study. 
 
3.6 The receptor binding domains of colicin M and syringacin M 
show extensive structural similarity  
Outside the C-terminal cytotoxic domain there is no clear sequence similarity between 
colicin M and syringacin M (Figure 3-4).  However, using the DALI server (201) to  search 
for proteins in the PDB that are structurally homologous to syringacin M revealed not 
only the expected structural homology between the cytotoxic domains of colicin M and 
syringacin M, but also extensive similarity within the respective receptor binding domains 
of these proteins. Indeed, structural homology extends from the C-terminus of the 
proteins and spans the entirety of the cytotoxic and receptor binding domains, with the 
exception of helix 1 in syringacin M (43-54) that adopts a more compact conformation.  
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The RMSD for the alignment of the receptor binding and cytotoxic domains (residues 43-
276 of syringacin M) with those of colicin M (entry 2XTR) is 3.3 Å with a Z score of 16.9. A 
structural alignment of the two proteins is illustrated in Figure 3-5. The superposition of 
colicin M and syringacin M structures shown in Figure 3-5-A/B is based on alignment of 
the catalytic domain half β-barrels, while Figure 3-5-C shows the alignment based on 
helices 2-4 of the receptor binding domains. These alignments illustrate a difference in 
angle between the receptor binding and cytotoxic domains in colicin and syringacin M. 
Alignment of the relevant regions (helices 2-4) of the receptor binding domains of colicin 
M and syringacin M are shown in Figure 3-5-D/E.  Given the lack of discernible sequence 
homology between the receptor binding domains of these proteins this structural 
similarity was unexpected.  Indeed, it has been previously postulated that these first 126 
amino acids of syringacin M represent receptor binding and translocation domains that 
are specific to P. syringae and unrelated to those of colicin M (198). The observed 
similarity in tertiary structure suggests a hitherto undetected divergent evolutionary 
relationship between the receptor binding domains of colicin M and syringacin M and 
suggests that the novel receptor binding function of these colicin M-like bacteriocins has 
been generated through diversifying selection and not through diversifying 
recombination as previously suggested (200). This is discussed further in section 3.9. 
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Figure 3-5 The receptor binding and cytotoxic domains of syringacin M and colicin M show structural 
homology  
A) Structural alignment of syringacin M 57-276 (green) and colicin M 48-271 (blue) based on the catalytic 
domain β-barrel, residues 180-190, 204-216, 220-229, 269-275 (minus 6 for colicin M residue numbers) 
(RMSD 1.765 Å). B) As for A but truncated to residues 145-276 for syringacin M and residues 140-271 for 
colicin M,  C) Structural alignment as A, based on of receptor binding domain helices 2-4, residues 58-70 
(53-65), 73-92 (73-92), 95-101 (97-103) (colicin M residues in brackets) (RMSD 2.051 Å). D/E) Stereo view 
overlay of receptor binding domains of syringacin M residues 57-125 (green) and colicin M residues 48-119 
(blue) showing structurally conserved core helices and random coil (RMSD 3.3 Å). 
 
3.7 Comparison of the syringacin M and colicin M active sites  
The syringacin M cytotoxic domain consists of residues 129-276 and forms the mixed 
helix/sheet structure, incorporating a half β-barrel structure in an overall fold that is 
unique to colicin M type bacteriocins (198).  Previous mutational studies on colicin M 
have identified the conserved residues D226 (D232), D229 (D235), H235 (H241) and R236 
(R242) (syringacin M numbering in brackets) as essential for activity.  These  
residues are surrounded by additional conserved residues and together these likely 
constitute the active site of these enzymes (Figure 3-6).  In the syringacin M structure a 
Ca2+ ion is present, coordinated by the side chain of D232, backbone carbonyl groups 
from L202 and N204, two water molecules and an ethylene glycol molecule Figure 3-6-B. 
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Figure 3-6 Comparison of the syringacin M and colicin M active sites.  
A) Superimposition of the active site of syringacin M (green) and colicin M (blue) showing location (stick 
representation) of key conserved residues (colicin M = red, syringacin M = black) and Ca2+ ion from 
syringacin M. B) Coordination of Ca2+ ion in the active site of syringacin M, residues and monomers 
involved in coordination shown as a stick model, 2Fo-Fc electron density map shown as chicken wire model 
at 1.71 σ. C) Surface representation of syringacin M active site showing conserved residues essential (red) 
and important (orange) for cytotoxicity. D) Surface representation of colicin M active site showing 
conserved residues essential (red) and important (orange) for activity in colicin M. 
 
The assignment of Ca2+ to this density as opposed to Mg2+, which is also a cofactor for the 
enzyme and is present in the crystallization buffer is based on a number of factors. Firstly, 
the difference Fourier Fo-Fc
 map shows insufficient electron density has been attributed 
86 
 
to the metal ion when Mg2+ is fitted but not when Ca2+ is fitted.  Secondly, the B-factors 
obtained for the metal ion when Mg2+ is fitted to this density
 (19.1 and 21.4 Å2 for 
molecules A and B, respectively) are significantly lower than the surrounding 
environment (average B-factor for coordinating protein oxygens in molecules A and B are 
23.6 and 25.1 Å2, respectively) suggesting that an insufficient number of electrons have 
been attributed to the metal ion when Mg2+ is modelled.  However, with Ca2+ modelled 
the metal ion B-factors (25.0 and 27.5 Å2 for molecules A and B, respectively) are in the 
expected range.  Thirdly, the average bond length of the coordinating oxygen atoms to 
the metal ion is 2.34 Å, close to the average value of 2.39 Å calculated from consideration 
of 3818 high resolution Ca2+ containing protein structures. The average bond length for 
magnesium-oxygen bonds from 2310 high resolution structures is 2.16 Å (202). Finally, 
the metal ion has a coordination number of eight. This coordination is common for Ca2+ 
but is not favoured by Mg2+, which rarely has a coordination number higher than six 
(203,204). The presence of this active site metal ion, which is absent in the colicin M 
structure, likely orientates the side chain of D232 close to the side chains of the other 
putative active site residues. In the structure of syringacin M a break in helix 8 within the 
cytotoxic domain results in the side chain of R242 being orientated away from the 
putative active site, whereas in the colicin M structure the equivalent arginine lies closer 
to the active site pocket. The surface model representation of syringacin M 40-276 shown 
in Figure 3-6-C reveals a potential active site binding pocket, formed by the essential Ca2+ 
and its coordinating residues on one side and key catalytic residues Y234, D235 and H241 
on the other. In contrast, in the colicin M structure 37-271 the unbroken confirmation of 
helix 9 and the loop extended due to the confirmation of D226 results in a pocket too 
narrow to accommodate the substrate (Figure 3-6-D).  Colicin M activity has been shown 
to be dependent on the presence of Mg2+ although it has not been reported whether Ca2+ 
and other metal ions are capable of supporting activity.  To determine if the Ca2+ bound 
structure of syringacin M likely represents a physiologically relevant cofactor and to 
determine the ability of other metal ions to support activity the ability of syringacin M to 
cleave lipid II in the presence of a range of metal ions was tested.   
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Figure 3-7 Dependence of syringacin M activity on divalent metal ions.  
A) Thin layer chromatography (TLC) visualization of reaction of syringacin M (wildtype top panel or D232A 
mutant bottom panel) and lipid II in the presence and absence of various divalent cations, all reactions 
identical except for labelled component (buffer = no additional reagents added). B) TLC visualization of time 
course reaction of syringacin M and lipid II in the presence of CaCl2 or MgCl2. 
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In addition to activity in the presence of Mg2+, both Ca2+ and Mn2+ ions were also able to 
support activity, while other divalent cations tested,  Zn2+, Ni2+ and Co2+ were not (Figure 
3-7-A). Semi-quantitative time course experiments show that syringacin M displays 
comparable catalytic activity in the presence of either Ca2+ or Mg2+ (Figure 3-7-B).  The 
syringacin M D232A mutant which displays no bactericidal activity was also found to be 
catalytically inactive under all conditions (Figure 3-7-A).  The structure of the D232A 
mutant was also determined and shown to lack the Ca2+ ion found in the active site of the 
wildtype protein, indicating that this side chain is critical to Ca2+ binding.  However, 
despite the loss of Ca2+ from the active site of syringacin M D232A the crystal structure 
and circular dichroism spectra of the mutant show the overall secondary structure and 
conformation of active-site side chains were analogous (Figure 9-3).  These data indicate 
that the lack of activity of the D232A mutant is due to its role in the coordination of a 
catalytically essential metal ion. 
While Ca2+ was identified as the metal ion bound in the active site of syringacin M, both 
Mg2+ and Ca2+ have been shown to be relatively abundant in the periplasm of Gram-
negative bacteria, at least under the conditions tested (204,205).  Ca2+ ions have been 
shown to be  concentrated in the periplasm relative to the cytoplasm or extra-cellular 
environment (205). As the ionic composition of the periplasm, where colicin M-like 
bacteriocins are active, is highly dependent on external conditions, flexibility in the use of 
metal ion cofactors could be advantageous and so this class of bacteriocins may have 
evolved to utilize both Mg2+ and Ca2+ as a cofactor.  Interestingly, published work on 
colicin M and our observations with syringacin M, show that cytotoxicity in liquid culture 
is dependent on the presence of Ca2+, suggesting that at least under some conditions Ca2+ 
acts as the metal cofactor (206).  
 
3.8 Isolation and characterisation of syringacin M resistant 
mutants 
In order to determine genetic factors involved in P. syringae susceptibility to syringacin 
M, P. syringae LMG5456, a syringacin M susceptible strain, was treated with purified 
syringacin (10mg ml-1) and resistant colonies isolated. Ten resistant isolates characterised 
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could be broadly divided into two groups, one group displayed normal colony 
morphology and the other displayed a highly mucoid phenotype (Figure 3-8). 
Representative isolates were selected from each group (P. syringae LMG 5456 MDC2 and 
MDC3, respectively). The stability of the syringacin M resistant phenotype was tested 
after growth in King’s B media. Both isolates showed a stable syringacin M resistant 
phenotype and so genomic DNA from the mutant and the wildtype strains was 
sequenced, using an Illumina MiSeq platform. Reads from wildtype LMG5456 were 
assembled de novo into 180 contigs ranging in size from 260,000 to 1000 bp in length. 
These contigs were then annotated and used as a scaffold to which the mutant reads 
were mapped. Analysis of genetic variation between MDC2 and wildtype LMG5456 
revealed two verifiable genetic changes, the first a single nucleotide polymorphism (SNP) 
in algE a gene encoding a putative outer membrane alginate transporter. The second was 
a single nucleotide insertion (SNI) in an open reading frame encoding a putative outer-
membrane ferric siderophore receptor, the closest homologue in P. syringae of the E. coli 
ferrichrome receptor FhuA. The mutation in algE leads to the substitution of leucine 385 
for phenylalanine and as both these residues are hydrophobic and relatively large, this 
mutation may not have a significant effect on the function of this protein. In contrast, the 
SNI into the gene for the FhuA homologue causes a frame shift at AA 389, leading almost 
certainly to a non-functional protein. Interestingly, colicin M is known to utilise FhuA as 
its cell surface receptor/translocator with FhuA knockout mutants entirely resistant to the 
colicin (207). This suggests that it is the truncation of the FhuA homologue rather than 
the mutation in algE which is providing syringacin resistance, however this remains to be 
tested by complementation of the knockouts.  
Comparing the MDC3 sequence with wildtype LMG5456 revealed a four nucleotide 
deletion in an open reading frame encoding a homologue of the periplasmic glucan 
synthesis protein MdoG. This deletion causes a frame shift at AA 356 (of 621 AA total 
length) and almost certainly inactivates the protein. The broader cellular function of 
MdoG has yet to be elucidated, however along with its paralogue MdoD it has been 
shown to be necessary for the synthesis of membrane derived oligosaccharides in the 
periplasm (208). MdoG knockouts have been shown to be associated with diverse 
phenotypes, including phage resistance, an enlarged periplasm and increased outer-
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membrane permeability  (208-210), and so the observed resistance to syringacin M may 
be due to pleiotropic effects (211). 
The results from the genomic analysis of the syringacin M resistant mutants are 
preliminary, and while the authenticity and uniqueness of the mutations discussed were 
verified as well as possible, further validation by complementation and phenotypic 
characterisation is required. (Raw genomic data and analysis is contained in 
supplementary electronic data).    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-8 Susceptibility of wildtype and mutant P. syringae LMG5456 strains to syringacin M  
Purified syringacin M (starting concentration 5 mg.ml
-1
 with 5 fold dilution from left to right) was spotted 
onto a soft agar overlay seeded with either wildtype or mutant P. syringae LMG5456. 
 
3.9 Discussion 
The overall structure of syringacin M shows that this bacteriocin shares an analogous 
arrangement of structural domains to colicin M with a partially disordered N-terminal 
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translocation domain that is a characteristic of colicins.  Colicin M binds to the FhuA 
receptor and utilizes TonB in order to gain entry into target cells. The translocation 
domain of colicin M spans the N-terminal 37 amino acids, with binding to TonB mediated 
by the first 7 amino acids that constitute the TonB box.  Mutation or deletion of the TonB 
box results in a protein that does not possess cytotoxicity, but is not deficient in receptor 
binding and catalytic activity (212). A similar loss of cytotoxicity is also observed for Δ10 
syringacin M and so it is reasonable to postulate that this region of syringacin M contains 
a binding box which is equivalent in binding the TonB orthologue of P. syringae. Adding 
further weight to this hypothesis, a putative colicin M homologue from P. syringae pv. 
morsprunorum str. M302280, has overall sequence identity with syringacin M of only 
18%, but shares a nearly identical N-terminal 8 amino acids (MPIELPPTY/MPVELPPTY).  
Diversifying recombination is a major evolutionary mechanism in generating bacteriocins 
that are able to exploit novel receptors or that possess novel cytotoxic activities, and 
clear examples of the results of recombination events can be observed through 
comparative sequence or structural analysis (4).  For example, colicin E3 and E9 share 
almost identical translocation and receptor binding domains but their cytotoxic domains 
share no sequence, structural or functional similarities, with the former possessing an 
rRNase domain and the latter a DNase domain. Similarly, the M-class pectocins (discussed 
in Chapter 4) and colicin M both share homologous lipid II cleaving catalytic domains but 
there is no sequence or structural similarity between their receptor binding domains, 
with the pectocin receptor binding domain closely related to 2Fe-2S plant ferredoxins and 
possessing an intact iron-sulphur cluster (92).  Given that diversifying recombination has 
been shown to be the major mechanism for the acquisition of novel receptor binding, 
translocation and cytotoxic functionalities and that the receptor binding domains of 
colicin M and syringacin M share no obvious sequence identity, the observed structural 
similarity between these proteins within their receptor binding domains is unexpected. 
However, as protein structure is conserved over much longer evolutionary distances than 
amino acid identity (213), the observed structural similarity, suggests that colicin M and 
syringacin M have evolved divergently from a common ancestor. This hypothesis is 
supported by our preliminary genomic data suggesting that the receptor for syringacin M 
is the FhuA homologue in P. syringae, suggesting that these bacteriocins have maintained 
their relationship with the ferrichrome receptor over an evolutionary time scale.  
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Furthermore, we have observed that the receptor binding and cytotoxic domains of 
colicin M homologues, which show clear sequence homology, show distinctly different 
levels of sequence identity in their cytotoxic and receptor binding domains. For example, 
a putative homologue from Salmonella identified bioinformatically shares a conserved 
receptor binding domain and an overall sequence identity of 43% with colicin M. This 
sequence identity is however distributed unevenly, with the receptor binding and 
cytotoxic domains sharing 31% and 51% identity, respectively. An analogous level of 
sequence divergence between the two domains is also observed in homologues from 
Burkholderia spp. and suggests different levels of selection pressure for mutation within 
the two domains.   
While it is worth considering that the structurally analogous receptor binding domains of 
colicin or syringacin M may have evolved through convergent evolution, it seems unlikely 
that such structural homology would have arisen independently given the structural 
diversity of receptor binding domains from other colicins, which essentially share the 
same function (9,64,214). Secondly, structural conservation is unlikely to have evolved in 
order to stabilize the catalytic domain or overall structure of colicin M-like bacteriocins, 
as the receptor binding domains of pectocin M1 and M2 consists of a ferredoxin-like 
protein with no structural similarity to the receptor binding domains of colicin M or 
syringacin M (92). Therefore, we suggest that diversifying selection, in addition to its role 
in the generation of novel cytotoxic domain-immunity protein pairs, may be an important 
evolutionary mechanism in the genesis of novel receptor-binding function in colicin-like 
bacteriocins. Interestingly and perhaps not unexpectedly, considering the data presented 
here, positive selection has also been detected in the outer membrane receptors of some 
colicin-like bacteriocins (215,216). The main documented evolutionary pathways of 
colicin-like bacteriocins are summarized in Figure 3-9. 
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Figure 3-9 Graphical representation of mechanisms of diversification of bacteriocins.  
Diversifying recombination for novel translocation (T), receptor binding (R) or cytotoxic domain (C) 
functions has been widely observed in colicin-like bacteriocins and diversifying selection is the mechanism 
through which novel cytotoxic-immunity protein (I) specificities are generated in the DNase and rRNase 
type colicins (16),(13).  The structural similarity between the receptor binding domains of colicin M and 
syringacin M suggest diversifying selection may also be important in the generation of novel receptor 
binding specificities. 
 
In the case of colicin M and syringacin M comparative sequence analysis is therefore not a 
reliable indicator of the evolutionary relationship between the receptor binding domains 
of these bacteriocins. As with other groups of proteins, direct structural comparison is 
required to detect this relationship (217).  
On a methodological note, in this work we improved the resolution of syringacin M 
crystals from 2.83 to 1.46 Å  by removing the N-terminal 37 amino acids  by utilizing the in 
situ trypsin digest method of Dong et al., 2007 (172,218). Flexible or disordered regions of 
a protein often limit resolution or prevent crystallization and as a disordered 
translocation domain is a hallmark of colicin-like bacteriocins, this technique may prove 
useful to a structural biologist working on these proteins.  
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4 Discovery and characterisation of pectocins from 
Pectobacterium spp 
Results from this section are included in: 
 
Grinter, R., Milner, J., and Walker, D. (2012) Ferredoxin containing bacteriocins suggest a 
novel mechanism of iron uptake in Pectobacterium spp., PLoS ONE 7, e33033 
 
Grinter, R.*, Josts, I.*, Zeth, K., Roszak, A. W., McCaughey, L. C., Cogdell, R. J., Milner, J. J., 
Kelly, S., Byron, O., and Walker, D. (2014), Structure of the atypical bacteriocin pectocin 
M2 implies a novel mechanism of protein uptake, Molecular Microbiology, Jul;93(2):234-
46 
* Denotes joint first authorship 
 
 
Disclaimer on work performed:  
SAXS data presented in this section was collected and analysed by Mr Inokentijs Josts. 
DMD modelling was also performed by I. Josts. These data are presented here for 
completeness as they provide additional and complimentary insight to that from the 
crystal structure. 
Initial screens for pectocins crystallisation conditions were conducted in conjunction with 
Dr. Kornelius Zeth, data for the P21
 form was collected and phased by K. Zeth, models for 
both forms were built and refined by me. 
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4.1 Introduction 
In the initial stages of this study, culture collection derived Pectobacterium strains were 
tested for the production of bacteriocins under mitomycin C induction. However, the 
production of colicin-like bacteriocins was not observed under these conditions and as 
such a genome mining strategy was adopted to identify bacteriocins in Pectobacterium. 
As discussed in detail below, the bacteriocins pectocin M1, M2, P were identified using 
this approach. These proteins consist of either an M-class cytotoxic domain or a 
lysozyme-like pesticin cytotoxic domain, fused to a plant-like ferredoxin domain. 
Ferredoxins are iron containing redox proteins (219) and this unusual structure provides 
insight not only into bacteriocin translocation but also how Pectobacterium obtains the 
essential nutrient iron during infection of its plant host. Due to its role in the creation of 
oxygen radicals via the Fenton reaction and to limit its availability to invading pathogens 
the vast majority of intracellular iron in plants is sequestered by haem or iron-sulphur-
proteins, or the iron storage protein ferritin (220) (221). In order to successfully infect its 
host plant Pectobacterium needs to obtain this iron. Experimental studies into the iron 
acquisition systems possessed by Pectobacterium, their regulation and role in virulence 
are limited. However, analysis of data from existing studies along with the genome 
sequences of a number of strains suggests the genera uses multiple systems for obtaining 
iron during infection (222). For example, the genome of P. carotovorum SCRI1043 
contains a gene cluster for the biosynthesis and transport of the siderophore 
enterobactin, which has been shown to be regulated by quorum sensing (51,223). Genes 
encoding the transport machinery, but not biosynthesis machinery of achromobactin are 
also present, suggesting it may be utilised as a xenosiderophore (222). The role of these 
systems in virulence is yet to be tested but as Pectobacterium can adopt a saprophytic, 
soil dwelling lifestyle, iron acquisition during infection may not be their prominent role 
(224). Pectobacterium possesses other iron-uptake systems more likely to be involved in 
virulence such as the ferric citrate uptake system and the HasA/HasR system.  Plants 
utilise citrate to transport ferric iron to photosynthetic tissues via the xylem, meaning 
uptake of this complex may be important during vascular colonisation by the pathogen 
(225).  As our understanding of pathogenesis related iron-uptake systems in 
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Pectobacterium is still limited, it is quite possible that the genus has evolved unique 
mechanisms to obtain iron from its host. 
 
4.2 Identification of pectocin M genes in the genomes of 
Pectobacterium spp 
In order to identify bacteriocins for use as biocontrol agents we searched the available 
genome sequences of Pectobacterium species for genes encoding putative colicin-like 
bacteriocins. Two putative colicin M-like bacteriocin genes were identified in the 
genomes of P. carotovorum sub spp. carotovorum PC1 (Pcc PC1) and P. carotovorum 
subspp. brasiliensis BPR1692 (Pcb BPR1692). The genes encode proteins that were named 
pectocin M1 and pectocin M2, respectively. Pectocin M1 and M2 have an N-terminal 
domain with approximately 60% identity to spinach ferredoxin I and a C-terminal domain 
with approximately 46% identity to the catalytic domain of colicin M (Figure 4-1).  The 
colicin M-like domains of both proteins contain all residues that have previously been 
shown to be important for the catalytic activity and consequently cytotoxicity of colicin M 
(200).  A linker region of approximately 20 amino acids, which is not conserved between 
pectocin M1 and M2 connects the two domains and overall these proteins share 58% 
sequence identity.  
Phylogenetic analysis of the ferredoxin domains of these pectocins show they cluster with 
a number of other ferredoxin and ferredoxin-domain containing proteins from 
Pectobacterium species. This cluster of sequences is most similar to [2Fe-2S] ferredoxins 
from plants and cyanobacteria, with ferredoxins from the genus Arabidopsis sharing the 
highest sequence identity. The domains are much more distantly related to typical 
bacterial ferredoxins. The cysteine residues of plant ferredoxins that coordinate the [2Fe-
2S] cluster in the active centre of these proteins are conserved in the pectocins, indicating 
that these proteins also contain the [2Fe-S2] cluster (Figure 4-1) .  
The domain structure of pectocins M1 and M2 consisting of a fusion between an M-class 
bacteriocin cytotoxic domain and a plant-like ferredoxin is unprecedented and highly 
unusual. It implies that the ferredoxin domain is somehow contributing to the receptor 
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binding and/or translocation function of the bacteriocin, roles not previously attributed 
to  ferredoxin domains (219). 
 
Figure 4-1 Domain structure, homology and molecular phylogeny of Pectocins M1 and M2  
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a) Domain structure of pectocin M1 and relationship to colicin M and plant ferredoxin.  b) Sequence 
alignment of pectocin M1, M2 and pectocin P (see discussion) with [2Fe-2S] ferredoxin type proteins and 
colicin M. For clarity of presentation prior to alignment pectocin P was truncated to amino acids 1-101 (N-
terminal domain) and colicin M was truncated to amino acids 128-271 (C-terminal domain). 
Genbank/PDBaccession numbers are as follows:  Ferredoxin I [S. oleracea] 1704156A, plant-like ferredoxin 
[Pcc PC1] YP_003017870, pectocin M1 [Pcc PC1] YP_003017875, pectocin M2 [Pcb BPR1692] ZP_03825528, 
colicin M [E. coli SMS-3-5] YP_001739994, pectocin P [Pcc WPP14] ZP_03830397. Invariant residues are 
highlighted in black, residues with similar properties in gray b) nearest neighbour joining molecular 
phylogenetic tree of [2Fe-2S] ferredoxins and pectocin ferredoxin domains. Bootstrap values (%) at major 
nodes are indicated. Species names represent independent ferredoxin proteins from listed species, 
typifying the class of ferredoxin. Proteins discussed in the study are named with species designation in 
brackets. Plant ferredoxins and adrenodoxin were aligned with signal peptides removed, pectocin 
sequences were trimmed to minimum region on homology with plant-like ferredoxin from Pcc PC1. Ellipses 
designate the following: blue = plant-type ferredoxins, red = ferredoxins found predominately in γ--
Proteobacteria, yellow = ferredoxins involved in electron transport to cytochrome P450. Scale represents 
substitutions per amino acid site. 
 
4.3 Evolution of the pectocin M1 gene through gene duplication 
and recombination 
Analysis of the genomic context of pectocin M1 gives clues to its evolutionary origin. As 
shown in Figure 4-2-A, approximately 3000 bp upstream of the gene coding for pectocin 
M1, is a predicted open reading frame encoding a plant-like ferredoxin with 
approximately 52% amino acid identity to the ferredoxin domain of pectocin M1. 
Alignment of the nucleotide sequences of these regions (Figure 4-2-B) shows high 
nucleotide conservation (>50%) that encompasses the area of sequence similarity 
between pectocin M1 and the plant-like ferredoxin, as well as part of a hypothetical open 
reading frame present in both regions, but truncated in the pectocin M1 region.  High 
levels of similarity and truncation of the adjacent open reading frame in the pectocin M1 
region strongly suggests a gene duplication event.  Evolution of the gene encoding the 
active bacteriocin is therefore likely to have occurred after this gene duplication event, 
through recombination between the duplicated ferredoxin gene and an ancestral 
bacteriocin carrying a colicin M-like cytotoxic domain.  An open reading frame directly 
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upstream of the pectocin M1 gene encodes a likely pectocin M1 immunity protein, which 
shares 24% amino acid identity with the immunity protein of colicin M.  Pectocin M2 does 
not share this genomic context, however the open reading frame directly upstream codes 
for a bacteriocin closely related to the RNA degrading carocin S2 (128), suggesting it may 
have been recruited to a  genomic island.  
 
 
 
 
 
 
 
 
 
 
 
 
4.4 Purification and characterisation of pectocin M1 and M2  
Pectocin M1 and M2 were expressed in E. coli BL21 (DE3) and purified by anion exchange 
chromatography and gel filtration to >90% homogeneity based on analysis by SDS-PAGE 
(Figure 4-3-A). The purified recombinant proteins were red-brown in colour and the 
absorption spectra of both proteins displayed maxima at 330 nm, 423 nm, and 466 nm 
(Figure 4-3-B), which are characteristic of plant ferredoxins (219).  These data show both 
pectocins M1 and M2 contain a [2Fe-2S] cluster. 
Initially the killing spectrum of pectocin M1 and pectocin M2 was tested against five P. 
atrosepticum and five P. carotovorum isolates using the agar overlay spot test method on 
LB agar. Under these experimental conditions pectocin M1 was found to be active against 
three P. atrosepticum strains and one P. carotovorum strain. The zones of inhibition in 
this experiment while distinct were hazy and varied in size upon repetition.  Pectocin M2 
did not show activity against any of the strains tested under these conditions.  
Figure 4-2 Genomic context of the pectocin M1 gene 
a) Position of genomic regions on the chromosome of Pcc PC1 containing the pectocin M1 gene and a 
related plant-like ferredoxin gene. b) Alignment of genomic regions from above, containing the 
pectocin M1 gene and the related plant-like ferredoxin gene showing annotated open reading frames 
and nucleotide homology shared between the two regions 
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Figure 4-3 Purification and characterisation of pectocin M proteins. 
 a) SDS-PAGE of purified pectocin M2, M1 and M1 D222A b) Absorbance spectrum of pectocin 
M1 at a concentration 1.2 mg ml
-1
. Maxima at 330, 423 and 466 nm, identical to those observed 
in plant ferredoxins, indicate the presence of a [2Fe-2S] cluster in pectocin M1. Spectra with 
identical absorbance peaks were obtained for the pectocin D222A mutant and pectocin M2. c) 
Agar overlay spot tests of a 10-fold serial dilution (7.5 µM-7.5 nM) of pectocin M1 spotted onto 
overlay of P. atrosepticum LMG 2386 cells grown in the presence of the iron chelator 2,2’-
bipryidine (200 µM). d) Liquid growth inhibition assay, test strain LMG 2386, grown in LB broth 
with 200 µM 2, 2’-bipyridine. Purified PM1 was added when indicated. 
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Since a number of bacteriocins utilise outer membrane receptors involved in iron uptake 
(4) we tested the activity of the pectocins under iron limiting conditions, induced by 
addition of the iron chelator 2,2’-bipryidine to the LB agar. Under these conditions the 
activity of pectocin M1 was greatly enhanced (Figure 4-3-C), with seven of ten 
Pectobacterium spp. being inhibited.  For pectocin M2, three of the ten strains were 
weakly inhibited (Table 9-2, Table 9-3).  The minimum inhibitory concentration of 
pectocin M1 under iron-limiting conditions was calculated, using the above method with 
serial dilutions of pectocin M1, varying from 14.5-145 nM among susceptible strains.  The 
cytotoxic effect of pectocin M1 in liquid culture was tested by adding varying 
concentrations of pectocin M1 to an iron limited log-phase culture of the susceptible 
strain P. atrosepticum LMG 2386. A concentration-dependent reduction in growth was 
observed upon the addition of pectocin M1 (Figure 4-3). To determine if pectocin M1 and 
M2 were active against more distantly related bacterial species, pectocin M1 and 
pectocin M2 were tested for inhibitory activity against strains of E. coli, Pseudomonas 
syringae, Pseudomonas aeruginosa and Erwinia rhapontici (Table 2-1).  None of these 
more distantly related bacteria showed any susceptibility to pectocin M1 or M2 (at 1.2 
and 10mg.ml-1 respectively) suggesting that the activity of these pectocins is limited to 
species of Pectobacterium closely related to the producing strain.  
 
4.5 The ferredoxin domain of pectocins M1 and M2 mediate 
receptor binding 
As ferredoxin is a potential iron source for phytopathogenic Pectobacterium species one 
possibility that pectocins M1 and M2 are parasitising an existing iron uptake system by 
using their ferredoxin domain to bind to a cell surface receptor, which has a normal 
physiological role in iron acquisition from ferredoxin.  If this is the case, the addition of a 
plant ferredoxin at sufficient concentration should abolish pectocin M1 binding to its 
receptor and therefore abolish its cytotoxic activity. To test this hypothesis spinach 
ferredoxin was spotted adjacent to pectocin M1 in an agar overlay spot test. Clear 
inhibition of cell killing was observed in the region where the diffusion zone of spinach 
ferredoxin overlaps with the pectocin M1 diffusion zone (Figure 4-4).  Indeed, for all 7 
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susceptible strains cytotoxicity of pectocin M1 could be abolished to a similar extent by 
the addition of spinach ferredoxin.  This effect was not observed with adrenodoxin, a 
more distantly related mammalian [2Fe-2S] cluster containing ferredoxin, indicating 
specificity for plant ferredoxins (Figure 4-4). Additionally, in five pectocin M1 susceptible 
strains that are not sensitive to pectocin M2 the cytotoxicity of pectocin M1 could be 
abolished by the addition of pectocin M2, indicating these two bacteriocins utilise the 
same receptor. To determine if the activity of the colicin M-like domain of pectocin M1 is 
essential for its cytotoxicity, mutant pectocin M1 was generated in which Asp226 is 
replaced by Ala. As discussed in chapter 3 the equivalent Asp of colicin M and syringacin 
M has been shown to be essential for the catalytic activity and consequent cytotoxicity 
(1,200). Purified pectocin M1 Asp226Ala had no detectable cytotoxicity, but was able to 
inhibit cytotoxicity of wildtype pectocin M1 in a competition assay, indicating that it is 
fully functional in binding to its receptor (Figure 4-4).  Taken together, these data indicate 
that receptor recognition occurs through the ferredoxin domain of pectocin M1 and M2 
and that the normal physiological role of pectocin M1/M2 receptor is to bind plant 
ferredoxins. 
 
4.6 Growth enhancement under iron limiting conditions by 
pectocins and spinach ferredoxin 
During spot tests on iron limiting media to determine the killing spectrum of pectocin M1 
and M2 it was observed that the growth of a number of insensitive Pectobacterium 
strains was enhanced where the pectocins were spotted onto the plate. Additionally, 
some strains that were inhibited by pectocin M1 displayed a zone of enhanced growth 
peripheral to the zone of inhibition. Four and five of the ten Pectobacterium isolates 
exhibited enhanced growth in the presence of pectocin M1 and M2, respectively. The 
enhancement of growth due to pectocin M1 was significantly more pronounced than that 
due to pectocin M2, with strongest enhancement present at 200 µM 2,2’-bipyridine for 
both pectocin M1 and pectocin M2 (Table 9-2,Table 9-3). This observation led to the 
hypothesis that Pectobacterium strains are able to utilise these ferredoxin domains as an 
iron source under iron limiting conditions. To test this idea further, and to test the 
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specificity of this growth enhancement, related plant and mammalian ferredoxin-type 
proteins (spinach ferredoxin I and human adrenodoxin) as well as syringacin M, a colicin 
M homologue from Pseudomonas syringae which contains an active colicin M catalytic 
domain but an unrelated N-terminal region (82) were tested for their ability to enhance 
the growth of Pectobacterium spp. under iron-limiting conditions. Five strains exhibited 
strongly enhanced growth due to the spinach ferredoxin at either 20 or 2 mg ml-1 (Figure 
4-5), this enhanced growth was dependent on the concentration of the iron chelator 2,2’-
bipyridine, with the strongest enhancement at 400 µM (Table 9-4). No enhanced growth 
was observed with the [2Fe-2S] cluster containing protein adrenodoxin at 30 mg ml-1 or 
syringacin M at 5 mg ml-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-4 Interference of pectocin M1 killing by inactive pectocins and plant ferredoxin but not human 
adrenodoxin.  
Interference of pectocin M1 growth inhibition zones against agar seeded with P. atrosepticum LMG2386, 
due to plant-like ferredoxin containing proteins, but not adrenodoxin. Protein concentration for spots were 
as follows: pectocin M1 1.2 mg ml
-1
, spinach ferredoxin 20 mg ml
-1
, adrenodoxin 30 mg ml
-1
, pectocin M2 10 
mg ml
-1
, pectocin M1 D222A 5.6 mg ml
-1
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Figure 4-5 Growth enhancement of P. carotovorum subspp. carotovorum LMG 2410 by plant-like 
ferredoxin containing proteins.  
Protein concentrations for spots were as follows: spinach ferredoxin 20 mg ml
1
, adrenodoxin 30 mg ml
-1
, 
Spinach ferredoxin 20 mg ml
-1 
:pectocin M1 1.2 mg ml
-1
. Pectocin M1 causes asymmetry in zone of 
enhancement due to spinach ferredoxin.  
 
 
4.7 The crystal structure of pectocin M2 
To provide structural insight into these unusual ferredoxin containing bacteriocins, 
crystallisation trials for pectocins M1 and M2 were setup. Despite extensive screening no 
crystals were obtained for pectocin M1, however, in initial crystallisation trials for 
pectocin M2, characteristic red-brown crystals formed with PEG 3350 and ammonium 
sulphate as precipitants (Figure 9-1-C). Data from these crystals were collected to 2.3 Å in 
the space group P21 and phased using anomalous scattering data from the metal centres 
of the [2Fe-2S] iron-sulphur cluster. The structure of pectocin M2 revealed an N-terminal 
domain with the predicted ferredoxin-fold (residues 2-94, in red), separated from the 
colicin M-like cytotoxic domain (residues 116-271, in blue) by a linker region (residues 95-
115, in green) that forms an α-helix (Figure 4-6-A/B). There is a significant difference in 
the orientation of the cytotoxic and ferredoxin domains of the two pectocin M2 
molecules in the asymmetric unit (ASU) with a root mean square deviation (r.m.s.d) of 3.4 
Å, between main chain atoms (Figure 4-7). The fold of the pectocin M2 ferredoxin domain 
is highly homologous (r.m.s.d 0.60 Å) to that of spinach ferredoxin (PDB ID = 1A70) and 
the C-terminal cytotoxic domain is highly similar to the lipid II-cleaving catalytic domain of 
colicin M (PDB ID = 2XMX, r.m.s.d 1.7 Å) (Figure 4-6-C/D) (198). In contrast to the compact 
structures of the homologous bacteriocins, colicin M, pyocin M and syringacin M, where 
the receptor binding and catalytic domains are not separated by linker regions and do not 
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form obviously structurally distinct elements (1,81,198), the catalytic and receptor 
binding domains of pectocin M2 do not form extensive interactions. The relative 
orientation of the ferredoxin domain, linker region and cytotoxic domain gives rise to a 
non-linear dog-leg structure. Interestingly, and again in contrast to colicin M, pyocin M 
and syringacin M, the N-terminal region of pectocin M2 lacks a disordered or flexible 
IUTD that is otherwise characteristic of the colicin-like bacteriocins, with the entire N-
terminus being integral to the globular ferredoxin domain. Thermal unfolding indicates 
that this iron-sulphur cluster containing domain is highly stable (Figure 4-6-E). These data 
suggest a mechanism of uptake distinct from closely related colicin-like bacteriocins.   
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Figure 4-6 The crystal structure of pectocin M1 reveals a ferredoxin-containing colicin-like bacteriocin 
that lacks an IUTD. 
 A) Amino acid sequence of pectocin M2, showing structural domains (ferredoxin domain = red, linker 
helix = green, catalytic domain = blue) and annotated with secondary structure. B) Schematic of the 
crystal structure of pectocin M2 observed in the P21 crystal form, with the cytotoxic domain in blue, 
plant-like ferredoxin domain in red and linker helix in green. The [2Fe-2S] iron-sulphur cluster is 
represented by spheres. C) Schematic of cytotoxic domain of pectocin M2 aligned with that of colicin M 
(PDB ID = 2XMX) (backbone r.m.s.d = 1.65 Å, pectocin M2 residues = 123-271, colicin M residues = 123-
271). D) Schematic of the ferredoxin domain of pectocin M2 aligned with that of spinach ferredoxin (PDB 
ID = 1A70) (backbone r.m.s.d = 0.6 Å, pectocin M2 residues = 2-96, spinach ferredoxin residues 2-96). E) 
Unfolding of the ferredoxin domain of pectocin M2 shown by change in circular dichroism spectra at 430 
nm, with increasing temperature (Tm = 50°C). 
Figure 4-7 Conformational difference between ferredoxin domains in the P21 crystal form 
 The difference in orientation of ferredoxin domains between the two molecules in the asymmetric unit of 
the P21 crystal form, alignment of molecules was based on the catalytic domain AA 116-271.  Distortion in 
the linking helix of one of the molecules leads to the majority of the difference. 
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4.8 Pectocin M2 is conformationally flexible 
Given that pectocin M2 lacks an IUTD required to contact the Tol or Ton complexes in the 
periplasm and mediate translocation of this protein across the outer membrane, 
alternative mechanisms of uptake must be considered. One possibility is that the entire 
bacteriocin passes through the lumen of its OM receptor. Since proteins involved in iron 
uptake are invariably TonB-dependent receptors that possess large 22-stranded β-barrels 
this hypothesis is plausible. However, such a mechanism would only be feasible if 
pectocin M2 were flexible and significant rearrangement of the dog-leg configuration 
observed in the crystal structure could be achieved. The observation that there is a 
relatively large difference in orientation between the cytotoxic and ferredoxin domains in 
the monomers of the ASU is suggestive of such flexibility and indicates that the crystal 
structure may not be wholly representative of pectocin M2 in solution.   
To assess the conformational flexibility of pectocin M2 small angle X-ray scattering 
(SAXS) was performed. SAXS data were obtained for a range of pectocin M2 
concentrations. Comparison of these data with a theoretical scattering curve generated, 
using CRYSOL (194), from the pectocin M2 crystal structure shows there are obvious 
differences between the theoretical curve and experimental scattering data (Figure 4-8-
A). In addition, the radius of gyration (Rg = 27 Å) obtained from Guinier analysis of the 
experimental scattering data is somewhat larger than that calculated from the pectocin 
M2 crystal structure (Rg = 24 Å) using SOMO (193)
 (Figure 4-8-B). Consistent with this, the 
P(r) function, which describes the paired set of vectors between all the electrons within 
the protein, indicates a maximum particle size (Dmax = 96 Å, Figure 4-8-C) that is much 
greater than the maximum dimension of the pectocin M2 crystal structure (77 Å, Figure 
4-6-B). These data suggest that the pectocin M2 crystal structure is not wholly 
representative of the conformational ensemble present in solution and that this protein 
adopts an elongated conformation, implying inter-domain flexibility. 
To test this idea further, the Porod-Debye plot of pectocin M2, where scattering decay is 
examined as q4 versus I(q)q4, was examined. Typically, for compact globular particles a 
plateau is reached within a limited q4 region of the curve. However, for pectocin M2 no 
discernible plateau was observed (Figure 4-8-D). For comparison, scattering data for 
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pyocin M which, as with colicin M and syringacin M, forms a compact structure were 
obtained and similarly analysed (81). In contrast to the curve obtained for pectocin M2, 
the Porod-Debye plot for pyocin M reached a plateau confirming its rigidity and 
compactness (Figure 4-8-D). In addition, the Kratky plot (I(q)q2 versus q) for pectocin M2 
normalised to the scattering intensity I(0) and Rg, has two maxima with increasing 
scattering at higher angles, consistent with a two-domain protein connected by a flexible 
linker (Figure 4-8-E). In comparison, there is a single maximum in the pyocin M Kratky 
plot, consistent with its single domain-like globular structure. Taken together these 
analyses indicate that pectocin M2 is flexible and adopts conformations distinct from that 
observed in the crystal structure. 
 
4.9 Pectocin M2 can adopt a highly extended conformation and 
exists as two distinct subpopulations in solution  
To determine if the SAXS data for pectocin M2 could be better described by an ensemble 
of conformations we first used discrete molecular dynamics (DMD) simulations (226) to 
explore the accessible conformational states of pectocin M2 and generated a random 
pool of 5,000 possible conformations using the crystal structure of pectocin M2. Next, a 
genetic algorithm was implemented in the program GAJOE (227) to select for ensembles 
of these models that would better describe our SAXS data. Model selection was 
successful as judged by the close correlation of the theoretical scattering curve generated 
from the selected ensemble with the experimental SAXS data (Figure 4-9-C), indicating 
that those scattering data are best described by an ensemble of pectocin M2 conformers 
in solution. Interestingly, the selected ensembles show a bimodal distribution in 
comparison with the random pool of DMD-generated pectocin M2 models when the 
population frequency is plotted against Rg or Dmax (Figure 4-8-A/B). Thus, in the 
population of selected conformations, a compact conformation is frequently found, 
described by the first peak (with maxima at approximately 23 and 75 Å for Rg and Dmax, 
respectively) that approximates closely to the conformation found in the pectocin M2 P21 
crystal structure for which Rg and Dmax were calculated as 24 and 77 Å, respectively. The 
second peak represents an ensemble of pectocin M2 conformers in an extended 
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conformation with Dmax values ranging up to 98 Å which correlates closely with the 
experimentally determined value of Dmax (96 Å). These analyses suggest that pectocin M2 
can adopt both bent and elongated linear conformations in solution. The bimodal 
distribution of the selected ensembles suggests discrete populations in solution, the more 
compact of which is similar to the conformation observed in the P21 crystals of pectocin 
M2. In an attempt to capture the more elongated conformation in crystallo, thus 
validating the solution scattering and modelling data, crystallisation of pectocin M2 was 
repeated. A custom re-crystallisation screen was devised exploiting information from the 
initial trials. Crystals were obtained in a number of conditions from this screen and were 
tested for diffraction as well as space group and unit cell variation, which is indicative of 
novel packing. A form with the radically different space group of P3121 was chosen for 
optimisation, which yielded crystals diffracting to 1.86 Å. As an alternative domain 
arrangement to the P21 form was expected, data from this crystal form were again 
phased using anomalous data from the metal centres of the [2Fe-2S] cluster. During 
model building from these data it was immediately apparent that in this crystal form 
pectocin M2 did indeed adopt an elongated conformation (Figure 4-10-A). The calculated 
Rg and Dmax for this structure were 28 and 97 Å, respectively. These values correlate well 
with the extended population from the DMD simulation, suggesting that this structure is 
representative of the second elongated pool identified by modelling. Alignment of this 
elongated P3121 form and the original P21
 form, based on their cytotoxic or  
ferredoxin domains, show a major difference in the relative orientations of these domains 
(Figure 4-10-B/C).  
 
 
 
 
 
 
 
 
111 
 
 
  
Figure 4-8 SAXS shows pectocin M2 is flexible.  
A) Overlay of the experimentally determined pectocin M2 SAXS curve (black points) with the scattering 
curve computed with CRYSOL from the P21 crystal structure (red line) produces a fit (χ=1.362) with 
visible deviations between the data, especially evident at low angles, suggesting that the crystal 
structure is more compact than that of pectocin M2 in solution. B) Derivation of Rg from a Guinier 
analysis (red) of the scattering curve; residuals of the fit are in green. C) Pair-distance distribution plot 
from experimental scattering data for pectocin M2 exhibiting two maxima which highlights the bimodal 
character of the molecule in solution. The Dmax of the particle is 96 Å. D) Porod-Debye and (e) 
normalised Kratky plots for pectocin M2 imply increased flexibility of the protein in solution (red). 
Pyocin M (black), a protein of similar molecular weight with a relatively rigid structure and strong inter-
domain contacts is used as a control.  
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Figure 4-9 Analysis of conformational heterogeneity of pectocin M2 reveals compact and 
extended ensembles in solution.   
Rg A) and Dmax B) distribution of solution ensembles selected by a genetic algorithm using GAJOE 
from a pool of 5000 random conformers of pectocin M2.  Compact and elongated molecule were 
both selected implying that the protein is conformationally heterogeneous in solution allowing for 
significant inter-domain re-arrangements about the linker helix (residues 96-115). C) Overlay of 
scattering curves of pectocin M2 between experimental data and the best ensemble selected by 
GAJOE indicates improved fit to the scattering data ( = 0.827).  
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Figure 4-10 Pectocin M2 P3121 structure confirms extended conformation predicted by solution 
scattering.  
A) Pectocin M2 in P3121 crystal form is highly elongated, consistent with the extended 
conformation predicted from solution scattering and DMD simulations. (B) Alignment of the 
catalytic domains of the P21 and P3121 crystal forms of pectocin M2, illustrating the difference in 
orientation between the ferredoxin and linker regions. C) Alignment of the ferredoxin domains of 
the P21 and P3121 crystal forms of pectocin M2, illustrating the difference in orientation of the 
catalytic domains. 
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4.10 The ferredoxin domain is a generic module for the delivery of 
cytotoxic domains to the periplasm 
In addition to pectocin M1 and M2, a putative third member of the ferredoxin-containing 
bacteriocin family, designated pectocin P was identified through bioinformatic analysis 
(92). The open reading frame for pectocin P, identified in the genome of Pectobacterium 
carotovorum subsp. carotovorum WPP14, consists of an N-terminal ferredoxin domain, 
connected to a pesticin-like cytotoxic domain, which is analogous to T4 lysozyme. Similar 
to pectocins M1 and M2, there is no sequence N-terminal of the ferredoxin domain, so 
this bacteriocin also lacks an IUTD. To confirm that this open-reading frame encodes an 
active bacteriocin, the cytotoxic activity of recombinantly expressed and purified pectocin 
P was tested against diverse Pectobacterium isolates. For this test a solid growth 
inhibition assay was conducted in parallel with pectocins M1 and M2 (151). As with 
pectocins M1 and M2, limited inhibition of growth was observed under iron-replete 
conditions (LB agar). However, under iron-limiting conditions, inhibition of growth was 
observed for 17 of the 19 strains (Figure 4-11). The existence of pectocin P, an additional 
ferredoxin-containing bacteriocin with no N-terminal IUTD and a pesticin-like cytotoxic 
domain, provides strong supporting evidence that the ferredoxin domain acts as a generic 
module for the delivery of cytotoxic domains to the periplasm in Pectobacterium spp. The 
cytotoxic domains of both M-class bacteriocins and pesticin have been studied 
extensively and there is no indication that they possess any intrinsic capacity to cross the 
OM (94,96,199,200), indicating that ferredoxin uptake represents an unprecedented 
example of receptor-mediated protein uptake for nutrient acquisition in bacteria. 
 
 
 
 
 
 
 
Figure 4-11 Growth inhibition of purified pectocins.  
Zones of inhibition by pectocins M1, M2 and P after spotting onto a soft agar overlay seeded with Pba 
LMG 2386.     
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4.11 The pectocin M2 cytotoxic domain has well defined substrate 
binding site 
The crystal structure of pectocin M2 adds to a growing body of structural and biochemical 
data on the colicin M-like cytotoxic domain, which is delivered to the periplasm by the 
ferredoxin domains of pectocin M1 and M2 (1,81,198-200). The enzymatic activity 
pectocin M1 and M2 was confirmed by a lipid II hydrolysis assay. As expected, both 
proteins were able to cleave the substrate in a metal dependent fashion, with pectocin 
M2 exhibiting higher relative activity (Figure 4-12). In the recently solved structures of 
pyocin M (PaeM) and syringacin M a divalent metal ion (Ca2+ or Mg2+) is coordinated by a 
key catalytic aspartic acid side chain in conjunction with two backbone carbonyls. The 
metal ions, Mg2+, Ca2+ or Mn2+ are required for catalytic activity of M-class bacteriocins, 
and analysis of these proteins has shown coordination at this position to be essential for 
activity (1,2). In the pectocin M2 structure this key asparate (D226) adopts an analogous 
conformation to syringacin M, however no density for a metal ion is observed in this 
position, which is occupied by a water molecule (Figure 4-13-A). This absence of a metal 
ion is unsurprising however, given the lack of divalent ions and the high ionic strength of 
the crystallisation conditions.  
 
 
 
 
 
 
 
 
 
 
Figure 4-12  Pectocin M1 and M2 cleave lipid II.  
Thin layer chromatography plate showing degradation of lipid II after incubation with either pectocin M1 
(PM1) or pectocin M2 (PM2). Control reaction contained no protein. The observed band corresponding to 
lipid II migrated at the expected Rf of 0.7, compared to the solvent front. 
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Comparative analysis of the catalytic domains of colicin M homologues reveals significant 
variation between the structures. In the structures of pyocin M and syringacin M the key 
conserved arginine is located distant from other conserved residues creating an open 
active-site cleft. In contrast, in the pectocin M2 structure this residue (R236) is orientated 
towards the other key catalytic residues (Figure 4-13-B). The electron density for R236 
permitted modelling of two conformations, one within hydrogen bonding distance of the 
aspartic acid coordinated water and the other forming a hydrogen bond with N184. In 
both conformations, R236 creates a defined active site tunnel capable of coordinating the 
lipid II pyrophosphate group in close proximity to all key catalytic residues (Figure 4-13). 
To test the capacity of this active site tunnel to accommodate lipid II, docking simulations 
were performed using Autodock Vina (195) with the N-acetylmuramic acid farnesyl 
pyrophosphate (FPP-MUB) portion of lipid II and the catalytic domain of pectocin M2. The 
best scored docking solution (score = -8.5) from this simulation threaded the hydrophobic 
farnesyl-chain into the hydrophobic cleft adjacent to the putative active site, positioning 
the phosphoester bond attacked by the enzyme within 3 Å of D226 and the Mg2+ cofactor 
(Figure 4-14-A/B). The binding of lipid II to an open conformation of the enzyme, was 
then simulated by docking FPP-MUB and catalytic domain of syringacin M (PDB ID = 4FZL). 
The best scored docking solution (score = -7.2) placed FPP-MUB in a very similar relative 
position and orientation to that in the simulation with pectocin M2, with a difference in 
the relative positions of the two phosphorous atom of 4.1 and 2.2 Å, in the superimposed 
docked structures. Interestingly, the farnesyl-chain fitted into an analogous hydrophobic 
cleft (Figure 4-14-C/D). As Autodock Vina docking is performed without the aid of external 
restraints, these docking results are validated by knowledge of catalytically important 
residues (2,200) and suggestive of a major conformational change upon substrate 
binding, which orientates the lipid II molecule for catalysis. A morphing simulation of the 
catalytic domain from the syringacin M to pectocin M2 docking simulations provides a 
plausible model for how this conformational change occurs upon substrate binding (228) 
(Movie S1).  
The cleavage of lipid II by M-class bacteriocins yields undecaprenol (C55-OH) and 1-
pyrophospho-MurNAc(pentapeptide)-GlcNAc. In most phosphatases, catalysis occurs in 
two steps with an initial attack by a nucleophilic side chain leading to the formation of a 
covalent enzyme-substrate intermediate and a subsequent phosphoryl-group transfer to 
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a water molecule.  The role of the metal cofactor is generally to bind the phosphate group 
of the substrate, correctly orientating the phosphorus atom for nucleophilic attack. In the 
phosphatases of the large haloacid dehydrogenase (HAD) family attack by the Asp 
nucleophile leads to the formation of an aspartylphosphate intermediate, which is 
hydrolysed by nucleophilic attack of a water molecule (229,230). 
In silico docking suggests that the lipid II phosphoester bond attacked by the enzyme is in 
the immediate vicinity of both the essential divalent cofactor and catalytically essential 
residues.  D235 which has been shown to be essential for catalytic activity in M-class 
bacteriocins, would be a likely candidate for the attacking nucleophile (200).  The 
essential role of D232 in Ca2+ binding and the bidentate coordination of this metal ion 
likely preclude it from acting as a nucleophile.  Also by analogy with the mechanism of the 
HAD phosphatases, H241 may act a  general acid in the first step of this mechanism by 
donating a proton to the leaving undecaprenol group on formation of the 
aspartylphosphate intermediate and then as a general base through abstraction of a 
proton from the attacking water molecule in the second step.  Alternatively, H241 could 
act as a nucleophile and D235 as a general acid/base.  While comparative analysis of 
structures and in silico docking provides valuable information for hypothesis generation, a 
clear view of the mechanism of lipid II cleavage will require further biochemical analysis 
and structures of colicin M-like bacteriocins in complex with substrate or substrate 
analogues. 
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Figure 4-13 The flexible active site of M-class bacteriocins 
 A) A stereo view of a stick model of the key active site residues of pectocin M2, showing a water 
molecule occupying the key metal binding site of the enzyme. B) A stereo view of the overlay of 
the catalytic site from all structurally characterised colicin-M class bacteriocins, showing 
conformational variability of the key catalytic arginine. Key arginine shown as sticks and colour 
coded according to structure; green = syringacin M (PDB ID = 4FZL), blue = pyocin M (PDB ID = 
4G75), red = colicin M (PDB ID = 2XMX) and yellow = pectocin M2 (PDB ID = 4N58), All other 
catalytically important residues shown as lines in yellow. 
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Figure 4-14 The lipid II substrate model utilised for docking into the active site of pectocins 
M2 and syringacin M.  
The section in red sticks represents the trimmed molecule used for docking simulations. The 
addition of the N-acetyl glucosamine and penta-peptide motif, along with the 9x carbon repeat 
represents the full lipid II molecule. 
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4.12 Isolation and characterisation of pectocin M1 resistant 
mutants 
In an attempt to determine the gene(s) encoding the receptor and associated molecular 
machinery responsible for ferredoxin and pectocin uptake, the pectocin M1 susceptible 
strain Pca. LMG 2386 was incubated with purified pectocin M1 and plated onto iron 
limiting LB agar (+ 200 µM bipryidine) to isolate pectocin resistant mutants. Resistant 
colonies were confirmed as Pectobacterium by 16S rRNA sequencing, and as having a 
stable pectocin M1 resistant or tolerant phenotype after repeat propagation in LB broth. 
The majority of colonies isolated were entirely resistant to pectocin M1, with some 
showing a very low level of sensitivity. In order to determine the genetic basis for this 
resistance the genomic DNA of 6 independently isolated resistant lines and wildtype LMG 
2386 was extracted and sequenced on an Illumina MiSeq platform. The phenotype and 
genetic polymorphisms between the mutant and wildtype strains were as follows: 
 
200(1) = Resistant to pectocin M1 (Possibly very faint inhibition) 
 SNV in putative gene for  AFG-1 Family ATPase, leading to mutation Glu 342 to Gly 
 SNV in gene for histidine sensor kinase EnvZ, leading to mutation Gln 45 to Pro 
200(2) = Tolerant to pectocin M1 (faint zone of inhibition half the size of wildtype) 
 SNV in gene for histidine sensor kinase EnvZ, leading to mutation Gln 283 to Leu 
 Two base pair deletion in putative dTDP-glucose 4-6-dehydratase, leading to 
frame shift from Asp 120  
200(3) = Resistant to pectocin M1 
 Genetically identical to 200(1) 
Figure 4-15 In silico docking of lipid II analogue reveals active-site binding site in an open and closed 
conformation.  
A) Surface representation of pectocin M2 catalytic domain docked with FPP-MUB, catalytically important 
residues shown in red. B) Stereo schematic of docking from (a) showing important residues as lines. C) 
Surface representation of syringacin M catalytic domain docked with FPP-MUB, catalytically important 
residues shown in red. D) Stereo schematic of docking from (c) showing important residues as lines. 
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400(1) = Resistant to pectocin M1 (Possibly very faint inhibition) 
 Two base pair deletion in putative dTDP-glucose 4-6-dehydratase, leading to 
frame shift from Asp 120  
 SNV in gene for histidine sensor kinase EnvZ, leading to mutation Arg 253 to Pro 
 SNV in gene for Lipoprotein NPLA, leading to mutation Phe 110 to Tyr 
400(2) Tolerant to pectocin M1 (Faint zone of inhibition the same size at wildtype) 
 SNV in putative gene for  AFG-1 Family ATPase, leading to mutation Glu 342 to Gly 
 SNV in gene for histidine sensor kinase EnvZ, leading to mutation Leu 135 to Pro 
400(3) Resistant to pectocin M1 
 Genetically Identical to 400(2) 
 
Of the 6 mutant strains selected for genome sequencing, 4 were genetically unique. 
Somewhat curiously, none of the mutations identified in these strains were in open 
reading frames encoding proteins expected to be involved in outer membrane nutrient 
uptake (i.e. TonB dependent receptors). As shown above, mutant strains had a limited 
number of genetic differences compared to the wildtype, with identical mutations 
occurring in open reading frames in two strains, encoding a putative AFG-1 Family ATPase 
and dTDP-glucose 4-6-dehydratase. As it is less likely that identical mutations would arise 
multiple times in response to bacteriocin selection, these mutations may represent pre-
existing polymorphisms in the population of wildtype cells unrelated to the bacteriocin 
resistant phenotype. However, this needs to be confirmed by experimentation. 
Interestingly, all four resistant strains isolated had accrued unique SNVs in the sensor 
histidine kinase EnvZ, leading to amino acid substitutions in the protein. The location and 
nature of these substitutions is shown in Figure 4-16. EnvZ in Pectobacterium shares 88 % 
AA sequence identity with its homologue in E. coli, in which it is known to be involved in 
the regulation of OmpF and OmpC in response to osmotic changes in the external 
environment (231,232). Mutations in EnvZ are also associated with more general 
pleiotropic effects on the Gram-negative outer envelope, which may explain the 
association with a pectocin M1 resistant phenotype (233). While the details of the 
mechanism by which the observed EnvZ mutations lead to pectocin M1 resistance needs 
to be characterised, it is interesting to note that none of the mutations occur in the 
enzymatic kinase 2 domain and 3 of the 4 mutations lead to the inclusion of a proline 
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residue. The general mechanism by which bacterial sensor kinases transmit a signal 
across the inner membrane is thought to occur by a conformational change in response 
to an environmental stimulus (234). It seems plausible that the inclusion of 
conformationally restrictive residue like proline could lock the sensor in an active (or 
inactive) conformation, forcing the cell into a regulatory state conducive to bacteriocin 
resistance.    
  
 
 
Figure 4-16 Mutations in the histidine sensor kinase EnvZ in Pba. LMG2386 conferring resistance to 
pectocins M1.  
A) Schematic of the histidine sensor kinase EnvZ showing it’s predicted domain structure and the location 
and effect of point mutations in Pba. LMG2386 mutants resistant to pectocins M1. B) The crystal structure 
of the Kinase 1 domain from EnvZ from E. coli showing the location of the histidine auto-phosphorylation 
site in relation to the mutations in EnvZ from 400(1) and 200(2) 
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4.13 Discussion 
The work presented in this chapter has identified the pectocins. A family of colicin like-
bacteriocins consisting of a fusion between cytotoxic domains analogous to previously 
identified colicin-like bacteriocins and a plant-like ferredoxin, which has horizontally 
acquired by Pectobacterium spp.. This structural arrangement is unprecedented for a 
colicin-like bacteriocin, with the receptor binding and translocation domains for 
previously characterised proteins sharing common characteristics, but without obvious 
structural homology to proteins which perform an unrelated function (4).  Despite this 
unusual and unprecedented domain structure, there are interesting parallels and 
contrasts between colicin-like bacteriocin receptor binding and translocation domains 
and how the pectocin’s ferredoxin domain appears to function. 
As discussed previously the majority of colicin-like bacteriocins bind to the surface of 
their target cell and often gain entry to the cell through the parasitisation of TonB-
dependent nutrient receptors and their associated uptake machinery (4,10,18,235-237). 
In conjunction with the identification of the pectocins the work performed in this chapter 
demonstrates that Pectobacterium possesses a receptor and import machinery necessary 
to utilise plant ferredoxin as an iron source. Indeed, it appears to be this system which 
the pectocins exploit to gain entry to the periplasm. As all iron-uptake systems identified 
to date in Gram-negative bacteria, either siderophore based or targeting a protein 
substrate, utilise a TonB-dependent receptor to transport iron across the outer 
membrane it is likely that the ferredoxin receptor belongs to this class of protein (238).  
Therefore, like other colicin-like bacteriocins it seems that a TonB-dependent receptor is 
responsible for mediating ferredoxin iron and pectocin uptake. Structural analysis of 
pectocin M2 revealed that unlike all other colicin-like bacteriocins identified thus far the 
pectocins lack an IUTD. In bacteriocins the IUTD normally functions to deliver an epitope 
to the periplasm, which mediates binding to the Tol or Ton complexes. This direct 
interaction occurs between the colicins and TolB for group A colicins and TonB for group 
B colicins and is essential for uptake of these bacteriocins. Since pectocin M1 and M2 lack 
an IUTD they are unable make direct contact with the Tol or Ton complexes in the 
periplasm and thus are unable to directly utilise the pmf for cell entry. However, the fact 
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that the pectocins parasitise a system for which the receptor binding and translocation 
domains are structurally analogous to the substrate provides an intuitive solution to this 
problem. A number of TonB-dependent receptors have been identified, which obtain iron 
from host proteins during infection. In all of these systems the iron or iron containing 
compound is liberated from the protein on the cell surface and transported into the cell, 
potentially because all of the proteins identified are too large to pass through the lumen 
of their receptor (238-240). Plant ferredoxin, however, is a small globular protein, which 
is in fact comparable in dimensions to the plug domain that ordinarily occludes the pore 
of a TonB-dependent receptor. This creates the possibility that the ferredoxin is imported 
intact into the periplasm. If this were the case it could readily explain the pectocins lack of 
an IUTD as the energy required for cell entry would still be provided by the Ton complex, 
but transduced through receptor plug domain, as with ordinary substrate importation.  
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5 Identification and characterisation of the ferredoxin 
uptake (Fup) receptor in Pectobacterium 
Disclaimer on work performed:  
NMR spectra of labelled ferredoxin discussed in the chapter were collected and analysed 
in conjunction with Mr Inokentijs Josts and Dr Brian Smith. Preliminary assignment of the 
pectocin M1 ferredoxin domain discussed in Section 5.4 was performed predominantly by 
I. Josts. 
CD analysis was performed in conjunction with Dr Sharon Kelly. 
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5.1 Introduction 
The results presented in this chapter relate to the discovery of the Fup operon, encoding 
the protein machinery required for pectocin import and plant-like ferredoxin based iron 
acquisition by Pectobacterium. The outer membrane receptor for this system is identified 
as FupA and is a TonB-dependent receptor. While this is the first description of a TonB-
dependent receptor obtaining iron from a host protein in a phytopathogen, the utilisation 
of TonB-dependent receptors for obtaining iron from host proteins is well described for a 
number of mammalian Gram-negative pathogens. As such, before proceeding to the 
details of the discovery and characterisation of FupA it is worth reviewing what is 
currently known about these systems.  
A number of bacterial pathogens specific to mammalian hosts possess systems for 
directly obtaining iron from host proteins such as transferrin and lactoferrin that 
sequester free iron in the body’s extracellular fluids. The most thoroughly characterised 
of these systems is the transferrin iron-aquisition system of Neisseria gonorrhoeae and 
Neisseria meningitidis (239). Transferrin-binding protein A (TbpA), a 100 kDa integral 
outer membrane protein and transferrin-binding protein B (TbpB) an 80 kDa membrane 
anchored co-receptor form the basis of this system. TbpA, a TonB-dependent receptor 
strongly binds transferrin and acts as the conduit for transport of the liberated ferric iron 
across the outer membrane. However, it lacks the ability to distinguish between the apo 
and holo forms of the protein (241). The co-receptor TbpB has a strong affinity for the 
iron loaded transferrin only and acts synergistically with TbpA, considerably increasing 
the efficiency of iron import (242). Following binding and extraction of iron, apo-
transferrin is released from the complex (243). The importance of this system for fitness 
is demonstrated by the fact that its inactivation renders N. gonorrhoeae avirulent (244).   
The majority of iron in a mammalian host is stored intercellularly as haemoglobin (245). 
As such haemoglobin and the haem it contains represent an important iron source for 
invading pathogens (240). As a result, pathogenic bacteria commonly secrete haemolysins 
and cytolysins that lyse host cells and release haemoglobin and other haemoproteins 
(246).  Uptake of the liberated haem is then achieved by a number of specialised systems, 
which in addition to the TonB-dependent outer membrane receptor consist of a 
periplasmic binding protein and an inner membrane ABC transporter (247). An example 
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of such a system is the HpuA/B system of N. meningitides, which is evolutionarily and 
mechanistically related to the transferrin binding system discussed above (245).  A second 
system identified in a number of Gram-negative bacteria and characterised from the 
opportunistic pathogens Pseudomonas aeruginosa and Serratia marcescens involves the 
TonB-dependent receptor HasR and HasA, a secreted haem binding protein termed the 
‘haemophore’ (248,249). Structural and biochemical studies of this system have 
demonstrated that HasA is able to bind free haem or wrest it directly from host proteins, 
HasA then binds to HasR to deliver its cargo. HasR is also able to obtain haem directly 
from the environment in the absence of HasA, however its presence greatly enhances the 
efficiency of haem uptake (250). Interestingly, members of the genus Pectobacterium, 
which possesses a highly lytic mode of infection (discussed below) also possess genes 
encoding HasA and HasR homologues (222). While not as abundant as in a mammalian 
host, haemoproteins still represent a potentially important source of iron for an invading 
phytopathogen (251,252). 
 
5.2 Identification of the pectocin receptor (FupA) 
The discovery of the pectocins, their characterisation and the ability of Pectobacterium to 
specifically utilise plant ferredoxin as an iron source, strongly suggested that 
Pectobacterium possesses an outer membrane nutrient receptor and associated 
periplasmic machinery for the import of ferredoxin derived iron. Additionally, the 
pectocins lack of an IUTD suggests that the mechanism through which the pectocins are 
translocated across the outer membrane is fundamentally different from other colicin-
like bacteriocins, which deliver a Tol or Ton binding epitope to the periplasm via the IUTD 
(4). The fact that the ferredoxin domain of the M-class pectocins shares a common 
receptor with ferredoxin, through which Pectobacterium spp. are able to acquire iron, 
suggests that these bacteriocins parasitise an existing ferredoxin uptake system to deliver 
their cytotoxic domains to the periplasm. To confirm this hypothesis, it was necessary to 
identify the receptor for ferredoxin and the ferredoxin-containing bacteriocins. 
As initial experiments performing genetic analysis on pectocin M1 resistant mutants, 
described in chapter 4, failed to identify the ferredoxin/pectocin receptor, a co-
purification experiment with His6-tagged pectocin M1, using nickel affinity 
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chromatography was performed. Isolated OMs of Pba LMG 2386 were applied to a nickel 
affinity column pre-loaded with His6-tagged pectocin M1 or, in control experiments, to an 
identical column that did not contain pre-bound proteins. After imidazole elution of 
bound protein and subsequent SDS-PAGE, bands corresponding to two proteins were 
observed, with molecular weights of approximately 100 and 40 kDa, which co-purified 
with pectocin M1 and were absent in control samples (Figure 5-1-A). Peptide mass 
fingerprinting identified the closest matches to these proteins as a 97 kDa TonB-
dependent receptor PCC21_007820 from Pbc subsp. carotovorum PCC21 and the 37 kDa 
OM protein OmpA. As TonB-dependent receptors are invariably responsible for iron 
uptake and OmpA is highly expressed and a common contaminant in the preparation of 
OM proteins, we thought it likely that PCC21_007820 (which we designated FupA for 
ferredoxin uptake protein) represents the ferredoxin receptor. The peptides identified as 
matching PCC21_007820 are shown in Figure 5-1-C. 
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Figure 5-1 Co-purification of Pectobacterium membranes with pectocin M1 identifies the ferredoxin 
receptor FupA. 
 A) Silver stained SDS-PAGE gel showing co-elution of FupA with pectocin M1 from Ni
2+
 affinity column with 
100 mM imidazole through which solubilised outer-membranes from Pba LMG 2386 had been passed in the 
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absence (lane 1) and presence (lane 2) of bound pectocin M1. Stars represent proteins which co-eluted in 
the presence of pectocin M1; the upper band at approximately 97 kDa was identified as FupA, B) Coomassie 
stained SDS-PAGE gel showing co-elution of FupA with pectocin M1 and M2 when recombinantly expressed 
in E. coli BL21(DE3), elution as in presence or  absence of bound pectocins and in the presence or absence 
of added OM fraction, C) Peptides identified by tandem MS from the approximately 97 kDa band of the gel 
from (a), identifying the protein as a TonB dependent receptor of unknown function, designated FupA.  
 
To test this further fupA from Pba. SCRI1043 was cloned into the E. coli expression vector 
pET21a and overexpressed the protein in E. coli BL21(DE3). To determine if recombinant 
FupA overexpressed in E. coli was able to bind the ferredoxin domains a pull-down assay 
was utilised, using nickel-affinity beads charged with His6-tagged pectocin M1 and 
pectocin M2 and the solubilised OMs from E. coli BL21(DE3) cells containing this vector 
and overexpressing FupA and from cells harbouring the empty pET21a vector. As shown 
in Figure 5-1-B interaction between pectocin M1/M2 and FupA was demonstrated 
(identity of FupA confirmed by mass spectrometry), further indicating that FupA is the 
Pectobacterium ferredoxin receptor. Interestingly, despite a higher concentration of 
pectocin M2, being used in this experiment, a significantly fainter FupA band was 
observed compared to pectocin M1. Pectocin M1 has much higher activity than pectocin 
M2 against Pba. SCRI1043, the strain from which the receptor used in the experiment 
originates and against the isolates tested in this study more generally. This observed 
difference in affinity for the receptor may in part be explained by this.  
 
5.3 Genetic confirmation of FupA as the pectocin/ferredoxin 
receptor 
The co-precipitation experiments with native and recombinant FupA provide evidence of 
an interaction with pectocin M1. However, to unambiguously prove that FupA is indeed 
the ferredoxin receptor additional genetic evidence was sought through the creation of a 
∆FupA mutant of Pba. LMG2386, using the suicide vector pMRS101. To create the ∆FupA  
strain, a mutagenesis cassette was created in which the middle 1 kb of the coding 
sequence of FupA from LMG2386 was removed and replaced with the stop codon TAA 
(Figure 5-2-A). When the suicide vector containing this cassette is introduced into 
LMG2386 it undergoes recombination with chromosomal copy of fupA inserting the 
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entire vector into this gene. This recombination event is selected for using the 
streptomycin resistance gene contained on the plasmid. The vector also contains the sacB 
gene, which confers sucrose sensitivity to Gram-negative bacteria. By growing cells 
harbouring the recombined plasmid in media containing sucrose a second recombination 
event is selected for, which excises the plasmid from the genome, leaving either the full 
length gene or the truncated cassette (146). Successful mutants from this process were 
confirmed as having a sucrose resistant, streptomycin sensitive phenotype, with PCR 
using primers for fupA resulting in the amplification of a truncated 2000 bp product 
compared to that from wildtype LMG2386. Pba. LMG2386 ∆FupA was found to be 
resistant to pectocin M1, with sensitivity restored by complementation with a T5 
expression vector containing full length fupA from Pbc. LMG2913. The pectocin M1 
susceptible phenotype in the complemented strain was most pronounced when FupA 
was induced by IPTG, under iron limiting conditions. This suggests that other iron 
regulated proteins play a role in activating FupA for bacteriocin uptake.  These data 
unambiguously show that ∆FupA is the ferredoxin receptor.          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-2 FupA knockout confers resistance to pectocin M1 in Pbc. LMG2386, 
 A) Schematic of the FupA mutation introduced by recombination of suicide vector. B) Inhibition of 
growth by pectocin M1 spotted onto a lawn of Pba. LMG2386 is observed for WT, but not for the FupA 
knockout strain (∆FupA), the ability of pectocin M1 to inhibit growth is restored by plasmid based 
complementation of FupA from Pbc. LMG2913. 
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5.4 Expression purification and characterisation of FupA  
In order better characterise FupA and its interaction with the pectocins and ferredoxin a 
FupA expression vector (derived from pET28a) was created in which the signal sequence 
was replaced with an N-terminal His6-tag. Overexpression using this construct gave large 
amounts of protein that could be isolated as inclusion bodies. After solubilisation and 
refolding in buffer containing LDAO, FupA was purified by nickel affinity chromatography 
and gel filtration and analysed by SDS-PAGE (Figure 5-3). FupA purified by this method 
was observed to be monodisperse by sedimentation velocity analytical 
ultracentrifugation and eluted from a gel filtration column as a single symmetrical peak 
(Figure 5-4-A/D). Thermal denaturation curves of FupA, monitored by the change in far 
UV circular dichroism, showed a sharp transition with a midpoint at 75 °C, indicating that 
purified FupA is folded (Figure 5-4-B/C).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-3 Purified FupA separated on an 8% SDS-PAGE gel, visualised by coomassie staining. 
FupA was expressed in E. coli BL21 DE3 as inclusion bodies before refolding and purification using Ni
2+
 
affinity chromatography and SEC. Purified FupA, ran at an expected molecular weight of approximately 
97 kDa  
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Figure 5-4 Validation of refolding of FupA.  
A) Analytical Superdex S200 gel filtration profile of purified FupA, shows a single species with Gaussian 
elution profile. B) Far-UV CD spectrum for purified FupA suggests a predominantly β-barrel structure. C) The 
melting profile with a discrete unfolding mid-point of 72.5°C suggests a folded, highly stable structure. D) 
Sedimentation velocity data for purified and refolded FupA (10 µM) shows that the protein is monodisperse 
and monomeric in solution, with a sedimentation coefficient (s20, w) of 5.05 S. 
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5.5 Analysis of FupA-ferredoxin interaction by NMR 
NMR represents a powerful technique for characterising the binding between FupA and 
plant ferredoxin or the isolated pectocin M1 ferredoxin. To probe interactions between 
the two molecules we produced recombinant 15N-labeled Arabidopsis ferredoxin and the 
isolated ferredoxin domain from pectocin M1 (pectocin M1fer). Both labelled ferredoxins 
gave rise to well dispersed and resolved 1H-15N HSQC spectra with cross-peaks of uniform 
line-shape. Spectra for Arabidopsis ferredoxin presented are in Figure 5-5. Despite the 
presence of the paramagnetic [2Fe-2S] cluster, which broadens resonances within a 5-8 Å 
radius (253), we could resolve in excess of 70 peaks for both ferredoxins in the HSQC 
spectrum, suggesting that only approximately 20% of the peaks were broadened beyond 
detection. To observe the effect of FupA binding on the ferredoxin spectra we acquired 
the 1H-15N HSQC spectrum for labelled ferredoxin domains in the presence and absence 
of the receptor. We observed the complete disappearance of Arabidopsis ferredoxin 
cross-peaks from the 1H-15N HSQC spectrum on incubation with FupA (mixed in a 1:1 
stoichiometry), which was not remedied through acquisition of TROSY spectra, indicating 
slow exchange and high affinity binding to the 97 kDa receptor. In contrast, for pectocin 
M1fer we observed concentration-dependent chemical shift and intensity changes in a 
discrete subset of cross-peaks in the presence of FupA, again indicative of binding but 
showing that in this case exchange is fast and that FupA binds to pectocin M1fer (Figure 
5-6). 
  
 
 
 
 
 
 
 
 
 
136 
 
Figure 5-5 1H-15N HSQC spectrum of 
15
N labelled Arabidopsis ferredoxin. 
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Figure 5-6 Interaction of pectocin M1 with the ferredoxin receptor (FupA) from Pectobacterium 
atrosepticum SCRI1043,  
A) 
1
H-
15
N HSQC spectrum of 
15
N labelled pectocin M1fer in the absence (black) and presence 
(stoichiometry 1:1) of FupA (red) shows concentration-dependent changes (B) in chemical shift 
positions and intensity.  The interaction with FupA causes shifts in a subset of cross-peaks in 
15
N 
pectocin M1fer suggesting a localised binding site within this domain.    
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 As the binding between FupA and pectocin M1fer is in fast exchange and discrete 
chemical shift are observable in a subset of peaks on the HSQC spectra, by assigning each 
of the peaks of the spectra to a specific amide bond of pectocin M1fer, the FupA binding 
site of the protein can be mapped.  To achieve assignment of peaks on the HSQC spectra 
15N/13C-labeled pectocin M1fer was prepared and additional spectra (NOSEY, HSQC TOCSY, 
HNCO, HNCOCACB, HNCACB, HNCACO) were recorded. At the time of writing full 
assignment protein is in progress with assignment of a number of peaks shifted in the 
+FupA HSQC spectra providing a preliminary picture of the FupA binding site of pectocin 
M1. These residues are outlined in Figure 5-7-A and when mapped onto a model of 
pectocin M1fer (generated using the Phyre2 server (254)), reveal a relatively compact 
binding site localised to the β-sheet portion of the molecule remote from the iron sulphur 
cluster. It should be noted that due to signal broadening it is impossible to detect 
interactions directly with or adjacent to the iron sulphur cluster with this technique. 
As the NMR analysis of FupA/ferredoxin interactions shows that FupA has stronger 
affinity for Arabidopsis ferredoxin than for the pectocin ferredoxin domain, correlating 
the amino acid variation between the two ferredoxins with the assigned residues shifting 
upon FupA binding should provide a preliminary indication of ferredoxin residues 
important for FupA interaction. A sequence alignment between the two ferredoxins is 
shown in Figure 5-9-B and these variations are mapped onto the surface of the pectocin 
M1 ferredoxin model in Figure 5-7-B.  A number of residues that form the preliminary 
binding interface vary between the two proteins, mutagenesis of these residues as well 
those which vary between the plant ferredoxins, coupled with binding and growth 
enhancement experiments can be utilised in future work to determine the importance of 
individual residues at the binding interface. 
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Figure 5-7 Mapping of NMR chemical shift data and sequence variation onto a model of the pectocin M1 
ferredoxin domain  
A) The preliminary FupA-ferredoxin binding surface of the pectocin M1 ferredoxin domain, defined by 
assigned residues exhibiting chemical shifts on the HSQC spectra (shown in yellow) in the presence of FupA, 
B) Sequence variation between the pectocin M1 ferredoxin domain and Arabidopsis ferredoxin, mapped 
onto a model of the ferredoxin domain of pectocin M1 (shown in blue). 
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5.6 Plant ferredoxins of different origin enhance Pectobacterium 
growth to a variable extent   
In order to further characterise the ability of Pectobacterium to utilise ferredoxin as an 
iron source plant ferredoxin from Maize, Potato and Arabidopsis were cloned and 
expressed. These proteins were purified and their ability to enhance a Pectobacterium 
overlay on iron limited agar (400 µM bipryidine) was tested. Three fold serial dilutions of 
ferredoxin at a starting concentration of 1 mg ml-1 were spotted onto the plates.  The 
growth of different strains of Pectobacterium was enhanced by the ferredoxin to differing 
degrees, with the strains exhibiting the strongest enhancement (LMG2410 and LMG2442) 
shown in Figure 5-8. An amino acid sequence alignment of the three ferredoxins in 
presented in Figure 5-9-A for reference. Table 5-1 shows the minimum concentration at 
which enhancement was observed for the strains tested, along with the relative strength 
of enhancement. This experiment clearly demonstrates that ferredoxins originating from 
different plants were able to enhance growth to differing degrees. Arabidopsis ferredoxin 
was able to enhance growth in nearly all strains tested, although the degree of 
enhancement varied widely.  In contrast, potato ferredoxin enhanced only half the strains 
tested and those strains to a lesser degree, while maize ferredoxin only enhanced 
LMG2442 weakly. Interestingly, these ferredoxins share a high level of AA sequence 
identity (approximately 70 %); all contain a two iron-atom payload and almost certainly 
share the same overall structure. One may therefore postulate that the differences in 
their ability to enhance growth in Pectobacterium derive from amino acid variation at the 
binding interface between the ferredoxin and FupA or another component of the 
ferredoxin iron uptake machinery.  
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Figure 5-8 Plant ferredoxin enhance growth of Pectobacterium strains to varying extent. 
 Three fold serial dilutions of purified plant ferredoxin starting at 1 mg/ml was spotted on a lawn of 
Pectobacterium cells on LB + 400 µM) 
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Figure 5-9 Sequence alignment of plant ferredoxins and pectocin M1 ferredoxin domain  
(A) Amino acid sequence alignment of plant ferredoxins, (B) Amino acid sequence alignment of Arabidopsis 
ferredoxin and the pectocin M1 ferredoxin domain. 
 
 
 
Table 5-1 Growth enhancement of Pectobacterium strains by plant ferredoxin. 
 Ferredoxin species of origin listed at top of table, dilution is the lowest spot on plate at which 
enhancement was observed; strength is the relative strength of the growth enhancement compared to the 
strongest observed spot.   
 
  Arabidopsis Potato Maize 
Collection Strain 
# 
Dilution 
(mg/ml) 
Strength Dilution 
(mg/ml) 
Strength Dilution 
(mg/ml) 
Strength 
SCRI 1043 0.04 Weak 0.33 Weak - - 
LMG 2374 - - - - - - 
LMG 2378 0.33 Weak - - - - 
LMG 2383 - - - - - - 
LMG 2384 0.04 Medium 0.11 Weak - - 
LMG 2385 0.04 Weak 0.33 V Weak - - 
LMG 2386 0.04 Weak - - - - 
LMG 2390 0.11 Weak - - - - 
LMG 2391 0.33 Weak - - - - 
LMG 2410 0.04 Strong 0.04 Medium - - 
LMG 2412 0.04 Strong 0.04 Medium -  
LMG 2442 0.04 Strong 0.04 Strong 0.33 Weak 
LMG 2443 0.04 Strong 0.04 Weak - - 
LMG 2444 0.04 Weak 1.00 Weak - - 
LMG 2454 0.33 Weak - - - - 
LMG 2686 - - - - - - 
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5.7 Crystallisation of FupA 
High resolution structural information on FupA would provide invaluable insight into how 
this protein functions in ferredoxin/iron uptake and would also provide complementary 
data to the binding information obtained by NMR. As such and due to the availability of 
relatively large quantities of purified FupA (Figure 5-3) crystallisation of this protein was 
attempted. The purification and refolding protocol for FupA utilises LDAO as the 
detergent for shielding the hydrophobic regions of the protein. However, as LDAO is often 
described as less than optimal detergent for crystallisation, due to its relatively large 
micelle size of approximately 20 kDa and tendency to denature some proteins (255). 
Therefore crystallisation with β-OG and DDM was also attempted. Crystals were initially 
obtained in a number of conditions from commercial screens in which protein had been 
transferred from LDAO to β-OG by dialysis utilising a 40-50,000 Mw cut off membrane. 
These crystals were of poor quality (small thin needles). However, this result was taken as 
an indication that β-OG was a useful detergent for crystallisation of FupA.  
For optimisation, the condition producing the best crystals from the MIDAS crystallisation 
screen containing PVP and PEG5000 MME as the precipitant was chosen (256). In order to 
more rigorously exchange FupA from LDAO to β-OG, purified protein was bound to a 
nickel column and the LDAO buffer was exchanged for one containing 0.8-1 % β-OG. The 
protein was then eluted and concentrated, before dialysis to remove excess imidazole 
and β-OG.  
Controlling and monitoring detergent concentration when purifying and concentrating 
membrane proteins is known to be problematic, concentration of purified membrane 
proteins leads to concentration of detergent especially in the case of detergents with a 
large micelle size (257). Due to micelle formation dialysis is often insufficient to remove 
this excess detergent. Because of this, when optimisation trials were set, FupA was buffer 
exchanged into a 0.8-1% β-OG containing buffer by immobilisation on a nickel column. 
When crystallisation trails were performed however, this protein precipitated in the 
crystallisation drops and failed to form crystals. A screen of 96 chemical additives was 
performed, in addition to the original MIDAS condition and it was found that the addition 
of either LDAO or DDM led to crystal formation while in all other wells of the screen the 
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protein precipitated. This result showed that β-OG was necessary for crystallisation of 
FupA, but that an additional detergent was required for stabilisation.  
Optimisation performed on the precipitant buffer and detergent composition improved 
the diffraction and morphology of the crystals (see section 2.15.4, Figure 9-1-E Figure 9-2-
E) with the best crystals diffracting to 2.8 Å. Selenomethionine labelled protein was 
prepared but failed to produce crystals of acceptable quality, using the above 
crystallisation conditions (or others from extensive screening) and so preparation of 
platinum, gold and samarium derivative crystals is currently in progress.     
 
5.8 Discussion 
Analysis of the genetic context of fupA, reveals that it exists in a putative operon with 
four other open reading frames, encoding proteins of hypothetical but unconfirmed 
function (Figure 5-10-A). The hypothetical function to these proteins based on homology 
to know proteins, provides an intriguing picture of the ferredoxin uptake (fup) operon 
(Figure 5-10-B). The first gene in the operon designated fupB encodes a homologue of 
TonB. TonB is an inner membrane anchored protein, which spans the periplasm and in 
conjunction with the inner membrane proteins ExbB and ExbD, energises TonB-
dependent receptors for nutrient import with energy provided by the proton motive 
force (258). Interestingly, while E. coli has been shown to possess only one version of the 
TonB protein, which energises the importation of substrates by a number of TonB 
receptor proteins, other Gram-negative bacteria, including Pseudomonas aeruginosa and 
Serratia marcescens have been shown to possess a number of TonB proteins often 
specialised to a specific receptor (259-261). It seems likely that FupB, a homologue of 
TonB, interacts uniquely with FupA to provide energy for substrate import.  
TonB dependent nutrient acquisition systems, for example the haemin uptake system 
from Yersinia enterocolitica, utilise a periplasmic binding protein (PBP) which binds the 
incoming substrate and delivers it to an inner-membrane ABC transporter for transport to 
the cell cytoplasm (262). While fupD encodes a putative ABC transporter, fupC the other 
open reading frame in the operon does not encode a PBP but rather a M16 family zinc 
protease. M16 proteases are large (100 kDa+) and consist of two domains forming a clam 
shell structure, with an internal cavity capable of engulfing their substrate during 
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proteolysis.  The M16 proteases are a diverse family represented in both prokaryotes and 
eukaryotes, including mitochondrial and chloroplastic signal peptidases, which function in 
removing the signal peptides from proteins imported into these vesicles (263).  
As ferredoxin is a small and globular protein of approximately 100 amino acids, it is 
entirely feasible and indeed structurally plausible that the role of FupC is to cleave 
ferredoxin as part of the mechanism of liberating iron from this protein. For this to occur 
however, the ferredoxin would need to be imported along with its iron payload into the 
periplasm. If this proves to be the case, it is to our knowledge the first example of protein 
import to obtain nutrients in Proteobacteria.  
The liberated iron-sulphur cluster, or its degradation product, may represent the iron-
containing substrate for the ABC transporter FupD to transport across the inner 
membrane to the cytoplasm. Based on the hypothetical function we can assign to its 
components it is our hypothesis that the putative fup operon encodes the proteins 
necessary for uptake of ferredoxin, the liberation of its iron and for the transport of iron 
across the cytoplasmic membrane. The hypothesis that ferredoxin is imported into the 
periplasm by the Fup system prior to the liberation of its iron provides an intriguing 
solution to the pectocins lack of an IUTD. If this importation hypothesis was correct, then 
presumably the energy required for ferredoxin import would be provided by the Ton 
system and mediated by interactions between ferredoxin and the plug domain. The 
ferredoxin domain of pectocin M2 and its flexible nature could allow it to follow the same 
importation route as the independent ferredoxin domain. In support of this hypothesis, 
ferredoxin and pectocins M2 in its extended confirmation adopt dimensions comparable 
with the plug domain of TonB-dependent receptors (Figure 5-11).   
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Figure 5-10  The ferredoxin uptake operon (fup) Pectobacterium 
 (A) The genetic constituents of the   fup operon from Pectobacterium (B)  The predicted cellular location 
and function of the products of the fup, based on the assigned function of homologues. Models of proteins 
in (B) are drawn using structural homologues available in the PDB. 
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Figure 5-11 The extended conformation of pectocin M2 has dimensions compatible with 
passage through the lumen of a TonB-dependent receptor.  
A) The extended conformation of pectocin M2 (blue cartoon and surface), fitted into the pore 
of the barrel of HasR from Serratia marcescens PDB ID = 3CLS, illustrating that the extended 
conformation of pectocin M2 is conducive to transport through the lumen of a TonB-
dependent receptor without unfolding. B) Dimensions of the ferredoxin domain of pectocin 
M2. C) Top-down view of the HasR barrel showing the internal dimensions of the barrel 
domain. D) The width of the plug domain, which ordinarily blocks the lumen of the receptor 
barrel, is similar to that of the elongated conformation of pectocin M2. 
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Searching the genomes of other Gram-negative bacteria reveals that  closely related 
homologues of fupA are found in all other sequenced strains of Pba and Pbc (76-85% 
amino acid sequence identity) and all strains of the related soft rot pathogens of the 
genus Dickeya (63-64% identity). In all cases, fupA is invariably found in a putative operon 
with the 3 additional fup genes (fupB, fupC and fupD). More distantly related homologues 
of fupACD can also be readily identified in a range of important human and plant 
pathogens including E. coli, Pasteurella spp., Yersinia spp., Actinobacillus spp., Neisseria 
spp. and Campylobacter spp. In a number of these bacteria the FupA and FupC 
homologues have been shown to be both upregulated during infection and important for 
virulence and persistence in animal models (264,265). Specifically, in D. dadantii (formerly 
Erwinia chrysanthemi), homologues of fupA and fupC are among the most highly 
upregulated genes during plant infection and in Pasteurella multocida the fupC 
homologue is upregulated in response to iron limitation and during infection of chicken. 
Taken together our results suggest a role for the Fup and homologous proteins in 
virulence, potentially functioning to obtain iron from host proteins during infection (266-
268). 
The identification of the Fup operon during this project is consistent with the 
colloquialism that the scientific process often leads to unexpected outcomes. The initial 
aim of the project was to discover and characterise bacteriocins from plant pathogens as 
targets for creating transgenic plants to combat disease. The discovery and 
characterisation of the unusually structured pectocins, with a ferredoxin receptor binding 
domain, inadvertently led to the discovery that Pectobacterium exploits plant ferredoxin 
as an iron source using the products of the Fup operon.  
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6 Characterisation and identification of cell surface 
receptor of lectin-like bacteriocins from Pseudomonas 
spp. 
Results from this section are included in: 
 
McCaughey, L. C.*, Grinter, R.*, Josts, I., Roszak, A. W., Waløen, K. I., Cogdell, R. J., 
Milner, J., Evans, T., Kelly, S., Tucker, N. P., Byron, O., Smith, B., and Walker, D. (2014) 
Lectin-Like Bacteriocins from Pseudomonas spp. Utilise D-Rhamnose Containing 
Lipopolysaccharide as a Cellular Receptor. PLoS Pathog. 10, e1003898 
* Denotes joint first authorship. 
 
 
 
Disclaimer on work performed:  
Structural and biochemical analysis of pyocin L1 discussed in this chapter was conducted 
in conjunction with Mrs Laura McCaughey and Mr Inokentijs Josts. Specifically: Isolation 
and characterisation of pyocin L1 and pyocin L1 tolerant mutants was performed by L. 
McCaughey. Purification of P. aeruginosa LPS and pyocin L1 mutants was performed in 
conjunction with L. McCaughey. ITC analysis of wildtype and mutant pyocin L1 binding to 
LPS and hexose sugars was performed in conjunction with L. McCaughey and I Josts.  
Crystals of pyocin L1 were produced by L. McCaughey. Data collection, structural solution, 
refinement and sugar soaks were conducted by me. 
Production of labelled pyocin L1 and collection of NMR spectra of pyocin L1 in the 
presence and absence of sugars and data analysis was performed in conjunction with I. 
Josts, L. McCaughey and B. Smith.  
SAXS data on pyocin L1 was collected by and analysed in conjunction with I. Josts.  
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6.1 Introduction 
On first observation the tandem β-prism architecture seems an unlikely scaffold for an 
extremely potent family of bacteriocins. However, even prior to the structural solution of 
putidacin L1 by Ghequire et. al., secondary structure prediction strongly suggested that 
the lectin-like bacteriocins shared direct common ancestry with MMBLs proteins from 
plants (14,103). Further analysis of this protein family reveals that the MMBL fold is 
widely distributed in plant, animal and prokaryotic kingdoms and this versatile scaffold 
has been adapted to perform diverse and unrelated functions. Interestingly, these 
functions may not make usage of the MMBL’s canonical mannose binding motifs (107). 
For example, in addition of the lectin-like bacteriocins, the MMBL fold is represented in: 
the S-receptor kinase protein of pollen incompatibility system in Brassicaceae, the sweet 
taste-modifying protein curculin and in pufflectin a protein produced by the pufferfish 
(Fugu rubripes) for parasite defence (110,269,270). Ironically, the biological function of 
the originally discovered MMBL lectins, which are produced in large quantities in the 
bulbs of garlic (A. sativum) and snowdrop lectin (G. nivalis) has not been definitively 
determined (271). During the experimental phase of this work, a paper presenting 
structural and functional analysis of putidacin L1 was published by Ghequire et. al.. In 
addition to the presentation of the crystal structure of the putidacin L1, this work showed 
that the two C-terminal sugar binding sites of putidacin L1 were synergistically important 
for cytotoxic activity. When the first site (designated IIIC) was inactivated the killing 
activity of the protein was reduced 5-6 fold. While inactivation of the second site (IIC) 
alone didn’t affect activity of the protein, inactivation of both sites decreased activity 35-
fold. As discussed below, this result is in agreement with role of these sites in the activity 
of pyocin L1. This work also showed, through the creation of chimeric lectin like 
bacteriocins, that the N-terminal MMBL domain is at least partially responsible for the 
specificity of lectin like bacteriocins (14). Lectin-like bacteriocins were first identified in 
2003 and subsequent work and bioinformatics analysis has shown them to be widely 
distributed throughout the proteobacteria (15,104,105,132). The potency and stability of 
these proteins, along with their genus level specificity makes them attractive targets for 
inhibiting the growth of pathogenic bacteria. The work presented in this chapter 
151 
 
identifying LPS as the lectin-like bacteriocin cell surface receptor takes the first step 
towards characterising this fascinating protein family (15).   
 
6.2  Putidacin L1 and syringacin L1 are active against multiple 
strains of P. syringae  
As discussed in the introductory section of this thesis, previous work by Parret et. al. 
identified a novel family of lectin-like bacteriocins with genus specific activity, produced 
by Pseudomonas species (103,104,272). Because of their stability, potency and relatively 
board spectrum this class of bacteriocin represent potentially useful targets for 
engineering bacteriocin expressing disease resistant transgenic plants, therefore their 
activity and mode of action was investigated. The previously characterised putidacin L1 
was shown to have activity against P. syringae isolates, and as such its gene and an open 
reading frame encoding a putative lectin like bacteriocin from Pss. 642 (designated 
syringacin L1) were obtained by gene synthesis (103). The proteins, putidacin L1 and 
syringacin L1, were expressed, purified and tested for activity against a range of P. 
syringae and other Gram-negative bacterial isolates (Figure 6-1) (Table 2-1). Expression 
and purification of syringacin L1 was problematic, with expression in E. coli leading to the 
accumulation of large quantities of inclusion bodies and a low yield (1-5 mg ml-1) of 
protein that precipitated during purification and concentration. Putidacin L1 which was 
highly stable and expressed at a yield of greater than 50 mg L-1 Both proteins were found 
to be active against a number of P. syringae strains tested, but not against other Gram-
negative bacterial species tested. The spectrum of killing of putidacin L1 and syringacin L1 
and their potency on a soft agar overlay is presented in Table 6-1. Syringacin L1 was 
found to kill the majority of isolates (10/12 tested) to a low µM concentration, with 
LMG5084 the most susceptible strain, killed down to a concentration of 0.27 µM. 
Putidacin L1 inhibited less strains (5/12 tested) but was generally more potent with killing 
activity at nM concentrations. The most susceptible strain LMG2222 was killed at 
concentrations down to 0.85 nM.   
Subsequent to the expression and preliminary characterisation of syringacin L1, a 
description of the cytotoxicity of this bacteriocin was published by Ghequire et. al. (105).  
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In parallel to this work L. McCaughey (University of Glasgow), isolated and characterised 
an additional lectin-like bacteriocin, designated pyocin L1, produced by P. aeruginosa 
C1433 which was shown to have activity against a range of P. aeruginosa isolates. See 
Figure 6-2  for a sequence alignment of these proteins 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-1  Purified of putidacin and syringacin L1. 
 Coomassie stained 15 % SDS-PAGE gel showing purified putidacin L1 (left) and syringacin L1 (right), 
utilised for toxicity assays, biochemical characterisation and crystallisation trials. The syringacin L1 gel is 
derived from two lanes of the same gel, loaded with Mw marker and purified syringacin L1 respectively, 
the intervening lanes have been cropped for simplicity. 
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Table 6-1 Susceptibility and sensitivity of P. syringae strains tested to putidacin and syringacin L1.  
Inhibition was tested with purified protein up to a concentration of 600 µM using the soft agar overlay; 
MICs listed are the lowest bacteriocin concentration as which a zone of inhibition was observed in this 
assay. 
 
 
 
 
 
 
 
 
 
 
 
  
Pathovar Strain Inhibition MIC (nM) Inhibition MIC (µM) 
tomato NCPPB3160 No - Yes 64.81 
syringae LMG5082 Yes 8.3 Yes 0.27 
morsprunorum LMG2222 Yes 0.85 Yes 2.40 
tomato NCPPB2563 No - Yes 21.60 
tomato NCPPB1107 No - Yes 7.20 
tomato DC3000 No - Yes 2.40 
lachrymans LMG5456 Yes 22.9 Yes 7.20 
syringae LMG5084 Yes 5.6 Yes 0.27 
coronafaciens LMG5060 No - Yes 583.33 
syringae LMG1247 Yes 1851.85 No - 
maculicola LMG2208 No - No - 
unknown Carlise1/2 No - Yes N/D 
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6.3 Characterisation of effect of putidacin L1 on bacterial cells 
The phenotype induced by putidacin L1 treatment was investigated, cells grown in liquid 
culture (Kings B media, with shaking) were treated with varying concentrations of 
putidacin L1 at an OD600 of between 0.1 or 0.3. After the addition of the bacteriocin the 
OD600 of treated cultures initially increased more rapidly than untreated cultures, 
however after 5 hours the OD600 increased more slowly than for untreated cells (Figure 
6-3). Analysis of treated cells by light microscopy showed that this rapid increase in OD600 
was not due to an increased rate of bacterial growth, but rather to agglutination and 
fillamentation of treated cells (Figure 6-4-A). Larger particles scatter light at 600 nm more 
effectively creating an artefact in the use of optical density for measuring cell growth.  
Cells treated with putidacin L1 became immobile and settled to the bottom of the culture 
flask in a dose dependent manner (Figure 6-4-B), most likely as a consequence of the 
agglutination observed after treatment. Treated cells remained viable until approximately 
12 hours after treatment and could be recovered by transfer to putidacin free media or 
by spotting on KB agar, however after 12 hours cells became spherical and by 18 hours 
extensive cell lysis was apparent. While this phenotypic characterisation does not provide 
direct evidence of the mechanism of action of the lectin-like bacteriocins, the inability of 
treated cells to divide normally (i.e. fillamentation), combined with the clumping 
observed suggests some function in disruption of the cell-envelope or cell division 
machinery (273). The delayed lysis of treated bacteria may be a direct consequence of the 
bacteriocin or downstream autolysis in response to a more general cellular effect on 
physiology due to bacteriocin treatment (274).   
 
Figure 6-2 Sequence alignment of reported MMBL-like bacteriocins. Dark blue shading designates 
sequence identity; light blue designates chemically conserved residues. The three conserved MMBL 
sugar-binding motifs (N1, C1 and C2) and the partially conserved motif (N2) are boxed in red. 
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Figure 6-3 Change in OD600 of P. syringae LMG2222 treated with putidacin L1, 
 Change in absorbance at OD600 of LMG2222 cultures treated with differing concentrations of putidacin L1 
at 1 or 2 hours post inoculation. The OD600 of cultures treated with putidacin L1 initially increased more 
rapidly than wildtype cells, before falling behind wildtype growth rate at approximately 2 hours after the 
addition of putidacin L1. 
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Figure 6-4 Phenotypic changes in P. syringae LMG2222 induced by putidacin L1 treatment 
A) Reduction of mobility of stationary cultures of LMG2222 treated with varying concentrations of putidacin 
L1, photos taken 8 hours after treatment. B) Phenotype of unstained/fixed LMG2222 cells treated with 
putidacin L1 at a concentration of 2.5 µM, visualised by light microscopy at 1000x magnification. 
 
6.4 Phenotypic and genetic analysis of putidacin L1 tolerant P. 
syringae strains 
To shed light on the function of the lectin-like bacteriocins, LMG2222 was incubated with 
putidacin L1 and colonies which survived the treatment were isolated.  A number of 
different mutant colonies were isolated and tested for increased resistance to putidacin 
L1.  None of the colonies isolated were found to be completely resistant to putidacin L1, 
but rather exhibited greatly increased tolerance. Three mutants designated, IN50, Imut 
and 20(1) were chosen as representative tolerant phenotypes for further study.  Both 
Imut and 20(1) exhibited an approximately a 30-fold higher resistance to putidacin L1, 
relative to wildtype LMG2222, on an agar overlay spot test, with hazy zones of inhibition 
observed at all concentrations suggesting tolerance to putidacin L1 even at high 
concentrations. Zones of inhibition of IN50 by putidacin L1 were clear, but the strain was 
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over 250 times more tolerant to putidacin L1 relative to wildtype LMG2222 (Figure 6-5-
A/B). Phenotypically both Imut and 20(1) were normal, with cells motile and of a size and 
shape analogous to wildtype LMG2222. Alternatively, IN50 cells were non-motile and 
grew in long filaments (Figure 6-5-C). On KB agar wildtype LMG2222 colonies display a 
smooth colony morphology. Both Imut and 20(1) shared this morphology, whereas IN50 
had a rough colony type. A rough to smooth colony type transition is often due to a 
change in cell-envelope LPS production and as the lectin like bacteriocins possess well 
defined sugar binding motifs, it was postulated that LPS binding is involved in cell entry or 
killing. To test if the change in morphology of IN50 was due to a change in LPS production, 
LPS was purified from wildtype and mutant LMG2222 and visualised by SDS-PAGE and 
silver staining. As shown in Figure 6-5-D, although the LPS profile of Imut and 20(1) were 
comparable to wildtype, IN50 lacks O-antigen LPS. This lack of O-antigen LPS in the IN50 
mutant may indicate that LPS recognition may play some role in putidacin L1 killing.  
Furthermore, phenotypic differences between IN50 and Imut/20(1) indicate that the 
tolerance of these mutants is due to a different mechanism.   
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Figure 6-5 Isolation and characterisation of putidacin L1 resistant mutants  
A/B) Difference in sensitivity of putidacin L1 tolerant and wildtype LMG2222 to putidacin L1, shown by 
soft agar overlay assay, C) morphology of untreated putidacin L1 tolerant mutants compared to 
wildtype visualised by light microscopy at 1000x magnification, D) Composition of purified LPS from 
wildtype and putidacin L1 tolerant LMG222, separated by 10 % SDS-PAGE gel and visualised by silver 
staining.   
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In order to determine the genetic basis the tolerant phenotype observed in the mutants, 
genomic DNA from wildtype LMG2222 as well as Imut, 20(1) and IN50 was extracted and 
sequenced. The sequencing reactions produced good data; the reads from wildtype 
LMG2222 were assembled de novo into approximately 150 contigs, for which the 
consensus sequence was extracted and annotated. These contigs then served as the 
reference sequence for the mutant data, with verifiable genetic differences outlined 
below: 
 
Imut, 30-fold more tolerant to putidacin L1, with hazy zones of inhibition 
 2 nucleotide deletion in open reading frame encoding histidine sensor kinase 
related to CpxA, leading to frame shift at Leu 149 
 SNV in putative open reading frame encoding histidine sensor kinase related to 
CheY/GacS, leading to mutation of residue 253 from Ala to  Thr   
20(1), 30-fold more tolerant to putidacin L1, with hazy zones of inhibition 
 4 nucleotide insertion in open reading frame encoding histidine sensor kinase 
related to CpxA, leading to frame shift at Ala 66 
IN50, 250-fold more tolerant to putidacin L1, with clear zones of inhibition and an 
aberrant phenotype 
 SNV in putative open reading frame encoding  histidine sensor kinase related to 
CheY/GacS family, leading to mutation of residue 490 from Gly to Ser  
 Dinucleotide deletion in open reading frame encoding a homologue of WbpM LPS 
biosynthesis, leading to frame shift at Glu 565 
 Single nucleotide insertion in open reading frame encoding a homologue of Wtz 
LPS ABC export protein, leading to a frame shift at Gly 256 
 
Interestingly, as with the pectocin M1 resistant mutants described in chapter 4, variant 
histidine sensor kinases featured prominently in the putidacin L1 tolerant mutants 
isolated. Both Imut and 20(1) acquired distinct frame shift mutations in a homologue of 
the E. coli kinase sensor CpxA, which functions in sensing and responding to outer-
membrane stress (275). As this was the only mutation identified in 20(1) it likely plays a 
significant role in the in tolerance of both mutants to putidacin L1. In both strains the 
frame shift mutation occurs in the N-terminal periplasmic sensor domain, leading to the 
production of a truncated protein lacking the cytoplasmic kinase domain.  
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Imut and IN50 both acquired a distinct SNV in a homologue of a sensor kinase of the 
CheY/GacS family, leading to A253T and G490S variants, respectively. As both strains 
acquired mutations in this gene it seems likely it contributes towards the tolerant 
phenotype. CheY and GacS have been shown to be involved in regulating chemotaxis, 
virulence factor and siderophore production and so a putative role in putidacin L1 
tolerance is not immediately obvious (276,277). 
Two further mutations were identified in IN50, both leading to frame shifts in core 
components of the bacterial LPS synthesis and transport machinery. WbpM is a highly 
conserved integral inner membrane C6 dehydratase essential for LPS synthesis and Wzt is 
and ABC transporter responsible for transport of synthesised LPS across the inner 
membrane. Strains deficient in either gene are unable to produce the O-antigen 
component of LPS (278,279), explaining the O-antigen deficient phenotype of IN50.  
The fact that lectin-like bacteriocins have well defined sugar binding motifs for hexose 
sugars, which are also utilised to construct LPS O-antigens and the correlation between 
lack of production of LPS in the LMG2222 mutant IN50, with tolerance to putidacin L1 
suggests the mechanism of action of these bacteriocins involves interaction with LPS at 
the bacterial cell surface (14). 
 
6.5 Pyocin L1 targets the common polysaccharide antigen (CPA) 
of P. aeruginosa LPS 
Concurrently with the isolation of putidacin L1 resistant P. syringae LMG2222, P. 
aeruginosa E2 was subjected to high concentrations of recombinant pyocin L1 and 
mutants were recovered with greatly increased tolerance (Figure 6-6-A). The genomes of 
two of these mutants were sequenced and comparative analysis with the genome of 
wildtype E2 revealed a dinucleotide deletion (CT) at 710-11 bp of the 1146 bp wbpZ. This 
deletion was common to both mutants. WbpZ a glycosyltransferase of 381 amino acids 
that plays a key role in lipopolysaccharide synthesis, specifically in the synthesis of the 
common polysaccharide antigen (CPA) also known as A-band LPS (280). Most strains of P. 
aeruginosa produce two distinct LPS-types that differ in their O-antigen, but share the 
same core oligosaccharide. The CPA is a homopolymer of D-rhamnose and the O-specific 
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antigen contains a heteropolymeric repeating unit that varies widely among strains (281). 
Consistent with mutation of wbpZ, we found that production of CPA, as determined by 
immunoblotting with a CPA-specific monoclonal antibody (282), in both M4(E2) and 
M11(E2) was reduced to undetectable levels (Figure 6-6-B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These observations correlate well with the LPS defficient phenotype of IN50 and suggest 
that pyocin L1 may utilise LPS, specifically the CPA as a cellular receptor. To test this idea 
further, two transposon insertion mutants of P. aeruginosa PAO1, which is sensitive to 
pyocin L1, with insertions in the genes responsible for the transport of CPA to the 
periplasm were obtained (283). These two genes, wzt and wzm, encode the ATP-binding 
component and membrane component of a CPA dedicated ABC transporter (281). Pyocin 
L1, which shows good activity against PAO1 showed no activity against strains with 
Figure 6-6 CPA production correlates with pyocin L1 killing.  
A) Inhibition of growth of P. aeruginosa E2 and tolerant mutants M4 and M11 by pyocin L1, as shown 
by a soft agar overlay spot-test. 5 µl of purified pyocin L1 (1.5 mg ml-1) was spotted onto a growing 
lawn of cells. Clear zones indicate cell death. B) Expression of CPA by P. aeruginosa E2 and tolerant 
mutants, visualised by immunoblotting with the CPA specific antibody N1F10. C) Inhibition of growth 
of P. aeruginosa PAO1 and PAO1 wzm and wzt mutants by pyocin L1 (details as for A). D) Expression of 
CPA by PAO1 and wzm and wzt strains (details as for B). (Experimental data produced by L McCaughey) 
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insertions in wzm and wzt (Figure 6-6-C) and immunoblotting with a CPA-specific 
antibody confirmed the absence of the CPA in these pyocin L1 resistant strains (Figure 
6-6-D). Thus, the presence of CPA on the cell surface is required for pyocin L1 killing.  
In order to determine if the requirement for CPA is due to a direct interaction with pyocin 
L1, LPS from wildtype PAO1 and from the pyocin L1 resistant, wzm and wzt mutants 
(which produce no CPA but do produce the O-specific antigen) was purified and the 
pyocin-CPA interaction was analysed by isothermal titration calorimetry (ITC). Titration of 
pyocin L1 into isolated LPS-derived polysaccharides (a mixture of CPA and the O-specific 
antigen containing polysaccharides) from PAO1 gave rise to strong saturable exothermic 
heats of binding with an apparent Kd of 1.6 µM (Figure 6-7-A), whereas no binding was 
detected on titration of pyocin L1 into an equivalent concentration of LPS carbohydrates 
from PAO1 wzt, which produces the O-specific antigen but not the CPA (Figure 6-7-B). 
These data show that pyocin L1 binds directly to the CPA and that this interaction is 
required for killing. The CPA is therefore likely to be the cellular receptor for pyocin L1. 
 
 
 
 
 
Figure 6-7 Pyocin L1 binds strongly to CPA from P. aeruginosa PAO1.  
A) ITC binding isotherm of pyocin L1 (150 µM) titrated into isolated LPS-derived polysaccharide (1 mg 
ml-1) from wildtype P. aeruginosa PAO1. Strong, saturable heats were observed indicative of a strong 
interaction. Curve fitted with a single binding site model. B) ITC isotherm of pyocin L1 (150 µM) 
titrated into isolated LPS-derived polysaccharide (1 mg ml-1) from PAO1 wzt. No saturable binding 
isotherm was observed. (Experimental data produced by L. McCaughey) 
164 
 
6.6 Pyocin L1 binds the monosaccharide D-rhamnose  
The evolutionary relationships between MMBL-like bacteriocins and the originally 
identified mannose-binding members of this protein family, led to the assumption that 
carbohydrate binding of polysaccharides by the lectin-like bacteriocins is primarily 
mediated through binding of D-mannose at one or more of their conserved QxDxNxVxY 
carbohydrate binding motifs. Indeed, the recent structures (100) of putidacin L1 bound to 
mannose-containing monosaccharides show this protein has at least some affinity for the 
sugar, although measured affinities between polysaccharides and putidacin L1 are weak 
(mM) and so may not be physiologically relevant. However, the strong interaction 
between pyocin L1 and the CPA, which does not contain mannose, is incompatible with 
this and suggests that D-rhamnose and not D-mannose is the likely physiological substrate 
for the QxDxNxVxY carbohydrate binding motifs. 
To determine the affinity of pyocin L1 for D-rhamnose and D-mannose, isothermal 
titration calorimetry (ITC) was performed. Titration of pyocin L1 into D-rhamnose gave 
rise to weakly saturable heats of binding that are significantly larger than the heats 
observed on titration of pyocin L1 into an identical concentration of D-mannose. From this 
experiment an apparent Kd of 5-10 mM was estimated for the interaction of pyocin L1 
with D-rhamnose with apparently weaker binding for D-mannose, Kd > 50 mM (Figure 6-8-
A/B). The interaction between pyocin L1 and these monosaccharides was also probed 
using NMR with 15N labelled pyocin L1, monitoring changes to its 15N-HSQC spectra on 
addition of D-rhamnose or D-mannose. In the absence of added monosaccharide 15N-
HSQC spectra of pyocin L1 were well dispersed, indicative of a folded protein. Addition of 
either D-rhamnose or D-mannose up to a concentration of 100 mM did not give rise to 
large global changes in chemical shifts but on addition of D-rhamnose strong and discrete 
chemical shift changes were observed for a number of peaks including the NH2 region of 
the 15N-HSQC spectra, with changes of a smaller magnitude observed on the addition of 
D-mannose (Figure 6-9-A/B). Plotting chemical shifts on addition of D-rhamnose for peaks 
showing strong chemical shift changes allows estimation of a Kd for the pyocin L1-D-
rhamnose complex in the range of 5 - 20 mM (Figure 6-8-C-F). It should be noted however 
that as saturation of the pyocin L1 binding sites with D-rhamnose was not achieved, this 
Kd is not regarded as precise.  These data correlated well with the ITC sugar binding data, 
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with low mM binding of pyocin L1 to D-rhamnose and much weaker binding to D-
mannose.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-8 Pyocin L1 shows specificity for D-rhamnose compared with D-mannose.  
A) ITC binding isotherm of D-rhamnose (50 mM) titrated into pyocin L1 (100 µM). Weakly saturable heats 
were observed, indicative of binding with weak affinity (Kd ~ 5-10 mM). B) ITC binding isotherm of D-
mannose (50 mM) titrated into pyocin L1 (100 µM). Small-weakly saturable heats were observed, indicative 
of very weak interaction (Kd ~ 50 mM). Titration of monomeric sugars into 15N-labelled pyocin L1, 
monitored using 1H-15N HSQC NMR spectroscopy. Shifts within spectra were converted to chemical shift 
perturbation (CSP) values using equation Δppm = √ *ΔδHN+(ΔδN*αN)2+. CSP values are plotted against 
sugar concentration in C) and E) and visualised in D) and F). Peak positions, which correspond to backbone 
amide signals, at selected sugar concentrations (blue: no sugar, green: 60 mM, red: 100 mM) are shown. 
Perturbation of peak position (ppm) is indicative of association between ligand and protein molecules in 
solution.  
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Figure 6-9 1H-15N HSQC spectra of 15N-labelled pyocin L1 in presence (red) and absence (black) of 100 
mM (A) D-rhamnose and (B) D-mannose 
Showing distinctive chemical shifts upon addition of associating sugars. Chemical shift changes specific to a 
small number of cross-peaks illustrates association of the sugars with a small subset of amino acids, which 
likely correspond to the residues within the binding sites.  Analogous changes are observed for D-rhamnose 
and D-mannose titrations indicative that the same sites are binding both ligands.  Greater shift magnitude is 
observed for D-rhamnose, indicative of a greater affinity towards this monosaccharide. Boxed regions 
include cross-peaks used for chemical shift perturbation analysis as shown in Figure 6-8. 
 
6.7 D-rhamnose binds to the C-terminal QxDxNxVxY motifs of 
pyocin L1 
In an attempt to determine the location of the pyocin L1, D-rhamnose binding site(s) and 
the structural basis of the D-rhamnose specificity of pyocin L1 the X-ray structures of 
pyocin L1 with bound D-mannose, D-rhamnose and in the unbound form were 
determined(Table 2-10). Pyocin L1, as predicted by sequence homology to MMBL 
proteins, consists of two tandem β-prism domains characteristic of MMBLs, connected by 
antiparallel strands propagating from the end of each MMBL domain and lending a strand 
to the reciprocal β-prism. The strands contain a tryptophan residue which forms -
stacking interactions with two other tryptophans in the -prism to stabilise the structure 
(Figure 6-10-A). This interaction is conserved throughout MMBLs, with most members of 
the class utilising it to form either homo- or hetero-dimers of single MMBL subunits. 
However, in pyocin L1, as with the recently described structure of putidacin L1, both 
domains are from a single polypeptide chain (100). Other structural elements are also 
common between the two bacteriocins, namely a C-terminal extension of 30 amino acids 
and a two-turn α-helix insertion into loop 6 of the N-terminal MMBL domain (Figure 6-10-
B). The overall rmsd for pyocin L1 and putidacin L1 is 7.5 Å, which is relatively high due to 
a difference in the relative orientation of the two MMBL domains. In contrast, the relative 
orientation of the tandem MMBL domains of pyocin L1 matches those of the dimeric 
plant lectins very closely, with alignment of pyocin L1 with the snowdrop lectin 
homodimer (pdb ID: 1MSA) giving an rmsd of 4.81 Å. Comparison of the respective N- and 
C- terminal domains from pyocin L1 and putidacin L1 shows they possess very similar 
folds with rmsds of 2.77 Å and 2.02 Å, respectively (Figure 6-10-C/D). The higher value for 
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comparison of the N-terminal domains is due to the presence of a 2-strand extension to 
β-sheet two of the putidacin L1 N-terminal MMBL domain, which is absent from pyocin L1 
and other MMBLs. A DALI search for structures similar to pyocin L1 reported significant 
hits for only putidacin L1 and proteins with the MMBL fold such as the snowdrop lectin. 
MMBL dimers of plant origin often form higher order structures, however small angle X-
ray scattering of pyocin L1 showed it to be monomeric in solution (Figure 6-11). 
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Figure 6-10 Crystal structure of pyocin L1 reveals tandem MMBL domains and sugar-binding motifs.  
A) Ribbon diagram of structure of pyocin L1 in complex with α-D-rhamnose, amino acids 2-256. N-
terminal domain (green), C-terminal domain (pink), C-terminal extension (red), α-D-rhamnose (spheres) 
and sugar binding sites containing the conserved or partially conserved QxDxNxVxY motif are highlighted 
(blue) and are designated N1, N2 and C1, C2 according to order of appearance in the primary sequence 
of the N- and C-terminal domains, respectively. Pyocin L1 residues involved in hydrogen bonding with α-
D-rhamnose are shown in stick representation. B) Sequence and secondary structure (β-sheets = arrows, 
α-helices = coils) of pyocin L1 with colours corresponding to the structure in (A). Residues conserved in 
sugar binding motifs are shown in bold. C) Structural alignment of pyocin L1 (green) and putidacin L1 
(blue) based on N-terminal MMBL domain in wall-eyed stereo. D) Structural alignment of pyocin L1 
(green) and Allium sativum agglutinin (1BWU) (pink) based on N-terminal MMBL domain in wall-eyed 
stereo. 
Figure 6-11 Small angle X-ray scattering of pyocin L1.  
A) Ab initio model of pyocin L1 computed with DAMMIF overlaid with the crystal structure. B) Guinier 
plot of scattering data indicates that the protein is monomeric in solution (I(0) gives a molecular 
mass of 29.53 kDa) by extrapolation of scattering intensity to zero scattering angle. Radius of 
gyration is 2.72 nm, indicative of a folded, globular monomeric particle in solution. 
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In order to determine which 4 conserved sugar binding motifs are important for binding 
LPS sugars, pyocin L1 crystals were soaked with both D-mannose and D-rhamnose.  
Electron density maps, derived from both D-mannose and D-rhamnose soaked crystals 
show clear density for sugar moieties in both sites, C1 and C2 (Figure 6-13). The sugars 
refined well in these densities at full occupancy, giving B-factors comparable to the 
surrounding protein side chains. The canonical MMBL hydrogen bonds observed for both 
D-mannose and D-rhamnose were the same: Gln to O3, Asp to O2, Asn to O2 and Tyr to 
O4. In addition, O6 of D-mannose forms a hydrogen bond with Tyr169 in C1 and His194 in 
C2. As D-rhamnose is C6 deoxy D-mannose, it lacks these interactions (Figure 6-13). The 
fact that D-mannose forms an additional hydrogen bond is counter-intuitive given that 
pyocin L1 has a significantly stronger affinity for D-rhamnose, however Val154, Val163 and 
Ala166 of C1 and Val184 and Ala191 of C2 form a hydrophobic pocket to accommodate 
the C6-methyl group of D-rhamnose (Figure 6-14). Weak density was observed for both 
sugars at site N1, however given the high concentrations used in the soak and the overall 
low binding affinity of pyocin L1 for monomeric sugars, it is unlikely that N1 represents a 
primary binding site for D-rhamnose (Figure 6-14). The conserved residues in site N2 form 
interactions with the C-terminal extension of the protein and as such are inaccessible. 
Weak density was also observed adjacent to the binding site C1 of mol B in both the soaks 
and in mol A of the D-rhamnose form. This density may correspond to a peripheral 
binding site utilised in binding to the carbohydrate chain of LPS, as is observed in the 
structure of putidacin L1 bound to oligosaccharides (100). 
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Figure 6-12 C-terminal MMBL-sugar binding motifs of pyocin L1 bind D-rhamnose and D-mannose. 
Electron density (at 1.3 σ) with fitted stick model of pyocin L1 MMBL-sugar binding site C1  
(A) D-rhamnose (XXR), (C) D-mannose (BMA), (E) no bound sugar, and sugar binding site C2 with: (B) 
D-rhamnose, (D) D-mannose, (F) no bound sugar. For clarity, electron density is clipped to within 1.5 
Å of visible atoms. 
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Figure 6-13 Hydrogen-bonding interactions between pyocin L1 MMBL sugar-binding motif 
C1 with D-rhamnose and D-mannose 
Hydrogen bonds between protein side chains with (A) D-rhamnose and (B) D-mannose are 
shown; all distances are in Å. 
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Figure 6-14 Coordination of D-rhamnose in C1, C2 and N2 binding sites of pyocin L1 
A) Stereo view of D-rhamnose coordination by binding site C1 A), C2 C) and N1 E), from D-rhamnose soak 
data. Core binding motif residues (blue) and additional residues contributing to the pocket (white) are 
shown. Omit map density for D-rhamnose in binding site C1 B), C2 D), N1 F) calculated by refinement of data 
from D-rhamnose soaked crystal with model built from unsoaked crystal. Density for all sites contoured to 
0.15e/Å3. 
 
To test the idea that the observed binding of D-rhamnose to sites C1 and C2 is reflective 
of CPA binding and that this binding is critical to pyocin L1 cytotoxicity, pyocin L1 variants 
were created in which the conserved aspartic acids of the QxDxNxVxY motifs of the C1 
and C2 sugar binding sites were mutated to alanine and compared their cytotoxicity and 
ability to bind the CPA by ITC was compared with the wildtype protein. Titrations with 
wildtype pyocin L1 and the D150A (C1) and D180A (C2) variants were performed by 
titrating protein at a concentration of 100 μM into a solution of LPS-derived 
polysaccharide (1 mg ml-1) from strain PAO1 (Figure 6-15). Under these conditions binding 
isotherms were generated that enabled us to accurately determine an apparent Kd of 
0.15 (± 0.07) μM for the wildtype pyocin L1-CPA complex. For both the D150A (C1) and 
D180A (C2) variants, affinity for CPA was reduced. For the pyocin L1 D180A-CPA complex 
a Kd of 1.52 (± 0.51) μM was determined, a 10-fold increase in Kd relative to the wildtype 
pyocin L1-CPA complex. However, CPA binding to the D150A variant was severely 
weakened and although heats of binding were still observed the Kd for this complex, 
which could not be accurately determined, is likely > 500 μM. We also produced a double 
mutant in which both D150A and D180A mutations were present. For this double mutant, 
no binding to CPA was observed by ITC. These data show that both the C1 and C2 sugar 
binding motifs are required for full CPA binding, but that the C1 binding site is the major 
CPA binding determinant.  The killing activity of these sugar binding motif variants 
showed a good correlation with their ability to bind the CPA. Both the D150A and D180A 
variants showed reduced cytotoxicity against PAO1 relative to pyocin L1, with the D150A 
showing a greater reduction in activity and for the D150A/D180A variant very low levels 
of cytotoxicity were observed (Figure 6-15). 
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Figure 6-15 Binding of the CPA at the C-terminal sugar binding motifs, C1 and C2, is critical to pyocin 
L1 cytotoxicity.  
ITC binding isotherms of A) wildtype B) D180A C) D150A and D) D150A/D180A pyocin L1 all at (100 
µM) titrated into isolated LPS-derived polysaccharide (1 mg ml
-1
) from wildtype P. aeruginosa PAO1. 
Fit to a single binding site model is shown. E) Spot tests to determine cytotoxic activity of wildtype and 
pyocin L1 variants against of P. aeruginosa PAO1.  Purified protein (starting concentration 400 µg ml
-1
 
with 2-fold sequential dilutions) was spotted onto a growing lawn of P. aeruginosa PAO1. Clear zones 
indicate pyocin L1 cytotoxicity. 
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6.8 Putidacin L1 binds to P. syringae LPS and D-rhamnose 
The crystal structure of pyocin L1 and the sugar binding data clearly demonstrates that 
pyocin L1 targets sensitive strains of P. aeruginosa through binding to LPS and utilises this 
as a cell surface receptor.  Our isolation of IN50 a mutant rendered tolerant to putidacin 
L1 due to its inability to produce LPS O-antigen strongly suggests that putidacin L1 also 
utilises LPS as its cell surface receptor. However, the fact that putidacin L1 is not active 
against P. aeruginosa strains containing CPA suggests that it targets a structurally distinct 
LPS polymer. To confirm that LPS binding is common to putidacin L1, susceptibility of a 
number of strains of P. syringae was correlated with the ability of putidacin L1 to bind to 
LPS-derived carbohydrates from these strains.  From the five strains of P. syringae tested, 
LMG 2222 and LMG 5456 were found to be highly susceptible to putidacin L1 with killing 
down to concentrations of 8.3 and 22 nM, respectively. DC3000 and NCPPB 2563 showed 
complete resistance to putidacin L1 and LMG1247 was highly tolerant (killing down to 0.6 
µM). Binding of putidacin L1 to the isolated LPS-derived polysaccharides of the above 
mentioned strains was tested by ITC. Large saturable heats of binding were observed for 
putidacin L1 and the LPS-derived polysaccharides from LMG 5456 and LMG 2222, while 
no binding was observed between putidacin L1 and the LPS-derived polysaccharides from 
LMG 1247, 2563 or DC3000 (Figure 6-16). Thus, there is excellent correlation between 
putidacin L1 cell killing and the binding of LPS-derived polysaccharide indicating that like 
pyocin L1, putidacin L1 utilises LPS as a surface receptor. Although P. syringae O-antigens 
are diverse relative to CPA, the incorporation of D-rhamnose is widespread and seemingly 
almost universal in strains of this species (284,285). Interestingly, in cases where D-
rhamnose is not a component of P. syringae LPS, L-rhamnose is present (284). As with 
pyocin L1 we utilised ITC to characterise the binding affinity of putidacin L1 for D-
rhamnose, in comparison with D-mannose and L-rhamnose. 
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Figure 6-16 Putidacin L1 binds strongly to LPS-derived polysaccharides from susceptible but not tolerant 
or resistant P. syringae isolates.  
ITC isotherm of LPS-derived polysaccharides (3 mg ml
-1
) from strains highly sensitive to putidacin L1: A) P. 
syringae LMG 2222, B) P. syringae LMG 5456 titrated into putidacin L1 (60 µM). Large, saturable heats are 
indicative of binding. LPS-derived polysaccharides (3 mg ml
-1
) from strains non-sensitive to putidacin L1: C) 
P. syringae NCPPB 2563, D) P. syringae DC3000, or highly tolerant E) P. syringae LMG 1247 to putidacin L1, 
show no heats of binding when titrated into putidacin L1 (60 µM). 
 
Putidacin L1 exhibited an affinity of 5-10 mM for D-rhamnose, which is comparable to that 
of pyocin L1, and approximately 10-fold stronger than its affinity for D-mannose (Figure 
6-17-A/B). No binding of L-rhamnose to putidacin L1 was observed (Figure 6-17-C). 
Interestingly, it was found that pyocin L1 is able to weakly inhibit strains of P. syringae, 
and the killing spectrum (but not the potency) of pyocin L1 and putidacin L1 is identical. 
This observation combined with the specificity of putidacin L1 for D-rhamnose, strongly 
suggests that it also binds to a D-rhamnose containing O-antigen, which is structurally 
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distinct from CPA. Indeed branched D-rhamnose O-antigens are common in P. syringae 
(284,285).  Our data for both pyocin L1 and putidacin L1 indicate that D-rhamnose 
containing O-antigens are utilised as surface receptors for lectin-like bacteriocins from 
Pseudomonas spp. This is an attractive hypothesis since the inclusion of D-rhamnose in 
the lipopolysaccharides from members of this genus is widespread and could form an 
important component of the genus specific activity of this group of bacteriocins. 
 
 
Figure 6-17 Putidacin L1 shows specificity for D-rhamnose, compared with D-mannose.  
A) ITC isotherm of D-rhamnose (50 mM) titrated into putidacin L1 (0.1 mM). Weakly saturable heats are 
indicative of binding with modest affinity (Kd ~ 5-10 mM). B) ITC isotherm of D-mannose (50 mM) titrated 
into putidacin L1 (0.1 mM). Binding is undetectable under reaction conditions. C) ITC isotherm of L-
rhamnose (50 mM) titrated into putidacin L1 (0.1 mM). Binding is undetectable under reaction conditions. 
 
6.9 Discussion  
In this work it was shown that pyocin L1 targets susceptible cells through binding to the 
CPA component of LPS and that primary recognition of the CPA occurs through binding of 
D-rhamnose at the conserved QxDxNxVxY sugar binding motifs of the C-terminal lectin 
domain. These data show the ability of both pyocin L1 and putidacin L1 to recognise D-
rhamnose containing carbohydrates is an important component of their ability to target 
sensitive strains of Pseudomonas spp. The use of the O-antigen as a primary receptor 
differentiates the lectin-like bacteriocins from other multidomain bacteriocins such as 
colicins and S-type pyocins (colicin-like bacteriocins) which generally utilise outer 
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membrane proteins as their primary cell surface receptors (66). However, the recent 
discovery that the pore forming colicin N, which binds core LPS sugars as a cell surface 
receptor, suggests this may be a more widespread phenomena (12).  
The colicin-like bacteriocins also possess a flexible, or natively disordered N-terminal 
region that is thought to pass through the lumen of a co-receptor and interact with the 
periplasmic Tol or Ton complexes that mediate translocation of the bacteriocin across the 
outer membrane (1,66). The lack of such a flexible N-terminal region in the lectin-like 
bacteriocins suggests that either they do not need to cross the outer membrane in order 
to mediate their cytotoxicity or they do so by a mechanism that is fundamentally 
different to the diverse family of colicin-like bacteriocins. Given the extensive structural 
homology between the lectin-like bacteriocins and plant lectins it seems likely that these 
bacteriocins share a common ancestor with plant lectins and from an evolutionary 
perspective are unrelated to the colicin-like bacteriocins. 
In addition to O-antigen recognition, additional factors, as yet to be determined, are 
clearly also important in strain and species specificity among the lectin-like bacteriocins. 
Indeed, recent work from Ghequire et. al. has shown through domain swapping 
experiments that for putidacin L1 (LlpABW) and the homologous lectin-like bacteriocin 
LlpA1Pf-5 from Pseudomonas fluorescens, species specificity is governed by the identity of 
the N-terminal lectin domain (100). Thus, in view of these and our own data it seems 
likely that the C-terminal lectin domain of this class of bacteriocins plays a general role in 
the recognition of D-rhamnose containing O-antigens, with the N-terminal domain 
interacting with species-specific factors and thus determining the precise species and 
strain specificity of these bacteriocins. Although there are few clues as to how the lectin-
like bacteriocins ultimately kill susceptible cells, this work has established a clear role for 
the C-terminal MMBL domain of these proteins. The roles of the N-terminal MMBL 
domain and the C-terminal extension, which are conserved in pyocin L1 and putidacin L1, 
remain to be discovered (100). However, from the previous work of Ghequire et. al., it is 
clear that all three of these regions are required for killing of susceptible cells. 
Interestingly, although rhamnose is frequently a component of plant and bacterial 
glycoconjugates, such as the rhamnolipids of P. aeruginosa (286) and pectic 
polysaccharides of plant cell walls (287), it is generally the L-form of this sugar that is 
found in nature. Although otherwise rare, D-rhamnose is found frequently as a 
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component of the LPS of plant pathogens and plant associated bacteria such as P. 
syringae (284,285), P. putida (288), Xanthomonas campestris (289) and Burkholderia spp. 
(290), but is a relatively rare component of the O-antigens of animal pathogens such as E. 
coli, Salmonella and Klebsiella where D-mannose is a predominant component (291). It is 
interesting to speculate that since D-rhamnose is a common component of the LPS of 
bacterial plant pathogens, that some of the many lectins produced by plants may have 
evolved to target D-rhamnose as part of plant defence to bacterial pathogens. It is also 
interesting to note that P. aeruginosa which produces distinct LPS species containing the 
CPA or an O-specific antigen is an opportunistic pathogen of both plants and animals 
(292).  
The specificity of lectin-like bacteriocins suggests that these protein antibiotics may be 
useful in combating plant pathogenic bacteria, either through the use of bacteriocin 
expressing biocontrol strains or by the production of transgenic plants engineered to 
express these proteins. The specific targeting mechanism described here, binding of D-
rhamnose containing polymers, indicates that the lectin-like bacteriocins would not 
interact with either plant or animal cells, since these lack D-rhamnose containing 
glycoconjugates. In addition, these narrow spectrum antibiotics would leave the majority 
of the soil microbiome and the gut microbiome of plant-eating animals intact and so 
would be likely to have minimal environmental impact and minimal impact on animal 
health. The former property makes these proteins ideal for utilisation in the generation of 
bacterial resistant transgenic plants, while the latter property and the potency of these 
protein antibiotics could also make the use of lectin-like bacteriocins in the treatment of 
chronic multidrug-resistant P. aeruginosa infections in humans an attractive proposition. 
  
  
180 
 
 
 
 
 
 
 
 
 
 
7 Expression of bacteriocins in plants to provide 
resistance against bacterial pathogens 
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7.1 Introduction 
The expression of non-endogenous proteins in plants, using GM technology, has created 
crop plants with resistance to a number of prokaryotic and eukaryotic pathogens (140). 
The most notable and widely utilised strategy is the creation of insect resistant plants 
expressing the Cry or Cyt toxins, naturally produced by the insect pathogen B. 
thuringiensis (293). Cry and Cyt toxins, form a crystalline coating around the B. 
thuringiensis spore, which dissolves upon ingestion of the spore by the insect gut. The Cry 
and Cyt toxins then oligomerise to form pores in the gut membrane, facilitating infection 
by the bacteria and ultimately killing the insect (294).  These proteins have been 
engineered into a number of different crop plants, of which maize, cotton and soybean 
represent the most prominent examples (141). Crops expressing these toxins have been 
highly successful in decreasing the level of insect predation and the levels of chemical 
pesticides required to control this predation (295,296). While Cry and Cyt are utilised to 
combat insect pathogens rather than bacteria, like colicin and lectin-like bacteriocins 
these toxins are of bacterial origin and are expressed as a single polypeptide. Additionally, 
like these bacteriocins, Cry and Cyt toxins bind to specific receptors on the surface of 
their target cells (297). A variety of different Cry and Cyt toxins have been identified, with 
different ranges of activity towards different insect pathogens, relating to the natural 
host range of the B. thuringiensis from which they were isolated. These natural toxins 
have then been further engineered to enhance their host range and activity. Transgenic 
plants expressing these toxins are generally engineered to simultaneously produce 
multiple toxin variants, maximising the range of insect pests to which the plant is 
resistant and minimising the chance of insect pests developing toxin resistance (298). 
Similar strategies will ultimately need to be applied in the generation of bacteriocin 
expressing plants.  
In addition to the commercially applied Cry and Cyt toxins, a number of studies in model 
plant systems have shown the engineering of plants to produce ribosomally encoded 
antimicrobial peptides, such as defensins has led to at least partial resistance to bacterial 
pathogens (299,300). However, no studies in which colicin or lectin-like bacteriocins have 
been used to create transgenic plants have been reported.  The aim of the work 
presented in this chapter was to test the ability of the model plants N. benthamiana and 
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A. thaliana to express the bacteriocins discovered in chapters 3 and 6.  These transgenic 
plants were then assessed for their ability to resist infection of bacteriocin susceptible 
strains of P. syringae.  
 
7.2 Transient expression of bacteriocins in N. benthamiana leaves 
using agroinfiltration 
To quickly assess the ability of the plants to produce active bacteriocins, the model plant 
N. benthamiana was used as a transient expression system. In order to achieve 
transformation, a culture of Agrobacterium tumefaciens GV3-101 (0.2-0.4 OD600) 
containing the desired gene in a binary expression vector (see chapter 2 for details) was 
syringe infiltrated into the N. benthamiana leaf. The transformation machinery of the 
Agrobacterium cells was activated prior to infiltration by the addition of the plant 
wounding hormone acetosyringone. In the wild, Agrobacterium utilises the large Ti 
plasmid to genetically transform the host plant and induce gall formation to provide a 
habitat for the bacteria. The binary vector system developed for the genetic 
transformation of plants using Agrobacterium utilises machinery that was originally 
encoded by the Ti plasmid. The ability to transform the host is assisted by ingress into the 
plant tissues through a wound. In order to recognise plant wounding, Agrobacterium 
senses the plant wounding hormone acetosyringone and activates  the expression of the 
Ti plasmid encoded transformation machinery (301).    
A series of binary vectors were created for the bacteriocins syringacin M, syringacin L1 
and putidacin L1, based on the gateway binary vector set designed by Nakagawa et. al. 
(147), as either untagged or C- or N-terminally 4xMyc or GFP tagged constructs (see Table 
2-2 for details). These constructs were transformed into N. benthamiana and protein 
expression and localisation was monitored by activity assays, confocal microscopy and 
western blotting. Confocal microscopy of leaves transformed with the GFP tagged 
bacteriocins revealed strong fluorescence in syringacin M and putidacin L1 transformed 
leaves for both C and N-terminal fusions. Very low signal was observed for syringacin L1 
constructs. Images for syringacin M and putidacin L1 are presented in Figure 7-1. 
Expression of the fusion protein was evenly distributed throughout the Agrobacterium 
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infiltrated area. However, significant variation in expression between the individual cells 
was observed, likely due to individual transformation events. Expression of both proteins 
was cytoplasmic. In epidermal cells, which possess a large central vacuole, expression was 
localised to the cell edges and surrounding the nucleus (shown in syringacin M-N GFP), 
while in mesophyll cells expression was generally distributed outside the chloroplasts 
(shown in syringacin M-C GFP). As the bacteriocin-GFP fusion proteins may be inactive 
activity assays were not performed.  
 
Figure 7-1 Confocal fluorescence microscopy of GFP-bacteriocin fusions transiently expressed in N. 
benthamiana leaves 
Top left panel shows distribution of GFP-fusion protein in leaf section, top right panel shows chloroplast 
fluorescence at GFP excitation wavelength, bottom leaf shows bright field image of leaf, bottom right 
shows merged view of three images 
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In order to assess protein expression and cytotoxicity of leaf tissue from transformed N. 
benthamiana leaves were homogenised in buffer and protein concentration was 
normalised by Bradford assay (302). Clarified leaf homogenate was separated by SDS-
PAGE and protein expression was assessed by western blotting. Leaf tissue extract from 
N- and C-terminally tagged syringacin L1, N-terminally tagged putidacin L1 and untagged 
syringacin M was tested (Figure 7-2-A). Strong bands were observed at approximately the 
correct Mw for C-terminally Myc tagged syringacin L1 and N-terminally Myc tagged 
putidacin L1. However for syringacin L1 an approximately 10 kDa lower band was also 
observed for the C-terminal construct suggesting some degradation of the protein was 
occurring. A comparatively weak single band was observed for N-terminal tagged 
syringacin L1. As expected no bands were observed for untransformed (wildtype) or 
syringacin M transformed leaf extracts. 
Bacteriocin expression by transformed leaf tissue was also tested by P. syringae growth 
inhibition using the soft agar overlay assay. N. benthamiana leaf extract from plants 
transformed with GFP was used as a control. Growth inhibition was observed for all 
bacteriocin transformed leaf extracts, however the level of inhibition varied markedly 
between construct and bacteriocin. The level of growth inhibition against P. syringae 
strains tested is presented in Table 9-5 and zones of inhibition from the most sensitive 
strains are presented in. N-terminally tagged putidacin L1 expressing leaf extracts were 
highly active at inhibiting growth of the most susceptible strain, LMG 2222, to 1:125 
dilution of neat leaf extract Figure 7-3. Syringacin M appeared to be less active or be less 
well expressed inhibiting growth to only a 1:5 dilution of neat extract. Interestingly, 
despite the seemingly higher levels of C-terminally tagged syringacin L1 determined by 
western blotting, extracts from the N-terminally tagged transformed plants were 
significantly more active, suggesting the location of the epitope tag may be effecting the 
activity and expression of the protein. 
These data validate the ability of plants to express bacteriocins and show that putidacin 
L1 represents the best of the three proteins tested in terms of cytotoxic activity. 
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Figure 7-2 Confirmation of bacteriocin expression in N. benthamiana leaves my western blotting  
 cMyc western blot of SDS-PAGE separated leaf extract from N. benthamiana leaves transiently transformed 
with bacteriocin constructs. Band of appropriate size for the lectin-like bacteriocin 4XMyc fusion (35-40 
kDa) are present in leaf extracts transformed with Myc fusion constructs. 
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Figure 7-3 Growth inhibition of P. syringae by leaf extracts from bacteriocin transformed N. 
benthamiana,  
5-fold serial dilutions of extracts from transformed N. benthamiana leaves (extract concentration 
normalised to 2 mg/ml) spotted onto King’s B agar plates seeded with an overlay of a susceptible P. 
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syringae strains. Plates were incubated at 28 °C for 12 hours. Zones of inhibition are apparent from 
transformed leaf extract; the left hand spot is neat leaf extract with dilutions proceeding to the right. The 
GFP sample is a negative control consisting of extract from leaves transformed with a GFP only expression 
construct. 
 
7.3 Creation of signal peptide bacteriocin fusion proteins for 
extracellular targeting 
For the majority of its infection cycle P. syringae is known to act as an intercellular 
pathogen, persisting and proliferating in the apoplast without entering or causing 
widespread lysis of infected tissues (32). As such, it is likely that bacteriocins localised to 
the apoplast of transgenic plants would be more successful in providing resistance to this 
pathogen. As such, constructs were designed and created to encode syringacin L1, 
putidacin L1 and syringacin M fused to signal peptides derived from 4 proteins that are 
known to lead to successful excretion of proteins in plants. C-terminal GFP fusions and 
untagged bacteriocin/signal peptide fusions were expressed in N. benthamiana to test for 
expression, localisation and cytotoxic activity. Observation of expression and localisation 
of the GFP tagged constructs by confocal microscopy showed very low levels of 
fluorescence and as a result it was impossible to accurately judge if proteins were being 
transported to the apoplast.  Additionally, plant extracts from the untagged and C-Myc 
tagged signal peptide fusion constructs did not exhibit any cytotoxic activity towards P. 
syringae strains. Consequently, it was decided not to pursue the extracellular targeting of 
bacteriocins further, but rather focus on assessing the disease resistant phenotype from 
cytoplasmically expressed bacteriocins. It is plausible however, that protein localisation 
may prove to be an important parameter for optimisation in future studies. 
 
7.4 P. syringae infection of transiently transformed N. 
benthamiana  
In order to obtain a preliminary indication of the ability of bacteriocin expressing plants to 
resist P. syringae infection, bacteriocin transformed leaves 72 hours post transformation 
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with either syringacin M or putidacin L1 constructs, were infected with 105 cfu.ml-1 of P. 
syringae LMG5084, a strain that is susceptible to both syringacin and putidacin L1. 
Bacterial growth was then monitored by determination of the cfu.cm-1 of leaf tissue at 
24h, 48h and 8 day post infection (Figure 7-4-A). Both untransformed and GFP 
transformed leaves were used as a negative control and it was immediately apparent that 
infiltration with Agrobacterium prior to infection with LMG5084, greatly reduced the 
ability of P. syringae to proliferate (Figure 7-4-A). This effect was also apparent upon 
observation of disease symptoms of infected leaves, with untransformed leaves 
(wildtype) quickly succumbing to disease in the infected area, while leaves infiltrated with 
Agrobacterium containing either a bacteriocin or GFP expression construct displaying 
much milder disease symptoms (Figure 7-4-B). This is unsurprising given the known role 
of bacterial molecules like LPS and flagella proteins in activating the plant innate immune 
system via the recognition of pathogen associated molecular patterns (PAMPs) (303). The 
introduction of Agrobacterium, which has been shown to activate the innate immune 
system in N. benthamiana, a number of days prior to infection effectively primes the 
plants immune system to resist the P. syringae infection (304). This activation of the 
immune response makes this transient expression system less than ideal for testing the 
ability of bacteriocins to combat bacterial infection. Interestingly, while bacterial load 
isolated from infected plants expressing syringacin M didn’t differ significantly from the 
control, no colonies were recovered from leaves expressing putidacin L1 (Figure 7-4-A). 
This effect was robust and reproducible over a number of experiments and a plausible 
explanation is that putidacin L1 is preventing bacterial infection in planta.  As the colony 
counting procedure involves homogenisation of the plant tissue to extract the bacterial 
cells, an alternative explanation is that putidacin L1 is released during this procedure 
killed the bacterial cells. However, as P. syringae remained viable for an extended period 
(12 hour plus) in liquid culturue containing recombinant putidacin L1, this hypothesis is 
less likely (see Section 6.3). 
It should be noted that comparable lesions were observed for putidacin infected leaves 
compared to those infected with other constructs suggesting some level of infection. This 
observation is at odds with the lack of viable LMG5084 isolated from the leaf tissue. 
However the lesions observed may be due to hypersensitive cell death induced by the 
initial inoculation of bacteria rather than bacterial proliferation (305). 
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The results from the transient expression of bacteriocins in N. benthamiana, combined 
with the infection assay demonstrate that putidacin L1 represents a good target for the 
creation of stably transformed plants. It also demonstrates the transient expression 
system is unsuitable for subsequent infection to assess enhanced disease resistance. 
Therefore, as the first choice stably transformed Arabidopsis expressing putidacin L1 was 
selected as a model to assess the ability of putidacin L1 to impart disease resistance 
against P. syringae. Additionally, to test the variability of bacteriocin expression between 
plant species, the creation of stably transformed Arabidopsis expressing syringacin L1 was 
also attempted.   
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Figure 7-4 Infection of transiently transformed N. benthamiana leaves with P. syringae LMG 5084,  
A) Cfu.cm
-1
 of P. syringae LMG 5084, recovered from leaves of untransformed, GFP or bacteriocin 
expressing N. benthamiana  infected with 10
5
 cfu.ml
-1
  at 24, 72 hours and 8 days post infection.  Colony 
counts from untransformed leaves were impossible at 8 days due to desiccation of the infected area. B) 
Infection symptoms of leaves 8 days after infection with P. syringae LMG 5084.  
 
7.5 Creation and characterisation of stable A. thaliana expressing 
putidacin and syringacin L1 
7.5.1 Vector construction and characterisation 
The binary vector pJO530 was selected for creating transgenic Arabidopsis (148). pJO530 
constructs were created containing putidacin L1 with either a C- or N- terminal 4xMyc tag 
and tested for activity in N. benthamiana as described above. Interestingly, while leaf 
extracts from both constructs were shown to produce comparable levels of Myc tagged 
protein by western blot, only extract from leaves transformed with the N-terminally 
tagged construct showed cytotoxicity (Figure 7-5-A/B). Structural analysis of lectin-like 
bacteriocins has shown that the C-terminal 30 amino acids form a beta hairpin that are 
necessary for cytotoxic activity of the protein (14).  As the 4xMyc tag consists of 60 amino 
acids representing 6.5 kDa of additional sequence, the fusion of the 4xMyc epitope to this 
region of the protein may interfere with its function. Alternatively, the N-terminal of 
lectin-like bacteriocins starts with a β-prism domain, which is more likely to play a 
structural role in the protein and may be less susceptible to inactivation by the fusion of 
the epitope (15). In the transient expression experiments only an N-terminally tagged 
putidacin L1 fusion was utilised. However, a C-terminally 4xMyc tagged syringacin L1 
construct was utilised, which displayed greatly reduced activity compared to the N-
terminal fusion. This suggests that C-terminal tags interfere with lectin-like bacteriocin 
killing. Large epitope tags provide a convenient and specific way of confirming protein 
expression in transgenic plants, via western blotting or immunofluorescence. However, as 
bacteriocins need to translocate across at least the outer membrane to elicit their 
cytotoxic effect, a large epitope tag represents unnecessary ‘extra baggage’ with the 
potential to reduce or abolish cytotoxic activity. As the success of transformation of an 
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untagged bacteriocin can be conveniently assessed with a simple cytotoxicity assay, the 
creation of untagged bacteriocin constructs, especially for poorly characterised 
bacteriocins is favourable. As such, for the creation of syringacin L1 expressing 
Arabidopsis, a pJO530 derived vector containing untagged syringacin L1 was created. 
 
 
Figure 7-5 Expression and activity of C or N-terminally 4xMyc tagged putidacin L1 in N. benthamiana. 
 A) Anti-Myc Western blot of SDS-PAGE separated leaf extracts from N. benthamiana expressing putidacin 
L1 with either an N- or C-terminal Myc tag. B) Cytotoxic activity of Myc-tagged putidacin L1 expressing leaf 
extracts against P. syringae LMG 5084, visualised by soft agar overlay.  
 
7.5.2 Transformation and characterisation of Arabidopsis 
The glabrous (i.e. lacking leaf hairs) mutant strain GL-7 of Arabidopsis thaliana Col-0 was 
utilised for the creation of N-terminally 4xMyc tagged putidacin L1 and or untagged 
syringacin L1 expressing plants, by the floral dip method (197). Plants were grown to 
anthesis and dipped in Agrobacterium harbouring the appropriate pJO530 derived 
bacteriocin containing vector (Table 2-2). Plants were allowed set seed and dried seeds 
were collected and transformants selected for on MS-agar containing 25 µg ml-1 
hygromycin B (the selection marker for pJO530). Successful transformants grew with an 
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analogous phenotype to wildtype seedlings on MS agar in the absence of selection, 
whereas the hygromycin sensitive seedlings (non-transformants) were visibly stunted and 
unable to produce a second set of leaves (Figure 7-6). Approximately 1-2 % of total seed 
from the floral dipped plants (T0 generation) displayed hygromycin resistance.   
 
 
 
 
 
 
 
 
 
 
 
Eight resistant seedlings for each bacteriocin were transferred to soil and grown under 
long day conditions to induce flowering. Leaf extract from these plants was tested for 
activity by western blotting and cytotoxicity assay. Plants from the syringacin L1 
transformation exhibited only very weak activity against the most susceptible strain P. 
syringae Carlise 1, an environmental isolate isolated during this study, suggesting that 
only a low level of expression of active protein was occurring. The putidacin L1 
transformed lines showed variable levels of expression by western blotting for the C-Myc 
epitope, with all lines showing significant activity in the cytotoxicity assay (Figure 7-7).  
Figure 7-6 Phenotypic differences between wildtype and putidacin L1/syringacin L1 transformed 
Arabidopsis seedlings, selected on hygromycin agar.  
 Approximately 2% of seeds from floral dip transformation were resistant to hygromycin and grew 
normally of nutrient agar plates containing hygromycin. Non-transformed seeds were able to germinate 
and produce chlorophyll but were stunted and unable to grow significant roots or produce a second set of 
leaves. 
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At this point due to their low expression level the syringacin L1 transformed plants were 
abandoned, while seed from the first 6 putidacin L1 transformed plants was collected, 
plated onto hygromycin selection as above and the ratio of sensitive to resistant progeny 
was analysed. As Arabidopsis are naturally self-pollinating these progeny, representing 
the T1 generation, should display a 3 to 1 resistant to sensitive ratio if transformation 
occurred through a single insertion even. Resistant/bacteriocin expressing plants from the 
T1 generation, with a single insertion will be heterozygous or homozygous for the 
bacteriocin gene. Progeny analysis revealed that lines 1, 2 and 6 displayed ratios 
sufficiently close to 3 to have resulted from a single insertion event. The 2.4 ratio of line 1 
is somewhat lower, but as it appeared to have the best expression of all lines, so it was 
taken forward for further analysis. Line 4 exhibited a segregation ratio lower than three, 
suggestive of gene silencing. Lines 3 and 5 possessed morphological defects suggestive of 
insertion into a developmental gene; these lines were abandoned at this point. See Table 
7-1 for progeny analysis.  
 
 
 
 
 
 
 
 
 
 
 
194 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7-7 Expression of putidacin L1 N-Myc by T0 generation transformed Arabidopsis 
A) Anti-Myc western blot of SDS-PAGE separated leaf extract, showing variable levels of expression 
between various transgenic nMyc-putidacin L1 expressing Arabidopsis lines (protein concentrations 
normalised by Bradford assay), B) Agar overlay spot test of cell lysate from T1 transgenic lines on 
LMG5084, showing significant cytotoxicity in all lines.  
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The leaf extract from resistant T1 generation plants was tested for cytotoxicity by agar 
overlay assay to confirm that hygromycin resistance correlated with putidacin L1 
expression Figure 7-9. All lines were found to have significant cytotoxicity towards P. 
syringae LMG5084.  T1 generation plants were then grown under long day conditions to 
induce flowering and seed was collected. This seed representing the T2 generation was 
plated onto hygromycin selection to isolate lines homozygous for putidacin L1. Lines 
displaying progeny with a 100% resistant phenotype are homozygous; where as those 
with a 3:1 resistant to susceptible ratio are heterozygous for the insert.  
Lines 1(2), Line 2(1) and Line 6(1) were found to be homozygous and as such they were 
selected for infection assays. The expression of putidacin L1 as a percentage of total leaf 
protein was estimated by comparing the lowest dilution at which killing was observed on 
the cytotoxicity assay with the minimum inhibitory concentration of recombinant 
putidacin L1.  Cytotoxicity was averaged over 6 different leaf sections with protein 
concentrations normalised by Bradford assay.  Putidacin L1 was found to constitute 
between 0.02 and 0.06 % of total leaf protein (Figure 7-9). 
 
Line Resistant Susceptible Ratio 
1   180 74 2.4 
2 366 111 3.3 
3 315 83 3.8 
4 125 14 8.9 
5 - - - 
6 145 50 2.9 
Table 7-1 Analysis of hygromycin resistance of T1 generation putidacin L1 N-Myc transformed 
Arabidopsis 
 Arabidopsis is self-fertilizing so a ratio of resistant to susceptible progeny of approximately 3:1 is 
indicative of a single cassette insertion event, which is desirable for the analysis of stable 
transgenic lines. 
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Figure 7-8 Expression putidacin L1 N-Myc by T1 generation transgenic Arabidopsis, assessed by spot 
test of leaf extract on LMG 5084.  
Clarified leaf extract from T1 generation putidacin L1 N-Myc expressing transgenic Arabidopsis plants 
(lines 1, 2, 4 and 6) was spotted onto a Kings B agar plate overlain with soft agar containing the putidacin 
L1 susceptible indicator strain LMG5084. Expression of putidacin L1 in these lines was assessed 
qualitatively by the zone of inhibition produced by the extract. No inhibition was observed for 
untransformed (WT) extract, while significant activity of observed for all transgenic plants. 
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7.6 Putidacin L1 expressing Arabidopsis displays resistance to 
susceptible P. syringe strains 
To assess the ability of the putidacin L1 expressing Arabidopsis to resist P. syringae 
infection, wildtype and transgenic Arabidopsis plants were challenged with infection by 
the three putidacin L1 susceptible P. syringae strains susceptible: LMG2222, LMG5084 
and LMG5456. P. syringae at 105, 106 and 107 cfu.ml-1 was syringe infiltrated into 
Arabidopsis leaves and disease symptoms and bacterial proliferation was monitored.  
In initial experiments more mature (approximately 6 week old) Arabidopsis seedlings 
were utilised and plants were incubated at ambient humidity after infiltration. Under 
these conditions only minor disease symptoms were observed, with no obvious 
Figure 7-9 Putidacin L1 expression by putidacin L1 N-Myc T2 transgenic Arabidopsis  
Expression of putidacin L1 N-Myc as was determined as a percentage of total leaf protein (determined 
by Bradford assay). 2-fold serial dilutions of transformed leaf extract were spotted on a Kings B agar 
plate overlain with a sensitive indicator strain.  The minimum dilution at which inhibition was observed 
was compared to that for purified recombinant putidacin L1 to give putidacin L1 content of the extract. 
This was then normalised to the protein content of the leaf extract. 
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distinction between wildtype and transformed lines. Additionally, bacterial counts from 
infected leaf tissue did not increase beyond 106 cfu.cm-1, suggesting that the bacteria 
were incapable of infecting under these conditions. 
As a result the infection protocol was modified and younger plants (3-4 weeks old) were 
utilised with the plants kept at >95 % humidity (i.e. in water containing trays with a 
transparent lid) for 16 hours after infiltration.  Under these conditions plants infected 
with 106 and 107 cfu.ml-1 of LMG5456 and LMG5084 displayed significant symptoms of 
disease, whereas LMG2222 infected plants still only displayed a mild symptoms. Despite 
the lack of disease symptoms as a result of LMG2222 infection, bacterial proliferation was 
assessed using the colony count method. In agreement with the observed symptoms no 
significant proliferation was observed beyond inoculation levels in either wildtype or 
transgenic plants. For this reason infection assays using this strain were not pursued 
further. Disease symptoms from LMG5456 infection were the same as for wildtype and 
transgenic plants, potentially due to the relatively low potency of putidacin L1 against this 
strain (Table 6-1), or due to programmed cell death due to activation of the 
hypersensitive response (305). As a result of the lack of difference in symptoms between 
wildtype and transgenic plants, plants infected by LMG5456 were also not investigated 
further.  
Infection of wildtype Arabidopsis by 106 or 107 cfu.ml-1 LMG5084 resulted in rapid onset 
of disease symptoms; lesions formed on infected leaves, followed by desiccation and 
withering of the infected area, the infection was most pronounced in plants infected with 
107 cfu.ml-1. In contrast, putidacin L1 expressing infected plants showed only mild 
symptoms and no withering or desiccation of leaves, suggesting that infection was 
alleviated by expression of the bacteriocin (Figure 7-10-A). Bacterial load in infected 
leaves was monitored at 0, 24 and 48 hours. After 48 hours, infected leaves from the 
wildtype plants had desiccated to the point that extraction of material for sampling was 
difficult and the plant had begun to outgrow the infection.  
Figure 7-10-B shows cfu.cm-1 of infected leaf tissue at the sampled time points. At 0 hours 
(directly after infection), comparable numbers of bacteria were isolated from both 
wildtype and transgenic plants, showing inoculation levels were consistent. Both wildtype 
and transgenic plants inoculated at 105 cfu.ml-1, did not exhibit bacterial proliferation 
above 105 cfu.cm-1, which is indicative of an unsuccessful infection and consistent with 
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the lack of disease symptoms observed in the wildtype plants. Consistent with observed 
disease symptoms only a modest increase in bacterial numbers were observed in 
putidacin L1 transgenic plants inoculated with 106 or 107 cfu.ml-1 of LMG5084, with 
neither surpassing 106 cfu.cm-1. In contrast, high levels of proliferation were observed in 
wildtype plants inoculated with either 106 or 107 cfu.ml-1 of LMG5084, with both 
inoculation levels reaching 108 cfu.cm-1. This level of bacterial growth in leaf tissue is 
indicative of successful infection by the pathogen and is consistent with the disease 
symptoms observed. Lower levels of bacteria were isolated from leaves at the 48 hour 
time point for wildtype plants inoculated with 106 cfu.ml-1, which was inconsistent with 
the high levels isolated at 24 hours. However, it was observed during this 48 h sampling 
of the 106 cfu.ml-1 infected leaves, that the sampled tissue had begun to desiccate.  When 
colony counts were performed on completely desiccated infected tissues from later time 
points, no viable P. syringae LMG5084 cells were not recovered, suggesting that P. 
syringae LMG5084 is unable to survive in the desiccated leaf tissue. This observation 
presents an explanation for the decline observed in the 106 cfu.ml-1 cell counts. The 
decline in bacterial numbers from infected tissues at later stages of the infection makes it 
difficult to ascertain the susceptibility of the plants to bacterial infection by colony counts 
alone. To provide a qualitative assessment of the difference in susceptibility between 
wildtype and transgenic plants, the relative disease symptoms of infected plants was 
scored (Table 7-2). This analysis showed that in all cases wildtype plants exhibited more 
severe disease symptoms than the transgenic lines, with all infected leaves displaying 
severe disease symptoms (>40% of the infected leaf area displaying lesions). The three 
transgenic lines tested varied in the level of disease resistance they displayed, with no 
plants from line 1(2) displaying more than mild disease symptoms (<20% of the infected 
leaf area displaying lesions), but a number of infected leaves from lines 2(1) and  6(1) 
displaying moderate disease symptoms (>20% of the infected leaf area displaying lesions). 
This may be due to the lower levels of putidacin L1 expression in these lines (Figure 7-9). 
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Figure 7-10 Infection by leaf infiltration of wildtype and putidacin L1 N-Myc (Line 1(2)) Arabidopsis, with 
P. syringae LMG5084 
A) Difference in disease symptoms between wildtype and putidacin L1 Arabidopsis after 48 hours, when 
infected with 10
7 
cfu.ml
-1
 of P. syringae LMG 5084, obvious wilting and desiccation was observed for 
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wildtype plants, whereas transgenic plants appear generally healthy, B) cfu.cm
-1 
recovered from wildtype 
and putidacin L1 expressing Arabidopsis at various time 0,24 and 48 hours post syringe infiltration with 10
5
 
to 10
7 
cfu.ml
-1
 of P. syringae LMG 5084. 
 
Table 7-2  Qualitative assessment of disease symptoms on leaves of wildtype and putidacin L1 N-Myc 
Arabidopsis, infected with 10
7
 cfu.ml
-1
 of P. syringae LMG5084 
Infection was conducted in three replicate plants, all infected leaves were assessed for symptoms, + = 
leaves displaying at least moderates symptoms, - = leaves displaying less than moderate symptoms, % = 
total percentage of infected leaves displaying at least moderate disease symptoms, Symptom notes: All 
wildtype leaves exhibited severe symptoms, 1(2) only displayed mild symptoms or no symptoms, 2(1) and 
6(1) leaves only displayed moderate symptoms at worst, Symptoms Key: Mild = Less than 20% of the leaf 
affected by lesions, Moderate = More than 20% of the leaf affected by lesions, Severe = Greater than 40% 
of leaf affected by lesions 
 
107 cfu.ml-1 LMG5084 Infected leaves exhibiting at least moderate symptoms 
 Plant 1 Plant 2 Plant 3  
Line + - + - + - % 
Wt 12 0 12 0 10 0 100 
1(2) 0 12 0 11 0 10 8 
2(1) 4 8 6 4 5 6 45 
6(1) 3 5 6 5 3 6 42 
 
7.7 Discussion 
In this work the expression of the bacteriocins syringacin M, syringacin L1 and putidacin 
L1 were assessed in N. benthamiana using a transient expression system. All three 
bacteriocins were shown to be expressed in this system, albeit to varying degrees. This 
result definitively shows that N. benthamiana is capable of expressing bacterially derived 
anti-microbial proteins, paving the way for futures studies. While it was outside the scope 
of this study, N. benthamiana represents an excellent model plant for infection studies 
and the creation of stable bacteriocin expressing lines would provide an ideal system for 
testing the efficacy of bacteriocins in mediating disease resistance.       
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Following the transient expression experiments, stably transformed Arabidopsis lines 
expressing putidacin L1 and syringacin L1 were created. While both these bacteriocins 
have the same overall structure and presumably a similar mechanism of killing (see 
chapter 6), they were produced by in planta to varying degrees. As putidacin L1 was 
expressed to high levels in Arabidopsis and is highly effective against a number of strains, 
the putidacin L1 expressing lines were utilised to test the efficacy of bacteriocin 
expression in mediating resistance to P. syringae infection. The results of these infection 
assays, in which putidacin L1 susceptible P. syringae strains were infiltrated into the 
leaves of Arabidopsis, showed that the transgenic plants exhibited both reduced disease 
symptoms and reduced bacterial proliferation compared to the wildtype plants. 
While expression of putidacin L1 was unable to completely eradicate P. syringae 
infection, these data provide a very positive indication of the ability of bacteriocins to 
increase disease resistance.  
It should be stressed that these results are preliminary and significant further work is 
required to confirm these findings and improve on the model system utilised in this study. 
As discussed previously, during infection of leaf tissue P. syringae predominantly exists in 
the intercellular space (28), confocal microscopy of plants expressing GFP-bacteriocin 
fusion proteins showed bacteriocin expression to be cytoplasmically localised. This means 
that the bacteriocin produced is effectively partitioned away from the P. syringae cells 
during infection. This suggests that the disease resistance observed is due to the exposure 
of P. syringae to trace levels of putidacin L1 due to lysis of a small percentage of plant 
cells. Extracellular targeting of bacteriocins was attempted in this study through the 
fusion of bacteriocins to extracellular targeting peptides, however approach did not prove 
successful. Optimisation of this approach or development of a novel strategy for targeting 
bacteriocins to the extracellular space may improve the efficacy of bacteriocins in 
combatting P. syringae infection. 
Assessment of disease resistance would also benefit from an improved infection assay. By 
necessity the P. syringae strains utilised for the infection assays needed to be sensitive to 
the bacteriocins used in the study and also able to cause infection in Arabidopsis. Due to 
the limited time and resources for this study, it was not possible to create transgenic 
plants other than Arabidopsis. P. syringae LMG5084 was the only putidacin L1 sufficiently 
susceptible strain available, capable of infecting Arabidopsis via leaf infiltration. P. 
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syringae LMG5084 was not particularity virulent, requiring an inoculum of at least 106 
cfu.ml-1 and careful control of infection conditions to establish and infection. Additionally, 
leaves successfully infected with P. syringae LMG5084 desiccated quickly with the 
bacteria not remaining viable. This made assessment of infection by colony counts 
difficult. The establishment of a model system in which the bacteria was highly 
susceptible to the bacteriocin utilised and also highly virulence to the host plant, would 
be highly beneficial for the development of this technology.           
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8 Concluding Remarks  
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8.1 Key findings of this study 
The aims of this study were to identify bacteriocins produced by plant pathogenic 
bacteria, to characterise them and to apply this knowledge to the creation of transgenic 
plants with increased resistance to specific bacterial pathogens. The results presented in 
chapters 3, 6 do the former, identifying and characterising the novel bacteriocins 
syringacin M, syringacin L1 and putidacin L1 active against P. syringae species. While 
those in chapter 4 identify pectocins M1, M2 and P active against Pectobacterium spp.. 
Chapter 7 shows that the three bacteriocins active against P. syringae can be expressed in 
planta and that the expression of putidacin L1 leads to increased disease resistance.  
Chapter 6 represents a tangent to the main aims of the thesis, detailing the discovery of 
the ferredoxin uptake receptor (FupA) possessed by Pectobacterium spp.. The unusual 
ferredoxin receptor binding/translocation domain of the pectocins led to the 
identification of this system, which allows this phytopathogen to utilise host ferredoxin as 
an iron source during infection. While tangential to the stated aims of this work, this 
discovery represents a key finding of the study, with implications for protein import and 
virulence in both Pectobacterium and Gram-negative bacteria more generally.    
The work in chapters 3 and 4, also provides key insights into the function of the M-class 
colicin-like bacteriocins. Firstly, the structures of syringacin and pectocin M show that 
both recombination and diversifying evolution drive the generation of new specificities in 
this class of bacteriocin. Despite the lack of sequence identity between the receptor 
binding and translocation domains of colicin M and syringacin M, comparison of their 
crystal structures show that they both possess the same overall fold derived from a 
common ancestor. Additionally, preliminary data suggests that syringacin M requires the 
homologue of FhuA (the colicin M receptor) for killing, suggesting that the cell surface 
receptor is also conserved. Alternatively, the recombination derived fusion of the M-class 
cytotoxic domain with a plant-like ferredoxin allows the M-class pectocins to utilise FupA 
as their receptor. Prior to this study, the crystal structure of colicin M provided a picture 
of the M-class active site at odds with the mutagenic and biochemical data. The key 
catalytic residues in the structure are distant from each other and no bound metal ion 
(known to be essential for activity) was observed in the putative active site. The structure 
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of syringacin M, revealed the location and coordination of this metal ion and comparison 
of the active sites of pectocin M2 and syringacin M combined with docking simulations 
with its lipid II substrate, provide a credible model for substrate binding. 
Phenotypic and structural analysis of the lectin-like bacteriocins in this study firmly 
established LPS as the cell surface receptor for these proteins. For pyocin L1 this was 
definitively shown to be the D-rhamnose homopolymer CPA, whereas for putidacin L1 
while D-rhamnose was shown to be bound by the protein, the story may be more 
complex. At the time this study was conducted, no colicin-like bacteriocins had been 
shown to utilise LPS as a receptor, however the concurrent identification of LPS binding in 
colicin N suggests this may be a more widespread phenomena (12). In addition to the LPS 
receptor discovery, this study provides clues to the killing mechanism of the lectin-like 
bacteriocins. The observed septation defect after treatment with putidacin L1 and the 
increased putidacin L1 resistance of mutants for the outer-membrane stress regulator 
CpxA, suggests a cytotoxic mechanism localised to the bacterial outer envelope. The data 
presented in chapter 7 shows, for the first time, that colicin and lectin-like bacteriocins 
can be expressed in planta and that this expression does not lead to reproductive or 
phenotypic defects. Additionally, this work shows that expression of putidacin L1 in 
Arabidopsis leads to a quantifiable reduction in both the ability of susceptible bacteria to 
replicate in these plants and in the severity of disease symptoms. These data provide a 
sound basis for future work on the commercial exploitation of bacteriocins in this 
context. 
In summary, this work represents an important advance in our theoretical and practical 
understanding of how bacteriocins from plant pathogens function. As illustrated in 
chapter 7, these proteins have considerable potential in controlling bacterial disease in 
plants, and that their utilisation for this purpose will require in-depth knowledge of how 
they function.  
 
8.2 Future work 
As with any scientific study of limited duration, there is never enough time or resources 
to ‘finish the story’ or characterise a system in adequate detail to satisfy the curiosity of 
the investigator. As such, future work is necessary to build on and increase our depth of 
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understanding of subjects of this study. This future work can be broadly classified into 
investigation of the function of bacteriocins and their associated nutrient uptake systems 
and development of bacteriocin expressing plants. 
 
8.2.1 Analysis of the M-class active site 
While in silico docking and analysis of the M-class catalytic domains provides a highly 
suggestive picture of the lipid II binding site, it would be beneficial to confirm this binding 
and elucidate the catalytic mechanism of lipid II hydrolysis. Co-crystallisation of M-class 
bacteriocins, mutated so they retain substrate binding but not hydrolysis activity, with 
lipid II or a substrate analogue provides a means of achieving this. However, due to the 
flexible nature of the active site of this enzyme, it may be difficult to capture the bound 
conformation in crystallo. NMR provides an alternative approach. While full length M-
class bacteriocins are approximately 30 kDa in length, making NMR analysis non-trivial, a 
number of studies have shown that the isolated cytotoxic domain, at approximately 17 
kDa, in size is still highly active (199,200). Assigning the HSQC spectra of this domain and 
mapping chemical shifts in the presence and absence of various substrate analogues 
would provide an alternative means of mapping the binding site.       
 
8.2.2 Conformation of the syringacin M receptor 
The syringacin M resistant P. syringae LMG5456 line MDC2, was shown by whole genome 
sequencing to possess a frame shift mutation in the gene encoding a homologue of the 
TonB-depedent receptor FhuA. FhuA from E. coli is the outer-membrane receptor for 
colicin M and as such it is likely that the homologue is the syringacin M receptor (207). 
This could be confirmed by complementation of the FhuA homologue mutation in MDC2, 
via transformation with a plasmid containing the gene or by allelic exchange. If the FhuA 
homologue proves to be the syringacin M receptor, expression, purification and co-
crystallisation with the syringacin M receptor binding domain, would provide insight into 
receptor binding for this bacteriocin.     
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8.2.3 Characterisation of the Fup operon and its role in iron acquisition 
In this study Pectobacterium was shown to utilise plant ferredoxin as an iron source and 
FupA was identified as the ferredoxin receptor. However, only limited characterisation of 
this system was performed. As homologues of the Fup operon are present in a number of 
mammalian pathogens, understanding how this system works in molecular detail has 
implications for bacterial virulence outside of Pectobacterium spp. (264). Determination 
of the structure of FupA and utilisation of a combination of crystallographic, mutagenic 
and NMR based approaches will allow for the binding interface between ferredoxin and 
FupA to be mapped. These data will provide information about the initial steps of iron 
acquisition, providing clues as to whether the entire ferredoxin or just its iron-sulphur 
cluster is imported. FupC, a large M16 zinc protease, present in the Fup operon may play 
a role in liberation of iron from ferredoxin once it has been imported into the periplasm. 
Expressing recombinant FupC and determining if it interacts with and cleaves plant 
ferredoxin would provide strong evidence for the importation of ferredoxin to the 
periplasm. Additionally, determining the localisation of FupC, by tagging and cell 
fractionation experiments, would confirm its presence in the periplasm. If FupC is shown 
to both cleave ferredoxin and be localised to the periplasm, analysis of ΔFupC strains for 
periplasmic ferredoxin accumulation and a lack of growth enhancement phenotype 
would provide definitive evidence for ferredoxin uptake by this system.   
 
8.2.4 Determination of the molecular target of lectin-like bacteriocins 
While this study showed that lectin-like bacteriocins utilise LPS as their cell surface 
receptor, given the potency of these molecules it seems unlikely that this LPS binding 
activity is solely responsible for their cytotoxic activity. Identification of the killing 
mechanism of these proteins would be useful from the point of view of understanding 
their function and also in potentially identifying a new target for antibiotic development. 
In addition to identifying genes responsible for LPS production as important for lectin-like 
bacteriocin killing, isolation of bacteria tolerant to putidacin L1 revealed that tolerance 
could be inferred by inactivation of CpxA. CpxA is the receptor component of a two-
component sensor kinase, which has been extensively implicated in antibiotic sensitivity 
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(275,306). Investigation of differences in cellular regulation of wildtype and ΔCpxA 
strains, in the presence and absence of lectin-like bacteriocins, should provide clues to its 
killing mechanism. 
 
8.2.5 Optimisation of lectin-like bacteriocin production in plants    
This study shows that colicin and lectin-like bacteriocins can be successfully expressed in 
plants and that this expression leads to increased disease resistance. However, in order to 
pave the way for commercial exploitation of bacteriocins in this way additional work is 
required. Two immediate aspects which could be focused on are improving the infection 
model for assessing bacteriocin mediated resistance, and optimising the cellular 
localisation of expressed bacteriocins. As discussed in chapter 7, the model system 
developed during this study had a number of short comings. The susceptible P. syringae 
strain utilised was not particularity virulent in the Arabidopsis leaf infiltration assay and 
didn’t survive in leaves which became desiccated due to infection. The infection system 
could be immediately improved by identifying P. syringae strains, which are putidacin L1 
sensitive, highly virulent against Arabidopsis and with increased persistence in the leaf 
post infection. Alternatively, a different infection assay could be utilised. Flood 
inoculation of Arabidopsis seedlings grown on plant-nutrient agar with P. syringae has 
been shown to be an effective model system for assessing disease resistance and could 
be applied (307). As P. syringae is an intercellular pathogen, extracellular localisation of 
bacteriocins would put both bacteria and bacteriocin in the same place, intuitively, 
maximising the chance of disease resistance. As such more effort into engineering 
bacteriocin constructs facilitating the secretion of active bacteriocins would be beneficial. 
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Figure 9-1 Images of protein crystals produced during this study.  
A) The P6322 crystal form of syringacin M, B) The P21 crystal form of syringacin M, C) The P3121 
crystal form of Pectocin M2, D) the C2221 crystal form of pyocin L1, E) the P21 crystal form of 
FupA, F) crystals of putidacin L1 in the space group P6522. 
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Figure 9-2 Examples of diffraction produced by protein crystals produced during this study.  
A) The P6322 crystal form of syringacin M, B) The P21 crystal form of syringacin M, C) The P3121 crystal form 
of Pectocin M2, D) the C2221 crystal form of pyocin L1, E) the P21 crystal form of FupA, F) crystals of 
putidacin L1 in the space group P6522. (Detector distances and resolution limits vary between images) 
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Figure 9-3 Structure and CD spectra of syringacin M D232A mutant 
A) A schematic of the crystal structure of syringacin M D232A, at 3 Å, showing key catalytic residues (orange 
sticks) and the lack of an associated metal ion cofactor. B) Near and far CD spectra of wildtype and D232A 
mutant syringacin M show unperturbed secondary structure. 
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Figure 9-4 The relationship between OD600 and Cfu.ml
-1
 for P. syringae strain LMG2222  
A) The OD600
 
an actively growing culture of LMG2222 was determined at hourly time points and cfu.ml
-1
 
were also determined by serial plating on Kings B agar. B to D) Graphical representation of relationship 
between optical density, hours of growth and Cfu.ml
-1
. The relationship between Cfu.ml
-1
 and OD600
 
was 
used to determine the Cfu.ml
-1
 for plant infection experiments. 
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Table 9-1 Production of antimicrobial compounds by P. syringae strains antagonistic to P. syringae 
growth  
Colonies of P. syringae strains, shown in the far left column, were grown on Kings B agar in the presence of 
0.25 µM Mitomycin C and lysed using chloroform vapours. Soft agar containing indicator strains was 
overlain over lysed colonies and zones of inhibition surrounding the colonies was observed after growth at 
28 °C for 12 hours. Indicator strains, shown in top and middle rows, inhibited are shown as an X while those 
uninhibited are shown as an O.  Except for the inhibition of LMG5456 by DC3000 and LMG1247 which was 
diffusible in the agar and shown to be due to syringacin M, all zones of inhibition were non-diffusible and 
suggestive of large phage tail type bacteriocins.   
 
 DC3000 LMG5456 NCPPB 2563 NCPPB 3160 LMG 5060 
DC3000 O X (8mm) O O O 
NCPPB 1107 O O O O O 
NCPPB 2563 O O O O O 
NCPPB 3160 O O O O O 
LMG 5060 O O O O O 
LMG5456 O O O O O 
LMG 2208 O O O O O 
LMG 2222 O O O O O 
LMG 1247 O X (15mm) O O O 
LMG 5082 O X (6mm) O O O 
LMG 5084 O X (7mm) X (7mm) X (7mm) X (7mm) 
      
 LMG 2208 LMG 2222 LMG 1247 LMG 5082 LMG 5084 
DC3000 O O O X (7mm) O 
NCPPB 1107 O O O X (7mm) X (7mm) 
NCPPB 2563 O X (8mm) O X (8mm) X (7mm) 
NCPPB 3160 O O O O O 
LMG 5060 O O O X (7mm) O 
LMG5456 O O O O O 
LMG 2208 O O O O O 
LMG 2222 O O O O O 
LMG 1247 O X (7mm) O X (7mm) X (7mm) 
LMG 5082 O X (7mm) O O X (7mm) 
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LMG 5084 X (7mm) O X (7mm) O O 
 
Table 9-2 Susceptibility of Pectobacterium strains to pectocin M1 at different concentrations of bipryidine 
 LB plates +/- bipryidine were overlain with soft agar seeded with the strain of interest, purified pectocin 
M1 was spotted onto the plate before incubation at 28 °C for 12 hours. The effect of pectocin M1 was 
assessed. E = growth enhancement due to pectocin M1, I = inhibition to pectocin M1, I/E = an internal zone 
of growth enhancement surrounded by growth inhibition, - = pectocin M1 didn’t effect growth of the strain. 
+ symbol represents the relative size and clarity of the zone, ranging from + = small hazy zone to ++++ = 
large pronounced zone 
 2,2 Bipryidine concentration 
 0 µM 100 µM 200 µM 400 µM 
LMG2444 -   E ++ -  -  
LMG2374 -   I ++ I +++ I ++++ 
LMG2391 -   I + I/E + I ++++ 
LMG2442 -   -  -  -  
LMG2410 -   -  E + -  
LMG2412 -   I/E ++ I +++ I ++++ 
SCRI1043 -   -  I + I ++++ 
LMG2386 -   I ++ I +++ I ++++ 
LMG2913 -   E ++ I/E ++ I/E +++ 
LMG2375 -   I + I + I ++++ 
 
Table 9-3 Susceptibility of Pectobacterium strains to pectocin M2 at different concentrations of bipryidine 
LB plates +/- bipryidine were overlain with soft agar seeded with the strain of interest, purified pectocin M2 
was spotted onto the plate and plates before incubation at 28 °C for 12 hours. The effect of pectocin M2 
was assessed. E = growth enhancement due to pectocin M2, I = inhibition to pectocin M2, I/E = an internal 
zone of growth enhancement surrounded by growth inhibition, - = pectocin M2 didn’t effect growth of the 
strain. + symbol represents the relative size and clarity of the zone, ranging from + = small hazy zone to 
++++ = large pronounced zone 
 2,2 Bipryidine concentration 
 0 µM 100 µM 200 µM 400 µM 
LMG2444 -   -  E ++ -  
LMG2374 -   -  I + -  
LMG2391 -   -  -  -  
LMG2442 -    -  E + -  
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LMG2410 -   -  E ++ -  
LMG2412 -   E ++ E ++ I ++ 
SCRI1043 -   -  -  -  
LMG2386 -   -  -  -  
LMG2913 -   E + E ++ -  
LMG2375 -  -  -  I + 
 
Table 9-4 Growth enhancement of Pectobacterium strains by spinach ferredoxin at different 
concentrations of bipryidine  
LB plates +/- bipryidine were overlain with soft agar seeded with the strain of interest; purified spinach 
ferredoxin was spotted onto the plate before incubation at 28 °C for 12 hours. The effect of spinach 
ferredoxin was then assessed. E = growth enhancement due to spinach ferredoxin, - = spinach ferredoxin 
didn’t effect growth of the strain. + symbol represents the relative size and clarity of the zone, ranging from 
+ = small hazy zone to ++++ = large pronounced zone 
 2,2 Bipryidine concentration 
 0 µM 100 µM 200 µM 400 µM 
LMG2444 -   -  -  -  
LMG2374 -   -  -  -  
LMG2391 -   -  -  -  
LMG2442 -   -  E + E ++++ 
LMG2410 -   -  E + E ++++ 
LMG2412 -   -  -  E ++++ 
SCRI1043 -   -  -  -  
LMG2386 -   -  -  -  
LMG2913 -   -  E + E ++++ 
LMG2375 -   -  -  -  
 
 
Table 9-5 Killing spectrum of leaf extracts from transiently transformed N. benthamiana leaves 
 Zone = diameter of zone in millimetres, Killing = clarity or turbidity of killing zone (+ = highly turbid zone, 
+++++ = no bacterial growth in zone), Purified Putidacin L1 was spotted at 2 mg.ml
-1
. PL1 = putidacin L1, SL1 
= syringacin L1  
 
       
 PL1 purified GFP-control Untagged MDC 
 Zone Killing Zone Killing Zone Killing 
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LMG 5084 20mm +++++ -  8mm ++ 
LMG5456 18mm ++++ -  13mm +++ 
LMG1247 12mm +++ -  -  
LMG 5082 5mm + -  -  
LMG2222 20mm +++++ -  5mm + 
LMG5060 -  -  -  
DC3000 -  -  -  
NCPPB1107 -  -  -  
NCPPB2563 -  -  -  
NCPPB3160 -  -  -  
LMG2208 -  -  -  
 
       
 SL1 C-Myc PL1 N-Myc SL1 C-Myc 
 Zone Killing Zone Killing Zone Killing 
LMG 5084 5mm ++ 12mm +++++ 9mm ++++ 
LMG5456 -  13m ++++ 6mm ++ 
LMG1247 -  -  -  
LMG 5082 -  -  -  
LMG2222 5mm ++ 12mm +++++ 6mm +++++ 
LMG5060 -  -  -  
DC3000 -  -  -  
NCPPB1107 -  -  -  
NCPPB2563 -  -  -  
NCPPB3160 -  -  -  
LMG2208 -  -  -  
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Abstract
In order to kill competing strains of the same or closely related bacterial species, many bacteria produce potent narrow-
spectrum protein antibiotics known as bacteriocins. Two sequenced strains of the phytopathogenic bacterium
Pectobacterium carotovorum carry genes encoding putative bacteriocins which have seemingly evolved through a
recombination event to encode proteins containing an N-terminal domain with extensive similarity to a [2Fe-2S] plant
ferredoxin and a C-terminal colicin M-like catalytic domain. In this work, we show that these genes encode active
bacteriocins, pectocin M1 and M2, which target strains of Pectobacterium carotovorum and Pectobacterium atrosepticum
with increased potency under iron limiting conditions. The activity of pectocin M1 and M2 can be inhibited by the addition
of spinach ferredoxin, indicating that the ferredoxin domain of these proteins acts as a receptor binding domain. This effect
is not observed with the mammalian ferredoxin protein adrenodoxin, indicating that Pectobacterium spp. carries a specific
receptor for plant ferredoxins and that these plant pathogens may acquire iron from the host through the uptake of
ferredoxin. In further support of this hypothesis we show that the growth of strains of Pectobacterium carotovorum and
atrosepticum that are not sensitive to the cytotoxic effects of pectocin M1 is enhanced in the presence of pectocin M1 and
M2 under iron limiting conditions. A similar growth enhancement under iron limiting conditions is observed with spinach
ferrodoxin, but not with adrenodoxin. Our data indicate that pectocin M1 and M2 have evolved to parasitise an existing iron
uptake pathway by using a ferredoxin-containing receptor binding domain as a Trojan horse to gain entry into susceptible
cells.
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Introduction
Bacteriocins are highly potent narrow-spectrum antibacterial
protein toxins produced by a variety of Gram-negative bacteria
that are active against bacteria closely related to the producing
strain [1]. The best characterised of the bacteriocins are the
colicins from E. coli and genes encoding putative bacteriocins with
cytotoxic domains highly homologous to cytotoxic domains of the
colicins can be identified in the genomes of a wide variety of
Gram-negative bacteria. The cytotoxic activity of colicin-like
bacteriocins is housed in a C-terminal domain, with central and N-
terminal domains encoding receptor-binding and translocation
functions [2]. Colicin cytotoxic domains take the form of a specific
nuclease domain that hydrolyses DNA, tRNA or 16S rRNA, a
pore-forming domain that depolarises the cytoplasmic membrane,
or as in the case of colicin M, inhibits cell wall production through
degradation of undecaprenyl-phosphate-linked peptidoglycan
precursors [3,4]. The C-terminal domain is also the site of
binding for a specific immunity protein that protects the producing
cell from the lethal effects of the toxin [5,6]. To gain entry into
target cells, colicins initially bind to a specific outer membrane
receptor and cross this membrane through recruitment of host
proteins of the TolABQR-Pal or TonB-ExbBD complexes in the
periplasmic space [7,8]. A number of the receptors for colicins and
for the closely related pyocins are TonB dependent with a normal
physiological role in iron siderophore uptake [9,10]. Unlike the
colicins, little is known about the receptors and mechanisms of
entry used by bacteriocins from plant pathogenic bacteria.
The genus Pectobacterium contains necrotrophic plant pathogens,
characterised by their ability to secrete cell wall degrading
enzymes including pectinases, cellulases, proteases and xylanases.
These enzymes are produced in greater abundance in Pectobacter-
ium spp. than in other phytopathogenic bacteria and give the genus
its distinctive soft rot phenotype. The genus Pectobacterium is divided
into four species atrosepticum, betavasculorum, carotovorum and wasabiae
[11,12]. Strains of carotovorum and wasabiae have a broad host
range, while atrosepticum and betavasculorum are restricted to potato
and sugar beet respectively [13]. P. atrosepticum is the causative
agent of black leg in potato, one of the most economically
important diseases of any temperate crop [14].
Iron acquisition mechanisms of Pectobacterium have not yet been
studied extensively, however the genus has been shown to acquire
iron by diverse mechanisms including siderophore, haem iron and
ferric-citrate production/absorption [15,16]. The closely related
soft rot pathogen Dickea dadantii (formerly Erwinia chrysanthemi) has
been shown to possess two high affinity iron siderophores
(achromobactin and chrysobactin) and mutants impaired in the
production of these siderophores are less virulent, suggesting iron
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acquisition is an important virulence determinant in infection [17].
Additionally, transcription of pectolysin genes responsible for
degradation of the host cell wall during infection, has been shown
to be triggered by iron limitation, suggesting a link between iron
limitation and pathogenesis [18].
Plant-type ferredoxins are a super family of proteins containing
a single [2Fe-2S] cluster. They are predominantly present in the
chloroplasts, where they primarily function as electron carriers
from photosystem one to enzymes responsible for carbon, nitrogen
and sulphur assimilation [19]. Plant-type ferredoxins are also
present in the non-photosynthetic tissues of plants suggesting a
wider physiological relevance. Genes very closely related to those
encoding plant-type ferredoxins are also present, seemingly
uniquely among heterotrophic bacteria, in the genomes of a
number of Pectobacterium species. These genes were likely acquired
by horizontal gene transfer [20]. [2Fe-2S] ferredoxins more
distantly related to plant-type ferredoxins are widely distributed
through prokaryotic and eukaryotic kingdoms [21].
In this work we have purified and characterised two novel
bacteriocins from Pectobacterium species. These bacteriocins, named
pectocin M1 and M2, contain a predicted N-terminal domain with
high levels of sequence similarity to plant ferredoxins and a C-
terminal domain highly homologous to the catalytic domain of the
E. coli bacteriocin, colicin M. The cytotoxic activity of these
bacteriocins is limited to Pectobacterium spp. and is dependent on
iron availability. Our data indicate that the ferredoxin domain acts
as a receptor binding domain and that these bacteriocins have
evolved to gain entry into susceptible cells through parasitisation of
a previously unreported iron uptake system in Pectobacterium spp.
Results
Identification of pectocin M genes in the genomes of
Pectobacterium spp.
As part of a wider study into the identification and potential use
of bacteriocins as biocontrol agents we searched the genome
sequences of plant pathogenic bacteria for genes encoding putative
colicin-like bacteriocins. Two putative colicin M-like bacteriocin
genes were identified in the genomes of P. carotovorum subspp.
carotovorum PC1 (Pcc PC1) and P. carotovorum subspp. brasiliensis
BPR1692 (Pcb BPR1692). These genes encode proteins that we
have named pectocin M1 and pectocin M2, respectively. Pectocin
M1 and M2 have an N-terminal domain with approximately 60%
identity to spinach ferredoxin I and a C-terminal domain with
approximately 46% identity to the catalytic domain of colicin M
(Figure 1a and b). The colicin M-like domains of both proteins
contain all residues that have previously been shown to be
important for the catalytic activity and consequently cytotoxicity of
colicin M [22]. A linker region of approximately 20 amino acids,
which is not conserved between pectocin M1 and M2 connects the
two domains and overall these proteins share 58% sequence
identity.
Phylogenetic analysis of the ferredoxin domains of these
pectocins show they cluster with a number of other ferredoxin
and ferredoxin-domain containing proteins from Pectobacterium
species (Figure 1c). This cluster of sequences is most similar to
[2Fe-2S] ferredoxins from plants and cyanobacteria, with
ferredoxins from the genus Arabidopsis sharing the highest sequence
identity. This cluster is much more distantly related to typical
bacterial ferredoxins (Figure 1c). The cysteine residues of plant
ferredoxins that coordinate the [2Fe-2S] cluster in the active
centre of these proteins are conserved in the pectocins, indicating
that these proteins may also contain the [2Fe-2S] cluster
(Figure 1b).
Evolution of the pectocin M1 gene through gene
duplication and recombination
Analysis of the genomic context of pectocin M1 gives clues to its
evolutionary origin. As shown in Figure 2a, approximately 3000bp
upstream of the gene coding for pectocin M1, is a predicted open
reading frame encoding a plant-like ferredoxin with 52% amino
acid identity to the ferredoxin domain of pectocin M1. Alignment
of the nucleotide sequences of these regions (Figure 2b) shows high
nucleotide conservation (.50%) that encompasses the area of
sequence similarity between pectocin M1 and the plant-like
ferredoxin, as well as part of a hypothetical open reading frame
present in both regions, but truncated in the pectocin M1 region.
High levels of similarity and truncation of the adjacent open
reading in the pectocin M1 region strongly suggests a gene
duplication event. Evolution of the gene encoding the active
bacteriocin is therefore likely to have occurred after this gene
duplication event, through recombination between the duplicated
ferredoxin gene and an ancestral bacteriocin carrying a colicin M-
like cytotoxic domain. An open reading frame directly upstream of
the pectocin M1 gene encodes a likely pectocin M1 immunity
protein, which shares 24% amino acid identity with the immunity
protein of colicin M. Pectocin M2 does not share this genomic
context, however the open reading frame directly upstream codes
for a bacteriocin closely related to carocin S2 [23], suggesting it
may have been recruited to a genomic island.
Purification and characterisation of pectocin M1 and M2
Pectocin M1 and M2 were expressed in E. coli BL21 (DE3) and
purified by anion exchange chromatography and gel filtration to
.90% homogeneity based on analysis by SDS PAGE (Figure 3a).
The purified recombinant proteins were red-brown in colour and
the absorption spectra of both proteins displayed maxima at
330 nm, 423 nm, and 466 nm (Figure 3b), which are character-
istic of plant ferredoxins [21]. These data show both pectocins M1
and M2 contain a [2Fe-2S] cluster.
Initially the killing spectrum of pectocin M1 and pectocin M2
was tested against five P. atrosepticum and five P. carotovorum isolates
using the agar overlay spot test method on LB agar. Under these
experimental conditions pectocin M1 was found to be active
against three atrosepticum strains and one carotovorum strain. The
zones of inhibition in this experiment while distinct, were hazy
(Figure 3c). Pectocin M2 did not show activity against any of the
strains tested under these conditions. Since a number of
bacteriocins utilise outer membrane receptors involved in iron
uptake [2] we tested the activity of the pectocins under iron
limiting conditions induced by addition of the iron chelator 2,29-
bipryidine to the LB agar. Under these conditions, the activity of
pectocin M1 was greatly enhanced (Figure 3c), with seven of ten
Pectobacterium spp. being inhibited. For pectocin M2, three of the ten
strains were weakly inhibited (Table 1, Table S1). The minimum
inhibitory concentration of pectocin M1 under iron-limiting
conditions was calculated using the above method with serial
dilutions of pectocin M1 and varied from 14.5–145 nM among
susceptible strains. The cytotoxic effect of pectocin M1 in liquid
culture was tested by adding varying concentrations of pectocin
M1 to an iron limited log-phase culture of the susceptible strain P.
atrosepticum LMG 2386. A concentration-dependent reduction in
growth was observed upon the addition of pectocin M1 (Figure 3d).
To determine if pectocin M1 and M2 might be active against more
distantly related bacterial species, pectocin M1 and pectocin M2
were tested for inhibitory activity against strains of E. coli,
Pseudomonas syringae, Pseudomonas aeruginosa and Erwinea rhapontici
(see Table S2). None of these more distantly related bacteria
showed any susceptibility to pectocin M1 or M2 (at 1.2 and
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10 mg/ml respectively) suggesting that the activity of these
pectocins is limited species of Pectobacterium closely related to the
producing strain.
The ferredoxin domain of pectocins M1 and M2 mediate
receptor binding
As ferredoxin is a potential iron source for phytopathogenic
Pectobacterium species we hypothesised that pectocins M1 and M2
were parasitising an existing iron uptake system by using their
ferredoxin domain to bind to a cell surface receptor, which has a
normal physiological role in iron acquisition from ferredoxin. If
this is the case, the addition of a plant ferredoxin at sufficient
concentration should abolish pectocin M1 binding to its receptor
and therefore abolish its cytotoxic activity. To test this hypothesis
spinach ferredoxin was spotted adjacent to pectocin M1 in an agar
overlay spot test. Clear inhibition of cell killing was observed in the
region where the diffusion zone of spinach ferredoxin overlaps
with the pectocin M1 diffusion zone (Figure 4a). Indeed, for all 7
susceptible strains cytotoxicity of pectocin M1 could be abolished
to a similar extent by the addition of spinach ferredoxin. This
effect was not observed with adrenodoxin, a more distantly related
mammalian [2Fe-2S] cluster containing ferredoxin, indicating a
level of specificity for plant ferredoxins (Figure 4a). Additionally, in
five pectocin M1 susceptible strains that are not sensitive to
pectocin M2 the cytotoxicity of pectocin M1 could be abolished by
the addition of pectocin M2, indicating these two bacteriocins
utilise the same receptor.
To determine if the activity of the colicin M-like domain of
pectocin M1 is essential for its cytotoxicity, we made a mutant
protein in which Asp222 is replaced by Ala. The equivalent Asp of
colicin M has been shown to be essential for the catalytic activity
and consequent cytotoxicity of colicin M [22]. Purified pectocin
M1 Asp222Ala had no detectable cytotoxicity, but was able to
abolish cytotoxicity of wild-type pectocin M1 indicating that it is
fully functional in binding to its receptor (Figure 4a). Taken
together, these data indicate that receptor recognition occurs
through the ferredoxin domain of pectocin M1 and M2 and that
the normal physiological role of pectocin M1/M2 receptor is to
bind plant ferredoxins.
Growth enhancement under iron limiting conditions by
pectocins and spinach ferredoxin
During spot tests on iron limiting media to determine the killing
spectrum of pectocin M1 and M2 we observed that the growth of a
number of insensitive Pectobacterium strains was observably
enhanced where the pectocins were spotted onto the plate.
Additionally, some strains that were inhibited by pectocin M1
displayed a zone of enhanced growth peripheral to the zone of
inhibition. Four and five of the ten Pectobacterium isolates exhibited
enhanced growth in the presence of pectocin M1 and M2
respectively. The enhancement of growth due to pectocin M1 was
significantly more pronounced than that due to pectocin M2, with
strongest enhancement present at 200 mM 2,29-bipyridine for both
pectocin M1 and pectocin M2 (Table S1). This observation led us
to hypothesise that Pectobacterium strains are able to utilise these
ferredoxin domains as an iron source under iron limiting
conditions.
To test this idea further, and to test the specificity of this
growth enhancement, related plant and mammalian ferredoxin-
type proteins (spinach ferredoxin I and human adrenodoxin) as
well as syringacin M, a colicin M homologue from Pseudomonas
syringae which contains an active colicin M catalytic domain but
an unrelated N-terminal region [24] (unpublished data) were
tested for their ability to enhance the growth of Pectobacterium spp.
Figure 1. Domain structure, homology and molecular phylogeny of pectocins M1 and M2. a) Domain structure of pectocin M1 and
relationship to colicin M and plant ferredoxin. b) Sequence alignment of pectocin M1, M2 and pectocin P (see discussion) with [2Fe-2S] ferredoxin
type proteins and colicin M. For clarity of presentation prior to alignment pectocin P was truncated to amino acids 1–101 (N-terminal domain) and
colicin M was truncated to amino acids 128–271 (C-terminal domain). Genbank/PDBaccession numbers are as follows: Ferredoxin I [S. oleracea]
1704156A, plant-like ferredoxin [Pcc PC1] YP_003017870, pectocin M1 [Pcc PC1] YP_003017875, pectocin M2 [Pcb BPR1692] ZP_03825528, colicin M
[E. coli SMS-3-5] YP_001739994, pectocin P [Pcc WPP14] ZP_03830397. Invariant residues are highlighted in black, residues with similar properties in
gray b) Nearest neighbour joining molecular phylogenetic tree of [2Fe-2S] ferredoxins and pectocin ferredoxin domains. Bootstrap values (%) at
major nodes are indicated. Species names represent independent ferredoxin proteins from listed species, typifying the class of ferredoxin. Proteins
discussed in the study are named with species designation in brackets. Plant ferredoxins and adrenodoxin were aligned with signal peptides
removed, pectocin sequences were trimmed to minimum region on homology with plant-like ferredoxin from Pcc PC1. Ellipses designate the
following: blue= plant-type ferredoxins, red= ferredoxins found predominately in c-proteobacteria, yellow= ferredoxins involved in electron
transport to cytochrome P450. Scale represents substitutions per amino acid site.
doi:10.1371/journal.pone.0033033.g001
Figure 2. Genomic context of the pectocin M1 gene. a) Position of genomic regions on the chromosome of Pcc PC1 containing the pectocin
M1 gene and a related plant-like ferredoxin gene. b) Alignment of genomic regions from above, containing the pectocin M1 gene and the related
plant-like ferredoxin gene showing annotated open reading frames and nucleotide homology shared between the two regions.
doi:10.1371/journal.pone.0033033.g002
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under iron-limiting conditions. Five strains exhibited strongly
enhanced growth due to the spinach ferredoxin at either 20
or 2 mg ml21 (Figure 4b), this enhanced growth was dependent
on the concentration of the iron chelator 2,29-bipyridine, with
the strongest enhancement at 400 mM (Table S1). No en-
hanced growth was observed with the [2Fe-2S] cluster con-
taining protein adrenodoxin at 30 mg ml21 or syringacin M at
5 mg ml21.
Discussion
In this work we have identified, purified and characterised two
novel bacteriocins, pectocin M1 and M2, which are active against
selected strains of Pectobacterium spp. These bacteriocins share a
common domain structure, with an N-terminal ferredoxin domain
containing a [2Fe-2S] cluster and a C-terminal cytotoxic domain
homologous to colicin M. Activity of pectocin M1 was inhibited by
Figure 3. Purification and characterisation of pectocin M proteins. a) SDS PAGE of purified pectocin M2, M1 and M1 D222A b) Absorbance
spectrum of pectocin M1 at a concentration 1.2 mg ml21. Maxima at 330, 423 and 466 nm, identical to those observed in plant ferredoxins, indicate
the presence of a [2Fe-2S] cluster in pectocin M1. Spectra with identical absorbance peaks were obtained for the pectocin D222A mutant and
pectocin M2. c) Agar overlay spot tests of a 3-fold serial dilution (68 mM-0.385 nM) of pectocin M1 spotted onto overlay of P. atrosepticum LMG 2386
cells grown in the presence (top) and absence (bottom) of the iron chelator 2,29-bipryidine (200 mM). d) Liquid growth inhibition assay, test strain
LMG 2386, grown in LB broth with 200 mM 2,29-bipyridine. Purified PM1 was added when indicated.
doi:10.1371/journal.pone.0033033.g003
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the addition of spinach ferredoxin, which strongly suggests that the
ferredoxin domain mediates binding to a receptor on the surface of
sensitive Pectobacterium strains. The mammalian ferredoxin adre-
nodoxin was unable to elicit this effect, even at a concentration 15
times higher than the lowest tested spinach ferredoxin concentra-
tion. This suggests that the pectocin M receptor is specific for
plant-type ferredoxin and is not merely binding due to the
presence of an iron sulphur cluster. The inhibition of bacteriocin
cytotoxicity as an indicator of competition is well established by
previous studies of bacteriocin-receptor interactions in E. coli. For
example, colicin M, which gains entry to the cell via the
ferrichrome receptor FhuA, can be blocked by the addition of
ferrichrome, the normal physiological ligand of FhuA. In addition,
colicin M is able to block albomycin activity, an antibiotic which
also uses FhuA as a receptor [22,25,26]. Similarly vitamin B12, the
substrate of the BtuB receptor, is able to inhibit cytotoxicity of the
E group colicins which also bind this receptor [27].
The cytotoxicity and spectrum of killing of pectocin M1 and M2
is greatly enhanced under iron limiting conditions suggesting that
production of their receptor is unregulated and that this receptor
likely plays a role in iron acquisition. This idea is supported by the
observation that some strains of Pectobacterium spp. are able to
exhibit enhanced growth under iron limiting conditions in the
presence of a plant-like ferredoxin, either in the form of spinach
ferredoxin or the pectocins themselves. The growth enhancement
is specific to the extent that adrenodoxin does not elicit this effect.
The enhanced growth observed under iron limiting conditions in
the presence of the pectocins and spinach ferredoxin, suggests that
the iron contained in plant-like ferredoxins can be specifically
utilised by Pectobacterium species. Taken together, these data
strongly suggest that the pectocin M receptor has a normal
physiological role in iron acquisition from plant ferredoxin.
The importance of iron acquisition in bacterial pathogenesis of
animals is well established and the ability to acquire sufficient iron
often determines the success or failure of an infection [28]. The
dynamics of iron availability during bacterial pathogenesis of
plants is less well understood, although a number of studies have
strongly correlated iron acquisition and virulence in planta
[17,18,29]. During infection, Pectobacterium species release large
quantities of pectinases and cellulases which macerate host tissues
creating the distinctive soft rot associated with the genus. This
disease phenotype results in cell lysis and the release of
intracellular nutrients for absorption by the bacteria [11]. Since
ferredoxin is the major iron containing protein in plants it
undoubtedly represents an attractive potential source of iron in an
environment of low iron availability [30]. As such, the ability of
Pectobacterium spp. to acquire iron from ferredoxin may represent
an important virulence mechanism, although this remains to be
tested.
A number of iron acquisition systems involving absorption from
iron containing proteins have been identified in pathogenic
bacteria [28]. The best studied system involves the transferrin-
binding proteins TbpA and TbpB of Neisseria spp. These outer
membrane proteins bind transferrin with a preference for the
holoprotein, strip the protein of its two iron atoms before releasing
the apoprotein into the extracellular environment. These proteins
have been shown to be specific for the transferrin of the host and
are essential for virulence [31]. Whether the entire ferredoxin
protein or simply the iron which it contains is taken into the cell by
Pectobacterium is currently unknown.
The ferredoxin domain of pectocin M1 is closely related to plant
ferredoxins and the pectocin M1 gene has seemingly evolved
through duplication of a horizontally acquired plant ferredoxin
gene and subsequent recombination with an ancestral colicin M-
like bacteriocin. The presence of ferredoxin genes in Pectobacterium
spp. that appear to have been acquired through horizontal gene
transfer from plants has been previously noted [20]. In addition to
pectocin M1 and M2, we have identified a further putative
bacteriocin that contains an N-terminal ferredoxin domain.
Analysis of the genome sequence of Pectobacterium carotovorum subspp.
carotovorum WPP14 revealed a gene encoding a putative bacteriocin
(designated pectocin P, Figure 1b) with an N-terminal ferredoxin
domain and a C-terminal domain with 41% identity to the C-
terminal 187 amino acids of pesticin, a peptidoglycan degrading
bacteriocin with muramidase activity from Yersinia pestis
Table 1. Susceptibility of Pectobacterium strains to pectocin
M1 and M2.
Species
No. Strains susceptible
to indicated Pectocin
No. Strains tested M1 M2
Pb. atrosepticum 5 5 1
Pb. cartovorum 5 2 1
doi:10.1371/journal.pone.0033033.t001
Figure 4. Asymmetric pectocin M1 spot test inhibition zones
and growth enhancement due to plant-like ferredoxin, but not
adrenodoxin a) Asymmetric pectocin M1 inhibition zones against P.
atrosepticum LMG2386 due to plant-like ferredoxin containing proteins.
Protein concentration for spots were as follows: pectocin M1
1.2 mg ml21, spinach ferredoxin 20 mg ml21, adrenodoxin 30 mg ml21,
pectocin M2 10 mg ml21, pectocin M1 D222A 5.6 mg ml21 b) Growth
enhancement of P. carotovorum subspp. carotovorum LMG 2410 by plant-
like ferredoxin containing proteins. Protein concentrations for spots were
as follows: spinach ferredoxin 20 mg ml21, adrenodoxin 30 mg ml21,
Spinach ferredoxin 20 mg ml21 :pectocin M1 1.2 mg ml21. Pectocin M1
causes asymmetry in zone of enhancement due to spinach ferredoxin in
LMG 2410 (400 mM 2,29-bipyridine) presumably through competition for
a common receptor. Pectocin M1 does not enhance growth of this strain
under these conditions.
doi:10.1371/journal.pone.0033033.g004
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[32,33,34]. Like colicin M the cellular target of pesticin is located
in the periplasm and as such a receptor binding and translocation
domain sufficient to deliver a colicin M catalytic domain to its site
of action would also be sufficient to deliver the cytotoxic domain of
a pesticin-like bacteriocin. Recombination and gene duplication
have been well established as evolutionary mechanisms for
generating bacteriocins with new specificities [1]. Many of the
colicins and related bacteriocins identified to date are mosaics of
related receptor binding, translocation and catalytic domains
[2,35]. However, the evolution of ferredoxin containing bacterio-
cins seems to be unprecedented in that Pectobacterium spp. has
successfully utilised a horizontally acquired host gene for
competition against closely related bacterial strains.
Methods
Bacterial strains and media
Strains of Pectobacterium spp. used in this study are listed in
Table 2. Other bacterial strains are listed in Table S2. All bacterial
strains were grown in LB broth with the exception of Pseudomonas
syringae pathovars which were grown in Kings B Broth. All strains
were grown at 28uC, with the exception of E. coli and P. aeurginosa
which were grown at 37uC. Media was supplemented with
ampicillin 100 mg ml21, kanamycin 50 mg ml21, isopropyl-ß-D-
thiogalactopyranoside (IPTG) 0.1–1 mM or 2,29-bipyridine 100–
400 mM when required.
Plasmid construction and DNA manipulation
Plasmids used in this study are outlined in Table 2. pJMPCI and
pJMBPR which contain the open reading frames of pectocin M1
and M2 and unique NdeI and XhoI sites at the start codons and
directly after the stop codons of the pectocin genes were
synthesized by DNA 2.0. Plasmids pETMPCI and pMBPR, used
for expression of the pectocin M1 and M2, respectively were
created by subcloning the NdeI/XhoI fragments of pJMPCI and
pJMBPR into the corresponding sites of pET-21a. The D222A
mutant of pectocin M1 was created using the QuikChange Site
Directed Mutagenesis Kit (Stratagene) utilising pETMPCI as a
template and the following primers, (59-GCA TCC GCG CAT
ATA ACG CTC TGT ATG ATG CTA ATC CG-39, 59-CGG
ATT AGC ATC ATA CAG AGC GTT ATA TGC GCG GAT
GC-39) to give the D222A pectocin M1 encoding plasmid
pETMPCID222A.
Protein expression and purification
Pectocin M1 and M2 were expressed in E. coli BL21 (DE3)
carrying the plasmid pETPCI or pETBPR, respectively. Cells
were grown at 37uC and protein expression was induced by the
addition of IPTG at an OD600 of approximately 0.6. Cultures
were grown for a further six hours at 28uC. Cells were harvested
and resuspended in 50 mM Tris-HCl, pH 7.5, 20 mM NaCl and
Complete EDTA free protease inhibitor cocktail tablets (Roche)
were added. After disruption by sonication the supernatant was
clarified by centrifugation and applied to a DE-52 anion
exchanged column (Whatman) equilibrated in 50 mM Tris-HCl,
pH 7.5, 20 mM NaCl. Bound protein was eluted with a linear
gradient of 20–600 mM NaCl in lysis buffer. Pectocin containing
fractions were identified based on colour and analysis by SDS-
PAGE. Pectocin containing fractions were pooled and dialysed
into 50 mM Tris-HCl, pH 7.5, 20 mM NaCl and loaded onto a
Superdex S75 26/60 column, (GE Healthcare). To obtain
homogenous protein a final purification step using a Mono Q
Table 2. Strains and plasmids used in this study.
Strain or Plasmid Relevant Characteristic(s) Source or Reference
P. carotovorum subspp. carotovorum
LMG 2410 Isolated from Cucumis sativus BCCM
LMG 2412 Isolated from Hyacinthus orientalis BCCM
LMG 2442 Isolated from Brassica oleracea BCCM
LMG 2444 Isolated from Solanum tuberosum (tuber soft rot) BCCM
LMG 2913 Isolated from soil BCCM
P. atrosepticum
LMG 2374 Isolated from Apium graveolens var. dulce BCCM
LMG 2375 Isolated from Solanum tuberosum (tuber soft rot) BCCM
LMG 2386 Isolated from Solanum tuberosum (stem rot) BCCM
LMG 2391 Isolated from soil BCCM
SCRI 1043 Isolated from Solanum tuberosum (tuber soft rot) [37]
Plasmids
pJexpress411 Kanr, cloning/expression vector, T7 promoter this study
pJexpress404 Ampr, cloning/expression vector, T5 promoter this study
pET21-a(+) Ampr, cloning/expression vector, T7 promoter Novagen
pJMPC1 Kanr, pJexpress411 with Pectocin M1 inserted into NdeI/XhoI sites this study
pJMBPR Kanr, pJexpress411 with Pectocin M2 inserted into NdeI/XhoI sites this study
pETMPCI Ampr, pET21-a(+) with Pectocin M1 inserted into NdeI/XhoI sites this study
pETMPCID222A Ampr, pET21-a(+) with Pectocin M1 D222A inserted into NdeI/XhoI sites this study
pETMBPR Ampr, pET21-a(+) with Pectocin M2 inserted into NdeI/XhoI sites this study
BCCM=Belgian Co-ordinated Collections of Micro-organisms, NCPPB=National Collection Plant Pathogenic Bacteria, SCRI = Scottish Crop Research Institute.
doi:10.1371/journal.pone.0033033.t002
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(GE Healthcare) anion exchange column was employed with
bound protein eluted with a linear gradient of 20–700 nM NaCl in
50 mM Tris-HCl, pH 7.5. Fractions were pooled as above and
dialysed into 50 mM Tris-HCl, pH 7.5, 100 mM NaCl. Dialysed
fractions were aliquoted and frozen at 280uC. The absorption
spectrum of purified pectocins was determined using a UV-1700
Pharma Spec, UV-VIS spectrophotometer (Shimadzu). Spinach
ferredoxin was obtained from Sigma-Aldrich. Adrenodoxin was
provided as a gift from Ms Alette Brinth (University of Glasgow)
and was judged as .90% holoprotein, based on the ratio of
absorbance at 414 nm and 276 nm.
Growth inhibition/enhancement assays
Inhibition of growth on solid media was determined using the
soft agar overlay method [36]. 100 ml of mid-log phase culture of
the test strain was added to 5 ml of 0.6% agar in dH2O melted
and cooled to 42uC. The molten agar was then overlayed onto LB
medium with or without 100–400 mM 2,29-bipyridine. Purified
protein was spotted directly onto the surface of the overlay once
solidified. To observe inhibition interference proteins were spotted
within the others zone of diffusion on the plate. Plates were
incubated for a further 12 hours and zones of inhibition/
enhancement observed. For inhibition of growth in liquid culture
cells were grown in LB broth with 200 mM 2,29-bipyridine purified
pectocin M1 was added to at mid-log phase and the OD600 was
monitored throughout the experiment.
Identification of pectocins and bioinformatic analysis
Putative pectocins were identified by interrogating the National
Center for Biotechnology (NCBI) non-redundant protein database
with the protein sequence for colicin M from E. coli, using the
pBlast algorithm. Genomic regions containing proteins of interest
were then investigated using the NCBI graphic interface.
Sequences were saved in FASTA format and analysed using
Bioedit, ClustalW multiple sequence alignment tool and CLC
genomics workbench.
Supporting Information
Table S1 Enhancement/Inhibition of growth of Pectobacterium
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Summary
The colicin-like bacteriocins are potent protein antibi-
otics that have evolved to efficiently cross the outer
membrane of Gram-negative bacteria by parasitizing
nutrient uptake systems. We have structurally char-
acterized the colicin M-like bacteriocin, pectocin M2,
which is active against strains of Pectobacterium spp.
This unusual bacteriocin lacks the intrinsically
unstructured translocation domain that usually medi-
ates translocation of these bacteriocins across the
outer membrane, containing only a single globular
ferredoxin domain connected to its cytotoxic domain
by a flexible α-helix, which allows it to adopt two
distinct conformations in solution. The ferredoxin
domain of pectocin M2 is homologous to plant ferre-
doxins and allows pectocin M2 to parasitize a system
utilized by Pectobacterium to obtain iron during infec-
tion of plants. Furthermore, we identify a novel
ferredoxin-containing bacteriocin pectocin P, which
possesses a cytotoxic domain homologous to lys-
ozyme, illustrating that the ferredoxin domain acts as
a generic delivery module for cytotoxic domains in
Pectobacterium.
Introduction
It is a dogma of colicin biology that after binding tightly to
their cognate outer membrane (OM) receptor, colicins
utilize an intrinsically unstructured translocation domain
(IUTD) to recruit the inner membrane-bound Tol or Ton
complex (Kleanthous, 2010; Housden et al., 2013). These
complexes, which are responsive to the proton motive
force (pmf), mediate translocation of the bacteriocin across
the OM (Cascales et al., 2007; Housden et al., 2010). The
formation of a colicin translocon has recently been visual-
ized directly for the DNase-type colicin E9 through the
isolation and imaging of the colicin in complex with its
primary receptor BtuB, the trimeric porin OmpF, which
allows passage of the IUTD across the OM and the peri-
plasmic protein TolB, which is a component of the cell
envelope-spanning TolABQR-Pal complex (Housden
et al., 2013). Similarly, the TonB-dependent pore-forming
colicin, colicin IA, uses one copy of the TonB-dependent
receptor Cir as its primary receptor and a second copy as
a translocation pathway for its IUTD to cross the OM to
deliver a TonB-binding epitope to the periplasm (Jakes and
Finkelstein, 2010). In addition to the colicins, which show a
potent narrow spectrum of killing activity against strains of
E. coli and other closely related bacteria, other colicin-like
bacteriocins have also been characterized. These include
the S-type pyocins from Pseudomonas aeruginosa,
klebicins from Klebsiella pneumonia and syringacin M from
P. syringae (Riley et al., 2001; Michel-Briand and Baysse,
2002; Barreteau et al., 2009). The recently determined
structures of the M-class bacteriocins pyocin M and syrin-
gacin M showed that like colicin M, these bacteriocins
possess a 30- to 40-amino-acid IUTD, which is essential
for translocation, indicating that translocation across the
OM likely occurs through the same mechanism as the
colicins (Zeth et al., 2008; Barreteau et al., 2012a,b;
Grinter et al., 2012b).
We recently described the novel M-class bacteriocins
pectocin M1 and M2, which are produced by and active
against strains of the soft-rot phytopathogens Pectobacte-
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rium atrosepticum (Pba) and Pectobacterium carotovorum
(Pbc) (Grinter et al., 2012a; 2013). The domain structure of
these proteins suggested that they challenge the dogma
that an IUTD is the universal mechanism by which colicin-
like bacteriocins achieve translocation. Pectocin M1 and
M2 consist of an M-class cytotoxic domain with lipid II
degrading activity, fused to a plant-like ferredoxin domain
(Grinter et al., 2012a; 2013). This ferredoxin domain, which
contains an intact [2Fe-2S] iron–sulphur cluster, substi-
tutes for the helical receptor binding domain and IUTD of
the M-class bacteriocins discussed above, that are
required to deliver the cytotoxic domain to the periplasm.
Further to this, we observed that the addition of plant
ferredoxin to strains of Pba and Pbc exposed to the pec-
tocins inhibited bacteriocin-induced killing (Grinter et al.,
2012a). These observations show first, that Pba and Pbc
possess an OM receptor able to bind ferredoxin and
second, that pectocins M1 and M2 parasitize this receptor
to target and ultimately gain entry to susceptible cells. The
role of ferredoxin binding for these plant pathogens is
apparent under iron-limiting conditions where, in the pres-
ence of plant ferredoxin, some strains of Pectobacterium
spp. show strongly enhanced growth (Grinter et al.,
2012a). This effect is not observed on addition of the
mammalian ferredoxin homologue, adrenodoxin, which
also contains a [2Fe-2S] iron–sulphur cluster (even at
greatly increased concentrations), indicating a high level of
specificity for plant ferredoxin. Similarly, adrenodoxin is not
able to rescue cells from pectocin M-induced killing (Grinter
et al., 2012a). Thus, like other colicin-like bacteriocins,
pectocins M1 and M2 parasitize an existing nutrient uptake
system to gain entry into target cells. However, for these
bacteriocins the mechanism is overt and unprecedented,
with the direct utilization of ferredoxin, a protein from which
Pectobacterium spp. is able to directly acquire iron, as the
targeting region of the bacteriocin (Grinter et al., 2013).
In order to gain further insight into the mechanism
through which pectocins M1 and M2 gain entry into target
cells, we have used X-ray crystallography and small angle
X-ray scattering along with in silico modelling approaches
to characterize the structural and dynamic properties of
pectocin M2. Our data show that there is a high degree of
conformational flexibility between the ferredoxin and
colicin M-like cytotoxic domain through movement of a
linking helix and definitively show that the protein lacks
the flexible IUTD that is characteristic of all other charac-
terized colicin-like bacteriocins. The lack of an IUTD indi-
cates that the ferredoxin-containing pectocins utilize an
existing ferredoxin uptake mechanism to cross the OM,
without direct interaction with the Tol or Ton complexes in
the periplasm. Additionally, we have determined the exist-
ence of an additional ferredoxin-containing bacteriocin,
pectocin P, which possesses a cytotoxic domain that is a
structural homologue of lysozyme, illustrating that ferre-
doxin can act as a generic module for the delivery of
structurally diverse cytotoxic proteins to the periplasm.
Results
The crystal structure of pectocin M2
In initial crystallization trials for pectocin M2, characteristic
red-brown crystals of this ferredoxin-containing bacteriocin
formed with PEG 3350 and ammonium sulphate as the
precipitants. Data from these crystals were collected to 2.3
Å in the space group P21 and phased using anomalous
scattering data from the metal centres of the [2Fe-2S]
iron–sulphur cluster. The structure of pectocin M2 revealed
an N-terminal domain with the predicted ferredoxin-fold
(residues 2–94, in red), separated from the colicin M-like
cytotoxic domain (residues 116–271, in blue) by a linker
region (residues 95–115, in green) that forms an α-helix
(Fig. 1A and B). There is a significant difference in the
orientation of the cytotoxic and ferredoxin domains of the
two pectocin M2 molecules in the asymmetric unit (ASU)
with a root mean square deviation (r.m.s.d.) of 3.4 Å,
between main-chain atoms (Fig. S1). The fold of the pec-
tocin M2 ferredoxin domain is identical (r.m.s.d. 0.60 Å) to
that of spinach ferredoxin (PDB ID = 1A70) and the
C-terminal cytotoxic domain is highly similar to the lipid
II-cleaving catalytic domains of colicin M (PDB ID = 2XMX,
r.m.s.d. 1.7 Å) (Fig. 1C and D) (Zeth et al., 2008). The
crystal structure of pectocin M2 adds to a growing body of
structural and biochemical data on colicin M-like cytotoxic
domains (Zeth et al., 2008; Barreteau et al., 2010; 2012b;
Helbig and Braun, 2011; Grinter et al., 2012b). We con-
firmed the enzymatic activity of pectocin M1 and M2 by a
lipid II hydrolysis assay (Fig. S2). In the recently solved
structures of pyocin M (PaeM) and syringacin M a divalent
metal ion (Ca2+ or Mg2+) is co-ordinated by a key catalytic
aspartic acid side-chain in conjunction with two backbone
carbonyls. Mg2+, Ca2+ or Mn2+ ions are required for catalytic
activity of M-class bacteriocins, and analysis of these
proteins has shown co-ordination at this position to be
essential for activity (Grinter et al., 2012b). In the pectocin
M2 structure this key aspartate (D226) adopts an analo-
gous conformation. However, no density for a metal ion is
observed in this position, which is occupied by a water
molecule (Fig. 2A). The absence of a metal ion is unsur-
prising given the lack of divalent ions and the high ionic
strength of the crystallization conditions.
Comparative analysis of the catalytic domains of colicin
M homologues reveals significant variation between the
structures. In the structures of pyocin M and syringacin M
a key conserved arginine is located distant from other
conserved residues creating an open active-site cleft. In
contrast, in the pectocin M2 structure this residue (R236) is
orientated towards the other key catalytic residues
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(Fig. 2B). The electron density for R236 permitted model-
ling of two conformations, one within hydrogen bonding
distance of the aspartic acid co-ordinated water and the
other forming a hydrogen bond with N184. In this confor-
mation, R236 creates a defined active site tunnel which
would enable co-ordination of the lipid II and positioning of
the pyrophosphate group in close proximity to all key
catalytic residues (Fig. 2A and B).
In contrast to the compact structures of the homologous
bacteriocins, colicin M, pyocin M and syringacin M, where
Fig. 1. The crystal structure of pectocin M1
reveals a ferredoxin-containing colicin-like
bacteriocin that lacks an IUTD.
A. Amino acid sequence of pectocin M2,
showing structural domains (ferredoxin
domain = red, linker helix = green, catalytic
domain = blue) and annotated with secondary
structure.
B. Schematic of the crystal structure of
pectocin M2 observed in the P21 crystal form,
with the cytotoxic domain in blue, plant-like
ferredoxin domain in red and linker helix in
green. The [2Fe-2S] iron–sulphur cluster is
represented by spheres.
C. Schematic of cytotoxic domain of pectocin
M2 aligned with that of colicin M (PDB
ID = 2XMX) (backbone r.m.s.d. = 1.65 Å,
pectocin M2 residues = 123–271, colicin M
residues = 123–271).
D. Schematic of the ferredoxin domain of
pectocin M2 aligned with that of spinach
ferredoxin (PDB ID = 1A70) (backbone
r.m.s.d. = 0.6 Å, pectocin M2 residues = 2–96,
spinach ferredoxin residues 2–96).
This figure is available in colour online at
wileyonlinelibrary.com.
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the receptor binding and catalytic domains are not sepa-
rated by linker regions and do not form obviously struc-
turally distinct elements (Zeth et al., 2008; Barreteau
et al., 2012b; Grinter et al., 2012b), the catalytic and
receptor binding domains of pectocin M2 do not form
extensive interactions. The relative orientation of the
ferredoxin domain, linker region and cytotoxic domain
gives rise to a non-linear dog-leg structure. Interestingly,
and again in contrast to colicin M, pyocin M and syringacin
M, the N-terminal region of pectocin M2 lacks a disor-
dered or flexible IUTD that is otherwise characteristic of
the colicin-like bacteriocins, with the entire N-terminus
being integral to the globular ferredoxin domain. These
data suggest a mechanism of uptake distinct from closely
related colicin-like bacteriocins.
Pectocin M2 is flexible
Given that pectocin M2 lacks an IUTD required to contact
the Tol or Ton complexes in the periplasm and mediate
translocation of this protein across the outer membrane,
alternative mechanisms of uptake must be considered.
One possibility is that the entire bacteriocin passes through
the lumen of its OM receptor. Since proteins involved in iron
uptake are invariably TonB-dependent receptors that
possess large 22-stranded β-barrels this may be plausible.
However, such a mechanism would only be feasible if
pectocin M2 were flexible and significant rearrangement of
the dog-leg configuration observed in the crystal structure
could be achieved. The observation that there is a relatively
large difference in orientation between the cytotoxic and
ferredoxin domains in the monomers of the ASU (Fig. S1)
is suggestive of such flexibility and indicates that the crystal
structure may not be wholly representative of pectocin M2
in solution.
To assess the conformational flexibility of pectocin M2
we performed small angle X-ray scattering (SAXS). SAXS
data were obtained for a range of pectocin M2 concentra-
tions. Comparison of these data with a theoretical scat-
tering curve generated, using CRYSOL (Svergun et al.,
Fig. 2. Colicin M-class bacteriocins possess
a highly flexible active site.
A. A stereo view of a stick model of the key
active site residues of pectocin M2, showing a
water molecule occupying the key metal
binding site of the enzyme.
B. A stereo view of the overlay of the catalytic
site from all structurally characterized
colicin-M class bacteriocins, showing
conformational variability of the key catalytic
arginine. Key arginine shown as sticks and
colour coded according to structure;
green = syringacin M (PDB ID = 4FZL),
blue = pyocin M (PDB ID = 4G75),
red = colicin M (PDB ID = 2XMX) and
yellow = pectocin M2 (PDB ID = 4N58), All
other catalytically important residues shown
as lines in yellow. This figure is available in
colour online at wileyonlinelibrary.com.
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1995), from the pectocin M2 crystal structure shows there
are obvious differences between the theoretical curve and
experimental scattering data (Fig. 3A). In addition, the
radius of gyration (Rg = 27 Å) obtained from Guinier analy-
sis of the experimental scattering data is somewhat larger
than that calculated from the pectocin M2 crystal structure
(Rg = 24 Å) using SOMO (Rai et al., 2005) (Fig. 3B). Con-
sistent with this, the p(r) function, which describes the
paired set of vectors between all the electrons within the
protein, indicates a maximum particle size (Dmax = 96 Å,
Fig. 3C) that is much greater than the maximum dimen-
sion of the pectocin M2 crystal structure (77 Å, Fig. 1B).
These data suggest that the pectocin M2 crystal structure
is not wholly representative of the conformational ensem-
ble present in solution and that this protein adopts an
elongated conformation, implying inter-domain flexibility.
To test this idea further, we examined the Porod-Debye
plot for pectocin M2, where scattering decay is examined
as I(q)q4 as a function of q4. This analysis reports directly on
particle flexibility and typically for compact globular parti-
cles an asymptotic plateau is reached for the low q part of
the data. However, for pectocin M2 no discernible plateau
was observed (Fig. 3D). For comparison, we also obtained
scattering data for pyocin M which, as with colicin M and
syringacin M, forms a compact structure and similarly
analysed these data (Barreteau et al., 2012b). In contrast
to the curve obtained for pectocin M2, the Porod-Debye
plot for pyocin M reached a plateau confirming its rigidity
and compactness (Fig. 3D). In addition, the Kratky plot
[I(q)q2 versus q] for pectocin M2 normalized to the scatter-
ing intensity I(0) and Rg, has two maxima with increasing
scattering at higher angles. The Kratky plot reports directly
on inter-domain flexibility and for pectocin M2 is consistent
with a two-domain protein connected by a flexible linker
(Fig. 3E). In comparison, there is a single maximum in the
pyocin M Kratky plot, consistent with its single domain-like
globular structure. Taken together these analyses indicate
that pectocin M2 is flexible and adopts conformations
distinct from that observed in the crystal structure.
Pectocin M2 can adopt a highly extended conformation
and exists as two distinct subpopulations in solution
To determine if the SAXS data for pectocin M2 could be
better described by an ensemble of conformations we first
used discrete molecular dynamics (DMD) simulations
Fig. 3. SAXS shows pectocin M2 is flexible.
A. Overlay of the experimentally determined pectocin M2 SAXS curve (black points) with the scattering curve computed with CRYSOL from
the P21 crystal structure (red line) produces a fit (χ = 1.362) with visible deviations between the data, especially evident at low angles,
suggesting that the crystal structure is more compact than that of pectocin M2 in solution.
B. Derivation of Rg from a Guinier analysis (red) of the scattering curve; residuals of the fit are in green.
C. Pair-distance distribution plot from experimental scattering data for pectocin M2 exhibiting two maxima which highlights the bimodal
character of the molecule in solution. The Dmax of the particle is 96 Å.
D. Porod-Debye and (E) normalized Kratky plots for pectocin M2 imply increased flexibility of the protein in solution (red). Pyocin M (black), a
protein of similar molecular weight with a relatively rigid structure and strong inter-domain contacts is used as a control. This figure is available
in colour online at wileyonlinelibrary.com.
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(Shirvanyants et al., 2012) to explore the accessible con-
formational states of pectocin M2 and generated a random
pool of 5000 possible conformationals using the crystal
structure of pectocin M2. Next, we used a genetic algorithm
implemented in the program GAJOE (Petoukhov et al.,
2012) to select for ensembles of these models that would
better describe our SAXS data. Model selection was suc-
cessful as judged by the close correlation of the theoretical
scattering curve generated from the selected ensemble
with the experimental SAXS data (Fig. 4A), indicating that
our scattering data are best described by an ensemble of
pectocin M2 conformers in solution. Interestingly, the
selected ensembles show a bimodal distribution in com-
parison with the random pool of DMD-generated pectocin
M2 models when the population frequency is plotted
against Rg or Dmax (Fig. 4B and C). Thus, in the population
of selected conformations, we frequently find a compact
conformation described by the first peak (with maxima at
approximately 23 and 75 Å for Rg and Dmax respectively)
that approximates closely to the conformation found in the
pectocin M2 P21 crystal structure for which Rg and Dmax
were calculated as 24 and 77 Å respectively. The second
peak represents an ensemble of pectocin M2 conformers
in an extended conformation with Dmax values ranging up to
98 Å, which correlates closely with the experimentally
determined value of Dmax (96 Å). These analyses suggest
that pectocin M2 can adopt both bent and elongated linear
conformations in solution.
The bimodal distribution of the selected ensembles sug-
gests discrete populations in solution, the more compact of
which is similar to the conformation observed in the P21
crystals of pectocin M2. In an attempt to capture the more
elongated conformation in crystallo, thus validating our
solution scattering and modelling data, we repeated crys-
tallization of pectocin M2. A custom re-crystallization
screen was devised exploiting information from the initial
trails. Crystals were obtained in a number of conditions
from this screen and were tested for diffraction as well as
space group and unit cell variation, which is indicative of
novel packing. A form with the radically different space
group of P3121 was chosen for optimization, which yielded
crystals diffracting to 1.86 Å. As an alternative domain
arrangement to the P21 form was expected, data from this
crystal form were again phased using anomalous data
from the metal centres of the [2Fe-2S] cluster. During
model building from these data it was immediately appar-
ent that in this crystal form pectocin M2 did indeed adopt an
elongated conformation (Fig. 5A). The calculated Rg and
Dmax for this structure were 28 and 97 Å respectively. These
values correlate well with the extended population from the
DMD simulation, suggesting that this structure is repre-
sentative of the second elongated pool indentified by our
modelling. Alignment of this elongated (P3121) form and
the original P21 form, based on their cytotoxic or ferredoxin
Fig. 4. Analysis of conformational heterogeneity of pectocin M2
reveals compact and extended ensembles in solution.
A. Overlay of scattering curves of pectocin M2 between
experimental data and the best ensemble selected by GAJOE
indicates improved fit to the scattering data (χ = 0.827).
B and C. Rg (B) and Dmax (C) distribution of solution ensembles
selected by a genetic algorithm using GAJOE from a pool of 5000
random conformers of pectocin M2. Compact and elongated
molecule were both selected implying that the protein is
conformationally heterogeneous in solution allowing for significant
inter-domain re-arrangements about the linker helix (residues
96–115).
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domains, show a major difference in the relative orienta-
tions of these domains (Fig. 5B and C).
The ferredoxin domain is a generic module for the
delivery of cytotoxic domains to the periplasm
In addition to pectocin M1 and M2, we previously identified
a putative third member of the ferredoxin-containing bac-
teriocin family, designated pectocin P (Grinter et al.,
2012a). The open reading frame for pectocin P, identified in
the genome of Pectobacterium carotovorum subsp. caro-
tovorum WPP14, consists of an N-terminal ferredoxin
domain, connected to a pesticin-like cytotoxic domain,
which is analogous to T4 lysozyme. Similar to pectocins M1
and M2, there is no sequence N-terminal of the ferredoxin
domain, so this bacteriocin also lacks an IUTD. To confirm
that this open-reading frame encodes an active bacteri-
ocin, we tested the cytotoxic activity of recombinantly
expressed and purified pectocin P against diverse Pecto-
bacterium isolates. For this test we utilized a solid growth
inhibition assay conducted in parallel with pectocins M1
and M2 (Fyfe et al., 1984). As with pectocins M1 and M2,
limited inhibition of growth was observed under iron-
replete conditions (LB agar). However, under iron-limiting
Fig. 5. Pectocin M2 P3121 structure confirms extended conformation predicted by solution scattering.
A. Pectocin M2 in P3121 crystal form is highly elongated, consistent with the extended conformation predicted from solution scattering and
DMD simulations.
B. Alignment of the catalytic domains of the P21 and P3121 crystal forms of pectocin M2, illustrating the difference in orientation between the
ferredoxin and linker regions.
C. Alignment of the ferredoxin domains of the P21 and P3121 crystal forms of pectocin M2, illustrating the difference in orientation of the
catalytic domains.
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conditions, inhibition of growth was observed for 17 of the
19 strains (Fig. 6, Table S1). The existence of pectocin P,
an additional ferredoxin-containing bacteriocin with no
N-terminal IUTD and a pesticin-like cytotoxic domain, pro-
vides strong supporting evidence that the ferredoxin
domain acts as a generic module for the delivery of cyto-
toxic domains to the periplasm in Pectobacterium spp. The
cytotoxic domains of both M-class bacteriocins and pes-
ticin have been studied extensively and there is no indica-
tion that they possess any intrinsic capacity to cross the
OM (Barreteau et al., 2010; Helbig and Braun, 2011;
Lukacik et al., 2012; Patzer et al., 2012), indicating that
ferredoxin uptake represents an unprecedented example
of receptor-mediated protein uptake for nutrient acquisition
in bacteria.
Discussion
In this work we present the structure and solution proper-
ties of the atypical bacteriocin pectocin M2, which con-
sists of a fusion between a colicin M-like cytotoxic domain
and a plant-derived ferredoxin domain. We have previ-
ously demonstrated that Pectobacterium spp. are able to
acquire iron directly from plant ferredoxin under iron-
limiting conditions through a receptor mediated process
and that the bacteriocins pectocin M1 and M2 parasitize
this system for cell entry through presentation of a ferre-
doxin domain (Grinter et al., 2013). In this study we
provide an insight into how this uptake occurs by showing
that pectocin M2 has an unprecedented structure among
bacteriocins in that it lacks an IUTD. Additionally, we
definitively show that pectocin M2 is highly flexible in
solution fluctuating between compact and extended
conformations.
All iron-uptake systems identified to date in Gram-
negative bacteria, either siderophore based or targeting a
protein substrate, utilize a TonB-dependent receptor to
transport iron across the outer membrane (Faraldo-Gomez
and Sansom, 2003). Likewise, binding and parasitization
of these receptors for cell entry is a characteristic trait of
colicin M, and other characterized colicins and pyocins,
including the E-type colicins (E1-E9), colicins A, B, D, IA
and IB and pyocins S1-S5 (Loftus et al., 2006; Buchanan
et al., 2007; Cascales et al., 2007; Denayer et al., 2007;
Devanathan and Postle, 2007; Elfarash et al., 2012). As
such, while it is yet to be confirmed that a TonB-dependent
receptor is responsible for mediating ferredoxin iron and
pectocin uptake, this class of protein is by far the most likely
candidate.
In bacteriocins the IUTD normally functions to deliver
an epitope to the periplasm, which mediates binding to the
Tol or Ton complexes. This direct interaction occurs
between the colicins and TolB for group A colicins and
TonB for group B colicins and is essential for uptake of
these bacteriocins. In addition to their subversion for bac-
teriocin import, Tol and Ton complexes have a general
physiological role in the bacterial cell. The Ton complex
provides the energy required for the import of iron con-
taining siderophores and related substrates through
TonB-dependent receptors, by interaction with the recep-
tor plug domain subsequent to binding of the substrate on
the outer surface of the receptor (Noinaj et al., 2010).
Given the universal role of TonB-dependent receptors in
iron transport across the outer membrane and their para-
sitization by colicin-like bacteriocins, it is reasonable to
speculate that the ferredoxin/pectocin receptor is a
member of this class of protein.
Since pectocin M1 and M2 lack an IUTD they are
unable make direct contact with the Tol or Ton complexes
in the periplasm and thus are unable to directly utilize the
pmf for cell entry. However, the fact that these proteins
parasitize a system for which the receptor binding and
translocation domains are structurally analogous to the
substrate provides an intuitive solution to this problem. A
number of TonB-dependent receptors have been identi-
fied, which obtain iron from host proteins during infection.
In all of these systems the iron or iron containing com-
pound is liberated from the protein on the cell surface and
transported into the cell, potentially because all of the
proteins identified are too large pass through the lumen of
their receptor (Wandersman and Stojiljkovic, 2000;
Faraldo-Gomez and Sansom, 2003; Noinaj et al., 2012).
Plant ferredoxin, however, is a small globular protein,
which is in fact comparable in dimensions to the plug
domain that ordinarily occludes the pore of a TonB-
dependent receptor (Fig. 7A and C). This creates the pos-
sibility that the ferredoxin is imported intact into the
periplasm. If this were the case it could readily explain the
pectocins lack of an IUTD as the energy required for cell
entry would still be provided by the Ton complex, but
Fig. 6. Activity of pectocin P against Pectobacterium atrosepticum
LMG 2386. Purified pectocins M1, M2 and P (2 mg ml−1) were
spotted onto a soft agar overlay seeded with Pba LMG 2386. Clear
zones indicate inhibition of growth due to the cytotoxic effect of
pectocins on cells.
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transduced through receptor plug domain, as with ordi-
nary substrate importation.
As the elongated conformation of pectocin M2 has com-
parable dimensions along its length (Fig. 5A) we manually
docked this model into the barrel domain of the hemo-
phore receptor HasR, a TonB-dependent receptor shown
to be responsible for importation of the relatively bulky
substrate, haem (Fig. 7B and D). This docking illustrates
that pectocin M2 in its elongated conformation could trav-
erse the lumen of such a receptor to gain entry to the cell,
with the flexibility of pectocin M2 observed in solution
allowing the protein to adapt to the shape of the lumen of
its transporter during importation. In the case of the trans-
port of iron-siderophores, it is generally thought that there
are two possibilities with respect to the role of TonB in
stimulating substrate transport. Either TonB induces a
rearrangement of the plug domain within the barrel that is
sufficient to allow passage of the substrate or it directly
pulls the plug domain completely from the barrel (Usher
et al., 2001; Udho et al., 2009; 2012). However, for an
intact protein such as ferredoxin to be translocated
directly through the lumen of a TonB-dependent receptor,
it would be necessary for the plug domain to completely
exit the barrel during substrate transport and it has not as
yet been directly demonstrated that this occurs in TonB-
dependent receptors. The identification of this receptor
and the testing of this importation hypothesis represents
an intriguing question for future work.
Fig. 7. The extended conformation of
pectocin M2 has dimensions compatible with
passage through the lumen of a
TonB-dependent receptor.
A. The extended conformation of pectocin M2
(blue cartoon and surface), fitted into the pore
of the barrel of HasR from Serratia
marcescens PDB ID = 3CLS, illustrating that
the extended conformation of pectocin M2 is
conducive to transport through the lumen of a
TonB-dependent receptor without unfolding.
B. Dimensions of the ferredoxin domain of
pectocin M2.
C. The width of the plug domain, which
ordinarily blocks the lumen of the receptor
barrel, is similar to that of the elongated
conformation of pectocin M2.
D. Top-down view of the HasR barrel showing
the internal dimensions of the barrel domain.
This figure is available in colour online at
wileyonlinelibrary.com.
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Experimental procedures
Expression and purification of ferredoxins and pectocins
A list of bacterial strains and plasmids used in this work is
provided in Table S1. The open reading frame for pectocin
P minus stop codon was synthesized by DNA 2.0 and
ligated into the expression vector pJ404 (T5 promoter,
C-terminal His6-tag). The resulting vector was designated
pJPP1. Vectors for expression of pectocins M1 and M2
were as previously described (Grinter et al., 2012a). All pro-
teins were expressed and purified as previously described
(Grinter et al., 2012a). Proteins were concentrated to 5–15
mg ml−1 using a centrifugal concentrator and stored at
−80°C in this buffer until required. For pectocins M1 and P,
5% glycerol was added to all buffers as it was found to
enhance protein stability.
Cytotoxicity assays
The cytotoxicity of purified pectocins was tested using the
soft agar overlay method (Fyfe et al., 1984). 200 μl of mid-log
phase culture of the test strain was added to 6 ml of 0.6%
agar melted and cooled to 42°C. The molten agar was then
overlaid onto LB medium with or without 100–400 μM 2,2′-
biyridine. Purified pectocins (2 mg ml−1) were spotted directly
onto the surface of the overlay, once solidified. Plates were
incubated at 28°C for 16 h, and monitored for zones of growth
inhibition.
SAXS data collection and analysis
SAXS data were collected on the X33 beamline at
the Deutsches Elektronen Synchrotron (DESY, Hamburg,
Germany). Pectocin M2 and pyocin M concentrations between
0.4 and 4.0 mg ml−1 were used. Average buffer scattering was
subtracted from the sample scattering. The first 200 points
(low angle data) of the scattering curve obtained for 1 mg ml−1
protein were merged with the rest of the high angle data from
the 4 mg ml−1 sample to avoid the influence on the data of any
inter-particle interference. All data processing was performed
using PRIMUS (Konarev et al., 2003). Porod-Debye [I(q)q4
versus q4] and normalized Kratky [I(q)q2 versus q] plots were
used to assess particle flexibility as described in the Results
section (Durand et al., 2010; Rambo and Tainer, 2011). The
distance distribution function, p(r), was obtained by indirect
Fourier transform of the scattering intensity using GNOM
(Svergun, 1992). A Guinier plot [ln I(s) versus q2] was used to
determine the radius of gyration, Rg, of pectocin M2 and pyocin
M. US-SOMO (Rai et al., 2005) was used to determine hydro-
dynamic parameters based on the crystal structures of pec-
tocin M2. CRYSOL (Svergun et al., 1995) was used to
compute theoretical scattering curves from high-resolution
X-ray structures.
DMD and EOM simulations
Discrete molecular dynamics simulations of the pectocin M2
linker region (residues 96–116) were undertaken with
US-SOMO (Brookes et al., 2010; Shirvanyants et al., 2012) in
order to explore pectocin M2 conformational space. The
Andersen thermostat temperature (T) was set to 0.5 kcal mol−1
K−1 to allow for sufficient sampling of conformational dynamics
around the native state without melting the structure of the
linker. The run time and pdb output step were adjusted in order
to generate 5000 models. Next, the pool of 5000 ‘random’
pectocin M2 conformers generated was refined by a genetic
algorithm implemented in the program GAJOE as part of the
ensemble optimization method (Bernadó et al., 2007;
Petoukhov et al., 2012).
Pectocin M2 crystallization and diffraction
data collection
Initial crystallization trials were performed at the high
throughput crystallization facility of the University of Zurich
using the vapour diffusion method (reservoir volume of 50
μl, drop size: 100 nl protein, 100 nl reservoir solution) with
pectocin M2 at a final concentration of 15 mg ml−1. Pectocin
M2 formed crystals or spherulites in a number of conditions
containing ammonium sulphate and PEG 3350. Crystals
were extracted from one of these conditions [15% PEG
3350, 0.2 M ammonium sulphate, 3% 2-methyl-2,4-
pentanediol (MPD), 0.1 M bis-tris pH 6.5], cryoprotected by
increasing PEG 3350 to 30% and data were collected at 100
K to 2.3 Å in the space group P21, at the SLS (Zurich).
Re-crystallization screening of pectocin M2 was performed,
using a custom screen with variations in the concentration/
ratio of precipitants from the original condition (ammonium
sulphate and PEG 3350), pH and additives. Clusters of large
rod-shaped crystals formed at high ammonium sulphate
concentrations. This was optimized giving a final condition of
1.8 M ammonium sulphate, 3% MPD, 0.1 M MES, pH 6.5.
These crystals were manually separated and cryoprotected
with 15–20% glycerol. Data were collected at 100 K on
beamlines I02 and I03 at the Diamond Light Source (Oxford-
shire, UK). Automatic data-processing was performed with
Xia2 within the EDNA package (Incardona et al., 2009).
Datasets for experimental phasing using the iron–sulphur
cluster of pectocin M2 were collected at the iron K-edge
(1.7433 Å) and high-resolution data were collected at 0.9796
Å. Data collection statistics from both crystal forms are
reported in Table 1.
Pectocin M2 structure solution and refinement
Phases for the P21 and P3121 datasets were obtained from the
anomalously scattering substructure from the pectocin–
ferredoxin domain iron–sulphur cluster, determined for the
iron-edge dataset using the Hybrid Substructure Search from
the Phenix package (Adams et al., 2010). Four positions were
located per ASU corresponding to two iron–sulphur clusters
(correlation coefficient = 0.5) from two pectocin M2 molecules.
These positions were then utilized by Phaser-EP (McCoy
et al., 2007; Adams et al., 2010; Winn et al., 2011) phases
were improved using RESOLVE density modification from the
Phenix package, and the initial model was built and refined
using Phenix Autobuild (Adams et al., 2010). The model was
then built and refined manually using Coot 0.7 and Refmac5
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(McCoy et al., 2007; Emsley et al., 2010; Murshudov et al.,
2011). Validation of refined structures was performed using the
Molprobity web server and Procheck from CCP4i (Laskowski
et al., 1993; Chen et al., 2010). Refinement statistics for both
datasets are reported in Table 1.
Lipid II cleavage assay
Lipid II hydrolysis assays were performed and visualized as
previously described by (Grinter et al., 2012b), with non-
radiolabelled lipid II substrate obtained from the UK Bacterial
Cell Wall Biosynthesis Network (Lloyd et al., 2008; Clarke
et al., 2009). A band corresponding to lipid II was observed
with an Rf of 0.7 as reported previously (Barreteau et al.,
2009).
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Introduction
The ability to target a subgroup of pathogenic bacteria in a
complex bacterial community has potential applications in
medicine and agriculture where the maintenance of a ‘normal’
microbiome is beneficial. For example, the use of broad spectrum
antibiotics to treat bacterial infections is known to cause a range of
complications associated with collateral damage to the micro-
biome, including antibiotic associated diarrhea and Clostridium
difficile infection [1,2]. In addition, there is growing evidence to
suggest that microbial dysbiosis may play a role in a range of
chronic diseases such as inflammatory bowel disease, diabetes,
obesity and rheumatoid arthritis [3,4,5,6]. Indeed, for Crohn’s
disease, where the link with dysbiosis is well established, the
administration of multiple courses of antibiotics is associated with
an increased risk factor for the development of this chronic form of
inflammatory bowel disease [7,8,9].
In contrast to the broad spectrum antibiotics that are widely
used in medicine and agriculture, protein antibiotics known as
bacteriocins often target a specific bacterial species or a group of
closely related bacterial species [10,11,12,13]. Well characterised
bacteriocins include the S-type pyocins from P. aeruginosa and the
closely related colicins of E. coli [12,13]. The colicin-like
bacteriocins form a diverse family of multidomain protein
antibiotics which share similar mechanisms of uptake and kill
cells through either a pore-forming activity, a specific nuclease
activity against DNA, tRNA or rRNA or through inhibition of cell
wall synthesis [14,15,16,17]. In the case of S-type pyocins it is
thought that their activity is limited to strains of P. aeruginosa,
whereas colicins show activity against E. coli and some strains of
closely related bacteria such as Salmonella spp. [18]. In the case of
colicins and S-type pyocins, killing specificity is primarily
determined by the presence of a specific outer membrane receptor
on the cell surface. For example, the well characterised E group
colicins utilise the TonB-dependent BtuB receptor, which has a
normal physiological role in vitamin B12 uptake [19]. Colicin-like
bacteriocins have also been shown to have a potent antibiofilm
activity, indicating their potential as useful therapeutics for the
treatment of chronic biofilm mediated infections [20,21]. In the
case of the opportunistic human pathogen P. aeruginosa there is an
urgent requirement for the development of novel therapeutic
options since its ability to form drug-resistant biofilms in
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combination with the presence of an outer membrane that is
highly impermeable to many classes of antibiotics can make this
pathogen essentially untreatable in some groups of patients. This is
exemplified in cystic fibrosis patients where chronic lung infection
with P. aeruginosa is the leading cause of mortality [22].
An interesting addition to this group of protein antibiotics is the
recently discovered lectin-like bacteriocins that contain two
carbohydrate-binding domains of the monocot mannose-binding
lectin (MMBL) family [23,24,25,26,27]. Lectin-like bacteriocins
from P. putida (putidacin L1 or LlpABW) P. syringae (LlpAPss642) and
P. fluorescens (LlpA1Pf-5) have been characterised and have the
unprecedented ability to kill strains of a broad range of bacterial
species within the genus Pseudomonas, but are not active outside this
genus [24,26,27]. Similarly the lectin-like bacteriocin LlpAXcm761
from Xanthomonas citri pv. malvacearum LMG 761 has the ability to
kill various species within the genus Xanthomonas [24]. The
molecular basis of this unusual genus specific activity has not
been explained.
Lectins are a structurally and evolutionarily diverse class of
proteins produced widely by prokaryotes and eukaryotes and are
defined by their ability to recognise and bind carbohydrates. This
binding is generally highly specific and mediates a range of diverse
functions, including cell-cell interaction, immune recognition and
cytotoxicity [28,29] MMBLs represent a structurally conserved
lectin subclass, of which the mannose-binding Galanthus nivalis
agglutinin (GNA) was the first to be characterised [30]. The
MMBL-fold consists of a three sided b-prism; each face of which
contains a sugar binding motif with the conserved sequence
QxDxNxVxY [31]. While originally identified in monocots like G.
nivalis or Allium sativum, it is now recognised that proteins of this
class are distributed widely throughout prokaryotes and eukary-
otes, where they have evolved to mediate diverse functions
[30,32,33,34]. Structural and biochemical analysis of MMBLs has
shown that they are generally translated as a single polypeptide
chain containing tandem b-prism domains that are then proteo-
lytically processed into monomers. These domains often form
homo- or hetero-dimers by strand exchange and p-stacking [35].
The lectin-like bacteriocins are not proteolytically processed and
thus consist of a single peptide chain, containing tandem b-prism
domains. Sequence alignments of members of this class from
Pseudomonas spp. show complete conservation of two sugar binding
motifs on the C-terminal domain and partial conservation of two
sites on the N-terminal domain [23]. Recent work by Ghequire et
al [23] on the characterisation of putidacin L1 shows these motifs
to be important for cytotoxicity. Mutagenesis of the first C-
terminal motif has the most dramatic effect on activity, while
mutagenesis of the second C-terminal and first N-terminal sugar
binding motifs leads to a synergistic reduction in activity. This
study also showed low-affinity binding between putidacin L1 and
methyl-a-D-mannose or a range of mannose containing oligosac-
charides. However, Kds for these protein-carbohydrate complexes
were reported in the range from 46 mM for methyl-a-D-manno-
side to 2 mM for a mannose containing pentasaccharide [23]. An
extensive search for high affinity carbohydrate binding through
the use of glycan arrays failed to detect high affinity carbohydrate
binding for this lectin-like bacteriocin [23].
Despite progress in our understanding of the structure and host
range of MMBL-like bacteriocins, the mechanism by which these
bacteriocins target susceptible strains and exert their antimicrobial
effects is unknown. Here we report on the discovery of a novel
member of this family, pyocin L1 from P. aeruginosa, and show that
it utilises lipopolysaccharide (LPS) as a surface receptor, specifi-
cally targeting the common polysaccharide antigen (CPA) that is a
conserved homopolymer of D-rhamnose. Structural and biophys-
ical analysis shows that the C-terminal carbohydrate binding
motifs are responsible for D-rhamnose recognition and that these
sites are specific for this sugar over D-mannose. Further to this, we
show that the previously described putidacin L1 also selectively
binds LPS from susceptible, but not from resistant, P. syringae
isolates and shows selectivity for D-rhamnose over D-mannose.
This work shows that the physiologically relevant ligand for the
QxDxNxVxY carbohydrate binding site of the lectin-like bacte-
riocins is indeed D-rhamnose and not D-mannose as previously
thought. As such, the genus-specific activity of lectin-like
bacteriocins from Pseudomonas spp. can be attributed to the
widespread inclusion of the rare D-rhamnose in the LPS of
members of the genus Pseudomonas.
Results
Identification and characterisation of pyocin L1
As part of a wider project, aimed at identifying bacteriocins that
could be used as novel therapeutics in the treatment of P. aeruginosa
infections, we searched the genomes of 10 recently sequenced
clinical and environmental isolates of P. aeruginosa for genes with
homology to known bacteriocins. One putative bacteriocin gene
identified in strain C1433, an isolate from a patient with cystic
fibrosis, encodes a protein with 31% identity to the lectin-like
bacteriocin LlpA1Pf-5, from P. fluorescens. This protein, designated
pyocin L1, contained 256-amino acids with a predicted molecular
mass of 28413 Da. Alignment of the pyocin L1 protein sequence
with other lectin-like bacteriocins, LlpA1Pf-5, LlpAPss642, putidacin
L1 (LlpABW), LlpAAu1504 from Burkholderia cenocepacia and
LlpAXcm761 from Xanthomonas citri pv. malvacearum shows that
pyocin L1 contains tandem MMBL domains with three conserved
QxDxNxVxY MMBL sugar-binding motifs (Figure S1). Two of
these motifs are located in the C-terminal domain of the protein
and one in the N-terminal domain. Comparison with the
sequences of other lectin-like bacteriocins shows that the C-
terminal QxDxNxVxY motifs are highly conserved, with only
LlpAXcm761 lacking one C-terminal motif. In contrast the
Author Summary
Due to rapidly increasing rates of antibiotic resistance
observed among Gram-negative pathogens, such as
Pseudomonas aeruginosa, there is an urgent requirement
for novel approaches to the treatment of bacterial infec-
tions. Lectin-like bacteriocins are highly potent protein
antibiotics that display an unusual ability to kill a select
group of bacteria within a specific genus. In this work, we
show how the lectin-like protein antibiotic, pyocin L1, can
kill Pseudomonas aeruginosa with extraordinary potency
through specific binding to the common polysaccharide
antigen (CPA) of P. aeruginosa lipopolysaccharide. The CPA
is predominantly a homopolymer of the sugar D-rhamnose
that although generally rare in nature is found frequently
as a component of the lipopolysaccharide of members of
the genus Pseudomonas. The targeting of D-rhamnose
containing polysaccharides by pyocin L1 and a related
lectin-like protein antibiotic, putidacin L1, explains the
unusual genus- specific killing activity of the lectin-like
bacteriocins. As we learn more about the link between
changes to the microbiome and a range of chronic
diseases there is a growing realisation that the ability to
target specific bacterial pathogens while maintaining the
normal gut flora is a desirable property for next generation
antibiotics.
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N-terminal sugar-binding motifs are less well conserved with only
LlpAAu1504 possessing two fully conserved QxDxNxVxY motifs
(Figure S1).
In order to determine the killing spectrum of pyocin L1 we
cloned the pyocin L1 open reading frame into the pET21a vector
and expressed and purified the protein by nickel affinity, anion
exchange and size exclusion chromatography. Purified pyocin L1
was tested for its ability to inhibit the growth of 32 environmental
and clinical isolates of P. aeruginosa using an overlay spot plate
method on LB agar [36]. Under these conditions, pyocin L1
showed killing activity against nine of the P. aeruginosa strains
tested. Strain E2, an environmental isolate from a tomato plant for
which the genome sequence is available, and strain P8, a clinical
isolate from a cystic fibrosis patient, showed the greatest sensitivity
to pyocin L1 with killing observed down to concentrations of
27 nM and 7 nM, respectively. Pyocin L1 also showed activity
against 5 of the 11 P. syringae strains tested, although the effect was
much weaker, with cell killing observed at high mM concentra-
tions.
Pyocin L1 targets the common polysaccharide antigen
(CPA) of P. aeruginosa LPS
In order to gain insight into the bacteriocidal activity of pyocin
L1, we subjected P. aeruginosa E2 to high concentrations of
recombinant protein and recovered mutants with greatly increased
tolerance to pyocin L1 (Figure 1A). The genomes of two of these
mutants were sequenced and comparative analysis with the
genome of wild-type E2 revealed a dinuclear deletion, C710 and
T711, of the 1146-bp wbpZ gene. This deletion was common to
both mutants. wbpZ encodes a glycosyltransferase of 381 amino
acids that plays a key role in lipopolysaccharide synthesis,
specifically in the synthesis of the common polysaccharide antigen
(CPA) also known as A-band LPS [37], (Figure S2). Most strains of
P. aeruginosa produce two distinct LPS-types that differ in their O-
antigen, but share the same core oligosaccharide. The CPA is
predominantly a homopolymer of D-rhamnose and the O-specific
antigen contains a heteropolymeric repeating unit that varies
widely among strains [38]. Consistent with mutation of wbpZ, we
found that production of CPA, as determined by immunoblotting
with a CPA-specific monoclonal antibody [39], in both M4(E2)
and M11(E2) was reduced to undetectable levels (Figure 1B).
Visualisation of LPS from these strains was performed via silver
staining and comparable quantities of LPS were shown to be
present. These observations suggest that pyocin L1 may utilise
CPA as a cellular receptor. To test this idea further, we obtained
two transposon insertion mutants of P. aeruginosa PAO1, which is
sensitive to pyocin L1, with insertions in the genes responsible for
the transport of CPA to the periplasm [40]. These two genes, wzt
and wzm, encode the ATP-binding component and membrane
component of a CPA dedicated ABC transporter [38]. Pyocin L1,
which shows good activity against PAO1 showed no activity
against strains with insertions in wzm and wzt (Figure 1C) and
immunoblotting with a CPA-specific antibody confirmed the
absence of the CPA in these pyocin L1 resistant strains (Figure 1D).
Thus, the presence of CPA on the cell surface is required for
pyocin L1 killing.
In order to determine if the requirement for CPA is due to a
direct interaction with pyocin L1 we purified LPS from wild-type
PAO1 and from the pyocin L1 resistant, wzm and wzt mutants
(which produce no CPA but do produce the O-specific antigen)
and analysed the pyocin-CPA interaction by isothermal titration
calorimetry (ITC). Titration of pyocin L1 into isolated LPS-
derived polysaccharides (a mixture of CPA and the O-specific
antigen containing polysaccharides) from PAO1 gave rise to strong
saturable exothermic heats of binding (Figure 2A), whereas no
binding was detected on titration of pyocin L1 into an equivalent
concentration of LPS carbohydrates from PAO1 wzt, which
produces the O-specific antigen but not the CPA (Figure 2B).
These data show that pyocin L1 binds directly to the CPA and that
this interaction is required for killing. The CPA is therefore likely
to be the cellular receptor for pyocin L1.
Pyocin L1 binds the monosaccharide D-rhamnose
The evolutionary relationships between MMBL-like bacterio-
cins and the originally identified mannose-binding members of this
protein family, led to the assumption that carbohydrate binding of
polysaccharides by the lectin-like bacteriocins is primarily medi-
ated through binding of D-mannose at one or more of their
conserved QxDxNxVxY carbohydrate binding motifs. Indeed, the
recent structures [23] of putidacin L1 bound to mannose-
containing monosaccharides adds weight to this idea, although
measured affinities between polysaccharides and putidacin L1 are
weak (mM) and so may not be physiologically relevant. However,
the strong interaction between pyocin L1 and CPA, is incompat-
ible with this and suggests that D-rhamnose and not D-mannose is
the likely physiological substrate for the QxDxNxVxY carbohy-
drate binding motifs.
To determine the affinity of pyocin L1 for D-rhamnose and D-
mannose, isothermal titration calorimetry (ITC) was performed.
Titration of pyocin L1 into D-rhamnose gave rise to weakly
saturable heats of binding that are significantly larger than the
heats observed on titration of pyocin L1 into an identical
concentration of D-mannose (Figure 3). From this experiment an
apparent Kd of 5–10 mM was estimated for the interaction of
pyocin L1 with D-rhamnose with apparently weaker binding for
Figure 1. CPA production correlates with pyocin L1 killing. (A)
Inhibition of growth of P. aeruginosa E2 and tolerant mutants M4 and
M11 by pyocin L1, as shown by a soft agar overlay spot-test. 5 ml of
purified pyocin L1 (1.5 mg ml21) was spotted onto a growing lawn of
cells. Clear zones indicate cell death. (B) Expression of CPA by P.
aeruginosa E2 and tolerant mutants, visualised by immunoblotting with
the CPA specific antibody N1F10. (C) Inhibition of growth of P.
aeruginosa PAO1 and PAO1 wzm and wzt mutants by pyocin L1 (details
as for A). (D) Expression of CPA by PAO1 and wzm and wzt strains
(details as for B).
doi:10.1371/journal.ppat.1003898.g001
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D-mannose, Kd.50 mM. The interaction between pyocin L1 and
these monosaccharides was also probed using NMR with 15N
labelled pyocin L1, monitoring changes to its 15N-heteronuclear
single quantum correlation (15N-HSQC) spectra on addition of D-
rhamnose or D-mannose. In the absence of added monosaccharide
15N-HSQC spectra of pyocin L1, which should contain one
crosspeak for each non-proline amide NH as well as peaks for the
NH groups in various side chains, were well resolved and
dispersed, indicative of a folded protein. Chemical shift perturba-
tion monitored by 15N-HSQC allows the mapping of changes to a
protein that occur on ligand binding. Addition of either D-
rhamnose or D-mannose up to a concentration of 100 mM did not
give rise to large or global changes in chemical shifts (Figure S3).
On addition of D-rhamnose significant chemical shift changes were
observed for a discrete subset of peaks including some in the amide
side chain region of the spectra, while changes of a smaller
magnitude were observed on the addition of equal concentrations
of D-mannose (Figure S3). Fitting the chemical shift changes that
occur on addition of D-rhamnose, for peaks showing strong shifts,
to a single site binding model indicates a Kd for the pyocin L1- D-
rhamnose complex in the range of 5–20 mM (Figures 3C–F).
These data correlated well with the ITC sugar binding data, with
low mM binding of pyocin L1 to D-rhamnose and much weaker
binding to D-mannose.
D-rhamnose and the CPA bind to the C-terminal
QxDxNxVxY motifs of pyocin L1
In an attempt to determine the location of the pyocin L1 D-
rhamnose binding site(s) and the structural basis of the D-rhamnose
specificity of pyocin L1 we determined the X-ray structures of
pyocin L1 with bound D-mannose, D-rhamnose and in the unbound
form (Table 1). Pyocin L1, as predicted by sequence homology to
MMBL proteins, consists of two tandem b-prism domains
characteristic of MMBLs, connected by antiparallel strands
propagating from the end of each MMBL domain and lending a
strand to the reciprocal b-prism. The strands contain a tryptophan
residue which forms p-stacking interactions with two other
tryptophans in the b-prism to stabilise the structure (Figure 4A).
This interaction is conserved throughout MMBLs, with most
members of the class utilising it to form either homo- or hetero-
dimers of single MMBL subunits. However, in pyocin L1, as with
the recently described structure of putidacin L1, both domains are
from a single polypeptide chain [23]. Other structural elements are
also common between the two bacteriocins, namely a C-terminal
extension of 30 amino acids and a two-turn a-helix insertion into
loop 6 of the N-terminal MMBL domain (Figure 4B). The overall
root mean square deviation (rmsd) of backbone atoms for pyocin L1
and putidacin L1 is 7.5 A˚, which is relatively high due to a
difference in the relative orientation of the two MMBL domains. In
contrast, the relative orientation of the tandem MMBL domains of
pyocin L1 matches those of the dimeric plant lectins very closely,
with alignment of pyocin L1 with the snowdrop lectin homodimer
(pdb ID: 1MSA) giving an rmsd of 4.81 A˚. Comparison of the
respective N- and C- terminal domains from pyocin L1 and
Figure 2. Pyocin L1 binds strongly to CPA from P. aeruginosa
PAO1. (A) ITC binding isotherm of pyocin L1 (150 mM) titrated into
isolated LPS-derived polysaccharide (1 mg ml21) from wild-type P.
aeruginosa PAO1. Strong, saturable heats were observed indicative of a
strong interaction. Curve fitted with a single binding site model. (B) ITC
isotherm of pyocin L1 (150 mM) titrated into isolated LPS-derived
polysaccharide (1 mg ml21) from PAO1 wzt. No saturable binding
isotherm was observed.
doi:10.1371/journal.ppat.1003898.g002
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putidacin L1 shows they possess very similar folds with rmsds of
2.77 A˚ and 2.02 A˚, respectively (Figures 4C–D). The higher value
for comparison of the N-terminal domains is due to the presence of
a 2-strand extension to b-sheet two of the putidacin L1 N-terminal
MMBL domain, which is absent from pyocin L1 and other
MMBLs. In order to identify protein structures which share a
similar fold to pyocin L1 we submitted the structure of the DALI
server (http://ekhidna.biocenter.helsinki.fi/dali_server/start). The
DALI server searches the protein data bank (PDB) to identify
proteins structurally related to the query structure [41]. Significant
structural homology was only identified for putidacin L1 and other
proteins previously characterised as containing a MMBL fold such
as the snowdrop lectin. MMBL dimers of plant origin often form
higher order structures, however small angle X-ray scattering of
pyocin L1 showed it to be monomeric in solution (Figure S4).
Electron density maps, derived from both D-mannose and D-
rhamnose soaked crystals show clear density for sugar moieties in
both sites, C1 and C2 (Figure 5). The sugars refined well in these
densities at full occupancy, giving B-factors comparable to the
surrounding protein side chains. The canonical MMBL hydrogen
bonds observed for both D-mannose and D-rhamnose were the
same: Gln to O3, Asp to O2, Asn to O2 and Tyr to O4. In
addition, O6 of D-mannose forms a hydrogen bond with Tyr169 in
C1 and His194 in C2. As D-rhamnose is C6 deoxy D-mannose, it
lacks these interactions (Figure 6). The fact that D-mannose forms
an additional hydrogen bond is counter-intuitive given that pyocin
L1 has a significantly stronger affinity for D-rhamnose, however
Val154, Val163 and Ala166 of C1 and Val184 and Ala191 of C2
form a hydrophobic pocket to accommodate the C6-methyl group
of D-rhamnose (Figure S5).
Figure 3. Pyocin L1 shows specificity for D-rhamnose compared with D-mannose. (A) ITC binding isotherm of D-rhamnose (50 mM) titrated
into pyocin L1 (100 mM). Weakly saturable heats were observed, indicative of binding with modest affinity (Kd ,5–10 mM). (B) ITC binding isotherm
of D-mannose (50 mM) titrated into pyocin L1 (100 mM). Small-weakly saturable heats were observed, indicative of very weak interaction (Kd
,50 mM). Titration of monomeric sugars into 15N-labelled pyocin L1, monitored using 1H-15N HSQC NMR spectroscopy. Shifts within spectra were
converted to chemical shift perturbation (CSP) values using equation Dppm = ! [DdHN+(DdN*aN)2]. CSP values are plotted against sugar concentration
in (C) and (E) and visualised in (D) and (F). Peak positions, which correspond to backbone amide signals, at selected sugar concentrations (blue: no
sugar, green: 60 mM, red: 100 mM) are shown. Perturbation of peak position (ppm) is indicative of association between ligand and protein molecules
in solution.
doi:10.1371/journal.ppat.1003898.g003
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Weak density was observed for both sugars at site N1, however
given the high concentrations used in the soak and the overall low
binding affinity of pyocin L1 for monomeric sugars, it is unlikely
that N1 represents a primary binding site for D-rhamnose (Figure
S5). The conserved residues in site N2 form interactions with the
C-terminal extension of the protein and as such are inaccessible.
Weak density was also observed adjacent to the binding site C1 of
mol B in both the soaks and in mol A of the D-rhamnose form.
This density may correspond to a peripheral binding site utilised in
binding to the carbohydrate chain of LPS, as is observed in the
structure of putidacin L1 bound to oligosaccharides [23].
To test the idea that the observed binding of D-rhamnose to sites
C1 and C2 is reflective of CPA binding and that this binding is
critical to pyocin L1 cytotoxicity, we created pyocin L1 variants in
which the conserved aspartic acids of the QxDxNxVxY motifs of
the C1 and C2 sugar binding sites were mutated to alanine and
compared their cytotoxicity and ability to bind the CPA by ITC
with the wild-type protein. Titrations with wild-type pyocin L1 and
the D150A (C1) and D180A (C2) variants were performed by
titrating protein at a concentration of 100 mM into a solution of
LPS-derived polysaccharide (1 mg ml21) from strain PAO1
(Figure 7). Under these conditions we were able to generate binding
isotherms that enabled us to accurately determine an apparent Kd
of 0.15 (60.07) mM for the wild-type pyocin L1-CPA complex. For
both the D150A (C1) and D180A (C2) variants, affinity for CPA was
reduced. For the pyocin L1 D150A-CPA complex a Kd of 1.52
(60.51) mM was determined, a 10-fold increase in Kd relative to the
wild-type pyocin L1-CPA complex. However, CPA binding to the
D180A variant was severely weakened and although heats of
binding were still observed the Kd for this complex, which could not
be accurately determined, is likely .500 mM. We also produced a
double mutant in which both D150A and D180A mutations were
present. For this double mutant, no binding to CPA was observed
by ITC. These data show that both the C1 and C2 sugar binding
motifs are required for full CPA binding, but that the C2 binding
site is the major CPA binding determinant. The killing activity of
these sugar binding motif variants showed a good correlation with
their ability to bind the CPA. Both the D150A and D180A variants
showed reduced cytotoxicity against PAO1 relative to pyocin L1,
with the D150A showing a greater reduction in activity and for the
D150A/D180A variant very low levels of cytotoxicity were
observed (Figure 7).
Putidacin L1 binds to P. syringae LPS and D-rhamnose
Pyocin L1 targets sensitive strains of P. aeruginosa through
binding to LPS and utilises this as a cell surface receptor. To
determine if LPS binding is common to the homologous and
previously characterised lectin-like bacteriocin putidacin L1, we
purified this protein and determined if the susceptibility of a
number of strains of P. syringae correlated with the ability of
putidacin L1 to bind to LPS-derived carbohydrates from these
strains.
From the five strains of P. syringae tested, LMG 5456 and LMG
2222 were found to be highly susceptible to putidacin L1 with
killing down to concentrations of 0.3 and 7.6 nM respectively.
DC3000 and NCPPB 2563 showed complete resistance and LMG
1247 was highly tolerant (killing down to 0.6 mM). Binding of
putidacin L1 to the isolated LPS-derived polysaccharides of the
Table 1. Crystallographic data collection and refinement statistics.
Sugar Free Form D-Rhamnose Soak D-Mannose Soak
Data collectiona
Space group C2221 C2221 C2221
Cell dimensions, a, b, c (A˚) 53.41, 158.40, 147.67 52.99, 160.65, 150.57 53.42, 162.1, 152.5
Resolution (A˚) 36.42 - 2.09 (2.14 - 2.09) 54.99 - 2.37 (2.43 - 2.37) 55.53 -2.55 (2.67 - 2.55)
Solvent content (%) 56 55 56
No. of unique observations 37131 (2751) 26242 (1922) 22096 (2901)
Multiplicity 4.8 (4.9) 4.4 (4.5) 5.5 (5.7)
Completeness (%) 99.0 (99.8) 99.1 (99.5) 99.9 (100.0)
Rmerge (%) 7.2 (59.2) 5.9 (83.0) 7.1 (85.6)
Rpim (%)
b 4.1 (33.0) 3.4 (44.9) 3.3 (39.2)
Mean I/sigma (I) 14.3 (2.1) 19.0 (2.1) 13.3 (2.3)
Refinement statistics
Rwork/Rfree (%) 17.8/22.2 20.9/25.7 19.4/24.8
No. of non-hydrogen atoms 4505 4178 4138
RMSD of bond lengths (A˚) 0.02 0.015 0.013
RMSD of bond angles (u) 1.96 1.63 1.70
No. of waters 344 95 27
Mean/Wilson plot B-value (A˚2) 40.2/33.8 54.2/43.6 65.9/59.1
Ramachandran plot (%)c
Favoured/Allowed/Outliers 97.2/2.2/0.6 97.4/2.2/0.4 96.6/3.0/0.4
PDB identifier 4LE7 4LED 4LEA
aValues in parentheses refer to the highest resolution shell.
bRpim =Shkl[1/(N21)]
1/2Si|Ii(hkl)2,I(hkl).|/ShklSiIi(hkl).
cPercentages of residues in favored/allowed regions calculated by the program RAMPAGE [68].
doi:10.1371/journal.ppat.1003898.t001
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Figure 4. Crystal structure of pyocin L1 reveals tandem MMBL domains and sugar-binding motifs. (A) Ribbon diagram of structure of
pyocin L1 in complex with a-D-rhamnose, amino acids 2-256. N-terminal domain (green), C-terminal domain (pink), C-terminal extension (red), a-D-
rhamnose (spheres) and sugar binding sites containing the conserved or partially conserved QxDxNxVxY motif are highlighted (blue) and are
designated N1, N2 and C1, C2 according to order of appearance in the primary sequence of the N- and C-terminal domains, respectively. Pyocin L1
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above mentioned strains was tested by ITC. Large saturable heats
of binding were observed for putidacin L1 and the LPS-derived
polysaccharides from LMG 5456 and LMG 2222, while no
binding was observed between putidacin L1 and the LPS-derived
polysaccharides from LMG 1247, 2563 or DC3000 (Figure 8).
Thus, there is excellent correlation between putidacin L1 cell
killing and the binding of LPS-derived polysaccharide indicating
that like pyocin L1, putidacin L1 utilises LPS as a surface receptor.
Although P. syringae O-antigens are diverse relative to CPA, the
incorporation of D-rhamnose is widespread and seemingly almost
universal in strains of this species [42,43]. Interestingly, in cases where
D-rhamnose is not a component of P. syringae LPS, L-rhamnose is
present [42]. As with pyocin L1 we utilised ITC and NMR to
characterise the binding affinity of putidacin L1 for D-rhamnose, in
comparison with D-mannose and L-rhamnose. Putidacin L1 exhibited
an affinity of 5–10 mM for D-rhamnose, which is comparable to that
of pyocin L1, and approximately 10-fold stronger than its affinity for
D-mannose (Figure S6). Interestingly, no binding of L-rhamnose to
putidacin L1 or pyocin L1 was observed (Figure S7). It is interesting
to note that in the strains of P. syringae we have tested, the killing
spectrum (but not the potency) of pyocin L1 and putidacin L1 is
identical. This observation combined with the specificity of putidacin
L1 for D-rhamnose, strongly suggests that it also binds to a D-
rhamnose containing O-antigen. Indeed branched D-rhamnose O-
antigens are common in P. syringae [42,43].
Our data for both pyocin L1 and putidacin L1 indicate that D-
rhamnose containing O-antigens are utilised as surface receptors
for lectin-like bacteriocins from Pseudomonas spp. This is an
attractive hypothesis since the inclusion of D-rhamnose in the
lipopolysaccharides from members of this genus is widespread and
residues involved in hydrogen bonding with a-D-rhamnose are shown in stick representation. (B) Sequence and secondary structure (b-
sheets = arrows, a-helices = coils) of pyocin L1 with colours corresponding to the structure in (A). Residues conserved in sugar binding motifs are
shown in bold. (C) Structural alignment of pyocin L1 (green) and putidacin L1 (blue) based on N-terminal MMBL domain in wall-eyed stereo. (D)
Structural alignment of pyocin L1 (green) and Allium sativum agglutinin (1BWU) (pink) based on N-terminal MMBL domain in wall-eyed stereo.
doi:10.1371/journal.ppat.1003898.g004
Figure 5. C-terminal MMBL-sugar binding motifs of pyocin L1 bind D-rhamnose and D-mannose. Electron density (at 1.3 s) with fitted
stick model of pyocin L1 MMBL-sugar binding site C1 with: (A) D-rhamnose (XXR), (C) D-mannose (BMA), (E) no bound sugar, and sugar binding site C2
with: (B) D-rhamnose, (D) D-mannose, (F) no bound sugar. For clarity, electron density is clipped to within 1.5 A˚ of visible atoms.
doi:10.1371/journal.ppat.1003898.g005
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could form an important component of the genus specific activity
of this group of bacteriocins.
Discussion
In this work we have shown that pyocin L1 targets susceptible
cells through binding to the CPA component of LPS and that
primary recognition of CPA occurs through binding of D-
rhamnose at the conserved QxDxNxVxY sugar binding motifs
of the C-terminal lectin domain. The ability of both pyocin L1 and
putidacin L1 to recognise D-rhamnose containing carbohydrates is
an important component of their ability to target sensitive strains
of Pseudomonas spp. The use of the O-antigen as a primary receptor
differentiates the lectin-like bacteriocins from other multidomain
bacteriocins such as colicins and S-type pyocins (colicin-like
bacteriocins) which utilise outer membrane proteins as their
primary cell surface receptors [44]. The colicin-like bacteriocins
also possess a flexible, or natively disordered N-terminal region
that is thought to pass through the lumen of a coreceptor and
interact with the periplasmic Tol or Ton complexes that mediate
translocation of the bacteriocin across the outer membrane
[11,44]. The lack of such a flexible N-terminal region in the
lectin-like bacteriocins suggests that either they do not need to
cross the outer membrane in order to mediate their cytotoxicity or
they do so by a mechanism that is fundamentally different to the
diverse family of colicin-like bacteriocins. Given the extensive
structural homology between the lectin-like bacteriocins and plant
lectins it seems likely that these bacteriocins share a common
ancestor with plant lectins and from an evolutionary perspective
are unrelated to the colicin-like bacteriocins.
In addition to O-antigen recognition, additional factors, as yet
to be determined, are clearly also important in strain and species
specificity among the lectin-like bacteriocins. Indeed, recent work
from Ghequire et al. has shown through domain swapping
experiments that for putidacin L1 (LlpABW) and the homologous
lectin-like bacteriocin LlpA1Pf-5 from Pseudomonas fluorescens, species
specificity is governed by the identity of the N-terminal lectin
domain [23]. Thus, in view of these data and our own data it
seems likely that the C-terminal lectin domain of this class of
bacteriocins plays a general role in the recognition of D-rhamnose
containing O-antigens, with the N-terminal domain interacting
with species-specific factors and thus determining the precise
species and strain specificity of these bacteriocins. Although there
are few clues as to how the lectin-like bacteriocins ultimately kill
susceptible cells, we have established a clear role for the C-
terminal MMBL domain of these proteins. The roles of the N-
terminal MMBL domain and the C-terminal extension remain to
be discovered [23]. However, from the previous work of Ghequire
et al, it is clear that all three of these regions are required for killing
of susceptible cells.
Interestingly, although rhamnose is frequently a component of
plant and bacterial glycoconjugates, such as the rhamnolipids of P.
aeruginosa [45] and pectic polysaccharides of plant cell walls [46], it
is generally the L-form of this sugar that is found in nature.
Although otherwise rare, D-rhamnose is found frequently as a
component of the LPS of plant pathogens and plant associated
bacteria such as P. syringae [42,43], P. putida [47], Xanthomonas
campestris [48] and Burkholderia spp. [49], but is a relatively rare
component of the O-antigens of animal pathogens such as E. coli,
Salmonella and Klebsiella. It is interesting to speculate that since D-
rhamnose is a common component of the LPS of bacterial plant
pathogens, that some of the many lectins produced by plants may
have evolved to target D-rhamnose as part of plant defence to
bacterial pathogens.
The specificity of lectin-like bacteriocins suggests that these
protein antibiotics may be useful in combating plant pathogenic
bacteria, either through the use of bacteriocin expressing
biocontrol strains or by the production of transgenic plants
engineered to express these proteins. The specific targeting
mechanism described here, binding of D-rhamnose containing
polymers, indicates that the lectin-like bacteriocins would not
interact with either plant or animal cells, since these lack D-
rhamnose containing glycoconjugates. In addition, these narrow
spectrum antibiotics would leave the majority of the soil
microbiome and the gut microbiome of plant-eating animals
intact and so would be likely to have minimal environmental
impact and minimal impact on animal health. This latter property
and the potency of these protein antibiotics could also make the
use of lectin-like bacteriocins in the treatment of chronic
multidrug-resistant P. aeruginosa infections in humans an attractive
proposition.
Materials and Methods
Bacterial strains, plasmids and growth conditions
Strains and plasmids utilised in this study are presented in
Supplementary Table S1. Strains of P. aeruginosa were grown in LB
at 37uC, P. syringae were grown in King’s B Media (KB) (20 g
Figure 6. Hydrogen-bonding interactions between pyocin L1 MMBL sugar-binding motif C1 with D-rhamnose and D-mannose.
Hydrogen bonds between protein side chains with (A) D-rhamnose and (B) D-mannose are shown; all distances are in A˚.
doi:10.1371/journal.ppat.1003898.g006
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Figure 7. Binding of the CPA at the C-terminal sugar binding motifs, C1 and C2, is critical to pyocin L1 cytotoxicity. ITC binding
isotherms of (A) wild-type (B) D180A (C) D150A and (D) D150A/D180A pyocin L1 all at (100 mM) titrated into isolated LPS-derived polysaccharide
(1 mg ml21) from wild-type P. aeruginosa PAO1. Fit to a single binding site model is shown. (E) Spot tests to determine cytotoxic activity of wild-type
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peptone, 10 g glycerol, 1.5 g MgSO4, 1.5 g K2HPO4 per liter
adjusted to pH 7.5) at 28uC.
Cloning and purification of lectin-like bacteriocins
Pyocin L1 was amplified from the genomic DNA of the
producing strain P. aeruginosa C1433 [50] by PCR using primers
designed to introduce an NdeI site at the start of the pyoL1 gene
(ACA GAT CAT ATG AAG TCT CCA AAC AAA AGG AGG)
and an XhoI site at the end of the gene (ACA GAT CTC GAG
GAC CAC GGC GCG CCG TCG TGG ATA GTC GTG GGG
CCA A). The PCR product was ligated into the corresponding
sites of the E. coli expression vector pET21a to give pETPyoL1
which encodes pyocin L1 with a C-terminal His6 tag separated
from the C-terminus of pyocin L1 by a 6 amino acid linker
(RRRAVV). Pyocin L1 was overexpressed from E. coli
BL21(DE3)pLysS carrying the plasmid pETPyoL1. Five litres of
LB broth was inoculated (1:100) from an overnight culture and
cells were grown at 37uC in a shaking incubator to an
OD600 = 0.6. Protein production was induced by the addition of
0.3 mM isopropyl b-D-1-thiogalactopyranoside (IPTG), the cells
were grown at 22uC for a further 20 hand harvested by
centrifugation. Cells were resuspended in 20 mM Tris-HCl,
500 mM NaCl, 5 mM imidazole (pH 7.5) and lysed using an
MSE Soniprep 150 (Wolf Laboratories) and the cell debris was
separated by centrifugation. The cell-free lysate was applied to a 5-
ml His Trap HP column (GE Healthcare) equilibrated in 20 mM
Tris-HCl, 500 mM NaCl, 5 mM imidazole (pH 7.5) and pyocin
L1 was eluted over a 5–500 mM imidazole gradient. Pyocin L1
containing fractions were identified by SDS PAGE, pooled and
dialyzed overnight into 50 mM Tris-HCl, 200 mM NaCl, pH 7.5
and remaining contaminants were removed by gel filtration
chromatography on a Superdex S75 26/600 column (GE
Healthcare) equilibrated in the same buffer. The protein was
concentrated using a centrifugal concentrator (Vivaspin 20) with a
molecular weight cut off of 5 kDa and stored at 280uC until
required. The putidacin L1 open reading frame was synthesised
(DNA 2.0) and cloned into pET21a via 59 NdeI and 39 XhoI
restriction sites. The stop codon was removed in order to utilise the
pET21a C-terminal His6 tag. Purification of putidacin L1 was
performed as for pyocin L1. Constructs to express the pyocin L1
mutants D31A, D97A, D150A and D180A were created using the
QuikChange Site Directed Mutagenesis Kit (Stratagene) utilising
pETPyoL1 as a template. The primers used were CAA ATT GGT
CAT GCA AGC GGC TGG CAA CTT GGT CCT TTA CG
and CGT AAA GGA CCA AGT TGC CAG CCG CTT GCA
TGA CCA ATT TG for D31A, GCG TAC CTG AAT CTT
CAA GAT GCT GGG GAC TTC GGT ATA TTT TC and
GAA AAT ATA CCG AAG TCC CCA GCA TCT TGA AGA
TTC AGG TAC GC for D97A, CGC CTA GCG TTT CAG
GGA GCT GGC AAC CTA GTG ATC TAT C and GAT AGA
TCA CTA GGT TGC CAG CTC CCT GAA ACG CTA GGC
G for D150A and GAT AGA GCA GTA GTG CAA GAG GCT
GGA AAT TTT GTT ATC TAC AAA G and CTT TGT AGA
TAA CAA AAT TTC CAG CCT CTT GCA CTA CTG CTC
and pyocin L1 variants against of P. aeruginosa PAO1. Purified protein (starting concentration 400 mg ml21 with 2-fold sequential dilutions) was
spotted onto a growing lawn of P. aeruginosa PAO1. Clear zones indicate pyocin L1 cytotoxicity.
doi:10.1371/journal.ppat.1003898.g007
Figure 8. Putidacin L1 binds strongly to LPS-derived polysaccharides from susceptible but not tolerant or resistant P. syringae
isolates. ITC isotherm of LPS-derived polysaccharides (3 mg ml21) from strains highly sensitive to putdacin L1: (A) P. syringae LMG 2222, (B) P.
syringae LMG 5456 titrated into putidacin L1 (60 mM). Large, saturable heats are indicative of binding. LPS-derived polysaccharides (3 mg ml21) from
strains non-sensitive to putidacin L1: (C) P. syringae NCPPB 2563, (D) P. syringae DC3000, or highly tolerant (E) P. syringae LMG 1247 to putidacin L1,
show no heats of binding when titrated into putidacin L1 (60 mM).
doi:10.1371/journal.ppat.1003898.g008
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TAT C for D180A. Mutant proteins were purified as described
above for wild-type pyocin L1.
Pyocin sensitivity assays: Overlay spot plate method
Soft agar overlay spot plates were performed using the method
of [35]. 150 ml of test strain culture at OD600 = 0.6 was added to
6 ml of 0.8% soft agar and poured over an LB or KB agar plate.
5 ml of bacteriocin at varying concentrations was spotted onto the
plates and incubated for 20 h at 37 or 28uC.
Isolation of pyocin L1 tolerant mutants
1.5 ml of a culture of P. aeruginosa E2 (OD600 = 0.6) was
centrifuged and resuspended in 100 ml of LB, to which 100 ml
(8 mg ml21) of purified pyocin L1 was added. The culture was
grown for 1 h, plated onto a LB agar plate and incubated for 20 h
at 37uC. Isolated colonies were identified as P. aeruginosa using 16S
PCR as described previously [51].
Whole genome sequencing
The genomes of P. aeruginosa E2 and derived pyocin L1 tolerant
mutants were sequenced at the Glasgow Polyomics Facility,
generating paired-end reads on an Illumina MiSeq Personal
Sequencer. Reads were mapped to the previously sequenced
parent genomes of P. aeruginosa E2 using the CLC genomics
workbench, MAUVE and RAST to create an ordered annotated
genome. The CLC genomics workbench was used for genome
comparisons and the identification of SNPs/INDELs.
LPS purification and isolation of LPS-derived
polysaccharide
LPS was purified from 1 litre cultures of P. aeruginosa and P.
syringae strains as described previously, with modifications includ-
ing the omission of the final trifluoroacetic acid hydrolysis and
chromatography steps [52]. Cells were grown for 20 h at 37uC
and 28uC for P. aeruginosa and P. syringae respectively, pelleted by
centrifugation at 6000 g for 20 min, and resuspended in 50 mM
Tris, pH 7.5 containing lysozyme (2 mg ml21) and DNase I
(0.5 mg ml21). Cells were lysed by sonication and the cell lysate
was incubated at 20uC for 30 min before EDTA was added to a
final concentration of 2 mM. An equal volume of aqueous phenol
was added and the solution was heated at 70uC for 20 min, with
vigorous mixing. The solution was then cooled on ice for 30 min,
centrifuged at 7000 g for 20 min and the aqueous phase extracted.
Proteinase K was added to a final concentration of 0.05 mg ml21
and dialysed for 12 h against 265 L H2O. LPS was pelleted by
ultracentrifugation at 100,000 g for 1 h, resuspended in H2O and
heated to 60uC for 30 min to remove residual proteinase K
activity. LPS-derived carbohydrates were isolated by heating LPS
in 2% acetic acid for 1.5 h at 96uC. Lipid A was removed by
centrifugation at 13,500 g for 3 min followed by extraction with
an equal volume of chloroform. The aqueous phase was then
lyophilised.
SDS-PAGE, silver staining and immunoblotting
Purified LPS from wild-type and mutant samples were resolved
by electrophoresis on 12% SDS-polyacrylamide gels. The LPS
banding patterns were visualised by the Invitrogen ultrafast silver
staining method. For immunoblotting LPS was transferred onto
nitrocellulose membranes and western immunoblotting was
performed as previously described using the CPA-specific mono-
clonal antibody N1F10 and alkaline phosphatase-conjugated goat
anti-mouse Fab2 as the secondary antibody [39]. The blots were
developed using SIGMAFAS BCIP/NBT tablets.
Isothermal titration calorimetry
ITC experiments were performed on a VP-ITC microcalorim-
eter (MicroCal LLC). For monosaccharide binding, titrations were
carried out at 299 K with regular 15 ml injections of ligands into
60–100 mM pyocin L1 or putidacin L1 at 300 s intervals. 50 mM
D-rhamnose, D-mannose or L-rhamnose were used as titrants and
reactions were performed in 0.2 M sodium phosphate buffer,
pH 7.5. D-rhamnose (.97%) was obtained from Carbosynth
Limited (UK) and D-mannose and L-rhamnose (.99%) from
Sigma-Aldrich (UK). For O-antigen-pyocin L1 binding reactions,
pyocin L1 or pyocin L1 variants were used as titrant at 100 or
150 mM with cleaved O-antigen sugars dissolved at 1 mg ml21 in
the chamber. For curve fitting we estimated the molar concen-
tration of LPS-derived CPA containing carbohydrate chains at
20 mM based on an estimated average molecular weight of 10 kDa
for CPA containing polysaccharides and estimating the percentage
of total LPS represented by CPA containing carbohydrates as 20%
of the total by weight [53]. This value may not be accurate and as
such the stoichiometry implied by the fit is likely to be unreliable.
However, the use of this estimated value has no impact on the
reported parameters of DH, DS and Kd. For O-antigen-putidacin
L1 binding reactions, O-antigen was used as the titrant at
3 mg ml21 with 60 mM putidacin L1 in the chamber. Reactions
were performed in 20 mM HEPES buffer pH 7.5. All samples
were degassed extensively prior to the experiments. Calorimetric
data were calculated by integrating the area under each peak and
fitted with a single-site binding model with Microcal LLC Origin
software. The heats of dilution for each titration were obtained
and subtracted from the raw data.
NMR titration experiments
NMR chemical shift perturbation analysis of sugar binding by
pyocin L1 and putidacin L1 was carried out at 305 K and 300 K
respectively. Fast-HSQC spectra [54] were recorded using 15N
labelled proteins (0.1–0.2 mM) and unlabelled ligands, D-rham-
nose and D-mannose (100 mM), on a Bruker AVANCE 600 MHz
spectrometer. Protein samples were prepared with and without the
sugars present and volumes were exchanged at fixed ratios,
making sure the protein concentration remained unchanged. The
spectra were processed with Topspin and analysed with CCPNmr
analysis [55].
Crystallisation and data collection for pyocin L1
Purified pyocin L1 at a concentration of 15 mg ml21 was
screened for crystallisation conditions using the Morpheus and
PGA crystallisation screens (Molecular Dimensions) [56]. Screens
were prepared using a Cartesian Honeybee 8+1 dispensing robot,
into 96-well, MRC-format, sitting drop plates (reservoir volume of
80 ml; drop size of 0.5 ml of protein and 0.5 ml of reservoir
solution). Clusters of needle shaped crystals grew in a number of
conditions in each screen over 3 to 7 days. Two of these
conditions, condition 1 (20% v/v ethylene glycol, 10% w/v PEG
8000, 0.03 M CaCl2, 0.03 M MgCl2, 0.1 M Tris/Bicine, pH 8.5)
and condition 2 (20% PEG 550 MME, 20% PEG 20 K, 0.03 M
CaCl2, 0.03 M MgCl2 0.1 M MOPS/HEPES, pH 7.5) from the
Morpheus screen were selected for optimisation by vapour
diffusion in 24 well plates (reservoir volume 500 ml, drop size
1 ml protein and 1 ml reservoir solution). Clusters of needles from
these trays grew after 3–7 days and were mechanically separated.
The un-soaked crystals were from condition 1, while soaked
crystals were from condition 2. Un-soaked crystals were looped
and directly cryo-cooled to 110 K in liquid nitrogen; D-mannose
and D-rhamnose soaked crystals were soaked for 2–12 min in
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artificial mother liquor containing 4 M D-mannose or 2 M D-
rhamnose, before cryo-cooling to 110 K. X-ray diffraction data
were collected at the Diamond Light Source, Oxfordshire, UK at
beam lines I04, I04-1 and I24. Automatic data processing was
performed with Xia2 within the EDNA package [57].
Structure solution and refinement for pyocin L1
A dataset from an un-soaked pyocin L1 crystal was submitted to
the Balbes pipeline along with the amino acid sequence for pyocin
L1 [58]. Balbes produced a partial molecular replacement solution
based on the structure of Galanthus nivalis agglutinin (PDB ID:
1MSA). Initial phases from Balbes were improved via density
modification and an initial model was built using Phase and Build
from the Phenix package [59]. The model was then built and
refined using REFMAC5 and Coot 0.7 [60,61]. Validation of all
models was performed using the Molprobity web server and
Procheck from CCP4-I [62,63]. Two structures of sugar soaked
pyocin L1 were solved by molecular replacement using Phaser
[64], with the sugar-free pyocin L1 as the search model.
Additional electron density corresponding to bound sugars, was
observed in both 2Fo-2Fc and Fo-Fc maps [65]. Sugars were fitted
and structures refined using Coot 0.7 and REFMAC5. b-D-
mannose (PDB ID: BMA) corresponded best to the density of
bound D-mannose. The density in the D-rhamnose complex best
corresponded to a-D-rhamnose, for which no PDB ligand exists; a
model for a-D-rhamnose was prepared by removing the oxygen
from carbon 6 of a-D-mannose and submitting these PDB
coordinates to the Prodrg server, which generated the model
and modeling restraints [65]. The resultant a-D-rhamnose was
designated with the PDB ID: XXR.
Small angle X-ray scattering
SAXS was carried out on the X33 beamline at the Deutsches
Elektronen Synchrotron (DESY, Hamburg, Germany). Data were
collected on samples of Pyocin L1 in the range of 0.5–5 mg ml21.
Buffer was read before and after each sample and an average of
the buffer scattering was subtracted from the sample scattering.
The data obtained for each sample were analysed using PRIMUS
[66], merging scattering data at low angles with high angle data.
The distance distribution function, p(r), was obtained by indirect
Fourier transform of the scattering intensity using GNOM [67]. A
Guinier plot (ln I(s) vs s2) was used to calculate the molecular
weight at I(0) and radius of gyration, Rg, of PyoL1. Ab initio models
of the protein in solution were built using DAMMIF [68],
averaged with DAMAVER [69] and overlaid with the available
crystal structure using SUPCOMB [70].
Supporting Information
Figure S1 Sequence alignment of pyocin L1 and previ-
ously reported MMBL-like bacteriocins. Dark blue shading
designates sequence identity, light blue designates chemically
conserved residues. The three conserved MMBL sugar-binding
motifs (N1, C1 and C2) and the partially conserved motif (N2) are
boxed in red.
(JPG)
Figure S2 Genetics of CPA biosynthesis in P. aerugi-
nosa. (A) CPA operon, annotated with location of P. aeruginosa E2
tolerant mutant (M4 and M11) deletion and PAO1 transposon
insertion mutants. (B) Summary of CPA biosynthetic pathway,
showing function performed by genes, shown to induce pyocin L1
tolerance or resistance.
(TIF)
Figure S3 1H-15N HSQC spectra of 15N-labelled pyocin
L1 in presence (red) and absence (black) of 100 mM (A)
D-rhamnose and (B) D-mannose, showing distinctive
chemical shifts upon addition of associating sugars.
Chemical shift changes specific to a small number of cross-peaks
illustrates association of the sugars with a small subset of amino
acids, which likely correspond to the residues within the binding
sites. Analogous changes are observed for D-rhamnose and D-
mannose titrations indicative that the same sites are binding both
ligands. Greater shift magnitude is observed for D-rhamnose,
indicative of a greater affinity towards this monosaccharide. Boxed
regions include cross-peaks used for chemical shift perturbation
analysis as shown in Figure 3.
(TIF)
Figure S4 Small angle X-ray scattering of pyocin L1. (A)
Ab initio model of pyocin L1 computed with DAMMIF overlaid
with the crystal structure. (B) Guinier plot of scattering data
indicates that the protein is monomeric in solution (I(0) gives a
molecular mass of 29.53 kDa) by extrapolation of scattering
intensity to zero scattering angle. Radius of gyration is 2.72 nm,
indicative of a folded, globular monomeric particle in solution.
(TIF)
Figure S5 Coordination of D-rhamnose in C1, C2 and N2
binding sites of pyocin L1. (A) Stereo view of D-rhamnose
coordination by binding site C1 (A), C2 (C) and N1 (E), from D-
rhamnose soak data. Core binding motif residues (blue) and
additional residues contributing to the pocket (white) are shown.
Omit map density for D-rhamnose in binding site C1 (B), C2 (D),
N1 (F) calculated by refinement of data from D-rhamnose soaked
crystal with model built from unsoaked crystal. Density for all sites
contoured to 0.15e/A˚3.
(TIF)
Figure S6 Putidacin L1 shows specificity for D-rham-
nose, compared with D-mannose. (A) ITC isotherm of D-
rhamnose (50 mM) titrated into putidacin L1 (0.1 mM). Weakly
saturable heats are indicative of binding with modest affinity (Kd
,5–10 mM). (B) ITC isotherm of D-mannose (50 mM) titrated
into putidacin L1 (0.1 mM). Binding is undetectable under
reaction conditions.
(TIF)
Figure S7 Putidacin L1 and pyocin L1 do not bind L-
rhamnose. ITC isotherms of L-rhamnose (50 mM) titrated into
putidacin L1 (A) and pyocin L1 (B) both at (0.1 mM). Binding is
undetectable under these conditions.
(TIF)
Table S1 Strains and plasmids used in this work.
(PDF)
Text S1 References for supplementary information.
(DOCX)
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